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  CtBP COOH-terminal-binding protein 
  CV(s) Column volume(s) 
    
D  Da Dalton 
  Dm Drosophila melanogaster 
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  dNTP Desoxyribonucleotidetriphosphate 
  Dr Danio rerio 
  DTT Dithiothreitol 
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  EPR Electron paramagnetic resonance  
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  ETD Electron transfer dissociation  
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 II Summary 
II. Summary 
The eukaryotic genome is compacted into a higher-order chromatin structure to facilitate the 
packaging of DNA into the cell’s nucleus and to allow for controlled accessibility of genetic 
information at any given time. The chromatin landscape is dynamic and changes in response to 
endogenous and exogenous stimuli such that essential nuclear processes (e.g., DNA 
transcription and replication) can be carried out. The fundamental units of chromatin are 
nucleosomes, which are composed of DNA wrapped around an octamer of histone proteins. 
ATP-dependent chromatin remodeling enzymes play a key role in the modulation of chromatin 
structure by catalyzing various reactions such as the repositioning of nucleosomes along DNA. 
Despite the importance of ATP-dependent chromatin remodeling enzymes in regulating 
chromatin structure, however, the structure and function of these proteins have largely 
remained elusive. 
In this PhD project, the structural architectures of prototypical imitation switch (ISWI)-type 
chromatin remodeling enzymes from Drosophila melanogaster (DmISWI) and humans 
(Snf2H) were probed across different functional states of the catalytic cycle using an 
integrative structural approach. The approach combines experimental data from protein cross-
linking coupled to high-resolution mass spectrometry and small angle X-ray scattering in order 
to guide computational modeling of three-dimensional enzyme structures.  
The findings of the present study are consistent with the notion that the full-length DmISWI 
and Snf2H enzymes assume an overall compact resting state in the absence of ligands in 
solution. While the C-terminal HAND-SANT-SLIDE domain packs against the ATPase 
module, the autoregulatory NTR and NegC domains bridge the ATPase lobe-lobe interface and 
keep the remodeling enzymes in a catalytically incompetent conformation. The findings thus 
provide a structure-based explanation for the repressed basal ATPase activity of ISWI-type 
proteins in the absence of substrate. In addition, the respective structural model of the DmISWI 
ATPase domain provides support for the recently captured X-ray crystal structure of an ISWI-
type remodeling enzyme from the thermophilic yeast Myceliophthora thermophilia. In order to 
leave the identified resting state, ISWI-type remodeling enzymes presumably undergo a series 
of conformational changes in the presence of ligands and/or substrate. These conformational 
changes may comprise a rotation of the two ATPase lobes relative to each other such that 
residues involved in ATP binding and hydrolysis are in close spatial proximity. Interestingly, 
the Snf2H enzyme appears to interact via the HAND-SANT-SLIDE domain with a highly 
acidic region on the nucleosome core in the presence of both the non-hydrolysable nucleotide 
analog ADP-BeFx and nucleosomes. Our structural data of the substrate-bound Snf2H enzyme 
thus substantiate the recent notion that this acidic patch represents an important nucleosomal 
epitope, which could play an important mechanistic role during ATP-dependent chromatin 
remodeling by ISWI-type enzymes.   
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III. Zusammenfassung 
Das eukaryotische Genom wird in höher geordneten Chromatinstrukturen organisiert, um die 
kompakte Verpackung von DNA innerhalb des Zellkerns zu ermöglichen und um die 
Zugänglichkeit zur genetischen Information zu kontrollieren. Die Chromatinstruktur ist 
dynamisch und ändert sich in Abhängigkeit von endogenen und exogenen Stimuli, sodass 
essentielle Zellkern-Prozesse (z. B. DNA-Transkription und -Replikation) durchgeführt 
werden können. Die grundlegenden Strukturelemente des Chromatins sind Nukleosomen, in 
denen DNA um ein Oktamer aus Histonen gewickelt ist. ATP-abhängige Chromatin-
Remodeling-Enzyme nehmen eine Schlüsselrolle bei der Veränderung der Chromatinstruktur 
ein, indem sie verschiedene Reaktionen, wie beispielsweise die Repositionierung von 
Nukleosomen entlang der DNA, katalysieren. Trotz der Wichtigkeit von ATP-abhängigen 
Chromatin-Remodeling-Enzymen bei der Regulation der Chromatinstruktur blieben die 
Struktur und Funktionsweise dieser Proteine weitgehend ungeklärt. 
In der vorliegenden Dissertation wurde der Aufbau von prototypischen Imitation Switch 
(ISWI)-Chromatin-Remodeling-Enzymen der Fruchtfliege Drosophila melanogaster 
(DmISWI) und des Menschen (Snf2H) mithilfe von integrativen Strukturmethoden untersucht. 
Die experimentellen Daten aus Protein-Crosslinking gekoppelt an hochauflösende 
Massenspektrometrie und Kleinwinkel-Röntgenstreuung wurden verwendet um 
computergestützte Modelle der dreidimensionalen Enzymstruktur für verschiedene 
funktionelle Zustände des Katalysezyklus zu erstellen. 
Die Ergebnisse der vorliegenden Arbeit stimmen mit der Vorstellung überein, dass sowohl 
DmISWI als auch Snf2H in ungebundener Form einen kompakten Ruhezustand in Lösung 
annehmen. Während die C-terminale HAND-SAND-SLIDE Enzymdomäne gegen das ATPase 
Modul packt, überbrücken die autoregulatorischen NTR und NegC Domänen das Interface 
beider ATPase Untereinheiten, um die Remodeling-Enzyme in einer katalytisch inkompetenten 
Konformation zu halten. Die Ergebnisse erklären auf struktureller Ebene die gehemmte 
ATPase-Aktivität von ISWI-Proteinen in Abwesenheit von Substrat. Des Weiteren stützt unser 
Strukturmodell der DmISWI ATPase Domäne die erst kürzlich mittels Röntgenkristallographie 
identifizierte ATPase-Konformation der thermophilen Hefe Myceliophthora thermophila. Es 
ist davon auszugehen, dass ISWI-Enzyme in Abhängigkeit von Liganden und/oder Substrat 
eine Serie von Konformationsänderungen durchlaufen um den Ruhezustand zu verlassen. Die 
zwei Untereinheiten der ATPase Domäne drehen sich vermutlich relativ zueinander, sodass 
Aminosäureseitenketten, die an der ATP-Bindung und -Hydrolyse beteiligt sind, sich räumlich 
nahe anordnen. In Gegenwart des nicht-hydrolysierbaren Nukleotidanalogs ADP-BeFx und 
Nukleosomen interagiert das Snf2H-Enzym wahrscheinlich über die HAND-SANT-SLIDE 
Domäne mit der negativ geladenen Region des Nukleosoms. Folglich stützen unsere 
Strukturdaten des substratgebundenen Snf2H-Enzyms neuste Forschungsergebnisse, dass diese 
negativ geladene Region des Nukleosoms ein wichtiges Erkennungsmerkmal darstellt und 
somit eine wichtige mechanistische Rolle bei der ATP-abhängigen Umstrukturierung des 
Chromatins durch ISWI-Enzyme spielen könnte.  
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1. Introduction 
1.1. Chromatin organization and dynamics 
The genetic information of eukaryotic organisms is organized into a compact chromatin 
structure, which comprises DNA and chromatin-associated proteins. Efficient DNA compaction 
is essential to pack the DNA into the dimensions of a cell’s nucleus and allows for controlled 
accessibility of genetic information at any given time. The molecular mechanisms that ensure 
access to the correct DNA sequence are essential for all fundamental nuclear processes such as 
DNA replication, gene expression, and DNA repair. Despite the groundbreaking achievements 
in sequencing the entire human genome (2), however, the central principles underlying the 
regulation of genetic information on a molecular level have remained elusive. A complex 
network of various factors and mechanisms control the accessibility of genetic information as 
well as prompt alterations in chromatin structure in response to endogenous and exogenous 
stimuli (3-7). 
The following sections outline the different hierarchical levels of the chromatin structure and 
delineate the dynamics of this supramolecular assembly. 
 
1.1.1. Nucleosome and chromatin structure 
The first level of eukaryotic DNA compaction is achieved by the formation of nucleosomes, the 
fundamental units of chromatin, which repeat every 160 to 240 base pairs (bp) across the 
genome depending on the cell type and species (8, 9). Each nucleosome core particle (NCP) 
consists of approximately 145−147 bp DNA, which is wrapped in roughly 1.65 left-handed, 
superhelical turns around an octamer of core histone proteins (Figure 1A) (10, 11).  
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Figure 1: Structure of the nucleosome. (A) The crystal structure (pdb 1AOI) of a nucleosome core particle 
in top and side view is shown (10). Human alpha-satellite DNA comprising 146 bp (purple) is wrapped 
around an octamer of Xenopus laevis histone proteins (H2A, green; H2B, yellow; H3, blue; H4, red). Histone 
tails protrude from the surface of the nucleosome and are only partially crystallized. (B) Electrostatic surface 
potential of the nucleosome highlights the acidic patch formed by H2A and H2B residues. The view is 
identical to (A, left). Negative and positive electrostatic potentials are shown in red and blue, respectively. 
The octamer comprises two copies of each of the evolutionarily conserved H2A, H2B, H3, and 
H4 histone proteins (12-14). Each of these histones has a structured core that includes a 
characteristic three-dimensional ‘histone fold’ motif. This motif consists of three α-helices 
being interconnected by two unstructured loops and facilitates the dimerization of histones (15). 
That is, histones H2A and H2B as well as histones H3 and H4 form heterodimers, which are 
predominantly stabilized through hydrophobic interactions (15). The H3/H4 dimers arrange in a 
tetramer and assemble with two H2A/H2B dimers to form the octamer (10, 13). The dynamic 
N-terminal tail of each core histone and the C-terminal tails of H2A subunits protrude from the 
NCP. Individual histone tails represent important interaction surfaces for cellular factors and 
contribute to the formation of higher-order chromatin structures (16, 17). 
The disk-shaped histone octamer carries a net positive charge under physiological conditions 
with basic residues being in particular concentrated along the outer curved edge to form a path 
for DNA wrapping (Figure 1B). The DNA contacts the histone octamer at regular intervals via 
direct DNA-protein and water-mediated interactions (18). The association of DNA with the 
histone octamer is described in the DNA superhelix relative to the central bp at the nucleosomal 
dyad axis as superhelical location (SHL) 0. Alternating regions of the DNA, where the major 
and minor grooves face the histone octamer, are defined in either direction from SHL 0 as SHL 
±1 to ±7 and SHL ±0.5 to ±6.5, respectively. The DNA-histone interactions at these sites are 
energetically not equivalent (19). Interactions at DNA entry/exit regions are typically weak to 
facilitate for instance unwrapping of the outer nucleosomal DNA, which might be initiated 
asymmetrically from one side as suggested recently (20). In contrast, the strongest interaction 
between the octamer and DNA occurs at the dyad. Notably, energetically weaker contacts are 
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also formed at SHL ±2.5 (19), in close proximity to the SHL 2 region, which acts as binding 
site for several chromatin remodeling enzymes (21-25).  
The complex electrostatic surface of the NCP (Figure 1B) also arises from conserved residues 
on the H2A/H2B dimer surface. These residues form a negatively charged surface area, termed 
‘acidic patch’, which represents an interaction platform for numerous proteins, including the 
histone H4 tail (26). Recent data also suggest that the acid patch plays an important role during 
the catalytic cycle of imitation switch (ISWI)-type remodeling enzymes (27, 28). The stability 
and electrostatic characteristics of NCPs can be affected by the incorporation of histone 
variants as well as posttranslational modiﬁcations (PTMs) of histones (cf. section 1.1.2.1). 
 
Individual NCPs are connected by stretches of linker DNA of varying length (approximately 
20−90 bp) in nucleosomal arrays. This primary structure of chromatin, which appeared as 
‘beads-on-a-string’ in early electron microscopy studies (29, 30), generates a fiber with a width 
of 11 nm. Nucleosomal arrays represent fundamental structural entities of chromosomal 
superstructures and play an important role during the transcription of genetic information (31). 
Further compaction of DNA is achieved by the association of linker histones. This class of 
histones bind proximal to DNA entry/exit sites of NCPs and influence the orientation of linker 
DNA of adjacent nucleosomes. Multiple isoforms of the mammalian linker histone H1 family 
have been identified, which differ in their binding affinities to chromatin (32). Linker histones 
are assumed to stabilize nucleosomes as well as higher-order chromatin structures such as the 
‘30 nm fiber’ (32, 33). 
The local packing of a nucleosomal array into a coil-like structure of approximately 30 nm in 
diameter, which was observed under distinct experimental conditions (34, 35), has been defined 
as the secondary level of DNA compaction. Experimental in vitro data have given rise to 
various models for the structural arrangement of the ’30 nm fiber’ including the solenoid and 
zigzag models (36-39). However, conclusive evidence for the existence of the ’30 nm fiber’ in 
vivo is still lacking and the subject of controversial debate (40-44). Recent models of chromatin 
organization suggest a rather dynamic and irregularly folded chromatin structure composed of 
10 nm fibers (45), which challenges previous static models such as the folding into ‘30 nm 
fibers’. That is, nucleosomal arrays are assumed to interact interdigitated through histone tail 
and inter-fiber interactions (46). Such folded nucleosome fibers might give rise to higher-order 
chromatin structures present in interphase chromatin and mitotic chromosomes.  
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1.1.2. Dynamic regulation of chromatin 
The packing of DNA into chromatin clearly restricts the access to genetic information. To 
assure controlled accessibility in DNA-mediated processes, several strategies have evolved to 
modulate structural properties of individual nucleosomes and of the higher-order chromatin 
organization. That is, individual nucleosomes are not static assemblies but were found to 
exhibit a pronounced dynamic behavior and to be capable of extensive crosstalk with various 
cellular factors such as chromatin remodeling enzymes (47). For instance, the nucleosome 
conformation can vary due to the breathing, unwrapping, and opening of DNA (48). The 
structural properties of nucleosomes depend on various factors including the incorporation of 
histone variants and/or a large variety of PTMs, which will be described in the following 
section. 
 
1.1.2.1. Histone variants and of posttranslational modifications  
Apart from canonical histones, numerous histone variants have been identified in vivo. These 
histone variants differ in the primary protein sequence from the canonical counterparts and 
some are expressed throughout the cell cycle. Whereas canonical histones are expressed during 
S-phase and are deposited in a replication-coupled manner, histone variants are incorporated 
into nucleosomes in a spatiotemporally uncoupled manner (49, 50). In general, the 
incorporation of histone variants changes intra-nucleosomal contacts, which in turn can affect 
the stability of nucleosomes (51, 52). Furthermore, variant nucleosomes exhibit differences in 
surface-exposed residues, which potentially impact various protein-nucleosome interactions as 
well as chromatin folding. For instance, nucleosomes comprising the H2A.Z histone variant 
have an expanded acidic patch region (53), which represents an important interaction platform 
for many proteins including the ISWI-type remodelers (26-28). Apart from H2A.Z, a multitude 
of other histone variants is known, in particular for H3 and H2A histones. The enrichment of 
individual histone variants is frequently associated with distinct functional chromatin states. For 
example, the H3.3 and H2A.Z variants have been observed to be enriched at transcriptionally 
active loci (54). Lastly, histone variants have been shown to facilitate the recruitment of cellular 
components. For instance, the phosphorylated form of H2AX is a key player in the DNA 
damage response by promoting the recruitment of many additional factors (e.g., Mediator of 
DNA Damage Checkpoint 1 protein, Mdc1) to the damaged DNA sites (55). New histone 
variants are still being discovered and their functions in remodeling the chromatin landscape 
has been a topic of intense research. 
 
Diverse PTMs add an additional level of complexity to the observed nucleosome diversity and 
potentially affect the function of histone proteins to modulate chromatin structure. Acetylation, 
methylation, phosphorylation, ubiquitylation, and ADP-ribosylation belong to the better studied 
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PTMs of histone proteins (56, 57), whereas additional modifications of lysine residues such as 
crotonylation, succinylation, and malonylation have been characterized more recently (58, 59). 
Notably, also histone variants represent profound targets for modifications. 
Histone PTMs can affect chromatin structure in different ways. That is, PTMs may directly 
alter histone-DNA or histone-histone interactions giving rise to changes in intrinsic nucleosome 
dynamics. The modifications predominantly occur at the flexible histone tails, whereas histone 
cores are less frequent targets for PTMs (57). PTMs on histones are dynamically set and 
removed by specific enzymes called ‘writers’ and ‘erasers’, respectively. For instance, the 
acetylation of lysine residues is catalyzed by histone acetyltransferases (HAT) and removes a 
positive charge, which causes a reduction in the electrostatic interaction with DNA (57). 
Historically, histone acetylation was described in connection with transcriptional activity as one 
of the first PTMs (60, 61) and decades later, the development of inhibitors targeting the 
dynamics of histone acetylation represents a promising avenue for cancer therapy (62).  
A PTM of particular interest is H4K16ac. That is, deacetylation of K16 in the basic patch of the 
H4 tail has been shown to be of functional relevance for heterochromatin formation in both in 
vivo and in vitro experiments (63-67). Furthermore, this modification may contribute to the 
regulation of nucleosome remodeling by ISWI-type enzymes, although the impact of histone 
acetylation on enzyme activity has been controversially discussed (65, 68-71).  
Histone PTMs can also affect chromatin structure in an indirect manner as they are sensed by 
molecular ‘readers’. Such ‘readers’ are often chromatin remodeling enzymes that harbor 
specific domains adjacent to the catalytic motor domain or as part of associated subunits. For 
instance, bromodomains, which are found in numerous subunits of the mating type 
switching/sucrose non-fermenting (SWI/SNF) family of remodeling complexes (72), are able to 
bind to acetylated lysine residues (73). Intriguingly, a single nucleosome can exhibit a 
combination of histone modifications. Thus, PTM patterns on histone proteins may represent a 
“molecular code”, which can be recognized by chromatin-associated proteins. The presence of 
combinatorial marks on histone proteins has resulted in the postulation of the ‘histone code’ 
hypothesis (17, 74), which links histone PTMs to gene regulation. Understanding the seemingly 
complex nature of modifications of histone proteins and their diverse potential to regulate and 
fine-tune chromatin organization have been investigated intensely (75, 76). 
 
Aside from the described histone-based mechanisms, additional strategies such as DNA 
methylation, association of small and long non-coding RNAs, as well as the binding of 
architectural proteins, such as the non-histone protein heterochromatin protein-1 (HP1), have 
evolved to modulate the chromatin state and to regulate chromatin-related processes (77-80). 
Furthermore, chromatin remodeling enzymes play a pivotal role in chromatin dynamics and 
will thus be further introduced in the subsequent section.  
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1.1.2.2. ATP-dependent chromatin remodeling 
Chromatin remodeling enzymes are generally involved in changing the molecular contacts 
between nucleosomal DNA and the histone octamer in an ATP-dependent manner (81, 82). 
These enzymes typically comprise a catalytic core and additional accessory subunit(s). The 
catalytic core is composed of a central bilobal ATPase domain that shares sequence homology 
with the superfamily (SF) 2 of helicases. Individual remodeling enzymes are classified into the 
SWI/SNF, ISWI, INO80 (inositol auxotroph mutant 80), or CHD (chromodomain helicase 
DNA-binding) families on the basis of unique domains that flank the ATPase lobes (83). 
Remodeling enzymes catalyze a diverse set of reactions on their nucleosomal substrate as 
schematically illustrated in Figure 2. That is, these enzymes facilitate (i) the reposition of 
nucleosomes along DNA without disrupting the histone octamers (generally referred to as 
’sliding’), (ii) the eviction of octamers or histone dimers, (iii) the de novo assembly of 
nucleosomes, (iv) the local unwrapping of nucleosomal DNA, and (v) the exchange/integration 
of histone variants. Importantly, distinct remodeling enzymes differ in their functionality. For 
example, members of the ISWI family are known to slide nucleosomes along the DNA strand, 
sometimes giving rise to evenly spaced nucleosomal arrays as in the case of the ACF complex 
(84, 85), yet they are not capable of ejecting histone octamers. On the contrary, members of the 
SWI/SNF family are capable of ejecting histone octamers as well as displacing H2A/H2B 
dimers (83, 86, 87), but they lack the competency to evenly space nucleosomes (83, 86-88). 
Notably, chromatin remodeling enzymes represent functionally important components of multi-
protein chromatin remodeling factors (cf. section 1.2.1) and are thus found in complex with 
various accessory proteins in vivo.  
Given the broad range of catalyzed reactions on nucleosomes, these highly abundant chromatin 
remodeling enzymes play an essential role in chromatin-related processes ranging from the 
regulation of transcription activity and DNA repair to more global phenomena such as 
embryonic development. For instance, the ATP-dependent sliding of nucleosomes allows 
access to the underlying nucleosomal DNA sequences to initiate critical cellular processes such 
as gene expression. Consequently, perturbations to this finely balanced system in terms of 
mutations and misregulation of chromatin remodeling enzymes have been associated with 
carcinogenesis and other diseases (89, 90). However, inhibition of the remodeling activity also 
represents a potentially promising strategy in cancer treatment (90, 91). 
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Figure 2: ATP-dependent chromatin remodeling. A schematic illustration of distinct remodeling activities 
is shown. The reposition (‘sliding’), eviction, and assembly of histone octamers (blue) along DNA (black) 
results in accessible and/or occluded DNA sites upon remodeling. Similarly, local DNA unwrapping enables 
the transient access to nucleosomal DNA. Individual remodeling enzymes are also associated with the 
exchange of canonical histones with histone variants (pink) and vice versa. 
 
1.2. ISWI-type chromatin remodelers 
1.2.1. Organization of ISWI-type remodelers  
The ISWI remodeling enzyme was first purified from Drosophila melanogaster (Dm) as the 
catalytic subunit of the nucleosome remodeling factor (NURF) complex (92, 93). Mammals 
have two homologs of the catalytic ISWI protein, which are termed sucrose non-fermenting 2 
homolog (Snf2H) and sucrose non-fermenting 2 like (Snf2L). Both mammalian enzymes not 
only share high sequence identity to each other (~ 86%) but they are also highly similar to their 
Drosophila (~ 75%) and yeast counterparts (i.e., Isw1 and Isw2, ~ 65%) (94, 95). 
As schematically illustrated in Figure 3A, the DmISWI enzyme assembles with different 
subunits into distinct multi-protein complexes in vivo. Apart from NURF, the DmISWI enzyme 
was also found to be an essential component in the ACF (ATP-utilizing chromatin assembly 
and remodeling factor) (85) and CHRAC (chromatin assembly complex) (96, 97) remodeling 
factors, for which the subunit composition has been evolutionarily conserved between 
Drosophila and mammals. A total of six additional multi-protein remodeling complexes have 
been identified in humans that comprise either the ISWI-type Snf2H or Snf2L enzyme: RSF 
(remodeling and spacing factor) (98, 99), NoRC (nucleolar remodeling complex) (100), WICH 
(WSTF-ISWI chromatin remodeling complex) (101), CERF (CECR2-containing remodeling 
factor) (102), BRF (BAZ2B‐ containing remodeling factor) (103), and SNF2H-cohesin (104). 
The notion that known accessory proteins can interact with both Snf2H and Snf2L has evolved 
recently in conjunction with the identification of the bromodomain adjacent to zinc finger 
domain 2B (BAZ2B) protein as seventh accessory factor for both ATPases (103) (Figure 3A). 
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Individual accessory proteins of remodeling factors may also contribute to the restructuring of 
chromatin. For instance, the Acf1 protein of the ACF and CHRAC remodeling factors 
comprises two plant homeodomain (PHD) zinc fingers, which are suggested to improve the 
efficiency of nucleosome sliding through interactions with the histone octamer (105). The 
bromodomain PHD finger transcription factor (BPTF) subunit of the human NURF complex 
represents another example of an accessory protein that comprises PHD fingers. The BPTF 
subunit furthermore harbors a bromodomain, which plays an important role in anchoring the 
remodeling factor to nucleosomes by binding to H4K16ac as well as H3K4me3 (106).  
 
Figure 3: Remodeling factors that comprise ISWI-type enzymes. (A) A schematic representation of the 
Drosophila and human ISWI complexes is shown. The drawing is not to scale. An explanation for each 
abbreviation can be found in section I. (B) Schematic representation of the domain architecture of the 
Drosophila and human ISWI enzyme. The ATPase domain consists of two lobes (yellow and red) and 
comprises seven sequence motifs (I−VI) typically found in helicase-like enzymes. The ATPase domain is 
flanked by the N-terminal region (NTR, light blue) and the NegC motif (orange). The NTR and NegC region 
are implicated in the regulation of the catalytic activity. The DNA-binding HAND-SANT-SLIDE (HSS) 
domain (green) is located near the C-terminus of the enzyme. 
The ISWI-type remodeling enzymes share an overall conserved domain organization (Figure 
3B). The ATPase domain is composed of two lobes (i.e., ATPase lobe 1 and ATPase lobe 2), 
both of which comprise conserved sequence motifs that play an important role during catalysis. 
Seven sequence motifs are characteristic of SF2 helicases (cf. roman numerals in Figure 3B) 
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and additional conserved sequence blocks have been identified that are typically not found in 
helicases (107-109). The helicase sequence motif I (i.e., “ILADEMGLGKT”, residues 202−212 
and 150−160 in the Snf2H and DmISWI enzymes, respectively) comprises a conserved lysine 
residue, which is essential for ATP binding (109, 110). Another important motif, named 
according to the conserved sequence of ATPase lobe 1, is the “DEAH” box (also known as 
motif II, residues 308−311 and 256−259 in the Snf2H and DmISWI enzymes, respectively). 
The respective aspartate and glutamate residues have been suggested to be involved in binding 
of the Mg2+ ion and ATP hydrolysis, respectively (111). Two arginine residues in motif VI of 
ATPase lobe 2 (i.e., “QAMDRAHR”, residues 588−595 and 536−543 in the Snf2H and 
DmISWI enzymes, respectively) constitute an ‘arginine finger’, which interacts with the ATP 
γ-phosphate and may stabilizes the transition state during the ATP hydrolysis reaction (112, 
113). Importantly, taking into account that these individual motifs facilitate the hydrolysis of 
ATP in a cooperative manner, it is assumed that the ATPase domain has to adopt a specific 
conformation with structural motifs being oriented towards each other in order to become 
catalytically competent. 
ATPase lobe 1 and ATPase lobe 2 are adjacent to regulatory domains termed N-terminal region 
(NTR) and NegC, respectively (114). The NTR exhibits partially conserved motifs (115) such 
as the N-terminal autoinhibitory region (AutoN), which has been proposed to negatively 
regulate the ATPase activity of ISWI-type remodeling enzymes (114).  
At the C-terminal region, ISWI-type enzymes typically comprise a domain, which is rich in α-
helical segments and that can be divided into three characteristic motifs referred to as HAND, 
SANT, and SLIDE (HSS) as well as a spacer region. The HAND module was characterized by 
X-ray crystallography and displays four α-helices connected by loop regions in an unique 
structural arrangement (116). On the contrary, the SANT domain is structurally related to the 
DNA-binding domain of the transcription factor c-Myb (116, 117) and is furthermore 
sequence-wise related to the SLIDE (SANT-like ISWI domain) module. The SANT and SLIDE 
domains contain three α-helices each and harbor a basic and acidic surface patch that are 
involved in mediating DNA and octamer interactions, respectively (116). In the DmISWI 
enzyme, the SANT domain is connected to the SLIDE module through a continuous spacer 
helix of approximately 50 Å in length. The length of the spacer helix varies among related 
chromatin remodeling enzymes. For instance, the SANT and SLIDE domains are 
approximately 15 Å closer to each other in the chromodomain-helicase-DNA-binding protein 1 
from Saccharomyces cerevisiae (ScChd1), relative to the DmISWI enzyme, due to a shorter 
spacer helix (116, 118).  
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1.2.2. Mechanism and regulation of ISWI-mediated nucleosome sliding 
In order to reposition nucleosomes along DNA, the ATP-dependent chromatin remodeling 
enzymes have to disrupt DNA-histone interactions without causing the dissociation of the 
histone octamer. The molecular mechanisms underlying the nucleosome sliding function have 
remained poorly understood. One experimental challenge in exploring nucleosome sliding 
relies on the complex series of events that take place during the catalytic cycle. An improved 
mechanistic understanding for this important class of enzymes may pave the way towards the 
development of therapeutic strategies to specifically target and regulate ISWI-comprising 
remodeling factors, which enjoy widespread interest in the scientific community. This section 
thus aims at describing the interactions between ISWI-type remodeling enzymes and 
nucleosomes and briefly summarizing current models for nucleosome sliding and the regulation 
of ISWI-type enzymes.  
 
The ATPase and HSS domains of ISWI-type remodeling enzymes have been demonstrated to 
directly interact with nucleosomes and DNA. That is, early experiments on ISW2 using site-
directed cross-linking suggested that the catalytic ATPase domain engages the nucleosome 
about two helical turns off the dyad axis at the SHL +2 position (22, 23). In line with this 
observation, DNA gaps or nicks at different positions in the nucleosome had no major effects 
on nucleosome sliding by ISWI-type enzymes, only when the gaps or nicks were located near 
the SHL +2 site (25, 119). The binding mode of the catalytic core of ISWI-type enzymes may 
represents a common strategy to approach the nucleosomal substrate. The catalytic core of 
other chromatin remodeling proteins belonging to the SWI/SNF (21, 25, 120, 121), RSC (122), 
and Chd1 (24, 123) families were also found to interact with the nucleosome at the SHL 2 
position. Notably, the region around SHL 2 typically exhibits energetically weak histone-DNA 
interactions (19) with the mechanistically important H4 tail being in close spatial proximity (10, 
115, 124, 125). The remodeling enzyme of the INO80 complex appears to represent an 
exception considering that the Ino80 protein was found to contact the nucleosome exclusively 
at SHL –6 (126). 
Another functionally important set of intermolecular interactions is formed between the C-
terminal HSS domain and DNA (23, 116, 127). The HSS domain of the ScIsw2 enzyme has 
been observed to contact approximately 30 bp of DNA. That is, while the SLIDE module binds 
to extranucleosomal DNA 19 bp away from the entry site, the HAND region contacts between 
11–13 bp of nucleosomal DNA (22, 23). Interestingly, the structurally related SANT-SLIDE 
(SS) domain of the ScChd1 enzyme has also been identiﬁed to interact with extranucleosomal 
DNA at a similar position (24, 118, 123, 128). However, the interaction interface is presumably 
not static during the catalytic reaction. Recent studies on the Snf2H enzyme suggest that the 
HSS domain is not permanently bound to flanking DNA during the catalytic cycle (28, 129). 
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Instead, the experimental findings imply that the HSS domain is released from the flanking 
DNA stretch prior to the DNA translocation event and may interact with the nucleosome core. 
 
A critical question that remains to be answered in chromatin research is how ATP hydrolysis is 
mechanistically coupled to nucleosome sliding. Several distinct models for the molecular 
mechanism of the ATP-dependent repositioning of nucleosomes have been proposed, which are 
the subject of controversial debate. For instance, in the ‘twist diffusion’ model the remodeling 
enzyme introduces a twist defect in the DNA such that the DNA then propagates around the 
octamer shifting the nucleosome by 1 bp at the time (130, 131). On the contrary, in the ‘loop 
propagation’ model, individual remodelers are thought to initiate the sliding reaction by 
detaching DNA from the octamer at the entry site giving rise to the formation of a DNA loop, 
which then propagates around the octamer and resolves at the DNA exit site of the nucleosome 
(132, 133). Notably, the twist diffusion and loop propagation models may not be mutually 
exclusive and perhaps both mechanisms occur in nucleosomes depending on other factors such 
as the underlying DNA sequence (134, 135). However, several single-molecule studies have 
pointed towards a sliding mechanism, which cannot be explained by the above mentioned 
models. For instance, it was shown that ACF and RSC reposition nucleosomes in a step size > 1 
bp (i.e., nearly 7 or 3-4 bp and 2 bp, respectively) as suggested by the ‘twist diffusion’ model 
(136, 137). In addition, it was demonstrated that the ISWI enzyme repositions nucleosomes 
such that a stretch of DNA is first translocated to the exit site (138), which stands in contrast to 
the formation of a DNA loop, but might be explained by local under-twisting of DNA (139). 
Consequently, the combination of complementary biochemical, biophysical, and computational 
approaches might pave the way towards the definition of a common nucleosome sliding 
mechanism and/or the identification of mechanistic differences between remodeling enzymes of 
distinct families. 
 
The molecular regulation of the ATPase activity represents another important aspect of the 
chromatin remodeling mechanism. It is remarkable that the DmISWI ATPase module on its 
own is capable of carrying out fundamental aspects of the nucleosome remodeling reaction 
(140). That is, ISWI lacking its HSS domain exhibits an intrinsic ability to bind and move 
nucleosomes along DNA. The HSS domain potentially plays an important role in increasing the 
affinity and specificity of the remodeling enzyme for its nucleosomal substrate. Consequently, 
accessory domains of chromatin remodeling enzymes may have evolved to modulate the 
catalytic activity. This notion is furthermore supported by the identification of the 
autoregulatory NTR and NegC domains (114), which flank the catalytic core. 
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The structure and function of the NTR region have not been completely characterized. As 
outlined in the previous sections, the NTR domain comprises several motifs such as AutoN, for 
which the primary sequence shares similarities with the basic patch of the histone H4 tail (114). 
Sequence-related changes to the AutoN motif, i.e. substitution of two arginines to alanines, 
generate an enzyme that no longer requires the H4 tail for high levels of ATPase activity and 
nucleosome sliding and even allows the ISWI enzyme to more effectively use free DNA to 
stimulate ATPase activity (114). Based on the identification of the AutoN region, it was 
inferred that this motif may inhibit enzyme activity by binding to the ATPase domain in the 
absence of the nucleosomal substrate. The H4 tail was proposed to compete with the AutoN 
region for the interaction site on the ATPase domain and to displace the inhibitory NTR motif 
in the presence of substrate. However, this model of activity regulation by the NTR region has 
recently been challenged by experimental data that pointed towards a more sophisticated, non-
competitive mechanism (115). That is, the binding sites for AutoN and the histone H4 tail were 
shown to be adjacent to each other but did not overlap on ATPase lobe 2 of the DmISWI 
enzyme. Furthermore, the study revealed that in the absence of nucleosomes, the AutoN region 
cooperates with the AcidicN motif of the NTR domain in order to retain an inactive 
conformation of the DmISWI protein.  
 
Apart from the NTR domain, the NegC region has been shown to negatively influence the 
activity of chromatin remodeling enzymes. In the crystal structure of the ScChd1 protein (pdb 
3MWY), the NegC region bridges both ATPase lobes thereby locking the ATPase module in a 
catalytically incompetent conformation (141). Consequently, the NegC region has been 
suggested to prevent the efficient coupling of ATP hydrolysis to nucleosome sliding in the 
absence of nucleic acids. Consistent with the proposed mechanism of inhibition, deletion of the 
NegC region has been found to enable nucleosome sliding in an ISWI construct lacking its 
DNA-binding domain (114). 
 
The activity of the DmISWI enzyme is positively regulated by two nucleosomal features. As 
mentioned above, the ATPase domain of DmISWI generally engages the nucleosome at the 
SHL +2 position, which is in close spatial proximity to the protruding N-terminal H4 histone 
tail. Interestingly, the ATPase activity of the DmISWI enzyme has been shown to rely on the 
interaction with the H4 tail (124). In particular residues R17H18R19 of the basic patch of the H4 
tail appeared to be crucial to enhance chromatin remodeling activity (71, 142, 143). 
Flanking DNA represents the second nucleosomal feature that impacts the remodeling activity 
of the ISWI protein. That is, flanking DNA above a certain length threshold is associated with a 
stimulated remodeling activity (84, 129, 144). For instance, mononucleosomes with 20 bp of 
flanking DNA were remodeled at a slower rate by the Snf2H enzyme than mononucleosomes 
comprising > 40 bp of flanking DNA. Furthermore, the ACF complex has been shown to be 
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able to distinguish linker lengths of up to 60 bp (84). In the context of nucleosome arrays, the 
ability to sense the length of DNA flanking either side of a nucleosome preferentially results in 
nucleosome sliding towards the longer DNA stretch and may enable evenly spaced NCPs (22, 
84). The flanking DNA length sensitivity of ISWI-type remodeling enzymes has predominantly 
been attributed to the HSS domain (89). Consistent with this notion, ISWI lacking its HSS 
domain slides mononucleosomes and remodels nucleosome arrays at a decreased rate with 
similar results being reported for the ScChd1 protein (140, 145). However, the underlying 
mechanisms of DNA sensing by the HSS domain and molecular details how the information is 
propagated to the catalytic core have remained elusive. A potential role of the regulatory NegC 
region in the DNA sensing mechanism has been controversially discussed. That is, the NegC 
domain has been observed to affect the DNA sensitivity of distinct remodeling enzymes (e.g., 
Snf2H and MtISWI) (129, 146), whereas the sensitivity of the ACF complex does not appear to 
rely on the regulatory domain (147).  
 
An additional regulatory potential is offered by the way how individual remodeling enzymes 
engage the nucleosomal substrate. Whereas the ScChd1 enzyme slides nucleosomes as a 
monomer (148, 149), the Snf2H protein was shown to act as a dimer on the nucleosome (150). 
The dimeric architecture of the Snf2H enzyme is associated with an enhanced remodeling 
activity and bidirectional movement (129, 150). The related ScISW1a protein in turn has been 
proposed to interact simultaneously with two nucleosomes (151).  
 
Taken together, the activity of ISWI-type enzymes is regulated in a highly complex manner 
involving inhibitory accessory domains and the structural interplay with the nucleosomal 
substrate. One may speculate that the regulation is even more complex in vivo considering that 
chromatin remodeling enzymes are essential components of the much larger, multi-protein 
remodeling factors. That is, the accessory proteins of such remodeling complexes may hold the 
potential to additionally modulate the ATPase activity of remodeling enzymes. Furthermore, 
the incorporation of histone variants and/or PTMs in the nucleosomal substrate may fine-tune 
the activity of remodeling enzymes in vivo. However, the fundamental mechanisms underlying 
nucleosome sliding by ISWI-type enzymes are still not fully understood.   
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1.2.3. Structural information about remodeling enzymes 
The establishment of detailed structure-function relationships for individual remodeling 
enzymes is believed to pave the way towards an improved mechanistic understanding of how 
chromatin remodeling is performed on a molecular level. However, high-resolution structural 
information about remodeling enzymes in terms of X-ray crystallographic data have proven 
difficult to obtain and are thus sparse and in most cases limited to isolated domains of the 
studied enzyme. The following section aims at summarizing available high-resolution structural 
data for remodeling enzymes that are relevant to this study.  
 
As of today, a full-length high-resolution structure of an ISWI-type enzyme is lacking. 
Attempts to crystalize the full-length DmISWI enzyme have remained unsuccessful. However, 
limited proteolysis analysis of the DmISWI enzyme suggested compact protein segments with 
one fragment being suitable for crystallization and X-ray diffraction (116). The fragment turned 
out to correspond to the HSS domain comprising residues 691–991 of the DmISWI enzyme. 
The structure (pdb 1OFC) revealed four modules that are rich in α-helical regions (cf. section 
1.2.1.). In addition, the structure of the HSS domain of the ScIsw1 enzyme (HSSScIsw1) has been 
solved (pdb 2Y9Y), which displays identical secondary structural elements as indicated by a 
root-mean-square deviation (RMSD) of 2.8 Å (151). In the same study, the structure of the 
HSSScIsw1 in complex with a 31 bp DNA fragment (pdb 2Y9Z) was determined, which shows 
that the SANT and SLIDE modules bind to DNA minor grooves. The observed binding mode 
of the HSSScIsw1 thus slightly differs from the structurally related DNA-binding domain of the 
cMyb protein. The comparison of the HSSScIsw1 structures, in the absence and presence of DNA, 
suggests that the DNA-binding module is rigid, a feature which may be shared across 
individual members of the ISWI family (116, 151). 
The catalytic cores of several chromatin remodeling enzymes have been successfully 
crystallized depicting a vast diversity in the relative orientation of both ATPase lobes to each 
other (Figure 4). In the case of the ScChd1 structure (pdb 3MWY), which represented the most 
closely related enzyme with available structure in the beginning of the PhD project, both 
ATPase lobes are held apart in a presumably inactive, open conformation (141). The ATPase 
activity of the ScChd1 protein appears to be regulated by N-terminal chromodomains, which 
mask the catalytically important motifs (141). In contrast, ATPase lobes and conserved 
structural motifs of the Rad54 protein have been captured in much closer spatial proximity to 
each other in the respective structure (pdb 1Z3I) (109). This arrangement of the two ATPase 
lobes in Rad54 may reflect structural characteristics that are compatible with ATP hydrolysis 
activity (152). Crystallographic efforts on enzymes from the yeast Myceliophthora thermophila 
(MtSnf2 and MtISWI) have resulted in two structures (pdb 5HZR and 5JXR), which depict the 
catalytic domain in a presumably inactive conformation with conserved structural motifs 
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pointing towards opposite directions (146, 153). Importantly, the MtISWI structure (pdb 5JXR) 
revealed a novel orientation of both ATPase lobes and comprised atomic coordinates for large 
parts of the flanking NTR and NegC domains (146). Notably, the NegC module of the MtISWI 
enzyme protrudes from the otherwise compact ATPase domain to interact with an adjacent 
protomer in the crystal. The orientation of the NegC region in the MtISWI structure is thus 
substantially different to the one observed for the ScChd1 enzyme (pdb 3MWY), in which the 
corresponding ‘brace-bridge’ segment (also referred to as ‘NegC’ hereafter) bridges both 
ATPase lobes of the same molecule (141). These pronounced differences in the arrangement of 
both ATPase lobes among Snf2-related enzymes raise the question whether the static snapshots 
reflect physiologically relevant conformations. It has furthermore remained unclear how the 
orientation of helicase-related motifs cooperatively function to couple DNA binding and ATP 
hydrolysis to chromatin remodeling. 
 
Figure 4: Available apo crystal structures of Snf2-type ATPases differ in the relative orientation of both 
ATPase lobes. A phylogenetic tree depicts the evolutionary relationship of the DmISWI enzyme to Snf2 
ATPase domains, for which crystal structures are available (109, 141, 146, 153, 154). The crystal structures 
are all aligned to ATPase lobe 2 (red). The relative orientation of ATPase lobe 1 (yellow) to lobe 2 varies 
drastically among the presented structures. Spheres indicate the position of motifs implicated in ATP 
hydrolysis (grey, motif I; green, motif II; blue, motif VI). The crystal structure of MtSnf2 lacks electron 
density for motif VI and thus the position of the closest neighboring amino acid is indicated instead. N/A: not 
available. Dm: Drosophila melanogaster; Mt: Myceliophthora thermophila; Sso: Sulfolobus solfataricus; Dr: 
Dario renio; Sc: Saccharomyces cerevisiae. The figure was adapted from (1) in accordance with Elsevier’s 
policies. 
Very recently, the high-resolution cryo-EM structure of the ScChd1 enzyme in complex with its 
nucleosomal substrate (pdb 5O9G) represented a groundbreaking achievement in chromatin 
research (24). The corresponding structure provides molecular cues for the binding mode 
between the monomeric ScChd1 enzyme and its nucleosomal substrate while showing 
consistency with previous low-resolution structural data for the protein (155). The ATPase 
domain adopts a closed, presumably active conformation and interacts with nucleosomal DNA 
at the SHL +2 position. The ATPase module is furthermore anchored to the N-terminal histone 
 16 Introduction 
H4 tail in a similar manner as observed in the MtSnf2 ATPase-nucleosome complex (pdb 
5JXR) (21) and in agreement with structural data for the DmISWI enzyme (115). The SS 
domain of the ScChd1 enzyme formed interactions with detached DNA, in close spatial 
proximity to the SHL –7 position and the N-terminal chromodomains. As such, the 
crystallographic results by Farnung and co-workers differ from the low-resolution structural 
data for the Snf2H enzyme, which suggest that a dimer of ATPases interacts with the 
nucleosome in a coordinated manner (150). 
 
1.3. Structural techniques to study chromatin remodeling enzymes  
X-ray crystallography represents a powerful approach to elucidate the structural architecture of 
chromatin remodeling enzymes, and thus has significantly contributed to our understanding of 
this important class of proteins. Individual crystal structures have established a structural and 
functional framework and given rise to mechanistic models for chromatin remodeling. 
However, these X-ray structures represent static snapshots of presumably highly dynamic 
remodeling enzymes and they have often been obtained using non-native conditions during the 
sample preparation procedure. Consequently, complementary biophysical and computational 
approaches are needed to study the higher-order structure and dynamics of individual 
remodelers in a more native-like environment in solution in order to comprehensively 
understand the molecular mechanisms underlying the chromatin remodeling activity. A variety 
of biophysical approaches including electron microscopy (EM) (21, 24, 123, 126, 150, 155, 
156), small angle X-ray scattering (SAXS) (148, 155), protein-protein and protein-DNA cross-
linking (22, 23, 28, 115, 123, 155-157), fluorescence resonance energy transfer (FRET) 
spectroscopy (28, 129, 138, 148, 150, 155, 158, 159), and electron paramagnetic resonance 
(EPR) spectroscopy (150, 159) have been applied to chromatin remodeling enzymes. The 
results from these biophysical measurements have substantially contributed to our 
understanding of chromatin remodeling by highlighting for instance the dynamic nature of 
chromatin remodeling enzymes in solution and providing insights into the interaction with the 
nucleosomal substrate. 
 
1.3.1. Small angle X-ray scattering 
As of today, SAXS represents a powerful and popular approach to characterize the higher-order 
structure and interactions of proteins under close-to-physiological conditions in solution (160, 
161). The fundamental principles of SAXS were developed in the late 1930s. 
In a conventional SAXS experiment, the sample solution containing macromolecules is 
exposed to high-energy X-rays of a specific wavelength, which scatter elastically dependent on 
the size and shape of the studied macromolecules, giving rise to a spatially averaged intensity 
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distribution (161-163). The scattering intensity (I(q)) is detected as a function of scattering 
vector length (q), which is defined as 
𝑞 =  
4𝜋 𝑠𝑖𝑛𝜃
λ
 
, where θ corresponds to half the scattering angle and λ signifies the radiation wavelength. 
Structural information about the macromolecules present in the sample solution can be derived 
from the scattering profile. That is, the radius of gyration (Rg), which is an important parameter 
for describing the size of the macromolecule, can be extracted by the Guinier approximation 
(valid in the low q-range) according to the following equation  
𝑙𝑛𝐼(𝑞) = 𝑙𝑛𝐼(0) −  
𝑅𝑔
2 𝑞2
3
 
, where I(0) signifies the zero angle scattering intensity (164). A monodisperse sample results in 
a linear Guinier plot, whereas aggregation is seen as a non-linear dependence (165).  
SAXS analysis furthermore allows for the assessment of the folding state of the target 
macromolecule based on Kratky plots. That is, in the Kratky representation, where (q) is plotted 
against (I(q)q2), one observes a bell-shaped curve for globular, folded macromolecules, whereas 
extended and/or unfolded particles exhibit a plateau or a slight increase in the larger q-range 
(166). Notably, the comparison of SAXS-derived structural parameters for the target protein 
across distinct steady-state conditions sometimes point towards conformational differences 
between studied states. For instance, the comparison of SAXS data may reveal a ligand-induced 
compaction of the overall protein shape if the Rg value is decreased in the ligand-bound state 
relative to apo state conditions (167-169).  
Lastly, SAXS data can be used for ab-initio shape reconstruction giving rise to three-
dimensional, low-resolution (i.e., 10–30 Å) models of biomolecules in solution (170). To 
evaluate the quality of the computationally generated ab-initio models with respect to 
experimental SAXS data, the χ-value (or alternatively χ2) is commonly used (171). This value 
reports on the goodness of the fit as discrepancy between the calculated, theoretical scattering 
intensity of the model and the experimental scattering data. Consequently, the χ-value is 0 for 
two identical scattering profiles and increases for dissimilar profiles. Notably, the χ-acceptance 
criterion for computed models differs among individual SAXS studies with upper limits being 
reported ranging from 2 to 5 (172, 173).  
Numerous structural studies on chromatin remodeling enzymes, including human CHD4 (174), 
ScChd1 (155), and MtSnf2 (153), have substantially benefited from SAXS analysis. 
Furthermore, integrative modeling strategies haven recently proven valuable to translate the 
SAXS-derived scattering data into high-quality models of protein-protein complexes (175).   
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1.3.2. Protein cross-linking coupled to mass spectrometry 
Protein cross-linking coupled to mass spectrometry (XL-MS) was introduced more than 15 
years ago (176) and represents a valuable approach in structural biology to gain structural 
insights on biomacromolecules in solution. Ongoing developments in MS instrumentation and 
cross-linking agents, as well as advances in bioinformatics have substantially improved the XL-
MS technique to provide important structural information about individual proteins and protein 
complexes, for which no higher-resolution data (e.g., X-ray crystallography and NMR) can be 
obtained (177). Protein cross-linking generally involves the reaction of a cross-linking agent 
with functional groups of the target molecule(s) resulting in the formation of a covalent bond. 
These reactive residues have to be in spatial proximity in order for a cross-link to be formed. 
Notably, the maximal spanned distance between two reactive residues differs for individual 
cross-linking agents and typically ranges from 0 Å to more than 35 Å (178). This distance 
dependency of cross-linking reactions in turn allows the cross-linking agent to act as a 
molecular ruler (179) providing information about the higher-order structure (e.g., orientation 
of individual domains and protein-protein interfaces) of the target protein(s) in solution.  
The conventional XL-MS workflow can be divided into distinct steps including (i) the cross-
linking reaction, (ii) the enzymatic digestion of the target protein, (iii) LC-MS/MS analysis, and 
(iv) the identification of cross-linked products. Each of these steps is important for the success 
of the XL-MS experiment and will thus be further introduced in the subsequent paragraphs.  
 
Different strategies for protein cross-linking have been described, which can be classified as 
targeted and untargeted approaches (180). Notably, both cross-linking strategies have 
experimental advantages and can complement each other. 
In a targeted cross-linking approach, an unnatural, photo-crosslinkable amino acid (e.g., p-
benzoyl-L-phenylalanine, Bpa) is genetically engineered at a desired position into the target 
protein. The Bpa amino acid (Figure 5A) can be site-specifically incorporated into the 
polypeptide chain in response to an amber stop codon (TAG) using an orthogonal 
tRNA/aminoacyl-tRNA synthetase pair (181). UV irradiation of the Bpa amino acid induces 
oxidative radicals, which facilitate the formation of a covalent cross-link. The Bpa residue 
exhibits a broad reactivity towards different amino acids, even though the benzophenone 
moiety has been observed to preferentially react with surrounding methionine side chains (182). 
In an untargeted cross-linking approach, a chemical cross-linking agent is added to the sample 
solution. Chemical cross-linkers comprise reactive groups that are capable of covalently 
binding to specific functional groups. In the present study, the chemical cross-linkers BS3 and 
BS2G were employed, which comprise two reactive N-hydroxysuccinimide (NHS) ester groups 
on each end of a spacer arm of defined length (Figure 5A). The NHS esters are designed to 
form a covalent adduct with primary amines, which are present at the N-terminus of each 
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polypeptide chain and in the side chain of lysine residues (Figure 5B). However, these cross-
linking reagents are susceptible to hydrolysis and have been observed to sometimes react with 
serine, threonine, and tyrosine residues (183, 184). Furthermore, isotope-labeled cross-linking 
agents have become commercially available, in which certain atoms are substituted with heavy 
stable isotopes (185). For instance, a total of four hydrogens are replaced with deuterium atoms 
in the “heavy” form of the BS3 cross-linker (BS3-D4, Figure 5A). Some studies rely on the 
simultaneous use of heavy and light cross-linking reagents to enhance the identification success 
of chemically cross-linked peptides (186, 187), which in mass spectra appear as two peptide 
envelopes that are separated on the mass-to-charge (m/z) scale with a mass shift according to 
the isotope label. In addition, isotope-labeled cross-linkers enable the relative quantification of 
cross-linking candidates to investigate the dynamics of the target protein(s) (188). That is, the 
probability of a cross-linking reaction and thus the yield of a cross-linked product is tightly 
coupled to the conformation of the target protein(s). Consequently, conformational differences 
in the target protein(s) in response to changed steady-state conditions can be revealed by 
calculating the extracted ratios between heavy- and light-labeled cross-linking candidates (189). 
 
Figure 5: Cross-linking agents. (A) The chemical structures for the BS
3
 and BS
2
G cross-linking agents as 
well as the photo-reactive amino acid Bpa are shown. The chemical BS
3
 and BS
2
G cross-linkers comprise 
identical Sulfo-NHS ester groups at either end of a spacer arm of defined length. (B) An exemplary reaction 
scheme for protein cross-linking by NHS-esters is shown. The NHS esters of the cross-linking agent BS
3
 
predominantly react with primary amines (-NH2) of the target protein(s). 
Following UV-induced or chemical cross-linking, protein samples are subjected to enzymatic 
proteolysis. In most XL-MS studies, trypsin is employed to cleave the target protein into 
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smaller peptides due to its high proteolytic activity, robustness, and substrate specificity (180, 
190). Trypsin cleaves the polypeptide chain C-terminally to arginine and lysine residues giving 
rise to a mixture of peptides with often favorable properties in terms of length, charge, and 
fragmentation behavior during MS/MS analysis (191). For instance, tryptic peptides typically 
comprise at least two positively charged residues located at the N- and C-terminus, which is 
beneficial for MS analysis in positive ionization mode. Consequently, the tryptic sample 
mixture comprises unmodified linear peptides and the desired inter-peptide cross-linking 
products, but it also includes so called “loop-links” (i.e., two reactive groups cross-linked 
within a single peptide) and “mono-links” (i.e., a single peptide modified with a hydrolyzed 
cross-linker) (Figure 6A) (192). Although mono-links generally do not provide distance 
information, they report on solvent accessibility and the relative reactivity of individual 
residues of the target protein(s) in solution (193). In the case of a targeted cross-linking 
approach using the unnatural Bpa amino acid, UV irradiation occasionally results in the 
unwanted elimination of hydrogen atoms from nearby amino acids without formation of a 
cross-linked product (157, 194). 
 
Figure 6: Cross-linking products and the Roepstorff and Fohlman nomenclature. (A) A schematic 
illustration of cross-links, loop-links, and mono-links is shown. The cross-linking agent and individual 
peptides are colored in blue and black, respectively. (B) Roepstorff and Fohlman nomenclature (195) for 
fragment ions observed in an MS/MS spectrum. The dashed lines indicate the site at which the peptide 
backbone is cleaved with arrows pointing towards the product ion. Fragment ions are labeled as a, b, c, x, y, 
and z depending on the cleavage site and which side retains the charge. Fragmentation by CID predominantly 
results in the cleavage of the peptide bond giving rise to b- and y-ions (blue). The fragment ions are 
furthermore labeled with a subscript number corresponding to the residue count and a superscript number (not 
indicated) specifying the charge state. R, amino acid side chain. 
The complex sample mixture is usually desalted and separated by reversed-phase liquid 
chromatography (LC) and peptides gradually eluted into a high-resolution mass spectrometer 
for mass analysis. That is, peptides are transferred from solution into the gas-phase using 
electrospray ionization (196, 197) and analyzed in MS1 mode to deduce the m/z ratio of the 
precursor ions. Alternatively, analyte molecules are selectively filtered based on their m/z value 
and subjected to collision-induced dissociation (CID) to produce a set of fragment ions that 
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allow sequence assignments (i.e., MS/MS analysis or MS2 mode). The precursor ions are 
thereby accelerated into a gas-filled collision chamber. Upon collision with inert gas molecules, 
the high kinetic energy is converted into vibrational energy, which causes the breakage of 
peptide bonds in the analyte molecules (198). Consequently, fragmentation of peptides by CID 
predominantly results in the generation of N-terminal “b-ions” and C-terminal “y-ions” (195) 
(Figure 6B), which can be used to deduce the sequence of the analyte molecules during MS/MS 
analysis (199).  
 
In a final step, the LC-MS/MS data is analyzed using specialized software such as ‘Crossfinder’ 
(200), which matches the observed precursor masses and fragment ions of identified cross-link 
candidates with the sequence of the target protein(s). Given the complexity and diversity of 
cross-linking products, in particular in chemical cross-linking experiments, the analysis of LC-
MS/MS data is primarily a computational challenge (201). Individual sequence assignments for 
cross-linked products are primarily validated by three distinct approaches (186). These include 
a score-based evaluation of the quality of the match between experimental and predicted 
fragmentation data of a given cross-link candidate as well as the implementation of false 
discovery rates (FDRs) to minimize the number of false positive identifications (186). 
Furthermore, individual sequence assignments should ideally be verified by manually 
inspecting the fragmentation spectra for a given cross-link candidate. 
 
Despite being straightforward in theory, XL-MS analysis of proteins and protein complexes is 
often challenging due to various technical and biological reasons, which will be described in 
the following paragraphs. 
Cross-linked peptides are typically of low abundance in the proteolytic reaction mixture 
resulting in suboptimal signal intensities during MS and MS/MS analysis. A possibility to 
overcome this technical challenge is to selectively enrich the cross-linked peptides prior to LC-
MS/MS analysis, for example by size-exclusion chromatography, cation exchange 
chromatography or purification through an affinity tag (202). However, even in enriched 
samples only a subset of all cross-linked peptides is typically detected during MS analysis due 
to either unfavorable ionization properties of the analyte molecules and/or ion suppression by 
interfering ion species. Thus, even though a particular cross-link is present in the sample 
solution, it is sometimes difficult to obtain fragmentation data of sufficient quality that allows 
an unambiguous identification of the candidate and/or the localization of cross-linking sites. Ion 
suppression is an inherent problem in LC-MS analysis, which in some instances may be 
counteracted by sophisticated chromatographic separation strategies and extensive sample 
cleanup (e.g., enrichment of cross-linked products) (203). 
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To be a proper target for the chemical cross-linking agent, reactive residues are ideally well 
distributed across the target protein(s) with corresponding side chains being accessible to the 
cross-linking agent. Accessibility is in most instances warranted if the reactive residue is 
located on the protein surface and/or occupies solvent-exposed regions. The formation of a 
cross-link between two distant sites furthermore requires that the bridged path lead through 
solvent-occupied space such that there are no steric clashes between the cross-linking agent and 
individual segments of the target protein(s). Consequently, one may observe substantially 
different experimental outcomes for individual cross-linking agents that differ in their 
functional groups and/or the length of the spacer arm. The formation of a cross-link generally 
implies that the corresponding residues were in sufficiently close proximity to each other and 
were accessible to the cross-linking agent. Consequently, the comparison of cross-linking data 
sometimes allows for the identification of conformational differences in the target protein(s) 
across different steady-state conditions. That is, conformational rearrangements in the target 
protein(s) can give rise to changes in the relative distance between two reactive residues, 
sometimes resulting in the loss and gain of established and novel cross-linked products during 
LC-MS/MS analysis, respectively. However, slight conformational differences often remain 
undetected, if the changes in the distance between reactive residues are beyond the resolution 
limit of the XL-MS approach. Considering that proteins are inherently dynamic, XL-MS data 
report on the sum of cross-links that can be formed from an ensemble of distinct structures 
present in solution (179). The assignment of identified cross-links to distinct, often unknown 
protein states of a conformational ensemble is currently not feasible. Thus, the target protein is 
ideally trapped in a desired, physiologically relevant conformation prior to the cross-linking 
reaction in order to ease the interpretation of XL-MS results. 
In principle, any biophysical technique that relies on the covalent modification of the target 
protein could give rise to structural artefacts in the studied molecule. For instance, the covalent 
binding of the cross-linking agent may bias the conformational ensemble of the target protein 
towards infrequent or even physiologically irrelevant solution-phase states. Several studies, in 
which XL-MS data are compared to high-resolution structures, have not provided experimental 
evidence for such cross-linking-induced structural artefacts in the investigated proteins (204-
206). However, in a recent study by Rozbesky et al. (207), it appears that chemical cross-
linking may cause local structural perturbations to the target protein, whereas the overall 
protein fold is well preserved even at an elevated cross-linker to protein ratio.  
 
Despite the above mentioned methodological challenges, the rapidly increasing number of 
studies, in which XL-MS is applied to probe the conformation and structural architecture of 
proteins and protein complexes in solution, underscores the usefulness of the approach in 
protein science. The XL-MS technique has proven to be in particularly powerful in combination 
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with complementary biophysical methods (e.g., SAXS) and computational modeling (cf. 
section 1.3.3). For instance, XL-MS-derived distance restraints are often used during 
computational docking of protein complexes. Selected scientific achievements that underline 
the power of XL-MS analysis include the chromatin remodeling complexes INO80 (156) and 
SWR1 (208), transcription- and translation-related protein complexes (e.g., RNA polymerase 
and the translation initiation complex) (209-213), ribosomes (214), chaperons (215-217), and 
complexes involved in exchange and trafficking of molecules (e.g., nuclear pore complex and 
the exocyst complex) (218, 219). 
 
1.3.3. An integrative structural approach to study the topology of ISWI-type 
remodeling enzymes  
Given the importance of ISWI-type chromatin remodeling enzymes in the regulation of 
fundamental nuclear processes, we set out to study the structural architecture of two of these 
proteins, DmISWI and human Snf2H, by means of an integrative structural approach (Figure 
7). The approach combines experimental data from XL-MS and SAXS analysis to guide the 
computational modeling of the higher-order structure of the remodeling enzymes. The 
combination of biophysical methods and computational modeling has previously proven useful 
for the structural characterization of proteins and/or protein complexes, for which no higher-
resolution data (e.g., X-ray crystallography) could be obtained (162, 220). 
 
Figure 7: Workflow of the integrative approach for the structural characterization of ISWI-type 
remodeling enzymes. Collaborative work is indicated by green boxes. 
a
, Dr. Christina Schindler and Prof. Dr. 
Martin Zacharias (TUM, Munich); 
b
, Dr. Linda Brützel and Prof. Dr. Jan Lipfert (LMU, Munich); 
c
, Dr. Ignasi 
Forné and Prof. Dr. Axel Imhof (LMU, Munich). 
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As illustrated in Figure 7, the general workflow for the structural characterization of ISWI-type 
remodeling enzymes comprised several distinct experimental steps. First, the DmISWI and 
Snf2H enzymes were purified from bacterial cell extracts to near homogeneity using different 
chromatographic separation techniques. Subsequently, samples were subjected to either XL-MS 
or SAXS analysis. 
Two complementary XL-MS strategies, UV and chemical cross-linking, were applied in the 
course of this project in order to obtain intra- and inter-domain distance restraints for each 
remodeling enzyme. The sample preparation procedures for UV- and chemical cross-linking 
differed and relied on in-gel and in-solution tryptic digestion, respectively. In the case of the 
DmISWI enzyme, we used the photo-reactive Bpa residue (ISWIM578B) as well as chemically 
cross-linked the enzyme with either the BS2G or BS3 cross-linking agent. The Snf2H protein 
was chemically cross-linked across distinct steady-state conditions (i.e., ± nucleotide analog, ± 
substrate) using the BS3 cross-linker. For selected DmISWI and Snf2H samples, I performed 
size-exclusion chromatography subsequent to protein proteolysis in order to enrich the cross-
linked products in a similar manner as demonstrated previously (177). The tryptic peptide 
mixture was then subjected to LC-MS/MS analysis using a high-resolution mass spectrometer 
and XL-MS data analyzed with the Crossfinder software. 
Given the XL-MS data, our collaboration partner Dr. C. Schindler (TUM, Munich) performed 
computational modeling to reconstruct the structural architecture of the full-length DmISWI 
and Snf2H enzymes. Individual DmISWI and Snf2H domains (e.g., ATPase module) were 
homology modeled according to corresponding high-resolution structures of related remodeling 
enzymes. These homology models were subjected to rigid body docking, which was guided by 
XL-MS-derived upper distance restraints. The upper distance thresholds for individual 
restraints were set to 25 Å and 29 Å for the chemical BS2G and BS3 cross-linking agents, 
respectively. The employed threshold values are in agreement with previous XL-MS studies 
(180, 188, 221, 222) and account for the length of lysine side chains (approximately 6.5 Å), the 
length of the spacer (7.7 Å for BS2G and 11.4 Å for BS3; cf. Figure 5A), and some degree of 
protein flexibility (223). Likewise, the distance threshold for Bpa-derived restraints was set to 
20 Å, which is comparable to previously published XL-MS studies (182, 224). The docking 
procedure typically resulted in a multitude of potential enzyme structures, from which the top-
ranked 200 models were further considered. These structural models for the DmISWI and 
Snf2H enzymes were validated with respect to experimental XL-MS data as well as screened 
against collected SAXS profiles. Generally, the structural model with the lowest discrepancy 
between theoretical and experimental SAXS data (i.e., the model with the lowest χ-value) was 
selected as the representative final model.   
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1.4. Aims of this study 
The lack of high-resolution structural information for chromatin remodeling enzymes has been 
limiting our mechanistic understanding of how the chromatin landscape is regulated on a 
molecular level. We thus aimed at characterizing the structural architecture of the full-length 
DmISWI enzyme and the human Snf2H homolog in solution. As outlined in the above section, 
we used an integrative structural approach that combines the solution-based, biophysical 
techniques XL-MS and SAXS with computational modeling. We were in particularly interested 
in elucidating structural characteristics of the catalytic core of both studied enzymes and to 
better understand how enzyme activity is regulated in a nucleotide- and substrate-dependent 
manner. We therefore applied our integrative structural approach to both enzymes under apo 
state conditions and when bound to the nucleotide analog adenosine-5′-diphosphate beryllium-
fluoride (ADP-BeFx). We reasoned that we could detect and visualize the conformational 
impact of ADP-BeFx binding on the full-length DmISWI and Snf2H enzymes using our 
integrative structural approach. In a subsequent step, we aimed at exploring the binding mode 
of the Snf2H protein to its nucleosomal substrate. The characterization of the interaction 
between chromatin remodeling enzymes and nucleosomes has proven to be very challenging by 
traditional structural techniques (e.g., X-ray crystallography), yet it will contribute to our 
mechanistic understanding of the remodeling activity by ISWI-type enzymes.  
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2. Results 
2.1. Purification of proteins 
2.1.1. An improved purification procedure for recombinant histone proteins 
In-vitro reconstitution of nucleosomes has become an indispensable part in chromatin research 
and relies on the time-consuming and labor-intensive expression and purification of 
recombinant histone proteins. In the conventional workflow (i.e., Inclusion Body Purification, 
IBP), individual core histones are expressed in bacteria cells and the proteins are solubilized 
from purified inclusion bodies (225, 226) (Figure 8A). An optimized protocol for the 
purification of histones (i.e., Rapid Histone Purification, RHP) has recently been developed in 
our research institute (Division of Molecular Biology, Biomedical Center, LMU Munich) 
(Figure 8B). My contribution in this project was to directly compare the IBP and RHP 
strategies for the purification of the four canonical histones from Drosophila melanogaster. 
My results have been published in the PLOS ONE journal (i.e., Fig. 4, Fig. S1 and Fig. S2 in 
(227)) and detailed purification protocols of both approaches are provided in the method 
section (cf. section 4.2.2.4).  
  
Figure 8: Schematic illustration of distinct purification strategies for recombinant histone proteins. 
The schematic workflows for (A) the conventional IBP and (B) the refined RHP approaches are shown. 
Notably, canonical histones can be purified in a time-saving manner using the RHP strategy. SAU 200, 
sodium-acetate-urea buffer supplemented with 200 mM NaCl. 
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To compare the IBP and RHP methods side-by-side, I recombinantly expressed the four 
canonical Drosophila histones in E. coli and split the cell pellets into two equal parts. As 
illustrated in Figure 8, the IBP and RHP protocols already differ at an early stage of the 
purification procedure. The IBP approach relies on the partition of the histones into inclusion 
bodies, which then have to undergo a time-consuming washing procedure before the proteins 
are solubilized under denaturing solution condition. In contrast, the cell lysis step is already 
conducted under denaturing conditions in the RHP protocol. Notably, we observed that a 
substantial fraction of the H2B protein (i.e., approximately 50%) did not partition into 
inclusion bodies in the conventional workflow and remained soluble in the supernatant (Figure 
9A). Processing the same cell extract under denaturing conditions resulted in a more efficient 
extraction of the H2B histone (i.e., approximately 80%, Figure 9B). In line with this 
observation, we obtained higher yields for the H2B histone using the RHP approach (Figure 
9E). 
The Drosophila core histones are highly basic proteins (228) (i.e., isoelectric points > 10.2) 
and thus carry a net positive charge under slightly acidic solution conditions. Consequently, in 
both IBP and RHP protocols, cation exchange chromatography provides an excellent 
opportunity to purify the recombinant histone proteins at pH 5.2 and denaturing conditions. In 
addition to the conventional workflow, we included anion exchange chromatography in the 
RHP protocol in order to minimize residual DNA and to remove contaminating protein 
species. This additional purification step can be performed independently (“Variant 1” in 
Figure 8B) or in tandem with cation exchange chromatography (“Variant 2” in Figure 8B). In 
the latter approach, the anion exchange column is placed upstream of the cation exchange 
column and has to be detached from the FPLC system prior to the salt gradient elution of the 
histones. The two presented RHP protocols resulted, as demonstrated for the H3 histone in 
Figure 9D and E, in comparable yields (i.e., 4.5 and 6.6 mg per liter bacteria culture for 
Variant 1 and 2, respectively) and equivalent sample purity. A direct comparison between the 
IBP and RHP approach revealed comparable purification parameters in terms of yields (2−11 
mg per liter cell culture) and sample purity (Figure 9C, E) for all investigated canonical 
histones.  
In conclusion, we find that the RHP strategy represents a convenient alternative to the 
conventional purification workflow. That is, the RHP protocol requires less hands-on working 
time, while sample purity and purification yields are comparable to the inclusion body-based 
approach. Consequently, canonical histones can be prepared in a time-saving manner, which is 
an important factor for subsequent downstream applications in chromatin research such as in-
vitro reconstitution of nucleosomes.  
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Figure 9: Comparison of purification strategies for canonical histone proteins by SDS-PAGE analysis. 
(A) For the conventional IBP approach, equivalent amounts of the soluble (S) and pelleted (P) fractions of 
the whole cell extracts were analyzed for each histone by SDS-PAGE analysis and Coomassie staining. 
Notably, a substantial fraction of the expressed H2B protein did not partition into inclusion bodies and was 
lost at an early stage of the IBP purification procedure. (B) In the RHP approach, the majority of H2B 
proteins are extracted under denaturing conditions during the cell lysis step. Similar results were obtained for 
the other investigated histones. (C) Comparison of sample purities obtained for the IBP and RHP (Variant 1) 
protocol. The SDS-PAGE analysis reveals comparable purities for all four canonical histones. (D) SDS-
PAGE analysis for the H3 protein, which was either purified by Variant 1 or Variant 2 of the RHP approach 
(cf. Figure 8B). The two RHP protocols resulted in comparable sample purity and protein yields. (E) 
Comparison of DNA contamination and protein yields (n = 1). Protein concentrations were obtained from 
UV A280nm absorption measurements. Histone extinction coefficients are provided in Table 13 in Material and 
Methods. DNA contamination was calculated from the UV absorption ratio A260nm:A280nm as described in 
(229). M, protein marker; Oct, histone octamer. The panels (A) and (C)–(E) were adapted from (227) in 
accordance with the Creative Commons Attribution (CC BY) license applied by the Public Library of 
Science. 
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2.1.2. Purification of remodeling enzymes 
Expression and purification strategies for the full-length DmISWI remodeling enzyme 
(ISWIWT, Figure 10A), its catalytic core (ISWI∆HSS, Figure 10D), and several point mutant 
constructs (i.e., ISWIM578B, Figure 10B) have already been well established prior to the 
beginning of the PhD project. However, corresponding procedures for the full-length Snf2H 
protein and the HSS domain of DmISWI (HSSISWI) were lacking and thus had to be established 
in the course of the project. The purification strategy for HSSISWI (Figure 10C) was set up on 
the basis of published work by Grüne and co-workers (116) and the procedure for the Snf2H 
enzyme (Figure 10E) was adapted from a protocol kindly provided by Prof. G. Narlikar and 
Dr. J. Leonard (UCSF, San Francisco, California).  
This section aims at describing the key steps of the purification procedures for the above-
mentioned remodeling enzymes and their variants with detailed protocols being provided in the 
method section (cf. chapters 4.2.2.2 and 4.2.2.3).  
 
Figure 10: Purification strategies for full-length and variant remodeling enzymes. Schematic illustration 
of the purification procedures for the following His6-tagged proteins: (A) full-length ISWIWT (157) and 
additional point mutation constructs (i.e., ISWIK337D, ISWID485K, and ISWIK337D D485K), (B) ISWIM578B 
comprising the UV-inducible cross-linking amino acid Bpa at position 578 (157), (C) HSSISWI (i.e., residues 
691−1027 in the full-length ISWI enzyme) (116), (D) ISWI∆HSS (i.e., residues 26−648 in the ISWI enzyme) 
(140), and (E) wild-type Snf2H. 
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The target proteins were all recombinantly expressed in E. coli and purified as schematically 
illustrated in Figure 10. The full-length and variant remodeling enzymes were expressed with 
an N-terminal His6-tag that allows for the purification by Ni-NTA affinity chromatography, as 
representatively shown in the purification progress for HSSISWI and Snf2H in Figure 11A and 
B, respectively. With the exception of the ISWIΔHSS variant, the His6-tag was subsequently 
cleaved off using tobacco etch virus (TEV) protease and most samples were again subjected to 
Ni-NTA affinity chromatography to remove unwanted protein species (i.e., the cleaved off 
His6-tag, uncleaved target protein, and His6-tagged TEV protease). The full-length enzymes 
were further purified by ion exchange chromatography in order to minimize sample impurities 
including nucleic acids and E. coli proteins. In a final step, we performed size-exclusion 
chromatography on all constructs to enhance sample purity to near homogeneity (Figure 11C). 
We observed that the sample purity was generally better for the ISWI constructs. However, the 
Snf2H enzyme was the most abundant protein in the respective samples such that the detected 
impurities likely did not interfere with XL-MS analysis (230). Furthermore, I did not observe 
protein species of higher molecular weight than the Snf2H enzyme during SDS-PAGE 
analysis, which is important for the analysis of SAXS data (231). The yield was on average 3.7 
mg and 1.4 mg per liter E. coli cell culture for purified full-length Snf2H and ISWIWT proteins, 
respectively. The yields ranged from 0.2 (ISWIK337D D485K) to 6.3 mg per liter cell culture 
(ISWIΔHSS) for the investigated ISWI variants. 
 
* continues next page * 
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Figure 11: Monitoring the purification progress for remodeling enzymes by SDS-PAGE analysis. I 
monitored the purification progress for individual remodeling enzymes and variants thereof by SDS-PAGE 
analysis and Coomassie staining. (A) Representative purification progress for the His6-tagged HSSISWI 
variant. The lysed whole cell extract (‘T’) containing soluble HSSISWI (‘SN’) was filtered (‘SNfiltered’) and 
subjected to a first Ni-NTA affinity purification (‘1st Ni-NTA’) in order to remove most bacterial 
contaminations. Following TEV protease cleavage and dialysis, the target protein was subjected to a second 
Ni-NTA affinity purification (‘2nd Ni-NTA’). In a last step, size-exclusion chromatography (‘SEC’) ensured 
near homogeneity of the final sample. Arrows mark the protein of interest. The three letter designations (e.g., 
1A2, 2B2, etc.) refer to individual FPLC-separated fractions. M, protein marker; P, pellet; FT, flow through. 
(B) Representative purification progress for the His6-tagged Snf2H enzyme. Ni-NTA affinity purification 
removed most soluble, contaminating protein species of the pre-cleared whole cell extract. The Snf2H 
enzyme was further separated from contaminating protein species and DNA fragments by MonoQ anion 
exchange chromatography and the concentrated flow-through (‘conc. FT MonoQ’) was subjected to TEV 
protease cleavage and dialysis. In a final step, the sample (‘After dialysis, SN’) was further processed using 
size-exclusion chromatography. (C) SDS-PAGE analysis for purified full-length and variant remodeling 
enzymes. Notably, individual target proteins were purified to near homogeneity.   
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2.2. Solution structure of the DmISWI enzyme under apo state conditions 
As of today, high-resolution structural evidence for the full-length DmISWI remodeling 
enzyme is lacking and only the respective HSS module has been successfully crystalized (116). 
As outlined in section 1.3.3, we developed an integrative structural approach (cf. Figure 7), 
which combines XL-MS and SAXS analyses as well as computational modeling, to probe the 
relative orientation of individual domains and thus the overall structural architecture of the 
full-length DmISWI protein in solution. 
Briefly, following UV and chemical cross-linking of the full-length target protein under apo 
state conditions, MS analysis of tryptic DmISWI digests resulted in the identification of 94 
cross-linked peptides providing a total of 61 unique cross-linked residue pairs (cf. STable 1, 
STable 2). I thereby included published cross-links from Forné et al. (157) (i.e., XLISWI 1, 2, 
24, 25) and Ludwigsen et al. (115) (i.e., XLISWI 3) and took advantage of an unpublished data 
set (i.e., XLISWI 6, 9–13, 16–18, 31–35, 39, 46, 47, 52, 53, 59–61), which was kindly provided 
by Dr. F. Müller-Planitz. Notably, 43 of all identified cross-linked residue pairs (including ten 
cross-links used for docking) were reproducible as further specified in STable 1 and STable 2. 
In collaboration with Dr. C. Schindler (TUM, Munich), we subsequently implemented a subset 
of the identified inter-domain cross-links as distance restraints to guide the computational 
modeling of potential solution structures for the DmISWI ATPase module and the full-length 
enzyme. Finally, candidate ATPase and full-length DmISWI structures were compared to the 
molecular shape information gathered from SAXS measurements, which were kindly 
performed by Dr. L. Brützel (LMU, Munich).  
The following sections describe the key findings from XL-MS analysis, SAXS measurements, 
and computational modeling for each functional domain of the DmISWI enzyme under apo 
state conditions in a step-by-step manner. 
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2.2.1. Conformation of the DmISWI ATPase domain  
2.2.1.1. The orientation of both ATPase lobes 
XL-MS analysis revealed 30 cross-linked residue pairs (cf. STable 1) within the ATPase 
module, which is defined in the following to include the NTR, ATPase lobe 1, ATPase lobe 2, 
and the NegC domain. Seven out of these 30 cross-linking positions (XLISWI 1–7) connected 
both ATPase lobes (Figure 12) and thus restricted the relative orientation of both ATPase lobes 
to each other in the full-length DmISWI enzyme. One UV and two chemical cross-links 
(XLISWI 3–5) connected the C-terminal region of ATPase lobe 1 with the C-terminal half of 
ATPase lobe 2. Moreover, three UV cross-links (XLISWI 1, 2, 7) bridged the N- and the C-
terminus of ATPase lobes 1 and 2, respectively, suggesting that these particular regions are in 
close spatial proximity to each other under apo state conditions. 
 
Figure 12: Identified cross-links for the full-length DmISWI protein. Identified cross-links for the 
DmISWI enzyme under apo state conditions are schematically illustrated in an arc plot. The UV and 
chemical cross-links that connect the homology models for region “” (residues 116−351) and region “” 
(residues 352−637) are highlighted in blue and cyan color, respectively. Residue numbering is denoted below 
each DmISWI domain. Arrows indicate the positions of Bpa-substituted amino acids. STable 1 provides 
further details for each presented cross-link. NTR, N-terminal region; HSS, HAND-SANT-SLIDE. The 
figure was adapted from (1) in accordance with Elsevier’s policies. 
Dr. I. Forné (LMU, Munich) performed the MS analysis. 
As a complementary approach to XL-MS analysis, we investigated the molecular shape of the 
ATPase module of the DmISWI protein in solution by means of SAXS. I therefore expressed 
and purified a truncated variant of the remodeling enzyme (i.e., residues 26−648), which lacks 
its HSS domain (ISWIΔHSS) and comprises an N-terminal His6-tag. Our collaboration partner 
Dr. L. Brützel (LMU, Munich) conducted the SAXS measurements and analyzed the data for 
the ISWIΔHSS variant at different protein concentrations ranging from 1.5 to 7.0 mg/mL. The 
experimental scattering curves were well superimposable after data normalization against 
intensity (Figure 13A) indicating that protein aggregation was minimal and that obtained data 
were of good quality. The Kratky representation of the scattering data furthermore suggested 
that the ISWIΔHSS enzyme was folded (Figure 13B). The reconstructed molecular envelope 
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(Figure 13C) visualizes that the ATPase module adopted a globular conformation under apo 
state conditions. 
 
Figure 13: SAXS data and scattering-derived parameters for the ISWIΔHSS variant. (A) Extrapolated 
scattering curves obtained at different ISWIΔHSS concentrations are shown. Notably, these curves are well 
superimposable indicating good data quality, because sample aggregation was negligible. (B) Kratky 
representation of merged SAXS scattering data. (C) The ab-initio determined molecular envelope of the 
ISWIΔHSS variant is depicted. The panels (A) and (B) were adapted from (1) in accordance with Elsevier’s 
policies. 
Dr. L. Brützel (LMU, Munich) conducted the SAXS measurements and analyzed the respective data shown in 
panels (A)–(C). 
In order to resolve and visualize potential orientations of both ATPase lobes in the DmISWI 
enzyme and thus generate a structural model of the ATPase module, we integrated the 
experimental XL-MS and SAXS data into a refined docking protocol for the ATTRACT 
software.  
In a first step, our collaboration partner Dr. C. Schindler (TUM, Munich) homology modeled 
the DmISWI ATPase domain according to the Chd1 structure from Saccharomyces cerevisiae 
(pdb 3MWY), the most closely related remodeler with an available high-resolution structure at 
this time. In order to model potential orientations of both ATPase lobes to each other in a rigid 
two-body docking approach, the generated homology model of the ATPase module was cut 
into two parts at a predicted hinge region that connects both ATPase lobes yielding two 
structural bodies (“”: residues 116–351; “”: 352–637 residues; cf. Figure 12). To validate 
the structural bodies with respect to experimental XL-MS data, I measured the Cα-Cα distance 
of identified intra-domain cross-links (i.e., XLISWI 13–30) in the computed structures. 
Importantly, all accessible intra-domain cross-links (XLISWI 15–22) were consistent with the 
computational models for the ATPase domain. Some cross-links (i.e., XLISWI 13, 14, and 23–
30), however, mapped to DmISWI regions, for which our structural models lack atomic 
coordinates.   
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In a second step, Dr. C. Schindler performed XL-MS-guided docking of the two structural 
bodies. The docking procedure was initiated by computing one million starting models with 
random ATPase lobe 1 and ATPase lobe 2 orientations, solely preventing direct steric clashes 
between the two rigid bodies. Subsequently, the distance between selected cross-linked residue 
pairs was restrained by implementing an upper harmonic restraint between the respective Cα 
atoms. That is, we employed inter-domain cross-links (XLISWI 1–3), which exhibited excellent 
fragmentation data during MS/MS analysis, as distance restraints to guide the computational 
docking of the ATPase lobes. The maximum distance thresholds were set to 20, 25, and 29 Å 
for the UV-, BS2G-, and BS3-derived cross-links, respectively. The ATTRACT software then 
provided a score-based ranking of the generated models of the ATPase module. The top-
ranked 200 models were further subjected to flexible refinement. Importantly, all these 200 
refined models of the ATPase module were fully consistent with the implemented distance 
restraints used for docking and furthermore displayed an overall highly similar topology as 
indicated by a model precision of 3.4 Å. Finally, the 200 different structures of the ATPase 
module were compared with the molecular shape information provided by the SAXS 
measurements of ISWIΔHSS in order to validate and select the most favorable structural model 
with respect to the experimental data. Consequently, the ATPase model with the lowest 
discrepancy between theoretical and experimental scattering curves, i.e. lowest χ-value, is 
generally shown as a representative structure in the following sections, unless stated otherwise, 
and will be termed “DmISWI ATPase model” hereafter. 
 
Our DmISWI ATPase model is shown in Figure 14A. Interestingly, compared to the 
conformation of the initial ScChd1-based homology model, ATPase lobe 1 had to undergo a 
remarkable rotation of almost 180° relative to ATPase lobe 2 in order to fulfill the cross-
linking distance restraints (Figure 14D). Such a striking, global rearrangement within the 
DmISWI ATPase module was unexpected considering that structures of related remodeling 
enzymes show a different relative orientation of both lobes (cf. section 2.2.1.2). 
To further validate our structural model of the ATPase module with respect to the experimental 
data, I assessed the Cα-Cα distances between individual residue pairs for inter-domain cross-
links not used during the docking procedure (i.e., XLISWI 4–12). Notably, the large majority of 
these additional inter-domain cross-links was in excellent agreement with the proposed 
DmISWI ATPase model with solely XLISWI 8 marginally violating the defined distance 
threshold by as much as 5 Å (cf. STable 1). The cross-linked residue K637 in XLISWI 8 is 
located in a potentially flexible loop region at the C-terminal region of the ATPase model, 
which in turn may provide a structure-based explanation for the minor inconsistency between 
experimental and computational data. Notably, also the SAXS scattering data for ISWIΔHSS 
showed consistency with the representative DmISWI ATPase model as reflected by a χ-value 
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of 1.03 (Figure 14B). The proposed ATPase structure can be fitted well into the SAXS-derived 
shape envelope as illustrated in Figure 14C. 
To evaluate the reliability and robustness of our DmISWI ATPase model, the docking 
procedure was repeated using all identified lobe-connecting cross-links (XLISWI 1–8). The 
obtained structural model resulted in an almost identical domain architecture with distinct 
DmISWI ATPase structures being well superimposable (Figure 14E) as indicated by an RMSD 
of 2.2 Å. Likewise, docking with all identified inter- and intra-domain cross-links for the 
ATPase module (XLISWI 1–12, 15–21) yielded superimposable structures (RMSD = 2.6 Å). 
These findings collectively demonstrate the robustness and reliability of our proposed 
DmISWI ATPase model. 
 
Taken together, by combining several structural techniques, we successfully reconstructed the 
three-dimensional architecture of the catalytic core of the DmISWI enzyme under apo state 
conditions. Our experimental data provide evidence for an ATPase conformation, which was 
remarkably different from the one observed in the ScChd1 structure. 
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Figure 14: Architecture of the DmISWI ATPase domain determined by our integrative structural 
approach. (A) Structural model of the DmISWI ATPase module is shown with ATPase lobe 1, ATPase lobe 
2, and the NegC domain being colored in yellow, red, and orange, respectively. Cross-linked amino acids are 
represented as spheres and are connected by grey rods. For individual distances spanned by the cross-linker 
see also STable 1. (B) The theoretical scattering curve obtained for the structural model depicted in (A) 
(black line) is in good agreement (χ = 1.03) with the measured scattering data for the ISWIΔHSS variant (red 
circles). (C) The structural model of the DmISWI ATPase module shown in (A) can be fitted well into the 
SAXS-derived molecular shape envelope for the ISWIΔHSS construct. Note that 19% of residues are missing 
in the structural model, which explains the excess of electron density. (D) Schematic illustration of the 
domain orientation revealed by our structural approach. (E) Incorporation of all ATPase lobe 1-lobe 2 cross-
links into the docking protocol led to a highly similar DmISWI ATPase model (grey; RMSD = 2.2 Å; cf. 
STable 1 for individual cross-linking distances). The structural model shown in (A) (yellow, red) is depicted 
for orientation. The panels (A), (B), and (E) were adapted from (1) in accordance with Elsevier’s policies. 
I expressed, purified, and cross-linked the DmISWI enzyme and analyzed the respective XL-MS data shown 
in panel (A). Dr. I. Forné (LMU, Munich) performed the MS analysis. Dr. L. Brützel (LMU, Munich) 
conducted and analyzed the SAXS-related data shown in panels (B) and (C). Dr. C. Schindler (TUM, 
Munich) generated the ATPase models depicted in panels (A), (C), and (E). 
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2.2.1.2. The DmISWI ATPase model shares a similar domain architecture with the 
MtISWI enzyme 
To uncover common structural features between our proposed DmISWI ATPase model and 
structures of related Snf2 ATPases, I examined the compatibility of the identified inter-domain 
cross-links used for docking with the following enzymes: Sso1653 (154), DrRad54 (109), 
ScChd1 (141), MtSnf2 (153), MtISWI (146), and a former model of the DmISWI ATPase 
module (157). That is, I measured the Cα-Cα distances for the inter-domain cross-links used 
for docking (i.e., XLISWI 1–3) at homologous positions in the related remodeling enzymes. As 
detailed in Figure 15, all accessible Cα-Cα distances consistently exceeded the defined 
distance thresholds in the high-resolution structures of Sso1653 (pdb 1Z6A), DrRad54 (pdb 
1Z3I), ScChd1 (pdb 3MWY), and MtSnf2 (pdb 5HZR) suggesting an overall deviating 
ATPase architecture for the DmISWI enzyme. The previous XL-MS-based DmISWI model by 
Forné et al. also displayed inconsistencies with our experimental data. For instance, the 
identified inter-lobe XLISWI 3 as well as XLISWI 5 (34.7 Å) do not lead through solvent-
occupied space and furthermore exceed the defined distance requirements. Strikingly, 
superimposition of our ATPase model of the DmISWI enzyme and the crystal structure of the 
MtISWI protein (pdb 5JXR) revealed an almost identical configuration of both ATPase lobes 
with an RMSD of 4.5 Å (cf. Figure 15). Indeed, all identified intra- and inter-ATPase lobe-lobe 
cross-linking distances (XLISWI 1−7, 15−22) were in excellent agreement with the crystal 
structure for the catalytic core of the MtISWI protein (cf. STable 1). In addition, the 
conformation of MtISWI is consistent with our SAXS data for ISWIΔHSS. The predicted 
scattering profile of a homology model of monomeric MtISWI provided an excellent fit to our 
experimental data (χ = 0.71; Note that, only 5% of residues are missing in the homology model 
of MtISWI compared to 19% in DmISWI ATPase). With the exception of ScChd1, other 
ATPase conformations of Sso1653, DrRad54, and MtSnf2 fitted the SAXS data significantly 
worse (i.e., χ(ScChd1) = 0.61, χ(Sso1653) = 2.69, χ(DrRad54) = 2.22, χ(MtSnf2) = 3.02). 
Consequently, our solution-phase XL-MS data for the DmISWI enzyme collectively provide 
evidence for a similar ATPase architecture as has been reported for the related MtISWI protein 
without prior knowledge of the crystal structure. 
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Figure 15: Comparison of our DmISWI ATPase model with available apo structures of related 
ATPases. The orientation of both ATPase lobes (yellow: ATPase lobe 1, red: ATPase lobe 2) in our model 
of the DmISWI ATPase module (upper left corner, cf. Figure 14A) deviates from the one observed for 
Sso1653, DrRad54, ScChd1, MtSnf2, and a former model of the DmISWI ATPase module (157). Notably, 
the large majority of Cα-Cα distances between cross-linked residue pairs substantially violated the defined 
distance threshold in the investigated structures (red values). Strikingly, our DmISWI ATPase model exhibits 
a similar domain architecture as observed for the MtISWI enzyme with respective Cα-Cα distances being in 
the expected range (green values). Structures of related enzymes are aligned to ATPase lobe 2 of our 
DmISWI ATPase model, which is shown in grey color for orientation. 
a
: Calculated distances were taken 
from (157). N/A: Not available, K1020 and neighboring residues are missing in the structure, precluding a 
measurement. Dm: Drosophila melanogaster; Sc: Saccharomyces cerevisiae; Dr: Danio rerio; Sso: 
Sulfolobus solfataricus; Mt: Myceliophthora thermophila.   
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2.2.1.3. The catalytic domain of ISWI adopts a resting conformation under apo state 
conditions 
The ATPase domain from the Snf2 family of ATPases generally comprise several conserved 
structural helicase-like motifs, which play a key role in ATP hydrolysis (232). Motifs I and II 
on ATPase lobe 1 assist in binding of ATP and Mg2+. These motifs work cooperatively with 
motif VI on ATPase lobe 2, which acts as an “arginine finger” to assist catalysis. The spatial 
arrangement of these individual motifs is assumed to determine the catalytic activity of the 
enzyme and consequently, both ATPase lobes must align to become competent to hydrolyze 
ATP. Interestingly, individual motifs were not oriented towards each other in our DmISWI 
ATPase model (cf. Figure 17A). Instead, the motifs were twisted towards opposite sides 
implying that the catalytic core of DmISWI rests in an inactive conformation under apo state 
conditions in solution. Thus, the proposed DmISWI ATPase model may provide a structural 
basis for the well documented repressed basal ATPase activity (140). 
 
To rule out that the employed docking protocol inherently favored the presumably inactive 
conformation of the ATPase domain, we repeated the docking procedure for the catalytic core 
in the absence of any XL-MS-derived distance restraints (ab-initio docking; only the obvious 
distance between amino acids 351 and 352 was restraint). As depicted in Figure 16, the top-
ranked ab-initio model exhibits a 
completely different orientation of both 
ATPase lobes and is, to a large extent, 
inconsistent with the experimental XL-
MS data (cf. STable 1). In particular, 
cross-links that bridged distant residue 
pairs with regard to the primary protein 
sequence (i.e., > 400 residues) were 
prone to be inconsistent with the 
generated ab-initio ATPase model. 
Considering that the ab-initio docking 
resulted in a substantially different 
domain architecture as observed for the 
XL-MS-based DmISWI ATPase model, 
an inherent bias towards the inactive 
conformation can most likely be ruled 
out. Intriguingly, the catalytically 
important motifs were found in close 
spatial proximity to each other in the ab-
 
Figure 1: Ab-initio docking model of DmISWI 
ATPase module. The orientation of both ATPase 
lobes in the ab-initio structure (light blue) was 
modeled in the absence of distance restraints. The 
ab-initio model was then aligned to lobe 2 of the XL-
MS-derived DmISWI ATPase model (yellow, red; 
cf. Figure 14A). Motifs I (purple), II (blue) and VI 
(black), are highlighted as spheres for both models. 
See also STable 1 for measured Cα-Cα distances. 
The figure was adapted from (1) in accordance with 
Elsevier’s policies. 
Dr. C. Schindler (TUM, Munich) generated the ab-
initio model of the ATPase module. 
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initio model, which perhaps reflects structural properties of an active configuration of the 
ATPase module. Consequently, activation of the DmISWI enzyme potentially relies on large-
scale conformational rearrangements to align the conserved, catalytically important ATPase 
motifs. 
 
To further characterize and validate the presumably inactive ATPase conformation, I perturbed 
a proposed interaction site between both DmISWI ATPase lobes by introducing point 
mutations and monitored the ATPase activity. We hypothesized that the disruption of a 
potential salt bridge in the lobe-lobe interface (i.e., K337-D485, cf. Figure 17B) by charge-
reversal mutations (K337D or D485K; Figure 17C) could lead to a destabilization of the 
inactive conformation and thus to an increased ATPase activity of the DmISWI enzyme. 
Notably, the MtISWI protein comprises corresponding charged residues in the ATPase lobe-
lobe interface (R394 and D544, pdb 5JXR) that point towards each other (Figure 17B). 
Consistent with our hypothesis, weakening of the lobe-lobe interface by mutation of D485K 
resulted in a nearly two-fold increase in ATPase activity, whereas double mutation of both 
residues completely restored wild-type ATPase levels (Figure 17E). Surprisingly, ISWIK337D 
exhibited a decreased ATPase activity. I therefore inspected our DmISWI ATPase model in 
order to pinpoint surrounding residues, which potentially interact with the negatively charged 
aspartic acid through a hydrogen bond or salt bridge. Two basic residues, H483 and R486, 
exist within a 12 Å radius (i.e., four times the median distance of a salt bridge (233) to account 
for protein flexibility), which may form compensatory interactions upon mutation (Figure 
17B). Finally, one has to keep in mind that residue K337 in the DmISWI protein may serve 
other important functions in addition to stabilizing the lobe-lobe interface and that charge-
reversal at this position could cause unexpected side effects. 
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Figure 17: The DmISWI ATPase module most likely assumes an inactive conformation under apo state 
conditions. (A) Structural motifs involved in ATP hydrolysis are represented as spheres in our ATPase 
model of the DmISWI enzyme (cf. Figure 14A). (B) Illustration of a potential inhibitory interaction between 
two residues of ATPase lobe 1 and lobe 2 in the apo state. The residues K337 and D485 (cyan) are located at 
the lobe interface in the ATPase model of DmISWI and might be sufficiently close to interact with each other 
(top left; section corresponds to dotted rectangle in (A)). The corresponding residues in the structure of 
MtISWI (pdb 5JXR) show a remarkably similar orientation (bottom left). On the contrary, in the ISWI model 
of Forné and co-workers (157), in which both lobes adopt a different orientation to each other, both residues 
are located in a way that an interaction is unfavorable (top right). I introduced charge-reversal mutations to 
perturb the proposed interaction between K337 and D485 in the DmISWI enzyme. However, a possible 
compensatory interaction might be formed between K337D and H483 or R486 (blue), respectively, in the 
ISWIK337D variant (bottom right). (C) Sample purity of DmISWI constructs evaluated by SDS-PAGE analysis 
and Coomassie staining. (D) Comparability of enzyme amounts used in ATPase assay. A fraction of each 
assay reaction mixture used in (E) was separated by SDS-PAGE, stained with Coomassie, and bands 
corresponding to ISWI quantified by densitometry relative to ISWIWT (n = 1). (E) Comparison of the ATPase 
activity for ISWIWT and lobe interface mutants. The reactions were performed in the presence of saturating 
concentrations of ATP and DNA. Errors bars represent standard deviations of ≥ 3 independent 
measurements. The unstimulated basal activity was ≤ 0.005 s-1 for all enzyme variants. A two-tailed t test 
was performed to determine statistical significance. **, p ≤ 0.01; n.s., not significant, p ≥ 0.05. The panels 
(B)–(E) were adapted from (1) in accordance with Elsevier’s policies. 
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2.2.2. The HSS domain contacts the ATPase domain in solution 
With the structural model of the ATPase module in our hand, we subsequently set out to 
elucidate the relative orientation of the HSS domain in the full-length DmISWI remodeling 
enzyme.  
The XL-MS analysis of the DmISWI protein yielded a total of 31 cross-linked residue pairs 
(XLISWI 31–61; STable 2) that mapped to the HSS domain. A subset of these cross-links 
(XLISWI 31–48) connected the HSS domain and the ATPase module (Figure 18). The cross-
linker sometimes bridged distant residue pairs (XLISWI 34, 35, and 37) with regard to the 
primary protein sequence (> 700 residues), suggesting a compact protein structure formed by 
the ATPase and HSS modules. Spatial proximity between the HSS domain and the ATPase 
module was evident from both chemical and UV-induced cross-linking. Numerous cross-links 
between the ATPase module and the HSS domain mapped to the SLIDE region (XLISWI 31, 34, 
35, 37−39, 41). The well-distributed lysine residues of the HAND region, however, reacted 
with the cross-linking agent to form mono-links (data not shown). The enrichment of mono-
links implies that the HAND region most likely remains solvent-accessible and is not part of 
the ATPase-HSS interface under apo state conditions. 
 
Figure 18: Identified cross-links for the full-length DmISWI protein under apo state conditions in 
solution. Identified cross-links for the DmISWI enzyme are schematically illustrated in an arc plot. The UV 
and chemical cross-links that bridge the ATPase module (““: residues 116−637) and the HSS domain 
(“”: residues 697−977) are further highlighted in blue and cyan color, respectively. Residue numbering is 
denoted below each DmISWI domain. The arrow indicates the position of the Bpa-substituted amino acid. 
STable 2 provides details for each colored cross-link. NTR, N-terminal region; HSS, HAND-SANT-SLIDE. 
The figure was adapted from (1) in accordance with Elsevier’s policies. 
Dr. I. Forné (LMU, Munich) performed the MS analysis. 
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Figure 19: Representative MS/MS spectrum for a single cross-link used for docking of full-length 
DmISWI. The cross-linked peptides were assigned based on the observed fragment ions. The monoisotopic 
peaks of y- and b-fragment ions from both peptides (blue and orange) are denoted in the MS/MS spectrum 
and are furthermore indicated in the sequence of the cross-linked peptides. Notably, the quality of the 
MS/MS spectrum as well as the number of fragment ions (e.g., consecutive y13-y4-ion series for the blue 
peptide) allows unambiguous sequence assignments and the identification of the cross-linking site. We also 
detected the triply charged precursor ion (M, black) with modifications, i.e. neutral losses of NH3 and/or 
H2O. SFigure 5 shows additional fragmentation spectra of cross-links, which were used to guide the 
computational docking. The figure was reprinted from (1) in accordance with Elsevier’s policies. 
Dr. I. Forné (LMU, Munich) performed the MS analysis. 
In addition to XL-MS analysis, we collected information about the molecular shape of both the 
full-length DmISWI enzyme and the HSS domain (i.e., ISWI691-1027) under apo state conditions 
in solution by SAXS measurements. The SAXS data for both DmISWI constructs collected at 
different protein concentrations resulted in largely superimposable scattering curves after 
rescaling by intensity (Figure 20A and C). However, slight concentration effects in the low q-
region were observed for both DmISWI constructs at the highest sample concentrations 
indicating attractive interactions between individual particles, which could result in unspecific 
protein aggregation (234). To obtain optimum data quality, our collaboration partner Dr. L. 
Brützel (LMU, Munich) scaled and merged the low angle data from the lowest protein 
concentration with the high angle data from the highest concentration. The comparison 
between experimental and theoretical (pdb 1OFC) scattering profiles for the HSS domain 
(Figure 20B) yielded a χ-value of 1.84. This discrepancy could originate from the missing 
atomic coordinates for 16% of the residues in the high-resolution structure of the HSS module 
compared to our measured construct or could point towards slight differences in protein 
conformation.  
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Figure 20: SAXS data for the full-length DmISWI enzyme and its HSS domain. (A) The extrapolated 
scattering curves for the HSS domain of the DmISWI enzyme are shown for different protein concentrations 
(left). Notably, these curves are largely superimposable. The ab-initio determined shape envelope for the 
HSS domain is depicted on the right side. (B) Superimposition of the experimental (green circles) and 
theoretical (blue line, pdb 1OFC) scattering profiles of the HSS domain of the DmISWI enzyme yielding a χ-
value of 1.84. (C) Same representation as shown in (A) for the full-length DmISWI enzyme. The molecular 
envelope depicted on the right side implies that the full-length protein adopted a compact conformation under 
apo state conditions. The panel (C), left was adapted from (1) in accordance with Elsevier’s policies. 
I purified both DmISWI protein constructs and prepared the samples for SAXS measurements, which were 
conducted and analyzed by Dr. L. Brützel (LMU, Munich). 
To visualize the relative orientation of the ATPase and HSS modules to each other in the full-
length DmISWI enzyme, our collaboration partner Dr. C. Schindler (TUM, Munich) docked an 
ensemble of ten DmISWI ATPase models, which were most consistent with the collected 
SAXS data for ISWI∆HSS (cf. section 2.2.1.1), against the available HSS crystal structure (pdb 
1OFC). The two-body docking was performed in an identical manner as described for the 
ATPase module in section 2.2.1.1. The docking was guided by five distance restraints, which 
were derived from identified inter-domain cross-links (XLISWI 31–35; cf. STable 2) that 
yielded excellent fragmentation data during MS/MS analysis (Figure 19 and SFigure 5). The 
top-ranked 200 models showed convergence with regard to the spatial arrangement of the 
ATPase module and the HSS domain as indicated by an overall model precision of 3.3 Å. The 
model with the lowest χ-fit to the SAXS data of ISWIWT was selected as the representative 
model of the full-length DmISWI enzyme (Figure 21). 
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Figure 21: Structural model of the full-length DmISWI enzyme under apo state conditions in solution. 
Our structural model of the full-length DmISWI enzyme is shown with ATPase lobe 1, ATPase lobe 2, and 
the HSS domain being colored in yellow, red, and green, respectively. Cross-linked amino acids are 
represented as spheres. Pink asterisks indicate residues that cross-linked to the NTR, for which atomic 
coordinates are lacking in the structural model. Grey rods connect individual residues of identified inter-
domain cross-links, for which the distance was restrained during the two-body docking procedure. STable 2 
provides further details for individual cross-links. The arrow denotes the N-terminus of the model (N; residue 
116). The Figure was adapted from (1) in accordance with Elsevier’s policies. 
I expressed, purified, and cross-linked the DmISWI enzyme and analyzed the respective XL-MS data. Dr. I. 
Forné (LMU, Munich) performed the MS analysis. Dr. C. Schindler (TUM, Munich) generated the full-length 
DmISWI model. 
To evaluate our full-length DmISWI model, Dr. C. Schindler (TUM, Munich) first compared 
the proposed model to the scattering data for ISWIWT. Notably, experimental and theoretical 
scattering data were found to be in overall good agreement as indicated by a χ-value of 1.04 
(Figure 22A). The SAXS-derived shape envelope allows for accommodation of the computed 
full-length DmISWI structure (Figure 22B). In a second step, I measured the Cα-Cα distances 
between cross-linked residue pairs in the full-length DmISWI model. The majority of cross-
links was largely consistent with the proposed DmISWI model (cf. STable 2). However, three 
cross-links (XLISWI 37, 38, and 40) exceeded the defined distance threshold by more than 20 Å. 
The cross-linked lysine residues in XLISWI 37 and 38 (i.e., K247, K945, and K353) are located 
in or are very close to flexible regions of the DmISWI enzyme, such that local protein 
dynamics at least partially account for the observed discrepancy between the computational 
and experimental data. The incompatibility of individual cross-linking distances with the 
proposed structural model (in particular XLISWI 40) could also arise from false sequence 
assignments or conformational heterogeneity of the protein sample. 
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Figure 22: SAXS analysis of the full-length DmISWI enzyme. (A) The theoretical scattering profile 
obtained for the structural model depicted in Figure 21 (red line) is in good agreement (χ = 1.04) with the 
measured scattering data for the full-length DmISWI protein (blue circles). (B) SAXS envelope 
reconstruction of collected SAXS data of ISWIWT (residues 1-1027). The model shown in Figure 21 fits well 
into the reconstructed envelope. Note that, 22% of residues are missing in the full-length model, explaining 
the excess of electron density. L. Brützel (LMU, Munich) initially prepared the figures. Panel (A) and (B) 
were adapted and reprinted from (1), respectively, in accordance with Elsevier’s policies. 
Dr. L. Brützel (LMU, Munich) obtained and analyzed the SAXS data for ISWIWT. Dr. C. Schindler (TUM, 
Munich) generated the full-length DmISWI model. 
Our collaboration partner Dr. C. Schindler (TUM, Munich) assessed whether the 
implementation of additional, XL-MS-derived distance restraints between the ATPase module 
and the HSS domain would result in an improved full-length DmISWI model with respect to 
the experimental data. Repetition of the two-body docking procedure using all available inter-
domain distance restraints (XLISWI 31–40 and 42–45, cf. STable 2) resulted in a similar 
structural architecture for the DmISWI enzyme (Figure 23A). However, we could again not 
obtain a single model that satisfied all cross-linking distances at once (cf. STable 2).  
We then considered that our models of the ATPase module might not be optimal. Dr. C. 
Schindler (TUM, Munich) thus separated the ATPase lobes at the hinge region of the ATPase 
module and docked them against the HSS domain in a three-body docking approach. The two 
separated ATPase lobes docked in a similar fashion against the HSS domain with an overall 
structural architecture of the full-length DmISWI enzyme resembling the one observed for the 
two-body docking approach (Figure 23B). Several distance restraints (cf. Table S1 and Table 
S2) as well as the fit to the SAXS data (χ = 0.85) were in better agreement with the generated 
model of the three-body docking approach. Nevertheless, XLISWI 37, 38, and 40 still severely 
violated the distance thresholds by as much as > 20 Å. Consequently, it appears plausible that 
the well-documented flexibility of DmISWI domains (114, 129, 140) does not allow us to 
compute a single structural model of the enzyme that fits all cross-linking data at once.  
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Figure 23: Evaluation of the structural model of the full-length DmISWI enzyme. (A) Incorporation of 
all identified ATPase-HSS cross-links into the two-body docking algorithm resulted in a similar domain 
arrangement (grey) as observed for the representative DmISWI model (colored) depicted in Figure 21. 
Structural models are aligned to ATPase lobe 2 for comparison. (B) Results of the three-body docking 
approach (light blue) are compared to our representative DmISWI model shown in Figure 21. The structural 
architecture in both full-length DmISWI models is similar. STable 1 and STable 2 provides cross-linking 
distances for both models. The Figure was adapted from (1) in accordance with Elsevier’s policies. 
Dr. C. Schindler (TUM, Munich) performed the computational modeling of the depicted structures.  
I subsequently evaluated whether the proposed domain architecture for the full-length 
DmISWI protein allows for DNA binding by the HSS domain as has been demonstrated in 
previous studies (23, 116, 127, 151). I thus superimposed the crystal structure of the Isw1a 
HSS domain in complex with DNA (pdb 2Y9Z, (151)) onto our structural model of the full-
length DmISWI enzyme (cf. Figure 21). Superimposition resulted in a direct steric clash 
between the ATPase module and the DNA strand (Figure 24) implying that the HSS domain in 
our DmISWI model is incapable of binding DNA without prior conformational changes. 
Notably, such a binding-incompetent orientation of the HSS domain supports the notion that 
the DmISWI enzyme assumes a resting conformation under apo state conditions in solution.  
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Figure 24: The full-length DmISWI model is not compatible with DNA binding via the HSS domain. 
The crystal structure of the HSS domain of ScISW1a (pdb 2Y9Z, (151); only the DNA is shown for clarity) 
was superimposed onto our structural model of the full-length DmISWI enzyme (ATPase lobe 1, yellow; 
ATPase lobe2, red; HSS domain, green; cf. Figure 21). Steric clashes between the ATPase module and the 
DNA strand can be observed. Consequently, our obtained model of DmISWI appears to be incompetent to 
bind DNA via the HSS domain. The Figure was adapted from (1) in accordance with Elsevier’s policies. 
Dr. C. Schindler (TUM, Munich) performed the modeling of the full-length DmISWI enzyme.  
In summary, we propose a potential structure for the full-length DmISWI enzyme under apo 
state conditions in solution by using an integrative approach. The results from XL-MS analysis 
and computational docking collectively suggest that the C-terminus of the HSS domain packs 
against the ATPase module. The proposed arrangement of the HSS domain appears to be 
incapable of binding to DNA without prior conformational changes. The minor inconsistencies 
observed between experimental and computational data may arise from inherent protein 
flexibility in one or more parts of the DmISWI enzyme.  
 
2.2.3. The NTR bridges both ATPase lobes and contacts the HSS 
In a recent study by Ludwigsen and co-workers (115), several NTR residues of the DmISWI 
enzyme formed cross-links with Bpa substituted at position H483 of ATPase lobe 2. However, 
the relative orientation of the NTR region in the full-length DmISWI protein has remained 
unclear. Here, I identified an additional, chemical cross-link candidate (XLISWI 13; cf. STable 
1), which connects the autoregulatory NTR region and ATPase lobe 1. Although high-
resolution structures for the NTR are lacking for the DmISWI protein, the partner cross-linking 
sites were found in close spatial proximity to the ATPase lobe-lobe interface in our structural 
model of the full-length enzyme (cf. pink asterisks in Figure 21). Consequently, the results by 
Ludwigsen et al. and my findings collectively suggest that the NTR domain is neighboring the 
ATPase lobe-lobe interface under apo state conditions in solution. 
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The MtISWI protein has recently been crystalized with large parts of the NTR domain (pdb 
5JXR) (146), which in turn allowed Dr. C. Schindler (TUM, Munich) to generate an MtISWI-
based homology model of the ATPase module. Using this homology model, I measured the 
Cα-Cα distances between cross-linked residue pairs of the NTR domain and the ATPase 
module. The here identified XLISWI 13 as well as the published cross-links by Ludwigsen et al. 
did not violate the distance threshold for the UV- and chemical cross-linkers (range 7.9–25.3 
Å) and thus were consistent with the MtISWI-based homology model (Figure 25). This finding 
is consistent with the notion that the NTR region of the DmISWI protein contacts the ATPase 
domain in a similar fashion as observed in the MtISWI structure and that the interaction site on 
the ATPase domain may be conserved between these two remodeling enzymes.  
 
Unexpectedly, I also identified inter-domain cross-links that connect the NTR domain and the 
HSS domain. The cross-linker bridged distant residue pairs (XLISWI 46–48, cf. STable 2) with 
respect to the primary protein sequence (i.e., > 800 amino acids), which indicates spatial 
proximity between the SLIDE region and the NTR domain. Mapping these cross-linking sites 
onto the HSS domain in our full-length DmISWI model (cf. pink asterisks in Figure 21) 
revealed that the cross-linked residues are also located in close spatial proximity to the lobe-
lobe interface of the ATPase module.  
Our collaboration partner Dr. C. Schindler (TUM, Munich) subsequently generated an 
MtISWI-based structural model of the full-length DmISWI enzyme that includes large parts of 
the NTR region. We applied the same docking protocol, including identical Cα-Cα distance 
restraints, to generate the MtISWI-based model as described for our representative full-length 
structure shown in Figure 21. The only difference was that an MtISWI-based homology model 
of the ATPase module (i.e., encompassing residues 38–592), instead of the ScChd1-based 
ATPase model, served as input structure. I subsequently assessed the compatibility of 
identified NTR-HSS cross-links (XLISWI 46–48) with the MtISWI-based structural model. 
Notably, the Cα-Cα distances between these cross-linked residue pairs consistently exceeded 
the distance threshold by almost 20 Å on average in the MtISWI-based model (cf. STable 2). 
However, the MtISWI-based model showed remarkable consistency with the experimental 
SAXS data for the full-length DmISWI enzyme as indicated by a χ-value of 0.88. 
We reasoned that the implementation of distance restraints that map to the NTR region (XLISWI 
46–48) would result in an MtISWI-based structural model that is more consistent with the 
experimental XL-MS data. Implementation of these additional distance restraints during 
docking indeed substantially improved the observed Cα-Cα distances between cross-linked 
residues of the NTR region and the HSS domain for XLISWI 46–48 by approximately 10 Å on 
average (Figure 25 and STable 2). However, this alternative MtISWI-based model resulted in a 
significantly poorer fit to the experimental SAXS data for the DmISWIWT enzyme as indicated 
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by a χ-value of 2.92. Possible explanations for the increased discrepancy between experimental 
and theoretical SAXS data upon implementation of NTR-HSS distance restraints is discussed 
in section 3.2. 
 
Taken together, our XL-MS data collectively suggest that the NTR domain is located near the 
interface of both ATPase lobes and potentially assumes a similar conformation as observed in 
the recent crystal structure of the MtISWI enzyme. In addition, the SLIDE region of the HSS 
module packs against the ATPase domain in spatial proximity to the NTR region. 
Consequently, the catalytic core of the DmISWI protein appears to be caged by the NTR 
domain and the C-terminal region of the HSS module, which may lock the remodeling enzyme 
in a resting conformation under apo state conditions in solution. 
  
Figure 25: The NTR is neighboring both ATPase lobes and the HSS domain in the full-length DmISWI 
enzyme. Identified cross-links originating from the NTR are shown in a structural model of full-length 
DmISWI including the NTR domain. Protein domains are colored according Figure 12. An MtISWI-based 
homology model of the ATPase module (NegC was omitted, discussed in section 2.2.4) was docked onto the 
HSS domain using cross-linking distance restraints as guides. Cross-links originating from the NTR (XLISWI 
13, 46–48 and published cross-links from (115)) are shown as rods. Cross-linked residue pairs published in 
(115) are furthermore marked by an asterisk. The measured Cα-Cα distances between individual residue pairs 
were below the distance threshold of the cross-linkers (see also STable 1 and STable 2 for individual values) 
suggesting a comparable orientation of the NTR in the full-length DmISWI and MtISWI enzymes under apo 
state conditions.  
Dr. C. Schindler (TUM, Munich) performed the computational modeling of the depicted structure.  
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2.2.4. The NegC adopts a Chd1-like conformation  
As of today, two significantly distinct conformations of the NegC domain have been reported. 
In the crystal structure of the ScChd1 protein (pdb 3MWY), the NegC domain bridges both 
ATPase lobes thereby locking the enzyme in an inactive state (114, 141) (Figure 26A). In 
contrast, the NegC domain protrudes from the catalytic core and interacts with a neighboring 
protomer in the crystal structure of the MtISWI protein (pdb 5JXR) (146). Consequently, XL-
MS analysis provided an excellent opportunity to probe the orientation of the NegC domain in 
the full-length DmISWI enzyme under apo state conditions in solution.  
We identified a total of 16 cross-linked peptides, which revealed five cross-linked residue pairs 
between the NegC domain and the ATPase module (XLISWI 8–12, cf. STable 1). Notably, the 
Cα-Cα distances between cross-linked lysine residues of XLISWI 9–12 complied with the 
defined distance threshold not only in our ScChd1-based model of the DmISWI ATPase 
module but also with the crystal structure of the ScChd1 protein (pdb 3MWY). Solely XLISWI 8 
modestly violated the maximal distance in our structural model of the ATPase module, as 
already discussed above, as well as in the ScChd1 crystal structure by less than 5 Å. 
In order to evaluate whether our XL-MS results are compatible with a protruding NegC 
conformation as observed recently for the MtISWI enzyme, I measured the Cα-Cα distances 
between cross-linked residue pairs, which map to the NegC region in the respective crystal 
structure. I thereby measured the distances between residues of a single protomer as well as 
between two neighboring protomers (see STable 1 for individual values). The XL-MS-derived 
distance restraints of XLISWI 9–12 were satisfied in the MtISWI dimer, in which the NegC 
domain serves as a dimerization interface. Thus, our XL-MS data could indicate a similar 
protruding conformation of the NegC region for the DmISWI enzyme presupposed that the 
protein is present as a dimer under the tested conditions. However, although the MtISWI 
enzyme has been crystalized as a homodimer, Yan and co-workers emphasized in the same 
study that the protein is predominantly (> 90%) present as a monomer in solution (146). We 
also hold experimental evidence that the DmISWI enzyme is present as a monomer under apo 
state conditions in solution. In particular, the SEC analyses of native and cross-linked DmISWI 
protein (Figure 26B) as well as the SAXS-derived molecular envelope (cf. section 2.2.2.) 
showed consistency with a monomeric solution state of the remodeling enzyme.  
The large majority of XL-MS-derived distance restraints, however, were severely violated in 
the monomeric MtISWI structure (Figure 26C and STable 1). That is, XLISWI 8 and XLISWI 10–
12 exceeded the defined Cα-Cα distance threshold by almost a factor two with cross-linked 
residue pairs frequently being 50 Å apart from each other. Consequently, given that the 
DmISWI protein appears to be present as a monomer under apo state conditions in solution, 
the XL-MS data for our remodeling enzyme are inconsistent with a protruding NegC 
conformation.   
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To further rule out that the NegC domain is protruding from the catalytic core in the DmISWI 
enzyme, Dr. C. Schindler (TUM, Munich) computationally docked the HSS domain (pdb 
1OFC) against an MtISWI-based homology model of the ATPase module comprising the 
NegC region (i.e., encompassing residues 38–651). The resulting structural model of the 
DmISWI protein displayed a deviating domain architecture with the HSS domain packing 
differently against the ATPase module (Figure 26D) when compared to our proposed, ScChd1-
based structure of the full-length enzyme depicted in Figure 21. Importantly, the large majority 
of distance restraints (> 88%) between the ATPase and HSS module (XLISWI 31–48; cf. STable 
2) suddenly exceeded the distance threshold of the cross-linking agent in the MtISWI-based 
structural model. Notably, this model furthermore exhibited a poorer fit to the SAXS-derived 
scattering data for DmISWIWT as indicated by a χ-value of 2.53. To test whether the protruding 
NegC conformation biased the docking towards a deviating domain architecture, Dr. C. 
Schindler (TUM, Munich) repeated the docking protocol in the absence of the NegC domain 
(i.e., residues 593−651 were removed from the ATPase module). The MtISWI-based structural 
model, in which the NegC region was removed, was well superimposable with our proposed, 
ScChd1-based model of the full-length DmISWI enzyme. The large majority of inter-domain 
cross-links between the ATPase and HSS module complied with the distance requirements of 
the cross-linking agent and we obtained a good fit to the SAXS data for DmISWIWT as 
indicated by a χ-value of approximately 1. Consequently, the computational simulations on the 
MtISWI-based homology model of the ATPase module further underscored that our 
experimental data for DmISWI are incompatible with a protruding NegC conformation.  
In summary, our experimental SAXS and XL-MS data as well as computational simulations 
collectively imply that the NegC domain of the DmISWI enzyme adopts a similar 
conformation under apo state conditions as has been observed for the related ScChd1 protein. 
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Figure 26: XL-MS data for DmISWI are inconsistent with a protruding NegC conformation. (A) The 
NegC conformations in the structures of MtISWI and ScChd1. Protomer 1 of dimeric MtISWI (light pink; 
pdb 5JXR) was aligned with monomeric ScChd1 (green; pdb 3MWY) on ATPase lobe 2. The NegC of 
MtISWI protomer 1 (light pink) protrudes from the surface to interact with protomer 2 (dark pink). Likewise, 
the NegC region of MtISWI protomer 2 bridges across the ATPase module of protomer 1. Remarkably, the 
NegC of ScChd1 (green) and of MtISWI protomer 2 pack against the ATPase domain in a similar manner 
(dashed ellipse). (B) Size-exclusion chromatography of cross-linked and DMSO-treated DmISWIWT. 
Superdex 200 10/300 GL elution profiles of DMSO-treated and cross-linked full-length DmISWI protein did 
not provide evidence for dimerization. (C) NegC cross-links mapped onto the structure of a single MtISWI 
protomer (pdb 5JXR). The majority of Cα-Cα distances between NegC and the ATPase lobes are violated 
(pink rods) in the MtISWI protomer. See also STable 1 for individual spanned distances of the cross-linker. 
Cyan, NTR; yellow, ATPase lobe 1; red, ATPase lobe 2; orange, NegC. (D) An MtISWI-based homology 
model including the NegC region (grey) was docked against the HSS domain (teal, pdb 1OFC). We observe a 
substantially different orientation of the HSS domain in the MtISWI- and ScChd1-based (yellow, red, green; 
cf. Figure 21) models of the DmISWI enzyme. See also STable 2 for individual distances spanned by the 
cross-linker. The panels (A)–(C) were adapted from (1) according in accordance with Elsevier’s policies. 
Dr. C. Schindler (TUM, Munich) performed the computational modeling of the structures in panel (D).  
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2.3. Solution structure of the Snf2H enzyme under apo state conditions 
To corroborate our findings for DmISWI (e.g., domain orientation, see section 2.2), we probed 
the in-solution structural architecture of the orthologous, human remodeling enzyme Snf2H 
using a similar integrative approach (i.e., XL-MS, SAXS, and computational modeling). We 
were in particular interested in elucidating whether Snf2H assumes an overall comparable 
conformation under apo state conditions as the DmISWI protein. 
Despite the availability of a low-resolution Snf2H structure (150), molecular details of the full-
length Snf2H enzyme as well as the mechanism of action have remained elusive. The human 
Snf2H remodeling enzyme shares 79% overall sequence identity with its Drosophila 
counterpart (Clustal Omega web service, EMBL-EBI). While residues of the functionally 
important ATPase, NegC, and HSS domains appear to be largely conserved across these two 
species, sequence homology is somewhat lost in the autoregulatory NTR region (< 32% 
sequence identity) (140). Considering the remarkable sequence homology, we envisaged that 
studying the structural architecture of human Snf2H in solution would not only allow us to 
indirectly validate the findings for DmISWI but also to draw mechanistic inferences on this 
important class of proteins. 
 
2.3.1. The Snf2H domain architecture viewed by chemical cross-linking 
To obtain structural information about the full-length Snf2H enzyme under apo state 
conditions, I chemically cross-linked the protein using the BS3 cross-linking agent and 
analyzed the XL-MS data (cf. sections 4.2.4.1.2 and 4.2.4.5), while our collaboration partner 
Dr. I. Forné (LMU, Munich) was responsible for high-resolution MS analysis (cf. section 
4.2.4.4).  
MS analysis resulted in the identification of 115 cross-linked peptides yielding a total of 84 
unique residue pairs for the Snf2H enzyme (Figure 27, STable 3). The large majority (81%) of 
these cross-linked residue pairs were reproduced in at least a technical replicate as further 
specified in column “Reproducibility group” in STable 3.  
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Figure 27: Identified BS
3
 cross-links for the full-length Snf2H enzyme under apo state conditions in 
solution. Schematic representation of Snf2H domains with identified inter- and intra-domain cross-links 
being indicated as solid and dotted arcs (cf. color scheme), respectively. Numbers refer to the residue 
numbering of the Snf2H enzyme. The grey bars below the arc plot specify the range of the generated 
homology models. STable 3 provides further details for each cross-link. NTR: N-terminal region; HSS: 
HAND-SANT-SLIDE. 
Dr. I. Forné (LMU, Munich) performed the MS analysis. 
Due to the lack of high-resolution structures for the Snf2H enzyme, our collaboration partner 
Dr. C. Schindler (TUM, Munich) homology modeled the ATPase module (residues 120–689) 
and HSS domain (residues 743–1012) according to the structures of ScChd1 (pdb 3MWY, 
41% sequence identity,) and DmISWI (pdb 1OFC, 81% sequence identity), respectively. The 
ATPase module was cleaved at a predicted hinge region into two structural bodies (i.e., 
residues 120−403 and 404−689). 
I validated these homology models based on identified intra-domain cross-links (cf. STable 3) 
for the HSS domain (XLSnf2H 70–75), ATPase lobe 1 (XLSnf2H 64–69), and ATPase lobe 2 
(XLSnf2H 53–63) (Figure 28). Importantly, all HSS cross-linking distance restraints were 
consistent with the homology model of the Snf2H domain. Likewise, the large majority of 
intra-domain linkages for individual structural bodies of the ATPase module were in excellent 
agreement with only two cross-links (XLSnf2H 63 and 67) negligibly violating the defined Cα-
Cα distance threshold by < 0.4 Å. Taken together, the generated homology models for the HSS 
domain and ATPase lobes were consistent with the XL-MS data and thus could be used to 
elucidate the overall structural architecture of the Snf2H enzyme.  
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Figure 28: XL-MS-based evaluation of homology models for distinct Snf2H domains. I measured the 
Cα-Cα distances between residues of identified intra-domain cross-links in the respective homology models 
of ATPase lobe 1 (yellow; i.e., XLSnf2H 64–69; STable 3), ATPase lobe 2 (red; i.e., XLSnf2H 53–63) and the 
HSS domain (green; i.e., XLSnf2H 70–75) of the Snf2H enzyme. Cross-links are indicated as grey lines and 
spheres in the homology models, in which the N- and C-termini are furthermore highlighted in cyan for 
orientation. The presented box plots signify the median (solid line) and the third and first quartile range (box) 
of the measured Cα-Cα distances in the respective Snf2H domain. The whiskers indicate the minimum and 
maximum measured Cα-Cα distances. The distance threshold given by the cross-linking agent is shown as a 
red dotted line in the box plot diagram. 
Dr. C. Schindler (TUM, Munich) performed the homology modeling of individual Snf2H domains.  
I identified a total 50 inter-domain cross-links that restricted the relative orientation of Snf2H 
domains to each other. A subset of these linkages connected the two ATPase lobes with the 
HSS domain (XLSnf2H 1–29, STable 3) with cross-linked peptides (i.e., XL XLSnf2H 7–12, 14, 
26, 28, 29) frequently providing excellent fragmentation data during MS analysis (SFigure 6). 
Intriguingly, we noticed that the majority of contacts from the ATPase module to the HSS 
domain were formed to the C-terminal SLIDE domain (cf. STable 3). In particular, lysine 
residues K929 and K990 of the SLIDE region appeared to represent cross-linking hotspots 
(Figure 29A). Cross-links originating from either K929 or K990 mapped to broadly distributed 
lysine residues of ATPase lobe 1 and ATPase lobe 2 (Figure 29B, C). Such a wide-ranging 
distribution of partner cross-linking sites was not observed for any other lysine residue and 
may indicate inherent protein flexibility in one or more regions of the Snf2H enzyme as further 
discussed in section 3.2. Consequently, a considerable number of cross-links substantiated the 
notion of spatial proximity between the SLIDE domain and the ATPase module in the Snf2H 
enzyme under apo state conditions. 
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Figure 29: Cross-linking hotspots of the SLIDE region. (A) Arc plot of identified cross-links for the 
Snf2H enzyme shown in Figure 27 with cross-links originating from lysine residues 929 and 990 of the 
SLIDE domain being colored in green. Remaining cross-links are depicted as grey arcs. (B) Mapping of 
partner cross-linking sites for residue K929 onto Snf2H homology models of ATPase lobe 1 (yellow) and 
ATPase lobe 2 (red). The partner cross-linking sites on the ATPase lobes are indicated as grey spheres with 
the radius of the spheres corresponding to the length of the BS
3
 spacer arm (i.e., 11.4 Å). The N- and C-
termini of the Snf2H homology models are denoted for orientation. (C) Mapping of partner cross-linking 
sites for residue K990 as shown in (B). 
Dr. C. Schindler (TUM, Munich) performed the homology modeling of individual Snf2H domains.  
MS analysis of cross-linked Snf2H samples only resulted in the identification of a single cross-
linked residues pair (i.e., XLSnf2H 43, STable 3) that restricted the relative orientation of both 
ATPase lobes to each other. That is, I found that K397 of ATPase lobe 1 cross-linked to K624 
of lobe 2 suggesting spatial proximity between the C-termini of both ATPase lobes. I 
subsequently checked the compatibility of the identified ATPase lobe-lobe cross-link XLSnf2H 
43 with our structural model of DmISWI (cf. Figure 21) as well as published structures of 
ScChd1 (pdb 3MWY) and MtISWI (pdb 5JXR). The Cα-Cα distance slightly exceeded the 
distance threshold by < 6.5 Å in the structures of DmISWI and MtISWI but showed 
consistency with the domain orientation of the ScChd1 protein. The increased Cα-Cα distance 
in the DmISWI and MtISWI structures may arise from local protein dynamics considering that 
the cross-linked lysine residue K397 resides in an unstructured and thus probably flexible 
Snf2H region. In conclusion, the limited number of identified lobe-lobe cross-links only 
provides a rough approximation of the relative orientation of both ATPase lobes to each other 
and does not allow for a conclusive statement.   
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The relative position of the autoregulatory NegC domain in the full-length Snf2H enzyme was 
restricted by a total of ten inter-domain cross-links (XLSnf2H 30–32 and 44–50, STable 3). 
These cross-links mapped to either the above-mentioned hotspot residues K929 and K990 of 
the SLIDE domain (i.e., XLSnf2H 30–32) or both ATPase lobes (XLSnf2H 44–50). A single cross-
link (XLSnf2H 44) connected the very N-terminus of ATPase lobe 1 with the NegC domain 
raising the possibility that NegC bridges the ATPase lobe-lobe interface under apo state 
conditions. The Cα-Cα distance restraints between cross-linked residue pairs of ATPase lobe 2 
and NegC (XLSnf2H 45–50) were consistent with our ScChd1-based homology model of the 
respective domains (Figure 30A). Assuming that the Snf2H is present as a monomer in 
solution (cf. SAXS data for Snf2H in section 2.3.2), the identified NegC-ATPase lobe 2 cross-
links argue against a protruding NegC conformation as depicted in the MtISWI crystal 
structure (pdb 5JXR). That is, mapping XLSnf2H 45–50 onto a single MtISWI protomer 
consistently violated the defined BS3 distance threshold by a factor of 1.7 to 3.1 (Figure 30B).  
In conclusion, I find that the NegC regions potentially assumes a ScChd1-like conformation in 
the full-length Snf2H enzyme with the autoregulatory domain packing against both ATPase 
lobe and the SLIDE region of the HSS domain. As such, XL-MS data for the NegC region 
appear to be similar for the full-length Snf2H and DmISWI enzymes under apo state 
conditions in solution (Figure 30C). 
 
 
 
 
 
 
 
Figure 30: XL-MS data for the Snf2H enzyme are consistent with a ScChd1-like orientation of the 
NegC domain. (A) NegC cross-links mapped onto our ScChd1-based homology model of ATPase lobe 2 
(red) and the NegC domain (orange). Identified inter-domain cross-links that connect these two regions 
(XLSnf2H 45–50) are indicated as grey rods. The Cα-Cα distance restraints between individual NegC-ATPase 
lobe 2 residue pairs were all satisfied in our homology model. (B) NegC cross-links mapped onto the 
structure of a single MtISWI protomer (pdb 5JXR). All Cα-Cα distances between NegC (orange) and ATPase 
lobe 2 (red) are violated (pink rods; XLSnf2H 45–50) and exceed the distance threshold by 19–60 Å in the 
MtISWI protomer. Cyan, NTR; yellow, ATPase lobe 1. (C) Identified NegC cross-links for the DmISWI 
enzyme are mapped onto the MtISWI crystal structure for comparison (Figure identical to Figure 26C). The 
comparison between (B) and (C) reveals similar cross-linked residue pairs suggesting a similar, ScChd1-like 
conformation of the NegC region in both Snf2H and DmISWI enzymes.  
Dr. C. Schindler (TUM, Munich) performed the homology modeling shown in panel (A). 
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Table 1: The Cα-Cα distances of NTR cross-links 
in the structure of MtISWI. 
 Snf2H 
(this study) 
MtISWI 
(pdb 5JXR) 
XLSnf2H 
Site 
Dist. 
thres- 
hold [Å] 
Site Dist. 
[Å] 1 2 1
 
 2
 
 
40 K160 K121 < 29  K166 K123 29.1 
41 K160 K128 < 29  K166 R136 24.8 
42 K160 K129 < 29  K166 K137 27.4 
 
In the case of the NTR region, various lysine residues of ATPase lobe 1 and the SLIDE 
domain formed cross-links with reactive residues of the NTR (XLSnf2H 33–42, STable 3). In 
particular lysine residues K121, K128, and K129 of the NTR, which are in close spatial 
proximity to the N-terminus of ATPase lobe 1, formed intra- and inter-domain linkages with 
surrounding residues (XLSnf2H 76–82 and 33, 34, 40–42, respectively). The structural 
interpretation of these XL-MS results 
in light of the limited number of 
available high-resolution structures is 
difficult due to the inherently low 
sequence homology in the NTR 
region among related remodeling 
enzymes. I evaluated the Cα-Cα 
distances for NTR-ATPase cross-
links between corresponding sites in 
the recently published MtISWI 
structure (pdb 5JXR) that comprises large parts of the NTR (Table 1). Notably, the identified 
inter-domain cross-links XLSnf2H 40–42 were in excellent agreement with the MtISWI structure 
with Cα-Cα distances ranging from 24.8–29.1 Å. The validity of XLSnf2H 38 and 39 could, 
however, not be assessed due to the lack of atomic coordinates in the NTR region that harbors 
the respective cross-linked residue.  
In summary, our XL-MS findings are consistent with an MtISWI-like conformation of the 
NTR region with the SLIDE domain being in close spatial proximity to the NTR region in the 
full-length Snf2H enzyme.  
 
In overall conclusion, our XL-MS data for the full-length Snf2H protein collectively point 
towards a rather compact enzyme conformation under apo state conditions. That is, the 
identified cross-links are consistent with the notion that the autoregulatory NTR and NegC 
regions pack against the ATPase lobes. In addition, I identified the SLIDE region of the HSS 
domain to form various contacts to the ATPase module including the NTR, NegC, and both 
ATPase lobes. From a XL-MS perspective, it thus appears possible that the Snf2H and 
DmISWI remodeling enzymes assume a similar conformation under the investigated solution 
conditions. 
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2.3.2. The Snf2H domain architecture viewed by computational modeling and 
SAXS 
To computationally resolve the structural architecture of the Snf2H enzyme under apo state 
conditions, we decided to perform a three-body docking using the ScChd1- and DmISWI-
based homology models for both ATPase lobes and the HSS domain (cf. section 2.3.1), 
respectively. Our collaboration partner Dr. C. Schindler (TUM, Munich) performed the 
computational docking of individual Snf2H domains by employing a total of eleven XL-MS-
derived distance restraints (i.e., XLSnf2H XL 7–12, 14, 26, 28, 29, 44; STable 3). These distance 
restraints were selected because the respective cross-linked peptides showed excellent 
fragmentation data during MS/MS analysis (SFigure 6). Notably, the modeling procedure for 
the Snf2H protein differed to the one described for DmISWI (i.e., two two-body docking 
procedure, cf. section 2.2.2) in order to overcome the limited number of identified cross-links 
between the two ATPase lobes. Using a three-body docking protocol, the arrangement of both 
ATPase lobes in the modeled Snf2H structure would primarily depend on their relative 
orientation towards the HSS domain. Briefly, the orientation of initially randomly orientated 
Snf2H domains (1x105 starting configurations) was guided by XL-MS derived upper harmonic 
distance restraints using the ATTRACT modeling software. The computed models were 
ranked by their ATTRACT energy score and the top-ranked 200 models were selected for 
atomistic refinement with iATTRACT. 
 
We observed a considerable heterogeneity among the generated structural models of the full-
length Snf2H enzyme under apo state conditions. For instance, structural alignment of the two 
top-ranked Snf2H models resulted in an RMSD of approximately 9.5 Å underscoring their 
divergent domain architecture. In particular the docking geometry of the HSS domain relative 
to the ATPase module remained ambiguous as shown in Figure 31A for 18 out of the total 200 
generated full-length Snf2H models (i.e., the top five and every fifteenth model).  
To validate individual Snf2H models with respect to the XL-MS data, I subsequently measured 
the Cα-Cα distances between cross-linked residue pairs of all accessible inter-domain cross-
links, including cross-links used for docking, in the representative structures depicted in Figure 
31A. The observed distribution of measured Cα-Cα distances for each inter-domain cross-link 
is summarized in Figure 31B. Importantly, none of the selected structural models of the full-
length Snf2H enzyme was entirely consistent with the implemented distance restraints used for 
docking and the majority of additional identified inter-domain cross-links exceeded the BS3 
distance threshold. Possible reasons for the discrepancy between the XL-MS and 
computational data may have diverse origins, which are further discussed in section 3.1.  
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Figure 31: Structural models of the Snf2H enzyme under apo state conditions in solution. (A) The top-
ranked Snf2H models (i.e., models #1-5 and every other fifteenth model) are shown and aligned to ATPase 
lobe 2 of model #1. ATPase lobe 1, ATPase lobe 2, and the HSS domain of model #1 are colored in yellow, 
red, and green, respectively. The remaining structures are depicted in grey color. (B) The Cα-Cα distances 
between reactive residues of identified inter-domain cross-links were measured in each Snf2H model shown 
in (A). Individual box plots summarize the observed distribution of measured Cα-Cα distances for each inter-
domain cross-link. That is, each box plot shows the median (solid line), the Q3-Q1 range (box), and the 
minimum and maximum measured Cα-Cα distance (whiskers). Cross-links are numbered according to 
STable 3. Cross-links with an asterisk were used as distance restraints during computational docking. The 
Cα-Cα distance threshold given by the cross-linking agent is shown as a red dotted line in the box plot 
diagram. 
Dr. C. Schindler (TUM, Munich) performed the computational docking of the full-length Snf2H enzyme 
shown in panel (A).  
As an additional complementary approach to XL-MS analysis, Dr. L. Brützel (LMU Munich) 
performed SAXS measurements on the full-length Snf2H protein in order to deduce the 
molecular shape of the remodeling enzyme under apo state conditions in solution. A series of 
SAXS measurements at different Snf2H concentrations resulted in well superimposable 
scattering profiles (Figure 32A). Reconstruction of the molecular envelope showed that the 
Snf2H protein predominantly assumes an overall globular, yet slightly elongated conformation 
(Figure 32B). The SAXS data thus show consistency with the computationally generated 
Snf2H models considering that representative structures can be fitted well into the molecular 
envelope (e.g., model #1; Figure 32B). Comparison between the experimental and the 
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theoretical scattering curves for the investigated Snf2H models depicted in Figure 31A resulted 
in an average χ-value of 4.2 ± 0.3, which is close to the upper limit of the acceptance criterion 
range of < 2 (172) to 5 (173). 
 
Figure 32: SAXS analysis of the Snf2H enzyme. (A) The extrapolated scattering curves for the Snf2H 
enzyme are shown for three different protein concentrations. The curves are well superimposable and 
indicate good data quality. (B) The top-ranked structural model #1 (cf. Figure 31A) can be fitted well into the 
SAXS-derived molecular envelope of the full-length Snf2H enzyme. Notably, 20% of residues are missing in 
the Snf2H model, which explains the excess of electron density. 
I purified the full-length Snf2H enzyme and prepared the samples for SAXS measurements, which were 
conducted and analyzed by Dr. L. Brützel (LMU, Munich) shown in panels (A) and (B). Dr. C. Schindler 
(TUM, Munich) generated the full-length model in panel (B). 
In conclusion, the ambiguous nature of the modeling results and the limitations in narrowing 
down the pool of candidate conformations by experimental data do not allow us to propose a 
single Snf2H structure for the remodeling enzyme under apo state conditions with the desired 
confidence. 
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2.4. Probing the conformation of remodeling enzymes upon changing the 
ATP state 
Our proposed structural model of the DmISWI ATPase module implies that both ATPase lobes 
are twisted against each other under apo state conditions such that motifs important for 
catalysis are not oriented towards each other (cf. section 2.2.1.3). It appears plausible that the 
catalytic core of the Snf2H enzyme favors a similar resting state under comparable solution 
conditions. The ATPase modules of both remodeling enzymes may have to undergo substantial 
conformational rearrangements in order to assume a catalytically competent configuration. The 
nucleotide analog adenosine-5′-diphosphate beryllium-fluoride (ADP-BeFx) has been shown to 
induce various nucleotide-dependent states of the Snf2H enzyme including the transition state 
during ATP hydrolysis (159). We thus envisaged that binding of ADP-BeFx to the Snf2H 
protein would shift the conformational ensemble towards an active enzyme conformation, 
which we could probe by XL-MS analysis, SAXS measurements, and computational modeling. 
To assess saturating ADP-BeFx concentrations, a competitive, thin-layer chromatography 
(TLC)-based ATPase assay was used to follow hydrolysis of [γ-32P]ATP in the presence of 
increasing concentrations of the nucleotide analog (cf. Materials and Methods section 
4.2.7.2.1). The ATP hydrolysis activities of DmISWI, DmISWI∆HSS, and Snf2H decreased with 
increasing ADP-BeFx concentrations with [γ-
32P]ATP turnover being negligible at a nucleotide 
analog concentration of > 0.5 mM (SFigure 2). Consequently, these preliminary findings 
suggested that 3 mM ADP-BeFx are sufficient to shift the conformational ensemble of the 
studied remodeling enzymes towards the transition state during ATP hydrolysis. 
The following subsections provide a detailed summary of the results obtained for the Snf2H 
enzyme in the presence of the nucleotide analogue ADP-BeFx. Furthermore, a side-by-side 
comparison of the XL-MS data for the Snf2H protein in the presence and absence of ADP-
BeFx allows for the identification of nucleotide-dependent changes in the higher-order 
structure of the remodeling enzyme.  
 
2.4.1. Elucidating the conformational impact of nucleotide analog binding on 
the Snf2H enzyme using XL-MS analysis and computational modeling 
To investigate the conformational impact of nucleotide analog binding on the Snf2H protein, 
we collected XL-MS data of the remodeling enzyme in the presence of ADP-BeFx in an 
identical manner as described for the Snf2H enzyme under apo state conditions (cf. section 
2.3.1). I identified a total 154 unique, cross-linked residue pairs for the Snf2H enzyme in the 
presence of ADP-BeFx (Figure 33 and STable 4) with the majority (76%) of cross-linking sites 
being reproduced in technical replicates (cf. STable 4, column “Reproducibility group”).   
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Figure 33: Identified cross-links for the full-length Snf2H enzyme in the presence of ADP-BeFx. 
Schematic representation of Snf2H domains with identified inter- and intra-domain cross-links (cf. STable 4) 
being indicated as solid and dotted arcs (cf. color scheme), respectively. The residue numbering is denoted 
below. The grey bars below the arc plot define the generated homology models of the distinct Snf2H domains 
(cf. section 2.3.1). NTR, N-terminal region; HSS, HAND-SANT-SLIDE. 
Dr. I. Forné (LMU, Munich) performed the MS analysis. 
The number of identified cross-links for Snf2H was thus considerably higher in the ADP-BeFx 
state than under apo state conditions. The increased number of identifications was primarily 
due to novel cross-links that map to either the NegC-HSS interconnecting region (i.e., residues 
690–742) or the very C-terminal segment (i.e., residues 1023–1052) of the Snf2H enzyme 
(Figure 34), for which we lack atomic coordinates in our structural models.  
 
Figure 34: Comparison of identified cross-links for the Snf2H enzyme in the presence and absence of 
ADP-BeFx. Schematic representation of Snf2H domains with identified inter- and intra-domain cross-links 
being indicated as solid and dotted arcs, respectively. Arcs on the top and bottom side refer to identified 
cross-links for the Snf2H enzyme in the presence and absence of ADP-BeFx, respectively. Individual cross-
links, which were identified under both conditions, are highlighted in cyan. Cross-links that were exclusively 
observed upon binding of ADP-BeFx or under apo state conditions are colored in purple and grey, 
respectively. NTR, N-terminal region; HSS, HAND-SANT-SLIDE. 
I also observed novel intra-domain cross-links for the ATPase module and the HSS domain in 
the ADP-BeFx state. In a first step, I thus evaluated the compatibility of all identified intra-
domain cross-links for ATPase lobe 1 (XLSnf2H,nt 67–78), ATPase lobe 2-NegC (XLSnf2H,nt 85–
90 and XLSnf2H,nt 59), and the HSS domain (XLSnf2H,nt 94–107) with the previously generated 
homology models of the respective Snf2H domains. As illustrated in Figure 35, the 
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experimental distance restraints for these functional domains still showed excellent consistency 
with the computed structures.  
 
Figure 35. Intra-domain cross-links for the Snf2H enzyme in the presence of ADP-BeFx. I measured the 
Cα-Cα distances between residues of identified intra-domain cross-links in the respective homology models 
of ATPase lobe 1 (yellow; i.e., XLSnf2H,nt 67−78), ATPase lobe 2 (red; i.e., XLSnf2H,nt 85−90), and the HSS 
domain (green, i.e., XLSnf2H,nt 94−107) of the Snf2H enzyme. Cross-links are depicted as grey rods in the 
homology models, in which the N- and C-termini are furthermore highlighted as cyan spheres for orientation. 
Notably, XLSnf2H,nt 68, which connects residues 249 and 298 in ATPase lobe 1, fulfilled the BS
3
 distance 
threshold but resulted in a direct steric clash by extending through the bulk of the domain. Thus, XLSnf2H,nt 68 
may represent a false positive identification. The presented box plots signify the median (solid line), the Q3-
Q1 range (box), and the minimum and maximum measured Cα-Cα distance (whiskers) for all intra-domain 
cross-links of a given domain. The Cα-Cα distance threshold given by the cross-linking agent is shown as a 
red dotted line in the box plot diagram. STable 4 provides further details for each cross-link.  
Dr. C. Schindler (TUM, Munich) performed the homology modeling of individual Snf2H domains. 
In a next step, I focused on inter-domain cross-links for the HSS domain and the ATPase 
module in order to elucidate similarities and differences in the cross-linking pattern for the 
Snf2H enzyme in the absence and presence of ADP-BeFx. Interestingly, approximately 70% of 
inter-domain cross-links that were identified under apo state conditions were also detected in 
the ADP-BeFx state pointing towards an overall similar structural architecture of the 
remodeling enzyme (Table 2). In line with this qualitative comparison, I found that the 
identified inter-domain cross-links for the ADP-BeFx state were consistent with a ScChd1-like 
conformation of the NegC region (XLSnf2H,nt 50–53, STable 4; Figure 36A) and with the HSS 
domain being in spatial proximity to the ATPase lobes (XLSnf2H,nt 1–18, 23–29) as well as the 
autoregulatory NTR and NegC domains (XLSnf2H,nt 37–46 and XLSnf2H,nt 54–58).  
  
 67 Results 
Cross-links that connected the NTR with the ATPase lobes did not map to identical sites in the 
Snf2H enzyme in the apo (XLSnf2H 38, 39; Table 3) and ADP-BeFx state (XLSnf2H,nt 34–36; 
STable 4). The novel NTR-ATPase lobe cross-links XLSnf2H,nt 34–36, however, remained 
consistent with the MtISWI crystal structure (pdb 5JXR) suggesting a similar positioning of 
the NTR in the ADP-BeFx-bound Snf2H enzyme (Figure 36B).  
 
Figure 36: Evaluation of NTR and NegC cross-links for the ADP-BeFx-bound Snf2H enzyme. (A) NegC 
cross-links mapped onto our ScChd1-based homology model of ATPase lobe 2 (red) and the NegC domain 
(orange). Identified inter-domain cross-links that connect these two regions (XLSnf2H,nt 50–53, STable 4) are 
indicated as grey rods with respective Cα-Cα distances being all satisfied. (B) NegC cross-links mapped onto 
the structure of a single MtISWI protomer (pdb 5JXR). All Cα-Cα distances between the NTR (cyan) and the 
ATPase lobes (ATPase lobe1, yellow and ATPase lobe 2, red) were satisfied. In contrast, all Cα-Cα distances 
between NegC (orange) and ATPase lobe 2 are violated (pink rods; XLSnf2H,nt 50–53) and exceed the distance 
threshold by 26–60 Å in the MtISWI protomer. 
Dr. C. Schindler (TUM, Munich) performed the homology modeling of the depicted structure in panel (A). 
Similar to the XL-MS results for the Snf2H protein under apo state conditions, I only obtained 
a single ATPase lobe-lobe cross-link that restricted the relative orientation of both ATPase 
lobes to each other in the ADP-BeFx state. The respective candidate (XLSnf2H,nt 84, STable 4) 
was identified on the basis of two distinct cross-linked peptides of various charge states and 
bridged the sequence-wise distant C-termini of both ATPase lobes in a similar manner as 
described for Snf2H under apo state conditions. This ATPase lobe-lobe cross-link for the 
ADP-BeFx-bound Snf2H enzyme, however, could not be used to distinguish between the 
markedly distinct orientations of both ATPase lobes depicted in available apo (cf. Figure 4) 
and nucleosome-bound structures of related remodeling enzymes. That is, the Cα-Cα distance 
between corresponding sites was consistently < 15.6 Å in the structures of ScChd1 (pdb 
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3MWY and 5O9G), Sso1653 (pdb 1Z6A), DrRad54 (pdb 1Z3I), MtSnf2 (pdb 5JXR), and 
ScSnf2 (pdb 5X0Y and 5X0X).  
In conclusion, the XL-MS data delineate a rather compact conformation of the ADP-BeFx-
bound Snf2H protein considering that the cross-linking agent bridged numerous domain 
interfaces. Alternatively, the increased number of identified cross-links in the ADP-BeFx state 
relative to apo state conditions could derive from enhanced flexibility of the Snf2H enzyme 
upon binding of the nucleotide analog. The high number of identical/similar cross-linked 
residue pairs for Snf2H in the presence and absence of ADP-BeFx may point towards an 
overall similar structural architecture of the remodeling enzyme under these solution 
conditions. However, I cannot rule out that potential ADP-BeFx-induced conformational 
changes in these Snf2H regions may remained undetected due to the resolution limit of the XL-
MS approach using the chemical BS3 cross-linking agent.  
 
 
Table 2: Identical and similar inter-domain cross-links for the Snf2H enzyme in the apo and ADP-BeFx 
state. Site 1 and site 2 of the cross-linked peptides, the respective protein domains, and the corresponding 
cross-link identification numbers are specified for each identical and similar inter-domain cross-link that was 
identified in both apo and ADP-BeFx states (cf. STable 3 and STable 4). Cross-linked peptides were 
considered similar if the cross-linking sites were within ± 10 amino acids with respect to the primary protein 
sequence. Similar cross-links are denoted in grey. Inter-domain cross-links that mapped to either the NegC-
HSS interconnecting region (i.e., residues 690–742) or the very C-terminal segment (i.e., residues 1023–
1052) are not included in the table. 
Site 1 
Domain  
site 1 
Site 2 
Domain  
site 2 
Apo state  
XLSnf2H 
ADP-BeFx state  
XLSnf2H,nt 
71 NTR 990 HSS 37 38 
97 NTR 990 HSS 36 40 
121 NTR 990 HSS 34 46 
128 NTR 990 HSS 33 45 
129 NTR 990 HSS     app. 33  44 
132 NTR 990 HSS 35 41 
160 NTR 644 NegC  44* 33 
160 NTR 929 HSS 13 42 
176 ATPase lobe 1 847 HSS     app.  9* 1 
176 ATPase lobe 1 855 HSS  9*  2* 
176 ATPase lobe 1 929 HSS  12*  3* 
176 ATPase lobe 1 990 HSS  14*  4* 
223 ATPase lobe 1 929 HSS  10*  6* 
264 ATPase lobe 1 847 HSS 16  11* 
264 ATPase lobe 1 929 HSS  8*  8* 
264 ATPase lobe 1 990 HSS  11*  9* 
328 ATPase lobe 1 929 HSS 3 14 
397 ATPase lobe 1 758 HSS 4 10 
397 ATPase lobe 1 929 HSS  7*  15* 
397 ATPase lobe 1 990 HSS 6  18* 
407 ATPase lobe 2 929 HSS 27     app. 15* 
408 ATPase lobe 2 929 HSS 18     app. 23 
408 ATPase lobe 2 990 HSS 17     app. 24* 
418 ATPase lobe 2 665 NegC 48 53 
418 ATPase lobe 2 929 HSS  26* 23 
418 ATPase lobe 2 990 HSS  29*  24* 
430 ATPase lobe 2 665 NegC 49 52 
    
 
* continues next page * 
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430 ATPase lobe 2 855 HSS 24 25 
430 ATPase lobe 2 990 HSS  28*  26* 
440 ATPase lobe 2 647 NegC 45 51 
443 ATPase lobe 2 644 NegC 46     app. 50 
443 ATPase lobe 2 647 NegC 47 50 
647 NegC 929 HSS 30 54 
665 NegC 990 HSS 31 57 
*:  Cross-links with an asterisk were used for computational docking of the full-length Snf2H enzyme in the 
apo or ADP-BeFx state. 
app.: Approximately 
 
 
 
Table 3: ADP-BeFx-dependent inter-domain cross-links for the Snf2H enzyme. Site 1 and site 2 of the 
cross-linked peptides, the respective protein domains, and the corresponding cross-link identification number 
(cf. STable 4) are specified for each ADP-BeFx-dependent inter-domain cross-link. Inter-domain cross-links 
that mapped to either the NegC-HSS interconnecting region (i.e., residues 690–742) or the very C-terminal 
segment (i.e., residues 1023–1052) are not included in the table. 
Site 1 
Domain  
site 1 
Site 2 
Domain  
site 2 
ADP-BeFx state  
XLSnf2H,nt 
71 NTR 684 NegC 32 
71 NTR 929 HSS 37 
83 NTR 328 ATPase lobe 1 35 
83 NTR 929 HSS 39 
97 NTR 328 ATPase lobe 1 36 
128 NTR 929 HSS 43 
129 NTR 496 ATPase lobe 2 34 
223 ATPase lobe 1 855 HSS 5 
264 ATPase lobe 1 758 HSS 7 
299 ATPase lobe 1 855 HSS  12* 
299 ATPase lobe 1 929 HSS  13* 
299 ATPase lobe 1 990 HSS  16* 
328 ATPase lobe 1 990 HSS  17* 
402 ATPase lobe 1 600 ATPase lobe 2 84 
440 ATPase lobe 2 990 HSS 27 
496 ATPase lobe 2 990 HSS 29 
624 ATPase lobe 2 990 HSS 28 
647 NegC 990 HSS 55 
665 NegC 929 HSS  56* 
684 NegC 990 HSS 58 
*:  Cross-links with an asterisk were used for computational docking of the full-length Snf2H enzyme in the 
ADP-BeFx state. 
 
 
Despite the similarities between cross-linking results for the Snf2H enzyme in the presence and 
absence of the nucleotide analog, I detected several inter-domain cross-links between the 
ATPase module and the HSS domain that were exclusively found in the ADP-BeFx state 
(Table 3) using comparable filtering criteria during MS data analysis (cf. Table 15 in Materials 
and Methods section). It thereby appeared that especially residues of the autoregulatory NTR 
region and ATPase lobe 1 formed cross-links with the HSS domain in an ADP-BeFx-dependent 
manner. Notably, many of these ADP-BeFx-dependent linkages for Snf2H were repeatedly 
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observed across distinct XL-MS analyses as further specified in column ‘Reproducibility 
group’ in STable 4. 
To resolve and visualize these potential ADP-BeFx-induced structural changes in the full-
length Snf2H enzyme, our collaboration partner Dr. C. Schindler (TUM, Munich) performed a 
three-body docking with homology models of both ATPase lobes and the HSS domain in a 
similar manner as described in section 2.3.2. The docking procedure was guided by a total of 
16 inter-domain distance restraints (i.e., XLSnf2H,nt 2–4, 6, 8, 9, 11–13, 15–18, 24, 26, 56; cf. 
STable 4), for which we obtained excellent fragmentation data during MS/MS analysis (cf. 
SFigure 7). As such, the docking procedure relied on previously implemented distance 
restraints as well as ADP-BeFx-dependent linkages between ATPase lobe 1, NegC, and the 
HSS domain (cf. asterisks in Table 3). Figure 37A shows our representative structural models 
of the ADP-BeFx-bound Snf2H enzyme (i.e., the top-ranked models #1−5 and every other 
fifteenth model). These structural models of the Snf2H enzyme in the presence of ADP-BeFx 
were rather heterogeneous. In particular, the orientation of the HSS domain relative to both 
ATPase lobes remained ambiguous, while the ATPase module itself displayed recurrent 
structural characteristics.  
I subsequently evaluated the quality of the structural models depicted in Figure 37A with 
respect to the experimental XL-MS and SAXS data. Measuring the Cα-Cα distances between 
cross-linked residue pairs revealed that none of the investigated Snf2H models satisfied all 
implemented distance restraints used for docking at once (Figure 37B, marked with an 
asterisk). Furthermore, the majority of additional identified inter-domain cross-links listed in 
Table 2 and Table 3 exceeded the BS3 distance threshold (Figure 37B). It thus appears 
plausible that the well-documented flexibility in one or more parts of the full-length Snf2H 
enzyme (89, 129) may hinder us from modeling a single ADP-BeFx-bound conformation of the 
remodeling enzyme. Nevertheless, the SAXS-derived scattering profile of the ADP-BeFx-
bound Snf2H protein (see section 2.4.2) showed partial consistency with the theoretical 
scattering curves of the investigated structural models as reflected by an average χ-value of 3.0 
± 0.23. 
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Figure 37: Structural models of the full-length Snf2H enzyme in the presence of ADP-BeFx. (A) The 
top-ranked structural models for the ADP-BeFx-bound Snf2H enzyme (i.e., models #1−5 and every other 
fifteenth model) are shown and aligned to ATPase lobe 2 of model #1. ATPase lobe 1, ATPase lobe 2, and 
the HSS domain are colored in yellow, red, and green for model #1, respectively. The remaining structures 
are depicted in grey color. (B) I measured the Cα-Cα distances between reactive sites of identified inter-
domain cross-links in each Snf2H model shown in (A). Individual box plots summarize the observed 
distribution of measured Cα-Cα distances for each inter-domain cross-link. That is, each box plot shows the 
median (solid line), the Q3-Q1 range (box), and the minimum and maximum measured Cα-Cα distance 
(whiskers). Cross-links are numbered according to STable 4. Cross-links with an asterisk were used as 
distance restraints during computational docking. The Cα-Cα distance threshold given by the BS3 cross-
linking agent is shown as a red dotted line in the box plot diagram. 
Dr. C. Schindler (TUM, Munich) performed the computational docking of the full-length Snf2H enzyme 
shown in panel (A).  
Despite the above outlined, partial inconsistencies between XL-MS and computational data, it 
is interesting to compare our representative models of the full-length Snf2H enzyme in the apo 
(cf. section 2.3.2) and ADP-BeFx state with each other. For a more structural perspective, I 
superimposed and aligned the top five structural models of each state with regard to the 
ATTRACT score (Figure 38). The superimposition of individual structural models suggests 
that ATPase lobe 1 rotates approximately 180° relative to ATPase lobe 2 upon changing the 
nucleotide state. Furthermore, I observed that the orientation of the HSS domain relative to 
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ATPase lobe 2 is substantially different between Snf2H models for the apo and ADP-BeFx 
states. The drastically different modeling outcomes for the Snf2H enzyme in the apo and ADP-
BeFx state are surprising considering that the large majority of distance restraints used to guide 
the computational docking was identical. The direct comparison of these structural models 
points towards the possibility that the Snf2H protein may undergo major conformational 
changes upon nucleotide analogue binding with identical/similar cross-linked residue pairs 
being formed in both states. However, the comparison between XL-based modeling results for 
the apo and ADP-BeFx states should be done with caution. That is, our structural models are 
too ambiguous to draw conclusive mechanistic inferences with the desired confidence. 
  
Figure 38: Superimposition of structural models of the full-length Snf2H enzyme in the presence and 
absence of ADP-BeFx. The top five ATTRACT-scored docking models of the full-length Snf2H enzyme in 
the apo (cf. Figure 31A) and ADP-BeFx-bound state (cf. Figure 37A) are aligned on ATPase lobe 2 (red). 
The superimposition of structures suggests that ATPase lobe 1 (colored in sand and yellow for the apo and 
ADP-BeFx state, respectively) undergoes a rotation of approximately 180° upon binding of the nucleotide 
analog. Likewise, the orientation of the HSS domain is markedly different in the apo (dark green) relative to 
the ADP-BeFx state (light green).  
Dr. C. Schindler (TUM, Munich) performed the computational docking of the full-length Snf2H enzyme in the 
apo and ADP-BeFx-bound state.  
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2.4.2. Nucleotide-induced conformational changes in ISWI-type remodeling 
enzymes viewed by SAXS analysis 
To further investigate nucleotide-dependent conformational changes in the Snf2H protein, our 
collaboration partner Dr. L. Brützel (LMU, Munich) performed SAXS measurements on the 
remodeling enzyme in the presence and absence of ADP-BeFx and compared the respective 
structural parameters with each other (Figure 39A). In addition, we examined whether the full-
length DmISWI enzyme would exhibit a similar conformational response to the binding of the 
nucleotide analog (Figure 39B). 
Binding of ADP-BeFx resulted in a 6.7% and 10.4% decreased radius of gyration for the full-
length DmISWIWT and Snf2H remodeling enzymes (Figure 39D), respectively. These findings 
suggest that the tested nucleotide analog induces an overall more compact solution-phase 
structure of both full-length proteins.  
In a subsequent step, we examined the impact of ADP-BeFx binding on the catalytic core of the 
DmISWI enzyme. Dr. L. Brützel (LMU, Munich) therefore conducted additional SAXS 
measurements on DmISWI∆HSS in the presence of the nucleotide analog and compared these 
results to corresponding data obtained under apo state conditions (Figure 39C, cf. section 
2.2.1.1). Interestingly, a similar compaction in the ISWI∆HSS variant was observed upon ADP-
BeFx ligation considering that the Rg value decreased by 5.3% relative to apo state conditions 
(Figure 39D). This finding implies that the ATPase module undergoes a global conformational 
change in response to ADP-BeFx binding.  
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Figure 39: ADP-BeFx-induced compaction of remodeling enzymes. Kratky representations for (A) full-
length Snf2H, (B) full-length ISWIWT, and (C) ISWIΔHSS are shown. (D) Tabular overview of the radii of 
gyration for the investigated remodeling enzymes in the presence and absence of the nucleotide analog. Data 
represent means ± standard deviation (n = 2−3). The presented data (A−D) collectively suggest an ADP-
BeFx-dependent compaction of the remodeling enzymes in solution. The panels (B) and (C) as well as values 
of (D) were adapted from (1) in accordance with Elsevier’s policies. 
I purified all protein constructs and prepared the samples for SAXS measurements, which were conducted 
and analyzed by Dr. L. Brützel (LMU, Munich). 
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2.5. Probing the interaction between remodeling enzyme(s) and 
nucleosomes 
Remodeling complexes have to recognize and bind to their substrate in order to fulfill their 
essential functions such as the reposition of nucleosomes along DNA. Detailed structure-
function relationships will pave the way towards a better mechanistic understanding of 
remodeling enzymes and how they interact with nucleosomes on a molecular level. However, 
the majority of structural information for individual enzyme-nucleosome complexes is either of 
low resolution (150), which does not allow for detailed mechanistic inferences or derive from 
truncated enzyme variants (21). The recently determined high-resolution, cryo-EM structure of 
the ScChd1 enzyme in complex with a nucleosome (pdb 5O9G) (24) shows how the 
monomeric ATPase module interacts with nucleosomal DNA at SHL +2 and how it is 
anchored to the N-terminal tail histone H4. The DNA-binding SANT and SLIDE domains 
furthermore contact the extranucleosomal DNA around SHL –7. The binding of remodeling 
enzymes to flanking DNA stretches, as observed in the ScChd1 structure, has been well 
documented (23, 116, 127). However, recent studies suggest an alternative binding mode for 
the HSS domain of the Snf2H enzyme (28, 129). That is, the HSS domain has been suggested 
to bind to the nucleosome core during the DNA translocation step.  
To better understand how the Snf2H protein engages its nucleosomal substrate, we performed 
XL-MS analyses of the ADP-BeFx-bound remodeling enzyme in the presence and absence of 
nucleosomes. The following subsections provide a step-by-step summary of obtained 
experimental results from XL-MS analysis and computational modeling. By comparing cross-
linking data in the presence and absence of nucleosomes in a quantitative manner, I was able to 
gain information about possible substrate-induced conformational changes in the Snf2H 
enzyme.  
 
2.5.1. In-vitro reconstitution of remodeling enzyme-nucleosome complexes 
The four Drosophila core histones were either purified from inclusion bodies or using the RHP 
method (cf. Materials and Methods section 4.2.2.4). Lyophilized histone proteins were mixed 
under denaturing solution conditions and were assembled into histone octamers by dialyzing 
the samples against a high salt refolding buffer. Histone octamers were subsequently purified 
by size-exclusion chromatography as specified in Materials and Methods section 4.2.3.2. The 
DNA for mononucleosomes derived from cut plasmids and was isolated by a native PAGE 
approach (cf. Materials and Methods section 4.2.3.1). Purified DNA fragments of 187 bp 
length comprised the 601 positioning sequence (235) and a flanking DNA stretch. 
Reconstitution of histone octamers with DNA was accomplished by using a salt gradient 
dialysis approach (cf. Materials and Methods section 4.2.3.3). For samples subjected to XL-
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MS analysis, excess of unbound DNA was subsequently removed by glycerol gradient 
centrifugation. As mentioned above, mononucleosomes comprised a one-sided linker DNA of 
40 bp length, which will be referred to as “0N40 mononucleosomes” hereafter. This 
extranucleosomal DNA stretch may serve as an interaction site for the HSS domain in the 
Snf2H-nucleosome complex (23, 151).  
 
In a next step, I screened for suitable conditions that allow for the formation of DmISWI- or 
Snf2H-nucleosome complexes in solution. I therefore incubated increasing concentrations of 
either the DmISWI or Snf2H remodeling enzyme with a constant amount of 0N40 
mononucleosomes as well as 3 mM ADP-BeFx and evaluated complex formation by an 
electrophoretic mobility shift assay (EMSA, cf. Materials and Method section 4.2.7.1). I 
decided to use ADP-BeFx for the reconstitution due to the reported potential of this particular 
nucleotide analog to increase the binding affinity of the Snf2H enzyme towards 0N40 
mononucleosomes (150).  
DmISWI as well as Snf2H appeared to form complexes with 0N40 mononucleosomes (Figure 
40). However, I observed a certain tendency of both remodeling enzymes to form aggregates in 
the presence of substrate (Figure 40A, B). Under comparable solution conditions at elevated 
protein concentrations, I often observed more visible aggregates during EMSA analysis for 
DmISWI than for Snf2H samples. The tendency of the DmISWI enzyme to form protein 
aggregates in the presence of nucleosomes has also been reported recently in the context of 
structural studies of the remodeler (236). I consequently endeavored to prevent aggregation of 
the DmISWI-nucleosome complex by changing potentially critical experimental parameters. 
My efforts encompassed the testing of alternative nucleotides (e.g., ADP and the non-
hydrolyzable AMP-PNP analog), substitution of 0N40 with 0N0 nucleosomes, and the use of 
distinct buffer solutions (cf. section 6.3 in Appendix) commonly employed in nucleosome-
based experiments (116, 150). Despite the sometimes promising EMSA results for the 
DmISWI enzyme for individual conditions (SFigure 3), the handling of these samples 
remained challenging. I therefore decided to focus on the Snf2H enzyme to study structural 
characteristics of an ISWI-type remodeling enzyme in complex with its nucleosomal substrate 
by means of XL-MS analysis.  
The EMSA results suggested that up to three Snf2H molecules might be bound to a single 
nucleosome in solution (Figure 40B) and that Snf2H-nucleosome complexes are compatible 
with the use of chemical cross-linking agents (Figure 40C). The single particle EM study by 
Racki et al. (150) already suggested that two Snf2H molecules bind to a single nucleosome in 
the presence of ADP-BeFx in order to facilitate the bidirectional movement of the substrate 
along DNA in a cooperative manner. The observation that up to three Snf2H engage the 
nucleosome in the present study may be explained by assuming an additional binding site on 
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the flanking DNA stretch (237). Attempts to separate these different Snf2H-nucleosome 
complexes and to remove unbound protein species by size-exclusion chromatography have 
remained ineffective because Snf2H-nucleosome complexes could not be eluted from the size-
exclusion column (data not shown). Notably, other laboratories also experienced challenges in 
separating different protein species in ISWI-nucleosome samples (i.e., free nucleosomes, 
several remodeler-nucleosome complexes as well as free remodeler, and aggregates) by size-
exclusion chromatography (236). 
 
In conclusion, I decided not to pursue XL-MS analysis of the substrate-bound DmISWI protein 
due to the experienced challenges associated with the handling of these samples. Instead, I 
focused on Snf2H-nucleosome complexes and found the following conditions to be most 
promising for XL-MS analysis: 1.5 µM Snf2H enzyme in the presence of either 1.5 or 0.8 µM 
0N40 mononucleosomes, 3 mM ADP-BeFx, and 1 mM BS
3 cross-linker in buffer solution [15 
mM Hepes-KOH (pH 7.6), 4% glycerol, 70 mM KCl, 1 mM DDT, and 1 mM MgCl2]. 
Although the sample heterogeneity under these conditions could complicate the interpretation 
of experimental results (Figure 40C), I envisaged having enough Snf2H-nucleosome 
complexes in solution that allow the unambiguous identification of intermolecular cross-links 
during MS/MS analysis. 
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Figure 40: Monitoring the interaction of DmISWI and Snf2H with mononucleosomes. I monitored 
complex formation between 0N40 mononucleosomes and either Snf2H or DmISWI by a 4.5% native 
PAGE/0.2x TBE approach and ethidium bromide staining. (A and B) I incubated increasing concentrations of 
DmISWI (left) and Snf2H (right) with 0N40 mononucleosomes and the indicated nucleotide (ADP or ADP-
BeFx) in EMSA buffer #4 (cf. Table 12). I predominantly observed protein aggregates at DmISWI 
concentrations > 1 µM. In contrast, protein aggregation was less pronounced for the Snf2H enzyme under 
comparable solution conditions. Titration furthermore revealed that more than one Snf2H molecules may 
bind to a single nucleosome. Notably, the nucleosomes used in (A) were not purified over a glycerol gradient, 
which explains the band corresponding to ‘overassembled nucleosomes’. (C) The formation of Snf2H-
nucleosome complexes appeared to be compatible with the use of chemical cross-linkers. M: Marker. See 
also SFigure 3 for additional EMSA results. 
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2.5.2. Cross-linking of the Snf2H-nucleosome complex 
I cross-linked the Snf2H enzyme in the presence of its nucleosomal substrate (i.e., 0N40 
mononucleosomes) using the BS3 cross-linker to gain a better structural understanding of this 
interaction and to uncover potential conformational changes in the target proteins upon 
complex formation. The XL-MS workflow was essentially the same as described above for the 
Snf2H enzyme with MS analysis being conducted by our collaboration partner Dr. I. Forné 
(LMU, Munich). 
A total of 253 peptides passed the filtering criteria during peptide identification (cf. Table 15 in 
Materials and Methods) yielding 181 unique cross-linked residue pairs for the Snf2H-
nucleosome state (Figure 41, STable 5). Notably, the large majority of these cross-linking sites 
(74%) were reproducible in at least technical replicates as further specified in STable 5. Cross-
linking candidates, for which the spacing between reactive sites was below ten amino acids, 
were not considered for further analysis. These candidates were often found in individual 
histone tails, which are very rich in surface-exposed lysine residues. 
 
Figure 41: Identified cross-links for the full-length Snf2H enzyme in complex with nucleosomes and 
ADP-BeFx. Schematic representation of the Snf2H enzyme and individual histone proteins with identified 
inter- and intra-domain cross-links being indicated as solid and dotted arcs (cf. color scheme), respectively. 
STable 5 provides further details for each presented cross-link. Identified inter-molecular cross-links (cf. 
SFigure 11 for MS/MS spectra) are shown as purple lines. Numbers refer to the amino acid numbering of the 
individual proteins. NTR, N-terminal region; HSS, HAND-SANT-SLIDE. 
Dr. I. Forné (LMU, Munich) performed the MS analysis. 
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In a first step, I focused on the identified intra-molecular cross-links for both the full-length 
Snf2H enzyme and the histone octamer. In the case of the octamer, the identified linkages were 
sometimes confined to a single subunit (XLSnf2H,c 1–17; STable 5) but frequently also provided 
information about the distance between two histone proteins (XLSnf2H,c 18–31). To examine 
potential conformational changes in the octamer upon Snf2H binding as suggested recently 
(238), I mapped the identified intra-molecular cross-links onto an available crystal structure of 
the nucleosome (pdb 2PYO). The majority of these linkages (XLSnf2H,c 1, 3–17, 19, 20, 23, 25, 
28, 30, 31), however, mapped to nucleosomal regions (e.g., histone tails) for which atomic 
coordinates are lacking in the crystal structure. Accessible cross-links for the histone octamer 
(XLSnf2H,c 2, 18, 21, 22, 24, 26, 27, 29) are illustrated in Figure 42A and showed consistency 
with the nucleosome structure because Cα-Cα distances between cross-linked lysine residues 
did not violate the defined distance threshold of the BS3 agent. Thus, our cross-linking data for 
the Snf2H-nucleosome state do not provide further experimental evidence for binding-induced 
conformational changes in the histone octamer within the resolution of the XL-MS approach.  
 
In the case of the Snf2H enzyme, I identified several intra-domain cross-links (XLSnf2H,c 86–
119), which I mapped onto the respective homology models (cf. section 2.3.1). I found that all 
distance restraints (XLSnf2H,c 90–103) were fulfilled in our structural models of both ATPase 
lobes (Figure 42B). Likewise, the large majority of intra-domain distance restraints for the 
HSS domain (XLSnf2H,c 104–119) were satisfied (Figure 42B). However, three cross-links that 
connect residues of the HAND and SLIDE regions (XLSnf2H,c 117–119) substantially exceeded 
the BS3 distance threshold by a factor of 2−3 (Figure 42C). This apparent mismatch between 
experimental data and our homology model of the DNA-binding domain may point towards a 
nucleosome-dependent conformational change of the HSS domain. However, the possibility 
that these incompatible cross-links were formed between two Snf2H molecules cannot be ruled 
out. The probability of false sequence assignments for XLSnf2H,c 117 and 118 is low given the 
consecutive ion series and good signal intensities of the fragment ions detected during MS/MS 
analysis of these candidates (SFigure 8). 
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Figure 42: Mapping of identified intra-molecular and intra-domain cross-links for the Snf2H enzyme 
in the presence of nucleosomes. (A) The crystal structure of the nucleosome (pdb 2PYO) is shown with 
individual histone proteins being colored as specified in Figure 41. All accessible intra-molecular cross-links 
for the histone octamer are depicted as grey rods and spheres in the nucleosome structure. The box plot 
signifies the median (solid line), the Q3-Q1 range (box), and the minimum and maximum measured Cα-Cα 
distance (whiskers) for all intra-molecular cross-links of the nucleosome. The Cα-Cα distance threshold of 
the BS
3
 cross-linker is indicated as a red dotted line in the box plot diagram. (B) The Cα-Cα distances 
between cross-linked residues of identified intra-domain linkages were measured in the respective homology 
models of ATPase lobe 1, ATPase lobe 2, and the HSS domain of the Snf2H enzyme. The presented box 
plots signify the median (solid line), the Q3-Q1 range (box), and the minimum and maximum measured Cα-
Cα distance (whiskers) for all intra-domain cross-links of a given domain. The Cα-Cα distance threshold of 
the BS
3
 cross-linker is shown as a red dotted line. (C) Identified cross-links for the HSS domain of the Snf2H 
enzyme in the presence of nucleosomes are mapped onto the respective homology model. Intra-domain 
cross-links (XLSnf2H,c 104–119) are indicated as rods and spheres in the homology model, in which the N- and 
C-termini are furthermore highlighted in cyan for orientation. Grey and pink rods connect cross-linked 
residue pairs for which the Cα-Cα distance threshold is satisfied and violated, respectively. STable 5 provides 
further details for individual cross-links. MS/MS spectra of cross-links XLSnf2H,c 117–119 are provided in 
SFigure 8. 
Dr. C. Schindler (TUM, Munich) performed the homology modeling of individual Snf2H domains, which 
were used in panels (B) and (C) for the evaluation of XL-MS data. 
In a next step, I examined the 86 inter-domain cross-links that were identified for the Snf2H 
enzyme in the presence of 0N40 mononucleosomes (XLSnf2H,c 32–85, 90, 91, and 120–149; 
STable 5). Approximately two-thirds of these linkages (i.e., XLSnf2H,c 38, 41, 42, 46–58, 75–85, 
91 and 120–149) mapped to either the NTR, the NegC-HSS interconnecting region (i.e., 
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residues 690–742) or the very C-terminal segment (i.e., residues 1023–1052) of the Snf2H 
protein, for which we lack atomic coordinates in our structural models. Furthermore, I noticed 
that numerous cross-linked residue pairs for the Snf2H-nucleosome state were identical or 
highly similar to the ones detected in the apo and ADP-BeFx-bound states (Table 4). These 
cross-links listed in Table 4 predominantly mapped to the HSS domain implying that the 
SLIDE region is spatially neighboring both ATPase lobes (XLSnf2H,c 32–37, 39, 40, and 43–45) 
as well as the autoregulatory NTR and NegC domains (XLSnf2H,c 53–58 and 71–74). The 
structural interpretation of shared inter-domain cross-links is not straightforward because these 
cross-links could also originate from unbound Snf2H molecules and thus may not reflect 
structural properties of the nucleosome-bound remodeling enzyme. As outlined above, 
attempts to separate complexed and unbound Snf2H molecules after the cross-linking reaction 
by size-exclusion chromatography have remained unsuccessful.  
 
 
Table 4: Identical and similar inter-domain cross-links for the Snf2H enzyme in the apo, ADP-BeFx, 
and nucleosome state. Site 1 and site 2 of the cross-linked peptides, the respective protein domains, and the 
corresponding cross-link identification numbers are specified for each identical and similar inter-domain 
cross-link that was identified in the apo, ADP-BeFx, and nucleosome state (cf. STable 3–STable 5 and 
SFigure 9 for MS/MS spectra). Cross-linked peptides were considered similar if the cross-linking sites were 
within ± 10 amino acids with respect to the primary protein sequence. Similar cross-links are denoted in grey. 
Inter-domain cross-links that mapped to either the NegC-HSS interconnecting region (i.e., residues 690–742) 
or the very C-terminal segment (i.e., residues 1023–1052) are not included in the table. 
Site 1 
Domain  
site 1 
Site 2 
Domain  
site 2 
Apo state  
XLSnf2H 
ADP-BeFx 
state  
XLSnf2H,nt 
Nucleosome 
state  
XLSnf2H,c 
121 NTR 990 HSS 34 46 56 
121 NTR 929 HSS N/D  app. 43 57 
128 NTR 929 HSS N/D 43  app. 57 
119 NTR 990 HSS  app. 34  app. 46 55 
128 NTR 990 HSS 33 45  app. 58 
129 NTR 990 HSS  app. 33 44 58 
132 NTR 990 HSS 35 41  app. 58 
176 ATPase lobe 1 847 HSS N/D 1 32 
176 ATPase lobe 1 929 HSS 12 3 33 
176 ATPase lobe 1 990 HSS 14 4 34 
264 ATPase lobe 1 929 HSS 8 8 35 
299 ATPase lobe 1 929 HSS N/D 13 36 
299 ATPase lobe 1 990 HSS N/D 16 37 
418 ATPase lobe 2 665 NegC 48 53 67 
418 ATPase lobe 2 990 HSS 29 24 43 
430 ATPase lobe 2 665 NegC 49 52 66 
430 ATPase lobe 2 990 HSS 28 26 45 
440 ATPase lobe 2 647 NegC 45 51 64 
443 ATPase lobe 2 644 NegC 46  app. 50 62 
443 ATPase lobe 2 647 NegC 47 50 63 
647 NegC 929 HSS 30 54 72 
647 NegC 990 HSS N/D 55 74 
665 NegC 929 HSS N/D 56 71 
665 NegC 990 HSS 31 57 73 
app.: Approximately 
N/D:  Not determined 
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However, I identified several inter-domain cross-links for the Snf2H enzyme that were solely 
detected in the presence of the nucleosomal substrate (Table 5). These nucleosome-dependent 
cross-links predominantly connected the autoregulatory NTR and NegC domains with ATPase 
lobe 1 and ATPase lobe 2, respectively. The qualitative comparison of XL-MS data for the 
Snf2H enzyme in the ADP-BeFx and nucleosome states may point towards conformational 
changes in the autoregulatory NTR and NegC regions upon substrate binding. Interestingly, 
both the NTR and the NegC region have previously been reported to undergo substrate-
dependent conformational changes with molecular details, however, remaining elusive and 
being the subject of extensive debate (28, 115, 140, 146). The identified cross-links for the 
nucleosome state, listed in Table 4 and Table 5, are consistent with the notion that the NTR 
and NegC of the Snf2H enzyme are spatially neighboring ATPase lobe 1 and ATPase lobe 2, 
respectively. Furthermore, both autoregulatory regions may contact the DNA-binding domain 
in the presence of substrate. 
 
 
Table 5: Nucleosome-dependent inter-domain cross-links for the Snf2H enzyme. Site 1 and site 2 of the 
cross-linked peptides, the respective protein domains, and the corresponding cross-link identification number 
(cf. STable 3, STable 5 and SFigure 10 for MS/MS spectra) are specified for each inter-domain cross-link. 
None of the listed cross-links was found in the ADP-BeFx state. However, some ATPase lobe 2-NegC and 
ATPase lobe 2-HSS cross-links that were identified in the presence of nucleosomes were also detected under 
apo state conditions. Similar cross-links are denoted in grey. Inter-domain cross-links that mapped to either 
the NegC-HSS interconnecting region (i.e., residues 690–742) or the very C-terminal segment (i.e., residues 
1023–1052) are not included in the table. 
Site 1 
Domain  
site 1 
Site 2 
Domain  
site 2 
Apo state  
XLSnf2H 
ADP-BeFx 
state  
XLSnf2H,nt 
Nucleosome 
state  
XLSnf2H,c 
83 NTR 990 HSS N/D N/D 53 
112 NTR 814 HSS N/D N/D 54 
119 NTR 328 ATPase lobe 1 N/D N/D 50 
121 NTR 176 ATPase lobe 1 N/D N/D 52 
121 NTR 319 ATPase lobe 1 N/D N/D 51 
128 NTR 176 ATPase lobe 1 N/D N/D 91 
160 NTR 176 ATPase lobe 1 N/D N/D 90 
176 ATPase lobe 1 758 HSS N/D N/D 39 
176 ATPase lobe 1 799 HSS N/D N/D 40 
407 ATPase lobe 2 684 NegC  app. 50 N/D 70 
408 ATPase lobe 2 684 NegC 50 N/D 69 
418 ATPase lobe 2 684 NegC  app. 50 N/D 68 
430 ATPase lobe 2 647 NegC  app. 45 N/D 65 
430 ATPase lobe 2 929 HSS 25 N/D 44 
440 ATPase lobe 2 647 NegC 45 N/D  app. 65 
490 ATPase lobe 2 647 NegC N/D N/D 59 
490 ATPase lobe 2 665 NegC N/D N/D 60 
490 ATPase lobe 2 684 NegC N/D N/D 61 
app.: Approximately 
N/D:  Not determined 
  
 84 Results 
2.5.3. Quantitative cross-linking revealed conformational change of the HSS 
domain triggered by nucleosomes  
To further explore the possibility of a nucleosome-dependent reorientation of the HSS domain 
relative to the ATPase module in the full-length Snf2H enzyme, I pursued a quantitative cross-
linking strategy that relies on the use of a “light” cross-linker and its deuterated, “heavy” 
analog (239). Briefly, I used the light BS3-H4 and heavy BS
3-D4 analogs for the relative 
quantification of shared inter-domain cross-links for the Snf2H enzyme in the ADP-BeFx and 
nucleosome state (cf. Table 4). These analogs display a constant mass difference of nearly 4 
Da and thus give rise to doublet signals during mass analysis. For my purpose, I cross-linked 
the ADP-BeFx-bound Snf2H enzyme in the absence and presence of 0N40 nucleosomes with 
the BS3-H4 and BS
3-D4 cross-linking agent, respectively. Subsequent to the quenching of the 
cross-linking reaction, both protein fractions were mixed in a 1:1 molar ratio and the combined 
sample was subjected to tryptic digestion. Cross-linked peptides were enriched by size-
exclusion chromatography and the samples were measured in collaboration with Dr. I. Forné 
(LMU, Munich) by LC-MS/MS analysis. In a final step, I integrated the peak areas of the light- 
and heavy-labeled cross-linking candidates using the Skyline software and calculated the ratio 
between the two cross-linker analogs (cf. Materials and Methods section 4.2.4.6). 
 
In a first step, I validated the quantification approach using a simplified experimental setup. 
That is, I cross-linked the Snf2H protein under apo state conditions with either BS3-H4 or BS
3-
D4 and mixed the two protein samples in a 1:1 molar ratio. Under these experimental 
conditions, I expected to find equal peak areas for the light- and heavy-labeled cross-links and 
thus a BS3-H4/BS
3-D4 ratio of approximately 1. I focused on the relative quantification of five 
cross-links in this control experiment: XLSnf2H 48 and XLSnf2H 31 were consistently identified 
in all investigated Snf2H states (cf. Table 4) and the remaining cross-links XLSnf2H 3, 19, and 
29 were selected due to favorable signal intensities in combination with good fragmentation 
data during MS/MS analysis. I assigned these cross-linking candidates in the Skyline software 
based on extracted ion chromatograms and the following criteria: (i) correct retention time, (ii) 
correct assignment of the elution peak boundaries used for integration, (iii) precursor mass 
accuracy < 7.5 ppm, (iv) correct charge state, and (v) correct isotope distribution of the 
precursor ions. I then integrated the peak areas and calculated the BS3-H4/BS
3-D4 ratio for each 
cross-linked peptide. The integration was performed for two technical replicates, different size-
exclusion fractions, and different charge states of the precursor ions (see blue diamond 
symbols in Figure 43C). The BS3-H4/BS
3-D4 ratio for each cross-link was calculated as the 
average of all supporting ratios for that linkage (see blue bars in Figure 43C). The analyzed 
cross-links in this control experiment displayed an average BS3-H4/-D4 ratio of 0.8 ± 0.1 (see 
blue dotted line in Figure 43C), which is close to the expected value of 1. Consequently, the 
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preliminary results overall indicated that the sample preparation procedure and the defined 
assignment criteria are adequate to relatively quantify individual inter-domain cross-links for 
the Snf2H enzyme.  
 
I proceeded to study the conformational impact of nucleosome binding on the Snf2H enzyme 
as described in the above paragraphs. I therefore determined the BS3-H4/BS
3-D4 ratio for 
shared inter-domain cross-links listed in Table 4 (Figure 43C). These cross-links 
predominantly connected the HSS domain with the ATPase module but sometimes also 
bridged the NegC region and ATPase lobe 2. In the case of individual NTR-HSS cross-links, I 
observed equal peak areas between the ADP-BeFx and nucleosome state suggesting that 
binding of the nucleosome did not alter the likelihood of cross-linking reactions between the 
respective Snf2H regions. Likewise, the large majority of NegC-HSS cross-links exhibited a 
BS3-H4/BS
3-D4 ratio of approximately 1. However, linkages between both ATPase lobes and 
the HSS domain appeared to be enriched in the ADP-BeFx state relative to the nucleosome-
bound state with average BS3-H4/BS3-D4 ratios ranging from 1.7 to 3.6. These results imply 
that binding of the nucleosome to the Snf2H enzyme hampered the formation of cross-links 
between the HSS domain and both ATPase lobes and potentially point towards a nucleosome-
dependent reorientation of the DNA-binding domain relative to the catalytic core. In contrast, 
four out of five cross-linked residue pairs between ATPase lobe 2 and NegC exhibited a 
decreased BS3-H4/BS
3-D4 ratio suggesting that the formation of ATPase lobe 2-NegC cross-
links is favorable in the presence of nucleosomes. 
In conclusion, the results for the relative quantification of inter-domain cross-links are 
consistent with the notion that binding of the nucleosome to the Snf2H enzyme resulted in a 
reorientation of the HSS domain relative to the catalytic core. These substrate-induced 
structural changes in the full-length Snf2H enzyme may encompass the partial disruption of the 
interface between the ATPase module and the HSS domain. Together with the observation that 
Snf2H-nucleosome cross-links almost exclusively mapped to the HSS domain (cf. STable 5), it 
is tempting to speculate that the position of the DNA-binding domain changes in a substrate-
dependent manner such that it can contact the nucleosome core during the catalytic cycle.  
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Figure 43: Quantitative cross-linking of the Snf2H enzyme. (A) Representative extracted ion 
chromatograms for XLSnf2H,c 71 that connected the NegC region and the HSS domain. The purple and green 
signal corresponds to the candidate cross-linked with the light and the heavy BS
3
 analog, respectively. The 
peak areas for the light- and heavy-labeled peptides are similar as indicated by a BS
3
-H4/-D4 ratio close to 1. 
(B) Representative extracted ion chromatograms for XLSnf2H,c 45 that connected ATPase lobe 2 and the HSS 
domain. This cross-linked residue pair exhibited a substantially increased BS
3
-H4/-D4 ratio suggesting that 
binding of the nucleosome to the Snf2H enzyme hampered the formation of this particular cross-link. (C) 
Quantitative analysis of inter-domain cross-links for the Snf2H enzyme. The BS
3
-H4/-D4 ratio for individual 
inter-domain cross-links listed in Table 4 (colored in grey) and the control experiment (colored in blue, see 
main text) are shown. Diamond symbols represent determined BS
3
-H4/-D4 ratios for a particular cross-linked 
residue pair with average values being shown as bars. For the control experiment, the Snf2H enzyme was 
cross-linked with either BS
3
-H4 or BS
3
-D4 under apo state conditions and individual quantified cross-links 
are denoted according to their XLSnf2H identification number provided in STable 3. The average BS
3
-H4/-D4 
ratio across all control peptides was 0.8 (blue dotted line), which is close to the expected value of 1. For 
inter-domain cross-links (‘XLSnf2H,c’, cf. STable 5) listed in Table 4, values above and below 1 signify an 
enrichment of a particular cross-link in the ADP-BeFx and nucleosome state, respectively. Cross-links, for 
which no quantification could be performed, are marked with ‘n.d.’ (n.d. = not determined). Superscript 
circles and asterisks indicate identical cross-links.  
Dr. I. Forné (LMU, Munich) collected the LC-MS/MS data that were used to quantify individual cross-links. 
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2.5.4. Binding of the HSS domain to the nucleosome 
ISWI-type remodeling enzymes have been demonstrated to interact with DNA that flanks the 
nucleosome via their characteristic HSS domain (23, 116, 127). Likewise, the SS domain of 
the ScChd1 enzyme has been observed to contact extranucleosomal DNA (24) thereby 
contributing to the affinity between the enzyme and the nucleosomal substrate (145). Recent 
experimental evidence point towards a conformational switch of the HSS domain during the 
transition from a DNA length sensing to a translocation-competent state. That is, the HSS 
domain is released from the flanking DNA stretch to interact with the core of the nucleosome 
(28, 129). XL-MS analysis provided an excellent opportunity to investigate how the HSS 
domain of the Snf2H enzyme interacts with the 0N40 mononucleosomes in the presence of 
ADP-BeFx.  
 
As indicated in Figure 41, I identified a total of 32 cross-links that connected the Snf2H 
enzyme and the histone octamer (XLSnf2H,c 150–181, STable 5; MS/MS spectra are provided in 
SFigure 11). Cross-links originating from individual histone proteins mapped to either ATPase 
lobe 1, the NegC-HSS interconnecting region (i.e., residues 690–742), the HSS domain or the 
very C-terminal segment (i.e., residues 1023–1052) of the full-length Snf2H enzyme. In 
particular, the SLIDE region of the HSS domain readily cross-linked to the histone octamer 
(XLSnf2H,c 150, 153–155, 164–167, 169, 170, 173–176, 179–181). The lack of adequate high-
resolution structural data for the histone tails, the NegC-HSS interconnecting region, and the 
very C-terminal segment of the Snf2H enzyme, however, hampered an in-depth structural 
interpretation of most Snf2H-nucleosome interactions. Instead, I noticed that the distribution of 
cross-linked lysine residues significantly differed for individual histone proteins of the octamer 
assembly. That is, inter-molecular cross-links for the H3 and H4 proteins mapped to the 
histone tails, whereas cross-linking sites for the H2A and H2B subunits were preferentially 
found at the nucleosome core (cf. STable 5). Interestingly, the cross-linked residues in H2B 
(i.e., K105, K117, and K122) were located at the αC-helix and thus were in spatial proximity 
to the solvent-exposed acidic patch of the nucleosome, which has been proposed to serve as an 
important interaction surface for the autoregulatory NTR and NegC domains of the Snf2H 
enzyme (28). Of particular interest are XLSnf2H,c 153−155, in which the BS
3 cross-linker 
bridged individual residues close to the acidic patch and the SLIDE domain. We lack atomic 
coordinates in our Snf2H homology models for the remaining Snf2H-nucleosome cross-links 
that mapped to the acidic patch region (XLSnf2H,c 151, 152, 156−158, 160, and 161). 
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To visualize potential binding modes of the HSS domain to the nucleosome, our collaboration 
partner Dr. C. Schindler (TUM, Munich) modeled the DNA-binding domain of DmISWI (pdb 
1OFC) onto the Drosophila nucleosome (pdb 2PYO) in a two-body docking procedure. The 
computational docking was performed in a similar manner as described in the above sections 
and was guided by a single distance restraint (XLSnf2H,c 154, Figure 44A). The remaining 
Snf2H-nucleosome cross-links XLSnf2H,c 150, 153, and 155 could not be considered as distance 
restraints during computational modeling because these linkages were not identified until the 
docking was completed. In addition, identified inter-molecular cross-links, which mapped to 
the histone tails, could not be considered during docking due to the lack of atomic coordinates 
for the respective residues in the nucleosome structure. 
The final 200 models of the HSS-nucleosome complex were validated with respect to XL-MS 
data by assessing the Cα-Cα distances between cross-linked residue pairs of accessible, inter-
molecular linkages (XLSnf2H,c 150 and 153–155). Model #22 was most consistent with the 
experimental data among the top-ranked docking structures and is depicted in Figure 44B. 
Notably, the measured Cα-Cα distances for individual SLIDE-H2B cross-links (XLSnf2H,c 153–
155) were all compatible with model #22 of the HSS-nucleosome complex. The detected 
SLIDE-H2A cross-link (XLSnf2H,c 150), however, exceeded the BS
3 distance threshold by 13 Å. 
The cross-linked K118 residue of XLSnf2H,c 150 is located in an unstructured and potentially 
flexible H2A region at the C-terminal tail, which provides a structure-based explanation for the 
violated Cα-Cα distance. 
 
In summary, our XL-MS data suggest that the SLIDE region of the Snf2H enzyme is in spatial 
proximity to the nucleosome core upon complex formation. The representative structural 
model of the HSS-nucleosome complex shown in Figure 44B illustrates a potential binding 
mode of DNA-binding domain to the histone octamer, which is largely consistent with the 
experimental XL-MS data. As such, these findings provide novel evidence for an alternative 
binding position of the HSS domain during the catalytic cycle of the Snf2H protein that are 
consistent with recent experimental results from the Narlikar laboratory (28, 129). 
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Figure 44: Proposed binding mode of the HSS domain. (A) MS/MS spectrum of XLSnf2H,c 154, which was 
used to guide the docking of the HSS-nucleosome complex shown in (B). The monoisotopic peaks of y- and 
b-fragment ions from the cross-linked H2B (blue) and SLIDE (orange) peptides are denoted. SFigure 11 
shows additional MS/MS spectra of cross-links depicted in (B). (B) Our XL-MS-based structural model of 
the HSS domain (green, pdb 1OFC) in complex with the nucleosome (grey, pdb 2PYO) is shown. Notably, 
the SLIDE domain is in close spatial proximity to residues of the acidic patch (magenta spheres) of the 
histone octamer. The black lines and spheres (labeled a–d) represent identified inter-molecular cross-links 
(i.e., XLSnf2H,c 150, 153, 154, and 155; cf. STable 5). The cross-link with an asterisk was used as a distance 
restraint during computational docking.  
Dr. I. Forné (LMU, Munich) performed the MS analysis shown in panel (A). Dr. C. Schindler (TUM, 
Munich) performed the computational docking of the HSS-nucleosome complex depicted in panel (B).  
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3. Discussion 
Changes in chromatin structure rely on the action of specialized chromatin remodeling 
complexes, which operate in any eukaryotic cell in an ATP-dependent manner and thus play a 
pivotal role in a vast variety of important cellular processes (82, 240, 241). Not surprisingly, 
mutation and misregulation of these chromatin remodeling complexes are linked to cancer and 
a plethora of severe diseases (242-244). The ISWI-family of chromatin remodeling complexes 
has been demonstrated to catalyze nucleosome assembly and sliding in vitro (85, 138, 245, 
246), and indeed most of the activity can be recapitulated by the ISWI remodeling enzyme 
itself. In the present thesis, I studied the structural architecture and function of two prototypical 
ISWI-type remodeling enzymes, DmISWI and Snf2H, using an integrative structural approach. 
The implications of the presented findings are discussed in the context of the existing structural 
and functional framework for ISWI-type and related enzymes in the following sections. 
 
 
3.1. Structure determination by an integrative approach 
X-ray crystallography and NMR spectroscopy have proven to be highly useful approaches for 
high-resolution structure elucidation of proteins and protein complexes and thus have been 
considered indispensable tools in modern structural biology. However, structure determination 
by these traditional methods often fails for larger, more heterogeneous, and/or more dynamic 
target proteins (247-249). ISWI-type chromatin remodeling enzymes have proven to be 
refractory to traditional X-ray crystallography and NMR spectroscopy, which is perhaps best 
reflected by the lack of comprehensive high-resolution structures for this class of proteins (cf. 
section 1.2.3).  
In this PhD project, I studied the structural architecture of ISWI-type remodelers across 
different steady-state conditions using an integrative structural approach that combines two 
complementary experimental data sources with computational modeling. We integrated SAXS 
and XL-MS analysis into our structural approach because we envisaged that these low and 
intermediate resolution techniques provide excellent complementary data to narrow down 
possible solution conformations of the DmISWI and Snf2H remodeling enzymes. That is, the 
combination of XL-MS data and computational modeling has proven useful to restrict the 
conformational search space during the docking procedure by implementing identified inter-
domain cross-links as distance restraints. Likewise, the global shape information provided by 
SAXS measurements was essential to select and validate individual DmISWI and Snf2H 
models from the ensemble of computed structures. The available high-resolution structures of 
related ATPases under apo state conditions differ drastically with respect to each other (Figure 
4) and thus did not provide molecular clues for the validity of the modeling outcomes. Our 
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proposed model of the DmISWI ATPase domain under apo state conditions (Figure 14A) 
exhibited a novel orientation of both ATPase lobes at the time the computational docking was 
completed. The XL-MS based model achieved an accuracy that was instrumental to driving 
further experimental investigations including for instance charge-reversal mutations in the 
putative lobe-lobe interface. Strikingly, the recently published crystal structure of the MtISWI 
protein (146) depicts an almost identical configuration of both ATPase lobes (Figure 15). 
Considering that X-ray crystal structures represent stable solid-state conformations, which is 
often a poor indicator for the most populated conformation in solution and solution-state 
dynamics (250), our structural data provide an independent validation of the MtISWI ATPase 
structure in solution. Consequently, our study is an excellent example of how docking driven 
by lower-resolution experimental data can offer an alternative to classical structure 
determination, especially when higher-resolution techniques such as X-ray crystallography 
prove difficult to be applied. Assuming that our model of the ATPase domain reflects the 
predominant conformation under apo state conditions, the implementation of XL-MS-derived 
distance restraints to guide computational docking was essential for the success of this study. 
That is, the ab-initio docking resulted in a substantially different and potentially irrelevant 
orientation of both ATPase lobes for DmISWI (Figure 16) underscoring the well-documented 
advantages of integrative modeling over ab-initio structure prediction (251).  
 
Despite the promising results for the DmISWI ATPase domain, I encountered several 
experimental challenges using the integrative structural approach. While chemical cross-
linking generally resulted in numerous cross-links between the HSS domain and the ATPase 
module for both remodeling enzymes, I identified only a limited set of linkages that connected 
both ATPase lobes. This discrepancy in terms of number of identified inter-domain cross-links 
for particular regions of the remodeling enzymes could have diverse origins. It appears most 
likely that the conformation of the ATPase domain was unfavorable for the formation of 
chemical ATPase lobe-lobe cross-links. Alternatively, these cross-linked products may exhibit 
less favorable ionization properties than other inter-domain cross-links or they were simply not 
detected/identified during MS/MS analysis due to interfering ion species and/or insufficient 
fragmentation data. The identification of cross-linked peptides based on LC-MS/MS data is 
tightly coupled to the criteria listed in Table 15. Lowering these identification criteria, 
however, increases the risk of false-positive identifications during data analysis. 
To rationalize potential reasons for the low number of identified ATPase lobe-lobe cross-links, 
I listed all theoretically possible cross-links for the full-length DmISWI model under apo state 
conditions (Figure 21) using the Xwalk software (http://www.xwalk.org/) (252) with the 
following settings: first and second residue in cross-links: Lys, intra-protein cross-links, and 
maximum Euclidean distance: 29 Å. Notably, only 7% of the predicted 399 cross-links 
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connected both ATPase lobes. Considering that solvent-accessibility of reactive sites, steric 
constraints in the DmISWI protein, and the ionization properties of the cross-linked products 
were neglected during the Xwalk approximation, I would expect to find a low number of 
ATPase lobe-lobe linkages. In line with this notion, XL-MS analysis of the Snf2H enzyme in 
the presence of substrate and ADP-BeFx by Gamarra et al. (28) resulted in a comparably low 
number of ATPase lobe-lobe connecting cross-links with less than 1% of all uniquely 
identified cross-links restricting the orientation of both ATPase lobes to each other. 
In the case of the DmISWI enzyme, we could counteract the low number of chemical cross-
links between both ATPase lobes by including previously published data from site-directed 
UV cross-linking experiments (115, 157). The broader specificity of genetically encoded Bpa 
appears to be beneficial to extract structural information at a desired position in the target 
protein, for which chemical cross-linking is less promising. In the case of the Snf2H enzyme, 
our collaboration partner Dr. C. Schindler (TUM, Munich) performed a three-body docking 
protocol in order to overcome the limited number of identified ATPase lobe-lobe cross-links. 
Thus, the conformation of the ATPase lobes in our full-length Snf2H model almost exclusively 
relied on distance restraints between the ATPase module and the HSS domain. Modeling of the 
full-length Snf2H enzyme based on identified HSS cross-links turned out to be challenging 
because the large majority of linkages used for docking involved either residues K929 or 
K990, which were also found to contact broadly distributed residues of the NTR, ATPase lobe 
1, ATPase lobe 2, and NegC (Figure 29). As a consequence, we were not able to obtain a full-
length Snf2H model under apo state conditions, in which all distance restraints used for 
docking were satisfied at the same time (Figure 31B). Most likely, I captured different 
conformational sub-states of the Snf2H enzyme that are present under the tested apo state 
conditions. However, assignment of individual cross-links to unknown states of a co-existing 
conformational ensemble was not feasible using our modeling protocol. Attempts of detailed 
modeling based on partially ambiguous and/or conflicting cross-linking data has recently been 
performed for the yeast RNA polymerase III complex using an alternative modeling software, 
termed XL-MOD (253). In contrast to our modeling protocol, the XL-MOD software allows 
for the identification of alternative conformations by automatically weighing individual cross-
links and by allowing subunit structures to be flexible during conformational sampling. While 
one could argue that the implementation of protein dynamics during conformational sampling 
might result in an even more complex and heterogeneous ensemble of computed structures, the 
classification of individual cross-links into conformation-specific subgroups is potentially 
worthwhile to explore.   
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In the present study, the modeling of ISWI-type remodeling enzymes was driven by selected 
XL-MS-derived distance restraints. The selection of distance restraints used for docking relied 
on the quality of fragmentation data obtained for cross-linked products during MS/MS 
analysis. This objective selection criterion allowed us to categorize cross-linked products as 
“low-“ and “high-confidence” cross-links thereby minimizing the risk of considering false-
positive identifications during computational modeling. Several studies have been published, 
in which a subset of “high-confidence” cross-links were used to elucidate the structural 
architecture of the target protein(s) by integrative modeling (223, 254, 255). In the case of the 
full-length DmISWI protein, the computational results were most consistent with the 
experimental XL-MS and SAXS data when we used a subset of identified distance restraints in 
a three-body docking procedure (Figure 23B). That is, the large majority of distance restraints 
were satisfied in the respective DmISWI model as further specified in STable 1 and STable 2. 
Applying the same modeling strategy to the Snf2H enzyme, however, was less successful due 
to the above-mentioned limitations in terms of number of identified ATPase lobe-lobe cross-
links as well as the ambiguous/conflicting nature of ATPase-HSS linkages. Consequently, 
performing UV cross-linking on the Snf2H protein might represent a promising future strategy 
to obtain more ATPase lobe-lobe cross-links that can be used to model the ATPase domain of 
the remodeling enzyme. Furthermore, incorporation of Bpa along the putative ATPase-HSS 
interface could give rise to complementary inter-domain distance restraints that do not include 
hotspot residues K929 and K990 of the DNA-binding domain.  
 
In conclusion, I find that our developed integrative structural approach was highly useful to 
elucidate the structural architecture of the ISWI-type DmISWI and Snf2H remodeling 
enzymes, for which only limited high-resolution structural data exist. The combination of XL-
MS, SAXS, and computational modeling allowed us to gain a first molecular glimpse of the 
full-length DmISWI enzyme under apo state conditions with the predicted ATPase domain 
sharing striking similarities with the crystallized MtISWI structure. Recent efforts of the 
Worldwide Protein Data Bank (wwPDB) to create a public database furthermore underscore 
the value of such an integrative approach and the resulting structural models (256). The 
developed modeling protocol has the potential to be applied for structural characterization of a 
large variety of proteins and protein complexes that have proven refractory to traditional 
structure determination techniques.   
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3.2. Structural characterization of ISWI-type enzymes under apo state 
conditions – A common regulatory mechanism? 
It is often assumed that proteins with similar sequences – the homologous DmISWI and Snf2H 
remodeling enzymes share approximately 75% sequence identity (94) – will also exhibit a 
similar structural fold. Kosloff and Kolodny investigated the validity of this concept and 
describe pairs of proteins, which share considerable sequence identity but display significant 
structure dissimilarity (257). Remodeling ATPases are all related to each other, yet the 
orientation of RecA-like ATPase lobes differ drastically in available apo crystal structures 
(109, 141, 146, 153, 154) (Figure 4). Does the sequence conservation between DmISWI and 
Snf2H also ensure structural (dis)similarity and are there common principles in the regulation 
of ATP-dependent chromatin remodeling activity by ISWI-type enzymes?  
We collected experimental XL-MS and SAXS data to reconstruct the structural architecture of 
these homologous remodelers under apo state conditions. These local and global structural 
information can be compared considering that individual protein regions fulfilled the 
prerequisites for comparison. That is, homology models of functionally important DmISWI 
and Snf2H domains are structurally highly similar as indicated by small RMSD values (i.e., 
RMSDHSS = 1.19 Å; RMSDATPase lobe1 = 0.24 Å; RMSDATPase lobe2-NegC = 0.18 Å). Furthermore, 
the number and distribution of chemically cross-linkable lysine residues are comparable across 
both remodeling enzymes with numerous intra-domain cross-links connecting identical/similar 
sites in the DmISWI and Snf2H proteins (Figure 45).  
 
Figure 45: Comparison of identified cross-links for the DmISWI and Snf2H proteins under apo state 
conditions. Identified cross-links for the DmISWI and Snf2H enzymes under apo state conditions are 
schematically illustrated in arc plots. The arc plots were manually aligned with residue numbering being 
denoted for both proteins. Green dots indicate the position of individual lysine residues. Identical and similar 
DmISWI and Snf2H cross-links are highlighted as pink arcs. Cross-linked peptides were considered similar if 
the cross-linking sites were within ± 10 amino acids with respect to the corresponding primary protein 
sequence. The data presented in this Figure is identical to the data shown in Figure 12 and Figure 27.   
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Applying our integrative structural approach to the full-length DmISWI enzyme under apo 
state conditions revealed a novel orientation of both ATPase lobes, which shows remarkable 
consistency with the lobe orientation observed in the MtISWI crystal structure (146) (Figure 
15). In our structural model of the DmISWI ATPase module, both ATPase lobes stack together 
with catalytically important motifs (i.e., motifs I, II, and VI) being twisted towards opposite 
directions (Figure 17A). The structural arrangement of both ATPase lobes is most consistent 
with the notion that the DmISWI protein assumes a resting conformation under apo state 
conditions in solution. Our findings thus provide a structure-based explanation for the low 
basal ATPase activity of DmISWI in the absence of substrate (140). In line with our 
interpretation of a resting DmISWI conformation, the related MtISWI protein (146) but also 
the MtSnf2 protein (153) have been proposed to adopt a catalytically incompetent state under 
apo state conditions. In order to become catalytically competent, these remodeling enzymes are 
thought to undergo activating conformational changes in their ATPase domain such that motifs 
involved in ATP binding and ATP hydrolysis are optimally positioned to cooperatively 
facilitate the enzymatic reaction. Likewise, the DmISWI protein is expected to undergo 
substantial structural rearrangements to become active (140). The active conformation of the 
DmISWI protein may be approximated by available structures of related enzymes including 
ScSnf2 (21), ScChd1 (24), and DmVasa (258), which were captured in complex with either 
RNA or the nucleosomal substrate. Superimposition of these catalytically competent structures 
shows a strikingly similar orientation of both ATPase lobes with motifs involved in catalysis 
occupying nearly identical positions in the three-dimensional space (Figure 46A). The 
convergence of these structures may point towards a common configuration of the active site 
that allows for efficient ATP hydrolysis. In order for the DmISWI enzyme to assume a 
comparable active conformation and thus to leave the resting state, we find that the ATPase 
domain has to undergo a considerable conformational change such that ATPase lobe 1 rotates 
by approximately 110−140° relative to ATPase lobe 2 around a predicted hinge region (Figure 
46B). Comparable nucleosome-dependent changes in the relative orientation of both ATPase 
lobes have been described in the context of the substrate-bound structures of ScSnf2 (21) 
(Figure 46C) and ScChd1 (24) (Figure 46D).   
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Figure 46: Conformational changes related to ATPase activation. Only the structures around central ß-
sheets of ATPase domains of distinct enzymes are shown for clarity. All structures were aligned to ATPase 
lobe 2 of our DmISWI model. Spheres indicate catalytically important motifs on both lobes with motif I and 
motif VI being colored in magenta and cyan, respectively. (A) Superimposition of the active, nucleosome-
bound ScSnf2 (grey, pdb 5X0Y) and ScChd1 (light grey, pdb 5O9G) structures as well as the active, RNA-
bound DmVasa complex (black, pdb 2DB3). Both ATPase lobes as well as the structural motifs are similarly 
arranged to each other in the depicted structures. (B) To assume a comparable active conformation as seen 
for ScSnf2 (grey) in (A), ATPase lobe 1 (yellow) of the DmISWI enzyme (cf. Figure 14A) has to rotate 
relative ATPase lobe 2 (red). (C) Liu and co-workers compared the structures of the nucleosome-ScSnf2 
complex (grey, pdb 5X0Y) and MtSnf2 in the resting state (yellow, red; pdb 5HZR) and proposed a 
comparable conformational change (21). (D) Structures of the inactive (yellow, red; pdb 3MWY) and active, 
nucleosome-bound ScChd1 enzyme (light grey, pdb 5O9G) are superimposed. Upon nucleosome binding, 
Farnung et al. suggest that ATPase lobe 1 moves relative to ATPase lobe 2 (24).  
To investigate whether the homologous DmISWI and Snf2H enzymes share a comparable 
ATPase conformation under apo state conditions, I superimposed our respective models of the 
ATPase domain for these two remodeling enzymes (Figure 47). Alignment of our structural 
models for the DmISWI and Snf2H enzymes reveals a markedly different orientation of both 
ATPase lobes in the absence of nucleotide and substrate. How can such a deviating ATPase 
conformation for closely related remodeling enzymes under comparable solution conditions be 
explained? While we had several UV and chemical lobe-lobe cross-links available to model the 
ATPase domain of the DmISWI enzyme, the predicted lobe-lobe interface in the Snf2H protein 
is insufficiently covered by experimental data. Although our collaboration partner Dr. C. 
Schindler (TUM, Munich) restrained the distance between the two structural bodies of the 
ATPase module, the identified cross-links that restrict their orientation (i.e., XLSnf2H 43, 44; 
STable 3) consistently exceeded the BS3 distance threshold in the final models of the full-
length Snf2H enzyme (Figure 31B). Consequently, the possibility of a similar ATPase 
conformation between the DmISWI and Snf2H enzyme should not be refused per se 
 97 Discussion 
considering the challenges in modeling the orientation of both ATPase lobes based on ATPase-
HSS cross-links and the overall ambiguity of the obtained full-length Snf2H models. In 
contrast, the DmISWI ATPase model displayed a remarkable model precision with the 
proposed structural architecture being largely consistent with experimental data and being 
robust across different modeling strategies.  
 
Figure 47: Superimposition of structural models of the DmISWI and Snf2H ATPase domain under apo 
state conditions. Our representative model of the DmISWI ATPase domain (yellow, red; cf. Figure 14A) is 
aligned on ATPase lobe 2 onto the catalytic core of Snf2H (grey; cf. model #1 in Figure 31A). Notably, these 
two structures display a markedly different orientation of both ATPase lobes. 
Remodeling enzymes have evolved intricate strategies to regulate their catalytic activity to 
ensure that ATP hydrolysis only takes place in the presence of substrate. ISWI-type 
remodeling enzymes comprise the NTR and NegC regions, which flank the ATPase domain 
and that are critically involved in the autoregulation of the catalytic activity (28, 114, 115, 129, 
146). How these auto-inhibitory modules are structurally organized in the full-length DmISWI 
and Snf2H enzymes, however, has remained elusive. 
In the course of this PhD project, I identified several NTR cross-links for the DmISWI and 
Snf2H remodeling enzymes. In the case of the DmISWI protein, the partner cross-linking sites 
of these NTR linkages were invariably located near the interface of both ATPase lobes (Figure 
21). Our XL-MS data for DmISWI (this study and (115)) may reflect an MtISWI-like 
conformation of the NTR, in which the autoregulatory domain bridges both ATPase lobes 
under apo state conditions. That is, in the MtISWI crystal structure (pdb 5JXR), the α3 helix of 
the NTR was found to span across the ATPase lobe-lobe interface such that the highly 
conserved AutoN motif can interact through H-bond/salt-bridge interactions with ATPase lobe 
2 (146). Binding of the NTR to ATPase lobe 2 is thought to represent an important 
autoregulatory mechanism to keep the ATPase motor domain in a catalytically incompetent 
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resting state in the absence of substrate. In line with this mode of inhibition, disruption of 
critical AutoN-ATPase lobe 2 interactions by site-directed mutagenesis or deletions of 
functionally important NTR regions has been shown to severely deregulate the activity of 
ISWI-type remodeling enzymes (114, 115, 146). Notably, the unrelated N-terminal 
chromodomains of ScChd1 also pack against a basic surface patch on ATPase lobe 2 
potentially repressing activation of the enzyme under apo state conditions (141). In the case of 
the Snf2H protein, the identified NTR-ATPase lobe 1 cross-links show consistency with both 
our results for the DmISWI enzyme as well as the MtISWI structure. The apparent lack of 
chemical NTR-ATPase lobe 2 cross-links for Snf2H should not be over-interpreted considering 
that respective distance restraints in the DmISWI enzyme were exclusively found upon UV 
irradiation of the ISWIH483B variant (115).  
Additional evidence that the NTR of the DmISWI and Snf2H assume a similar conformation in 
the absence of substrate is provided by the observation that the autoregulatory domain of both 
enzymes formed cross-linked products with the distant SLIDE region of the HSS domain. The 
notion of spatial proximity between the very N- and C-terminal domains in DmISWI and 
Snf2H are supported by chemical cross-linking results for the ScChd1 protein, for which the 
poorly conserved chromodomains were also found to form linkages to the DNA-binding 
domain in the absence of substrate (155). Overall, the detected NTR-HSS cross-links in 
DmISWI and Snf2H signify that the studied remodeling enzymes assume a compact solution 
structure with the catalytic domain being potentially caged by these domains. Implementation 
of NTR-HSS distance restraints in the modeling protocol, however, resulted in a significantly 
poorer fit of the DmISWI model to the experimental SAXS data for the full-length enzyme 
(Figure 25). Most likely, local conformational fluctuations in one or several functional 
domains of the DmISWI may not allow us to simultaneously satisfy all cross-linking 
information during rigid body docking. The possibility of false sequence assignments for the 
NTR-HSS cross-links is minimal considering the number of identified linkages and the 
concordance of experimental XL-MS data for the DmISWI, Snf2H, and ScChd1 remodeling 
enzymes (155). 
The structural information gained from XL-MS analysis provided a further rationale to the 
regulation and autoinhibition mechanism of the full-length DmISWI and Snf2H enzymes by 
the NegC domain. The NegC domain has been suggested to play an important role in inhibiting 
the coupling of ATP hydrolysis to nucleosome sliding (114), DNA linker length sensing and 
nucleosome centering (129), as well as regulating the transition from a DNA length sensing to 
a translocation competent state (28, 129). Two different conformations of the NegC domain 
have been described for related chromatin remodeling enzymes. While the NegC domain 
protrudes from the globular ATPase domain to interact with a neighboring protomer in the 
MtISWI structure (pdb 5JXR) (146), the autoregulatory region bridges both ATPase lobes in 
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the monomeric structure of ScChd1 (pdb 3MWY) (141) (Figure 26A). The identified NegC-
ATPase cross-links for the Snf2H and DmISWI proteins were strikingly similar (compare 
Figure 30B with Figure 30C), which argues for a comparable arrangement of NegC in these 
homologous remodeling enzymes under apo state conditions. The observed cross-linking 
pattern for the NegC region are consistent with the ScChd1 structure with the large majority of 
NegC-ATPase distance restraints being furthermore satisfied in the proposed ScChd1-based 
structural models of the full-length DmISWI (Figure 21) and Snf2H proteins (Figure 30A). In 
stark contrast, I find that most distance restraints are markedly violated in the structure of a 
single MtISWI protomer (Figure 30B, C). I considered the possibility that the detected NegC-
ATPase linkages may derive from intermolecular cross-linking of DmISWI and Snf2H 
homodimers. However, the results from size-exclusion chromatography of native and cross-
linked protein (Figure 26B and SFigure 1B) as well as SAXS data for DmISWI (Figure 22) 
and Snf2H (Figure 32) argue against dimer formation under apo state conditions, in overall 
accordance with previous experimental data (140, 150, 157). Thus, the protruding NegC 
conformation observed in the MtISWI structure probably represents a physiologically 
irrelevant crystallization artifact. This notion is supported by the observation that NegC of 
protomer 1 contacts the ATPase domain of protomer 2 in a ScChd1-like manner in the MtISWI 
structure (Figure 26A). A ScChd1-like NegC conformation, in which both ATPase lobes are 
contacted, potentially enables the regulatory domain to sense and influence catalytic core 
actions (141).  
 
Although the fundamental nucleosome sliding reaction does not rely on the HSS domain in 
DmISWI (140) and Snf2H (129), the DNA-binding domain has been suggested to facilitate 
chromatin remodeling by increasing the affinity and specificity of the enzyme for the 
nucleosomal substrate. In addition, the HSS domain may form interactions with accessory 
proteins in the multi-protein remodeling factors (105) and contributes to nucleosome 
positioning and spacing (23, 151, 259). Applying our integrative structural approach to 
DmISWI and Snf2H allowed us to resolve the relative orientation of the HSS domain in the 
full-length remodeling enzymes under apo state conditions.  
In the case of DmISWI, implementing as set of reliable ATPase-HSS distance restraints during 
computational modeling resulted in a compact structural model, in which the HSS domain 
packs against the catalytic core (Figure 21). In a study by Hota and co-workers (127), residues 
in the presumable ATPase-HSS interface of ScIsw2 were mutated and resulted in almost an 
order of magnitude reduced nucleosome remodeling and ATP hydrolysis activity of the 
enzyme. The respective mutated residues are very close or being part of the predicted interface 
between the ATPase module and HSS domain in our structural model of the full-length 
DmISWI protein (Figure 48). Notably, the predicted ATPase-HSS interface was well 
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restrained by experimental data with individual cross-links originating from complementary 
UV- and chemical cross-linking approaches connecting residues of both domains. 
Consequently, our structural DmISWI model reveals the previously predicted ATPase-HSS 
interface for ScIsw2, which might be of functional importance for catalysis and could be 
investigated in future studies. 
 
Figure 48: The proposed ATPase-HSS interface in DmISWI. The ATPase-HSS interface of our structural 
model of the full-length DmISWI enzyme (yellow, red, green; cf. Figure 21) is displayed. Residues of the 
ATPase-HSS interface in the DmISWI model were identified using an adapted version of the 
‘InterfaceResidue’ script (Vertrees, 2009; https://pymolwiki.org/) and are shown in stick and surface 
representation. A previous study mutated residues in ScIsw2 (127). The corresponding four residues (i.e., 
K900, R954, R955, and R965) are shown as spheres and are very close or being part of the ATPase-HSS 
interface in the structural model of DmISWI. Cross-links originating from the interface are shown as grey 
lines and are numbered according to STable 2. The Figure was adapted from (1) in accordance with 
Elsevier’s policies. 
As a consequence of the tight packing of the HSS domain against the ATPase module, it 
appears unlikely that such a compact conformation is compatible with DNA binding to the 
HSS domain. That is, superimposition of the DNA-bound HSS domain of ScISW1a (pdb 
2Y9Z, (151)) onto our structural model of the full-length DmISWI resulted in a direct steric 
clash between the DNA strand and the ATPase domain (Figure 24). This finding is consistent 
with the notion that the DmISWI protein is trapped in a resting state under apo state conditions 
with the HSS domain being unable to bind DNA. An occluded DNA-binding site on the HSS 
domain in the resting state may represent a regulatory strategy to prevent binding to unrelated 
DNA. In line with this argumentation, the ATPase-HSS interface is expected to break up upon 
activation of the DmISWI enzyme such that the HSS domain can reach its binding sites on 
flanking DNA (23, 116, 151) and the nucleosome core (28, 129) during the catalytic cycle.   
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In the case of the Snf2H enzyme, I also identified numerous cross-links that connected 
individual residues of the ATPase module and the HSS domain. As for DmISWI, the majority 
of these linkages mapped to the SLIDE region of the HSS domain. However, the key 
difference between the XL-MS data sets for the DmISWI and Snf2H remodeling enzymes 
under apo state conditions relies on the distribution of cross-linked residues in the HSS 
domain. That is, residues K929 and K990 in Snf2H represented cross-linking hotspots within 
the HSS domain, which accounted for 70% of all identified intra- and inter-domain cross-links 
that mapped to the DNA-binding domain (Figure 29A and STable 3). Comparable hotspot 
residues were absent for the DmISWI enzyme although the number and localization of lysine 
residues in the HSS domain appears to be highly similar for the homologous remodeling 
enzymes (data not shown). How can such cross-linking hotspots be explained? The tendency 
of individual residues to excessively form linkages to diverse target sites has been observed in 
cross-linking studies of human serum albumin (260) and the photosystem II protein complex 
(261). The diversity of Snf2H cross-links involving K929 and K990 might be best explained 
by assuming that these hotspot residues are easy accessible for the BS3 cross-linker and that the 
C-terminal region of the HSS domain exhibits a pronounced dynamic behavior under apo state 
conditions. This notion is supported by the observation that the BS3 cross-linking agent 
preferentially reacts with flexible regions of proteins (261, 262). An enhanced flexibility of the 
SLIDE region may increase the likelihood of the chemical cross-linker to first react with either 
K929 or K990, which is followed by scanning for a reachable target residue located in a less 
flexible part of the protein. Thus, the unequal distribution of cross-linked HSS residues 
between the DmISWI and Snf2H proteins could point towards different local dynamics in the 
DNA-binding domains. The conflicting nature of identified HSS-ATPase cross-links for the 
Snf2H enzyme may furthermore reflect the dynamic equilibrium of co-existing structures 
under apo state conditions with individual conformations of the Snf2H enzyme being present at 
a different ratio than for the DmISWI protein. This could explain the fact that our collaboration 
partner Dr. C. Schindler (TUM, Munich) was unable to obtain a single Snf2H model that 
satisfied all identified distance restraints at once. Notably, several other chromatin remodeling 
enzymes such as ALC1 (263) and SsoRad54 (158) have been suggest to exhibit a high degree 
of conformational heterogeneity under a given steady-state condition revealing potentially 
interesting parallels to our findings.  
 
In overall conclusion, our integrative approach allowed us to delineate and compare the 
structural architecture of the full-length DmISWI and Snf2H remodeling enzymes under apo 
state conditions. Although we cannot claim for an identical domain arrangement between these 
homologous enzymes in the absence of substrate, our results point towards a shared molecular 
mechanism to regulate the ATPase activity of ISWI-types remodelers. That is, the XL-MS data 
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for both DmISWI and Snf2H are consistent with an MtISWI-like conformation of the NTR 
domain (pdb 5JXR) as well as a ScChd1-like orientation of NegC (pdb 3MWY). These 
autoregulatory domains have been suggested to bridge the ATPase lobe-lobe interface thereby 
trapping the enzymes in a resting conformation under apo state conditions. In the case of the 
DmISWI enzyme, our structural model reveals that catalytically important motifs of the 
ATPase lobes are twisted towards opposite directions with productive ATP hydrolysis being 
unlikely to happen. The number of identified ATPase-HSS cross-links for both studied 
remodeling enzymes furthermore imply that the HSS domain is packing against the catalytic 
core with the very N- and C-terminal regions being in close spatial proximity to each other. As 
such, DmISWI and Snf2H appear to assume an overall compact conformation under apo state 
conditions. Given our more reliable model of the DmISWI protein, activation of ISWI-type 
remodelers would require a series of conformational changes including a reorientation of both 
ATPase lobe, release of the autoinhibition by NegC and NTR, and the HSS domain in order to 
become catalytically competent.  
 
 
3.3. Impact of ADP-BeFx-binding on ISWI-type remodeling enzymes  
To uncover and visualize potential activating conformational changes in the catalytic core of 
ISWI-type remodeling enzymes, we applied our integrative structural approach to the 
prototypical Snf2H enzyme in the presence of a molar excess of the nucleotide analog ADP-
BeFx. That is, ADP-BeFx has been suggested to shift the conformational ensemble of ISWI-
type remodelers from a presumably inactive conformation towards various nucleotide-
dependent states including the functionally important transition state during the ATP 
hydrolysis reaction (159). This notion is supported by X-ray crystallography data for other SF2 
ATPases such as the yeast DEAD box protein Mss116p (264). Notably, using 3 mM ADP-
BeFx during chemical cross-linking and SAXS analysis, the large majority of Snf2H molecules 
should be bound to the nucleotide analog given the preliminary results from the competitive, 
TLC-based ATPase assay (SFigure 2).  
 
Although I identified many identical/similar cross-linked residue pairs between the apo and 
ADP-BeFx-bound Snf2H state (Table 2), I repeatedly detected several nucleotide analog-
dependent inter-domain cross-links (Table 3). These ADP-BeFx-dependent cross-links 
predominantly connected residues of either the NTR or ATPase lobe 1 with the HSS domain. 
Including a subset of these ATPase lobe 1-HSS cross-links as distance restraints during 
computational docking of individual Snf2H domains resulted in markedly different 
conformation of the ATPase domain. That is, comparison of structural models of the full-
length Snf2H enzyme in the apo and ADP-BeFx-bound states (Figure 38) suggested that 
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binding of the nucleotide analog caused an approximately 180° rotation of ATPase lobe 1 
relative to ATPase lobe 2. Interestingly, the ATPase lobes of several chromatin remodeling 
enzymes have been suggested to undergo large-scale reorientations in a nucleotide- and 
substrate-dependent manner (21, 24, 141, 154, 158). For instance, the Snf2 family ATPase core 
of the Rad54 protein from Sulfolobus solfataricus (SsoRad54) has been crystallized with and 
without bound DNA revealing an unexpected, outward-oriented placement of motifs IV to VI 
of ATPase lobe 2 in both states (154). The authors hypothesized that it requires a 180° flip of 
ATPase lobe 2 relative to ATPase lobe 1 in order to align structural motifs for efficient 
catalysis. Results from FRET experiments on the same SsoRad54 construct in the presence and 
absence of DNA and different nucleotides showed consistency with a highly dynamic 
conformational ensemble of the remodeling enzyme, in which one ATPase lobe may 
undergoes a 180° flip during the catalytic cycle (158). Thus, a high degree of flexibility 
between the two ATPase lobes may be of functional importance for chromatin remodeling and 
activity regulation furthermore explaining the substantially different conformations of the 
ATPase domain observed for distinct remodeling enzymes (Figure 4).  
The notion of nucleotide-dependent conformational rearrangements in the ATPase domain was 
also substantiated by our SAXS measurements on the full-length DmISWI enzyme and the 
DmISWI∆HSS construct (Figure 39). Binding of ADP-BeFx to DmISWI and DmISWI∆HSS 
decreased the Rg value by 7% and 5%, respectively. These findings collectively imply that the 
DmISWI enzyme assumes a more compact conformation upon nucleotide analog binding than 
under apo state conditions with structural rearrangements primarily taking place within the 
ATPase module. Notably, the full-length Snf2H enzyme exhibited a highly similar 
conformational response upon ADP-BeFx binding when compared to the SAXS results of the 
DmISWI protein (Figure 39). Interestingly, a nucleotide-dependent compaction has also been 
described in the context of the ScIsw2 remodeling enzyme (265). Furthermore, individual 
remodeling enzymes such as SsoRad54 (158) and ScChd1 (24, 141) have been proposed to 
sample distinct “open” and “closed” ATPase conformations during the catalytic cycle. It is 
tempting to speculate that the observed nucleotide-dependent compaction of DmISWI and 
Snf2H in the present study derives from the reorientation of both ATPase lobes. Thus, ADP-
BeFx may shift the conformational ensemble of the studied ISWI-type remodeling enzymes 
towards a closed ATPase conformation, in which both ATPase lobes are not splayed apart 
anymore.  
Our developed XL-MS protocol could also be applied to probe the conformational impact of 
ADP-BeFx binding on the DmISWI enzyme. However, due to time constraints, XL-MS 
analyses were not performed for the DmISWI protein in the presence of ADP-BeFx. Taking 
into consideration that our structural model of the ATPase module of the DmISWI enzyme 
showed a remarkable model precision under apo state conditions, a comparison of XL-MS data 
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for the DmISWI enzyme in the absence and presence of ADP-BeFx would be a promising 
approach to further pinpoint ADP-BeFx-dependent conformational changes in ISWI-type 
remodeling enzymes. 
 
In overall conclusion, our XL-MS and SAXS data are consistent with ADP-BeFx-dependent 
conformational changes in the DmISWI and Snf2H proteins. These remodeling enzymes 
assume a more compact conformation in the presence of the nucleotide analog, which may 
reflect structural properties of a closed ATPase conformation and potentially involves a 
substantial reorientation of the ATPase lobes. The homologous DmISWI and Snf2H enzymes 
appear to respond in a similar manner to ADP-BeFx and thus may share a common molecular 
mechanism to reach a state primed for catalysis.  
 
 
3.4. Structural characteristics of the Snf2H-nucleosome complex 
The molecular interactions between chromatin remodeling enzymes and their nucleosomal 
substrates are of key importance for a large variety of essential cellular processes (82, 240, 
241). Shedding light on structural characteristics of enzyme-nucleosome complexes is thought 
to increase our mechanistic understanding of how the chromatin landscape is remodeled in an 
ATP-dependent manner. In the present study, we probed the interaction between the ADP-
BeFx-bound Snf2H enzyme and 0N40 mononucleosomes using XL-MS analysis in 
combination with computational modeling. We envisaged that we could delineate the impact of 
nucleosome binding on the higher-order structure of the Snf2H enzyme by comparing the XL-
MS data for the Snf2H-nucleosome complex and ADP-BeFx-bound state from a qualitative and 
quantitative perspective. Furthermore, we reasoned that this comparison of XL-MS data might 
provide information about the molecular mechanism related to substrate recognition by ISWI-
type remodeling enzymes.  
According to EMSA analysis, the chosen conditions to study the structural characteristics of 
Snf2H-nucleosome complexes by XL-MS analysis resulted in considerable sample 
heterogeneity. That is, staining of the native PAGE gels by ethidium bromide revealed multiple 
Snf2H-nucleosome complexes, which differed in the Snf2H to nucleosome stoichiometry 
(Figure 40 and SFigure 3). I observed that up to three Snf2H molecules may bind to a single 
nucleosome with higher molecular weight complexes being preferentially formed at a molar 
excess of the Snf2H enzyme. Our findings from EMSA analysis thus show consistency with 
previous studies for ISWI-type remodeling enzymes, in which similar sample heterogeneity 
was detected in the presence of substrate (150, 236, 237). Fluorescence microscopy and 
spectroscopy experiments on living human cells indicated that the total concentration of all 
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chromatin remodelers in the cell nucleus might be in the 10 µM range (266). Given an average 
nucleosome concentration of 140 µM in human cells (267), it has been inferred that the 
predominant bound Snf2H species in vivo is monomeric (237). In stark contrast, biophysical 
measurements on Snf2H (129, 150) and the human ACF complex (136) suggested that these 
remodelers modulate the chromatin landscape by acting as a dimeric ATPase motor on the 
nucleosomal substrate. Consequently, it may be important to understand how two Snf2H 
molecules can bind to a single nucleosome in order to cooperatively slide the substrate along 
DNA. The observation of (Snf2H)3-nucleosome complexes in the present study could be a 
structural consequence of an additional Snf2H binding site on the 40 bp flanking DNA as 
suggested recently (237). Given a dissociation constant of approximately 260 nM for the 
Snf2H-0N40 complex in the presence of ADP-BeFx (150), there was likely also a fraction of 
unbound Snf2H molecules under the employed solution conditions. The possibility of having 
unbound and complexed Snf2H molecules during chemical cross-linking complicated the 
structural interpretation of identified inter-domain cross-links for the remodeling enzyme. In 
particular, the origin of inter-domain cross-links that were identified in the ADP-BeFx as well 
as nucleosome-bound state (cf. Table 4) remained ambiguous. I therefore pursued a 
quantitative cross-linking strategy for these shared inter-domain cross-links to uncover 
potential nucleosome-dependent conformational changes in the Snf2H enzyme. Interestingly, I 
found that the formation of cross-links between both ATPase lobes and the HSS domain was 
consistently less favorable in the nucleosome-bound state than for the ADP-BeFx-bound state 
(Figure 43C). This finding may be interpreted as a reorientation of the DNA-binding domain 
relative to both ATPase lobes upon nucleosome binding, which could be accompanied by 
partial disruption of the predicted ATPase-HSS interface. Alternatively, the HSS domain may 
simply be less flexible in the presence of substrate such that the formation of ATPase-HSS 
cross-links is hampered in the nucleosome-bound state without disruption of the ATPase-HSS 
interface. The detected inter-molecular cross-links between the Snf2H enzyme and the histone 
octamer, however, collectively argue against the latter binding scenario. These inter-molecular 
cross-links exclusively derive from Snf2H-nucleosome complexes and they may only be 
explained by assuming that the SLIDE region of the HSS domain contacts the core of the 
nucleosomal substrate in the presence of ADP-BeFx. Thus, it appears most likely that the 
ATPase-HSS interface is disrupted in the presence of substrate with Snf2H assuming an 
overall less compact conformation than in the apo and ADP-BeFx-bound states.  
Importantly, our findings show consistency with recent experimental results by the Narlikar 
laboratory for the Snf2H remodeling enzyme (28, 129). That is, results from a FRET-based 
assay, in which the dyes were attached to the end of a single 20 bp flanking DNA and the 
SLIDE region of the HSS domain, implied that the HSS domain moves away from the well-
documented binding site on flanking DNA in a nucleotide-dependent manner (129). Using this 
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approach, Leonard and Narlikar observed that the degree of energy transfer between the donor 
and acceptor dye was significantly higher in the presence of ADP than ADP-BeFx. Together 
with thermodynamic data on the Snf2H-nucleosome complex, the authors speculated that the 
HSS domain is stabilizing the binding of the remodeling enzyme to the nucleosome core prior 
to the DNA translocation step. The notion of a nucleotide-dependent conformational switch of 
the HSS domain during the catalytic cycle of the Snf2H enzyme has subsequently been 
substantiated by XL-MS analysis using the zero-length, carbodiimide-based reagent EDC (28). 
Cross-links between the HSS domain and the H2A/H2B subunits thereby suggested that the 
DNA-binding domain binds to the acid patch region of the nucleosome in the presence of 
ADP-BeFx. In the same study, Gamarra et al. provided experimental evidence for the acidic 
patch to be involved in the relief of autoinhibition by the NegC and NTR region and that these 
autoregulatory domains of the Snf2H enzyme also bind to the nucleosome core during the 
catalytic cycle. Interestingly, the acid patch may also play an important role in the catalysis of 
other ISWI-type remodeling enzymes (27) as well as the INO80 complex (28). Furthermore, a 
large variety of unrelated proteins and peptides including Bre1 (268), RCC1 (pdb 3MVD) 
(269), Sir3 (pdb 3TU4) (270), PRC1 (pdb 4R8P) (271), LANA peptide (pdb 1ZLA) (272), and 
CENP-C peptide (pdb 4INM) (273) were found to use the acidic patch as a nucleosome 
anchor.  
Notably, our identified inter-molecular cross-links shown in Figure 44B also provide direct 
evidence for a HSS binding site in close proximity to the acidic patch. As such, our XL-MS 
data are most consistent with the notion of a translocation-competent Snf2H-nucleosome 
complex in the presence of ADP-BeFx as opposed to a DNA length sensing enzyme 
conformation. Interestingly, binding of the HSS domain to the acid patch may be accompanied 
by conformational changes within the DNA-binding domain itself. That is, I identified several 
nucleosome-dependent, intra-domain cross-links that connected distant residues of the SLIDE 
and HAND regions (Figure 42C). These long-range intra-domain linkages consistently violated 
the Cα-Cα distance threshold of the BS3 cross-linker pointing towards the possibility of a 
bended HSS conformation in the presence of the nucleosomal substrate. Alternatively, these 
incompatible HSS cross-links may be formed between two nucleosome-bound Snf2H 
protomers and thus do not reflect binding-induced structural transitions in the HSS domain. 
Considering the recent findings by Gamarra et al. (28), adjacent interaction sites of the HSS 
domain and both autoregulatory domains in the nucleosome-bound state may provide an 
explanation for the unchanged BS3-H4/-D4 ratio for the studied NTR-HSS and NegC-HSS 
linkages during quantitative cross-linking (Figure 43C). The enrichment of ATPase lobe 2-
NegC cross-links in the presence of substrate points towards a nucleosome-dependent 
reorientation of the NegC region within the full-length Snf2H enzyme (Figure 43C). The 
enrichment of these inter-domain cross-links in the nucleosome-bound state could be a 
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consequence of changed steric constraints that favor the formation of covalent linkages 
between individual residues of ATPase lobe 2 and NegC using the BS3 cross-linking agent.  
Taken together, our XL-MS data are consistent with a translocation-competent Snf2H-
nucleosome complex, in which the HSS domain bridges the nucleosome core to contact 
individual residues of the acidic patch region. The XL-MS-based structural model of the HSS-
nucleosome complex (Figure 44B) visualizes a potential binding mode of the DNA-binding 
domain to the nucleosomal substrate that is largely consistent with the experimental XL-MS 
data. 
 
 
3.5. Nucleosome sliding by ISWI-type remodeling enzymes 
In the present study, we studied the mechanism of ISWI-type remodeling enzymes across 
different steady-state conditions using XL-MS and SAXS analyses in combination with 
computational modeling. Combining our results for the homologous DmISWI and Snf2H 
proteins with the structural and functional framework for ISWI-type enzymes as well as 
unrelated chromatin remodelers allows me to propose the following, speculative model of the 
nucleosome sliding mechanism (Figure 50). 
Under apo state conditions (Figure 50A), DmISWI and Snf2H appear to assume a resting 
conformation in solution with catalytically important motifs of both ATPase lobes being 
twisted towards opposite directions. The proposed arrangement of ATPase lobes provides a 
structure-based explanation for the repressed basal ATPase activity of DmISWI (140). The 
autoregulatory NTR and NegC domains thereby keep the remodeling enzymes in a 
catalytically incompetent state by bridging the ATPase lobe-lobe interface. In addition, the 
HSS domain packs against the catalytic core to form an overall compact enzyme conformation 
with the very N- and C-termini of ISWI-type remodelers being in close spatial proximity to 
each other.  
 108 Discussion 
 
Figure 49: Proposed binding mode of ISWI-type remodeling enzymes to nucleosomes. The DmISWI 
enzyme assumes a compact resting conformation under apo state conditions. The NTR (cyan, pdb 5JXR) 
(146) and HSS domain (green) thereby pack against ATPase lobe 1 (yellow) and ATPase lobe 2 (dark red). 
This representative DmISWI model may bind to the nucleosome (grey, adapted from pdb 5O9G) via ATPase 
lobe 1. A series of conformational changes are expected to take place upon docking to the nucleosomal 
substrate (indicated by arrows) to reach a similar enzyme-nucleosome state as observed for the nucleosome-
bound ScChd1 structure (pdb 5O9G) (24). The ATPase domain of the ScChd1 structure was aligned with our 
representative DmISWI model on ATPase lobe 1 with ATPase lobe 2 of the ScChd1 enzyme being colored in 
light red. The Figure was adapted and reprinted from (1) in accordance with Elsevier’s policies. 
How does the remodeling enzyme become catalytically active? Our representative model of 
the resting DmISWI enzyme could theoretically bind the nucleosome at SHL +2 via ATPase 
lobe 1 without causing a direct steric clash with the substrate or relying on a prior 
conformational change (Figure 49). ATPase lobe 2 is expected to rotate relative to lobe 1 in 
order to reach its binding site on the nucleosomal substrate (Figure 49, red arrow) and to align 
the conserved structural motifs for efficient ATP binding and hydrolysis. The active site of the 
ATPase in DmISWI and Snf2H may share many structural features with the nucleosome-
bound ScSnf2 (pdb 5X0Y) (21) and ScChd1 (pdb 5O9G) (24) structures, which are partially 
shown and aligned in Figure 46A. Our quantitative XL-MS data suggest that the interface 
between the ATPase and HSS domains disrupts in the presence of the nucleosomal substrate. 
As a consequence, the DNA binding site on the HSS domain may no longer be occupied such 
that it can bind to flanking DNA (Figure 49, green arrow) (23, 129, 151) giving rise to a DNA 
length sensing state (Figure 50B). Recognition of flanking DNA by the HSS domain likely 
represents the molecular basis to form evenly spaced nucleosomal arrays (22, 84, 259), which 
is followed by several conformational changes that facilitate the formation of a DNA 
translocation-competent enzyme-nucleosome complex (Figure 50C). That is, our identified 
inter-molecular cross-links between the Snf2H enzyme and the histone octamer (Figure 44B) 
as well as recent experimental findings by the Narlikar laboratory (28, 129) are consistent with 
the notion that the HSS domain is released from flanking DNA and that it binds to the 
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nucleosome core in a nucleotide-dependent manner. While it is possible that binding of the 
HSS domain to the nucleosome core assists in stabilizing the translocation-competent enzyme-
nucleosome complex (129), the mechanistic significance of this interaction with regard to 
DNA translocation remains to be further elucidated. Relief of autoinhibition by the NTR and 
NegC in the translocation-competent complex is presumably achieved by direct interactions of 
these regulatory domains with the acidic patch of the nucleosome core (28). Notably, the 
herein identified nucleosome-dependent, inter-domain cross-links for the NTR and NegC 
region (Table 5) are supportive of substrate-induced conformational changes in these domains 
for the Snf2H remodeling enzyme. Furthermore, it has been demonstrated that the basic patch 
of the H4 tail (not indicated in Figure 50) represents an important nucleosomal epitope for 
ISWI-type remodelers during the catalytic cycle (71, 114, 159). The underlying molecular 
mechanisms that confer maximal remodeling activity upon engagement of the H4 tail (124, 
125), however, remain largely elusive taking into account recent experimental findings that 
argue against overlapping AutoN and H4 tail binding sites on ATPase lobe 2 (115, 146). 
Alternating switching between the DNA length sensing and the translocation-competent states 
allows ISWI-type remodeling enzymes to move nucleosomes relative to DNA by one (138) or 
more (28, 136) base pairs per catalytic cycle in an ATP-dependent manner (28, 129). The 
coupling of ATP hydrolysis to DNA translocation as well as the fundamental principles of the 
actual sliding reaction, however, are poorly understood.  
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Figure 50: Model of nucleosome sliding by ISWI-type enzymes. (A) ISWI-type enzymes assume a 
compact resting conformation under apo state conditions with accessory domains packing against the ATPase 
domain. Motifs involved in ATP binding and hydrolysis are twisted towards opposite directions. (B) Several 
conformational changes are predicted upon nucleosome binding to reach a DNA length sensing state of the 
enzyme-nucleosome complex. These structural rearrangements include the reorientation of the ATPase 
domain as well as disruption of the HSS-ATPase domain such that the HSS domain can bind to flanking 
DNA (23, 129, 151). The NTR and NegC domains inhibit DNA translocation by the ATPase domain. (C) 
The DNA length sensing state is in equilibrium with the translocation-competent state (28). In this active 
enzyme-nucleosome configuration, the HSS domain binds to the nucleosome core and autoinhibition by 
NegC and NTR is relieved due to direct interaction of these autoregulatory domains with the acidic patch. 
Furthermore, the H4 tail (not indicated in the model) binds to ATPase lobe 2 (115, 146). (D) The nucleosome 
is moved relative to DNA in the translocation-competent state in an ATP-dependent manner.  
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3.6. Future perspectives 
Despite groundbreaking achievements in establishing a structural and functional framework for 
chromatin remodeling enzymes, the underlying molecular mechanism by which the chromatin 
landscape is modulated by these proteins have remained elusive. The mechanism of action of 
ISWI-type remodelers appears to rely on a series of complex conformational changes that are 
difficult to capture by traditional structure determination techniques such as X-ray 
crystallography and NMR spectroscopy. In the present thesis, I probed the conformation of the 
prototypical DmISWI and Snf2H enzymes across different steady-state conditions using an 
integrative structural approach that combines XL-MS and SAXS analyses with computational 
modeling. Our findings for Snf2H and DmISWI provide valuable information about the 
structural architecture and conformational response of these remodeling enzymes to substrate 
and ADP-BeFx binding in a near-native environment. The obtained structural models for 
DmISWI and Snf2H resulted in several work hypotheses for the catalytic cycle of ISWI-type 
enzymes, which invite future investigations. In particular, it will be important to validate the 
herein proposed domain interfaces for the studied remodeling enzymes and to better 
understand the sequence of conformational rearrangements and the underlying allosteric 
couplings in the enzyme-nucleosome complex that facilitate chromatin remodeling.  
To validate and/or refine our structural models for DmISWI and Snf2H, it might be beneficial 
to pursue an UV-based cross-linking strategy. The site-specific incorporation of Bpa at 
strategically favorable positions may not only result in additional, shorter distance restraints 
that can be used to guide computational modeling but also allows the interrogation of the 
current DmISWI and Snf2H models. Furthermore, it would be desirable to develop a modeling 
algorithm that can deal with distance restraints that derive from co-existing conformations in 
solution. Alternatively, one could consider finding solution conditions under which the sample 
heterogeneity is minimized.  
Hydrogen/deuterium exchange mass spectrometry (HDX-MS) could represent a promising, 
complementary biophysical approach to probe the higher-order structure and dynamics of 
ISWI-type remodeling enzymes as well as their interactions with nucleosomes under near-
native conditions in solution. The exchange of hydrogen to deuterium of backbone amides in a 
protein is critically dependent on the hydrogen bonding status with exchange rates being 
significantly slower when the amide hydrogens engage in a stable inter- or intra-molecular 
hydrogen bond (274-276). The target protein(s) are typically diluted into deuterated buffer and 
labeled for distinct time intervals. The exchange reaction is subsequently quenched, the sample 
subjected to proteolysis, and the deuterium uptake for individual protein regions determined by 
LC-MS analysis (277). As such, the HDX-MS technique has proven useful to map binding 
interfaces and to identify and characterize functionally important allosteric couplings within 
the target protein(s) (278-280). In particular, the potential of the HDX-MS approach to uncover 
allosteric couplings could be interesting in order to better understand how the chromatin 
landscape is remodeled in ATP-dependent manner by ISWI-type remodeling enzymes.  
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4. Materials and Methods 
4.1. Materials 
4.1.1. Technical devices 
 
Table 6: Technical devices used in this study. 
Description  Manufacturer 
Centrifuge rotor, SW 41 Ti Beckman Coulter 
Centrifuge rotors, Sorvall SLA3000 and SS34 ThermoFisher Scientific 
Centrifuge, Eppendorf 5417C  Eppendorf 
Centrifuges, Sorvall RC 6 Plus, Heraeus Megafuge 2.0,  
Heraeus Multifuge X3R 
ThermoFisher Scientific 
Fluorescent Image Analyzer, FLA-3000  Fujifilm 
FPLC systems ÄKTA FPLC, ÄKTApurifier, and ÄKTA Pure GE Healthcare Life Sciences 
French Pressure Cell Press, Model FA-078 Thermo Spectronic 
Gel imaging system, ChemiDoc Bio-Rad Laboratories 
Gradient Master BioComp 
HPLC systems, UltiMate 3000 and RSLCnano ThermoFisher Scientific 
Incubator shaker, HT Multitron  Infors 
Incubator shaker, New Brunswick Innova Eppendorf 
Lyophilizer Alpha 1–2 and connected pump RZ 2.5 Christ; Vacuubrand 
Mass spectrometer, LTQ-Orbitrap XL and Q-Exactive HF  ThermoFisher Scientific 
Microfluidizer, LM10 Microfluidics 
Peristaltic pump, MINIPULS Evolution Gilson 
Sonicator, Sonifier S-250 D digital Branson Ultrasonics 
Spectralphotometer, PowerWave HT BioTek 
Thermocycler, Applied Biosystems 2720 Thermal Cycler ThermoFisher Scientific 
Thermomixer comfort Eppendorf 
Ultracentrifuge, Optima MAX-XP Beckman Coulter 
UV lamp Ultra Violet Products 
UV-Crosslinker, Bio-Link 365  Vilber 
UV-Vis Spectrophotometer, NanoDrop ND1000 Peqlab Biotechnologie GmbH 
UV-Vis Spectrophotometer, Ultrospec 2000 Pharmacia Biotech 
Vacuum centrifuge, Concentrator Plus Eppendorf 
Whatman Elutrap electroelution system GE Healthcare 
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4.1.2. Chemicals and Consumables 
 
Table 7: Chemicals and consumables used in this study. 
Description  Manufacturer 
[γ-32P]ATP PerkinElmer 
384 well plate  Greiner Bio One International GmbH 
Acetic acid Promega 
Acetone Merck 
ACN Carl Roth GmbH & Co 
Acrylamide/bisacrylamide solution, Rotiphorese  
Gel 30 (37.5:1) 
Carl Roth GmbH & Co 
ADP Merck 
Agarose Bio&SELL GmbH 
Amicon Ultra-4 centrifugal filter units, 10 and 30 kDa 
MWCO 
Merck Millipore 
Ampicillin Carl Roth GmbH & Co 
AMP-PNP Merck 
Aprotinin Genaxxon Bioscience 
APS Sigma 
ATP Merck 
Benzonase Merck Millipore 
Bpa Bachem 
Bromophenol blue Merck 
BS2G-H4/D4 ProteoChem 
BS3-H4/D4 ProteoChem 
BSA Merck 
Chloramphenicol Carl Roth GmbH & Co 
Complete Protease Inhibitor Cocktail tablet Roche Diagnostics GmbH 
Coomassie Brilliant Blue R Merck 
DMSO Merck 
DTT Carl Roth GmbH & Co 
EDTA Merck 
Ethanol Carl Roth GmbH & Co 
Ethidium bromide Merck 
Formic acid Merck 
Glycerol VWR 
Guanidine hydrochloride Merck 
Hepes Serva Electrophoresis GmbH 
HisTrap HP column, 1 and 5 mL GE Healthcare 
HiTrap Q HP column, 5 mL GE Healthcare 
HiTrap SP column, 5 mL GE Healthcare 
HPF Millex syringe filter Merck Millipore 
IAA Merck 
Igepal CA-630 Merck 
Imidazole Carl Roth GmbH & Co 
IPTG Carl Roth GmbH & Co 
KCl Merck 
KOAc Merck 
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LB agar Serva Electrophoresis GmbH 
Leupeptin Genaxxon Bioscience 
LiCl Merck 
L-lysine–HCl Merck 
Mg(OAc)2 Merck 
MgCl2 VWR 
Mono Q 5/50 GL column GE Healthcare 
Mono S 5/50 GL column  GE Healthcare 
MultiScreen HTS plate, 96 well Merck Millipore 
NaCl ThermoFisher Scientific 
NADH Merck 
NaH2PO4 VWR 
NaOAc VWR 
NH4HCO3 Merck 
OMIX C18 pipette tip, 10–100 µL Agilent Technologies 
PEG 8000 Promega 
Pepstatin  Genaxxon Bioscience 
PMSF Genaxxon Bioscience GmbH 
Polypropylene tube, 14 x 89 mm Beckman Coulter 
SDS-PAGE gel, NuPAGE Bis-Tris Protein Gel, 10%, 
12%, and 4-16% 
Invitrogen 
ReproSil-Pur C18-AQ 2.4 μm  Dr. Maisch GmbH 
Rotilabo-syringe filter, 0.2 and 0.45 µm Carl Roth GmbH & Co 
Salmon sperm DNA ThermoFisher Scientific 
SDS Serva Electrophoresis GmbH 
Sep-Pak tC18 cartridge Waters 
Slide-A-Lyzer MINI dialysis device, 7000 Da MWCO ThermoFisher Scientific 
Spectra/Por dialysis tubing, 3500, 7000, and 6000–8000 
Da MWCO 
Spectrum 
Superdex 200 10/300 GL column GE Healthcare 
Superdex 200 HiLoad 16/60 column GE Healthcare 
Superdex 200 Increase 10/300 GL column GE Healthcare 
Superdex Peptide PC 3.2/300 column GE Healthcare 
TCA Merck 
TEMED Carl Roth GmbH & Co 
TFA Merck 
Thiourea Merck 
TLC PEI cellulose F plate Merck Millipore 
Tris Diagonal GmbH & Co. KG 
Triton X-100  Merck 
Trypton BD Biosciences 
Tween 20 Merck 
Urea Merck 
Yeast extract BD Biosciences 
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4.1.3. Enzymes, Kits and Markers 
 
Table 8: Enzymes, kits and markers used in this study. 
Description  Manufacturer 
1 kb ladder New England BioLabs 
100 bp ladder New England BioLabs 
dNTP mix New England BioLabs 
DpnI New England BioLabs 
Lactate dehydrogenase  Merck 
NucleoSpin Plasmid EasyPure Macherey-Nagel GmbH & Co 
peqGOLD protein marker IV VWR 
peqGOLD protein marker V VWR 
Phosphoenolpyruvate Molekula 
Phusion High-Fidelity DNA polymerase with 5x HF 
reaction buffer 
New England BioLabs 
Plasmid Mini, Midi, and Giga Kit Qiagen 
Pyruvate kinase  Merck 
SmaI with 5x Buffer 4 New England BioLabs 
T5 exonuclease New England BioLabs 
Taq ligase New England BioLabs 
Trypsin, Sequencing Grad Modified, with Trypsin 
Respuspension Buffer 
Promega 
 
4.1.4. Bacterial strains 
 
Table 9: E. coli strains used in this study. 
Strain  Manufacturer 
BL21-Gold(DE3) Agilent Technologies 
RosettaTM 2(DE3) Merck 
DH5α NEB 5-alpha, New England BioLabs 
 
4.1.5. Plasmids 
 
Table 10: Plasmids used in this study. 
Name Encoded sequence  Origin Vector Tag 
pFMP210 ISWI 1−1027; full-length Drosophila  pProExHT His6-TEV  
pFMP383 ISWI; full-length K337D Drosophila  pProExHT His6-TEV  
pFMP384 ISWI; full-length D485K Drosophila  pProExHT His6-TEV  
pFMP386 ISWI; full-length K337D D485K Drosophila  pProExHT His6-TEV  
pFMP163 
ISWI full-length with TAG amber 
codon at amino acid position 578 
Drosophila  pProEX-Htb His6-TEV  
pFMP302 Snf2H 1−1052; full-length Human  pBH4 His6-TEV  
pFMP375 ISWI 691−1027 Drosophila  pProEX-Htb His6-TEV  
     
  * continues next page * 
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pFMP153 
Suppressor tRNA and synthetic 
tRNA synthetase for genetically 
encoding Bpa 
  His6-TEV  
pFMP114 ISWI 26−648 Drosophila  pProEX-Htb His6-TEV  
pFMP128 Histone H2A 
Drosophila, codon 
optimized 
pET15b  none 
pFMP129 Histone H2B 
Drosophila, codon 
optimized 
pET15b  none 
pFMP186 Histone H3 Drosophila  pET3c none 
pFMP187 Histone H4 Drosophila  pET3c none 
pFMP151 187 bp Widom 601 derivative  pUC18 none 
pFMP109 147 bp Widom 601 derivative  pT7blue3 none 
 
 
4.1.6. Oligonucleotides 
 
Table 11: Oligonucleotides used in this study. 
Name 5‘-3‘ Sequence Usage 
oFMP219 TGGATGATTTCGCTTTACGA 
Forward primer, sequencing of 
pFMP210/383/384/386/114 
oFMP220 GACGAATGGTTCAACACGAA 
Forward primer, sequencing of 
pFMP210/383/384/386/114 
oFMP221 GAATTTAACATGGACAACAGCG 
Forward primer, sequencing of 
pFMP210/383/384/386  
oFMP222 CAATTCGAGGGTGAGGATTG 
Forward primer, sequencing of 
pFMP210/383/384/386 
oFMP223 GATGCACTGAGTTGCAGGAT 
Forward primer, sequencing of 
pFMP210/383/384/386/375 
oFMP224 CAGAGATATGGTCTGCAGGG 
Reverse primer, sequencing of 
pFMP210/383/384/386 
oFMP709 GACCGCTAATCGTCTACTTATCAC 
Forward primer, sequencing of 
pFMP386 
oFMP742 
GTGCTGGACCCTTTCCTGCTCCGTC
GTC 
Forward primer, point mutation in full-
length DmISWI K337D: AAA to GAC 
oFMP743 
CAGGAAAGGGTCCAGCACGGCATG
CAAAC 
Reverse primer, point mutation in full-
length DmISWI K337D: AAA to GAC 
oFMP744 
CACGAAAAGCGTAACAGGCAGATT
CAGGAA 
Forward primer, point mutation in full-
length DmISWI D485K: GAT to AAG 
oFMP745 
CCTGTTACGCTTTTCGTGCGGCGTC
TGA 
Reverse primer, point mutation in full-
length DmISWI D485K: GAT to AAG 
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4.1.7. Buffers and solutions 
 
Table 12: Buffers and solutions. All buffers and solutions used for FPLC analysis were sterile filtered.  
Buffer/so- 
lution name 
Composition Usage (section) 
0.5x TBE  
4.5 mM Tris-HCl (pH 8.3), 45 mM boric 
acid, 0.1 mM EDTA (pH 8.0) 
Agarose gel electrophoresis 
(4.2.1.5) 
1x TAE  
40 mM Tris-HCl (pH 8.0), 20 mM acetic 
acid, 1 mM EDTA (pH 8.0) 
Agarose gel electrophoresis 
(4.2.1.5) 
5x Laemmli 
loading  
250 mM Tris-HCl (pH 6.8), 10% (w/v) SDS, 
0.1% (w/v) bromophenol blue, 50% (v/v) 
glycerol, 0.5 M DTT 
SDS-PAGE analysis (4.2.1.7) 
ATPase 
assay 
25 mM Hepes-KOH (pH 7.6), 3 mM MgCl2, 
0.1 mM EDTA (pH 8.0), 10% (v/v) glycerol, 
50 mM NaCl, 0.2 mg/mL BSA 
NADH-coupled ATPase assay 
(4.2.7.2.2) 
Coomassie 
Blue 
staining  
0.1% (w/v) Coomassie Brilliant Blue R, 
50% (v/v) ethanol, 10% (v/v) acetic acid 
SDS-PAGE analysis (4.2.1.7) 
c-XL #1 
25 mM Hepes-KOH (pH 7.6), 0.1 mM 
EDTA (pH 8.0), 10% (v/v) glycerol, 100 
mM KOAc, 1.5 mM MgCl2, 2 mM DTT 
Chemical cross-linking (4.2.4.1.2) 
c-XL #2 
25mM Hepes-KOH (pH 7.6), 210 mM KCl, 
10% (v/v) glycerol, 1 mM MgCl2, 1 mM 
DTT 
Chemical cross-linking (4.2.4.1.2) 
c-XL #3 20 mM Hepes-KOH (pH 8.3) Chemical cross-linking (4.2.4.1.2) 
c-XL #4 
25 mM Hepes-KOH (pH 7.6), 1 mM MgCl2, 
0.1 mM EDTA (pH 8.0), 10% (v/v) glycerol, 
50 mM NaCl, 1 mM DTT 
Chemical cross-linking (4.2.4.1.2) 
c-XL #5 
15 mM Hepes-KOH (pH 7.6), 4% (v/v) 
glycerol, 70 mM KCl, 1.5 mM MgCl2, 1 
mM DTT 
Chemical cross-linking (4.2.4.1.2) 
EMSA #1 
15 mM Hepes-KOH (pH 7.6), 0.1 mM 
EDTA (pH 8.0), 10% (v/v) glycerol, 70 mM 
KCl, 0.5 mM MgCl2, 1 mM DTT 
EMSA (4.2.7.1) 
EMSA #2 
15 mM Hepes-KOH (pH 7.6), 0.1 mM 
EDTA (pH 8.0), 10% (v/v) glycerol, 70 mM 
KCl, 0.5 mM MgCl2, 0.1 mg/mL BSA, 1 
mM DTT 
EMSA (4.2.7.1) 
EMSA #3 
15 mM Hepes-KOH (pH 7.6), 0.1 mM 
EDTA (pH 8.0), 10% (v/v) glycerol, 70 mM 
KCl, 0.5 mM MgCl2, 5% (w/v) sucrose, 1 
mM DTT  
EMSA (4.2.7.1) 
EMSA #4 
15 mM Hepes-KOH (pH 7.6), 4% (v/v) 
glycerol, 70 mM KCl, 1 mM MgCl2, 1 mM 
DTT 
EMSA (4.2.7.1) 
EMSA #5 
15 mM Hepes-KOH (pH 7.6), 4% (v/v) 
glycerol, 70 mM KCl, 1 mM MgCl2, 0.02% 
(v/v) Igepal CA-630, 1 mM DTT  
EMSA (4.2.7.1) 
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Histone Q-A 15 mM Tris-KOH (pH 8.0) 
Purification of histones, RHP 
protocol (4.2.2.4.2) 
Histone Q-B 15 mM Tris-KOH (pH 8.0), 2 M NaCl 
Purification of histones, RHP 
protocol (4.2.2.4.2) 
Histone-
unfolding 
7 M guanidine-HCl, 20 mM Tris-HCl (pH 
7.5), 10 mM DTT 
Purification of histones, IBP 
protocol (4.2.2.4.1) 
Histone-
wash 
50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 
mM EDTA (pH 8.0), 5 mM DTT, 0.2 mM 
PMSF 
Purification of histones, IBP 
protocol (4.2.2.4.1) 
HSS-
Dialysis 
20 mM Tris-HCl (pH 7.6), 500 mM NaCl, 
20 mM imidazole (pH 7.4) 
Purification of HSSISWI (4.2.2.2.4) 
HSS-NiA 20 mM Tris-HCl (pH 7.6), 500 mM NaCl  Purification of HSSISWI (4.2.2.2.4) 
HSS-NiB  
20 mM Tris-HCl (pH 7.6), 500 mM NaCl, 
500 mM imidazole (pH 7.4) 
Purification of HSSISWI (4.2.2.2.4) 
HSS-SEC  20 mM Tris-HCl (pH 7.4), 500 mM NaCl Purification of HSSISWI (4.2.2.2.4) 
ISWI 
dialysis 
150 mM NaCl, 15 mM Tris-HCl (pH 7.4), 1 
mM DTT 
Purification of ISWWT, ISWIK337D, 
ISWID485K, ISWIK337D D485K, 
(4.2.2.2.1); ISWIM578B (4.2.2.2.2) 
ISWI His-A 50 mM Tris-HCl (pH 7.4), 300 mM NaCl 
Purification of ISWWT, ISWIK337D, 
ISWID485K, ISWIK337D D485K, 
(4.2.2.2.1); ISWIM578B (4.2.2.2.2) 
ISWI His-B 
50 mM Tris-HCl (pH 7.4), 300 mM NaCl, 
400 mM imidazole (pH 7.4) 
Purification of ISWWT, ISWIK337D, 
ISWID485K, ISWIK337D D485K, 
(4.2.2.2.1); ISWIM578B (4.2.2.2.2) 
ISWI 
MonoS-A 
15 mM Tris-HCl (pH 7.4), 1 mM DTT 
Purification of ISWWT, ISWIK337D, 
ISWID485K, ISWIK337D D485K 
(4.2.2.2.1) 
ISWI 
MonoS-B 
15 mM Tris-HCl (pH 7.4), 2 M NaCl, 1 mM 
DTT 
Purification of ISWWT, ISWIK337D, 
ISWID485K, ISWIK337D D485K 
(4.2.2.2.1) 
ISWI SEC 
50 mM Hepes-KOH (pH 7.6), 0.2 mM 
EDTA (pH 8.0), 200 mM KOAc, 1 mM 
DTT 
Purification of ISWWT, ISWIK337D, 
ISWID485K, ISWIK337D D485K, 
(4.2.2.2.1); ISWIM578B (4.2.2.2.2) 
ISWI ΔHSS 
Lysis 
50 mM Tris-HCl (pH 7.4), 300 mM NaCl 
Purification of ISWIΔHSS 
(4.2.2.2.3) 
ISWI ΔHSS 
SEC 
20 mM Hepes-KOH (pH 7.6), 200 mM KCl, 
0.2 mM EDTA (pH 8.0), 1 mM DTT 
Purification of ISWIΔHSS 
(4.2.2.2.3) 
ISWI 
ΔHSS-A 
25 mM Tris-HCl (pH 7.4), 130 mM KOAc, 
0.06% (v/v) Tween 20, 10% (v/v) glycerol 
Purification of ISWIΔHSS 
(4.2.2.2.3) 
ISWI 
ΔHSS-B 
25 mM Tris-HCl (pH 7.4), 130 mM KOAc, 
0.06% (v/v)Tween 20, 10% (v/v) glycerol, 
400 mM imidazole (pH 7.4) 
Purification of ISWIΔHSS 
(4.2.2.2.3) 
LB medium 
10 g/L trypton, 5 g/L yeast extract, 10 g/L 
NaCl 
Cultivation of E. coli cells 
(4.2.1.3) 
LB medium, 
rich 
20 g/L trypton, 10 g/L yeast extract, 10 g/L 
NaCl 
Expression of Snf2H in E. coli 
cells (4.2.2.1) 
Mononuc-0 
20 mM Tris-HCl (pH 7.7), 0.1 mM, EDTA 
(pH 8.0), 1 mM DTT 
Nucleosome reconstitution 
(4.2.3.3) 
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Mononuc-
2000 
20 mM Tris-HCl (pH 7.7), 0.1 mM EDTA 
(pH 8.0), 2M KCl, 1 mM DTT 
Nucleosome reconstitution 
(4.2.3.3) 
Nucleosome 
binding 
15 mM Hepes-KOH (pH 7.6), 70 mM KCl, 
4% (v/v) glycerol, 1 mM MgCl2, 1 mM DTT 
Enzyme-nucleosome complex 
formation (4.2.3.3); EMSA 
(4.2.7.1) 
Octamer 
refolding  
2M NaCl, 10 mM Tris-HCl (pH 7.5), 1 mM 
EDTA (pH 8.0), 1 mM DTT 
Octamer reconstitution (4.2.3.2) 
Octamer 
unfolding 
7 M guanidine-HCl, 20 mM Tris-HCl (pH 
7.5), 10 mM DTT 
Octamer reconstitution (4.2.3.2) 
SAU 
7.5 M Urea, 40 mM NaOAc (pH 5.2), 1 mM 
EDTA (pH 8.0), 10 mM L-lysine–HCl, 5 
mM DTT 
Purification of histones, IBP and 
RHP protocol (4.2.2.4) 
SAXS 
50 mM Hepes-KOH (pH 7.6), 1.5 mM 
Mg(OAc)2, 0.2 mM KOAc, 10% (v/v) 
glycerol, 1 mM DTT 
Preparation of proteins for SAXS 
measurements (4.2.5.1) 
SDS-PAGE 
fixing  
10% (v/v) acetic acid, 50% (v/v) ethanol SDS-PAGE analysis (4.2.1.7) 
SDS-PAGE 
running  
25 mM Tris-HCl (pH 6.8), 192 mM glycine, 
0.1% (w/v) SDS 
SDS-PAGE analysis (4.2.1.7) 
SEC mobile 
phase 
70% (v/v) water, 30% (v/v) acetonitrile, 
0.1% (v/v) TFA 
Enrichment of tryptic peptides 
(4.2.4.3) 
Snf2H 
Elution  
25 mM Hepes-HCl (pH 7.0), 300 mM KCl, 
400 mM imidazole (pH 7.4), 1 mM DTT 
Purification of Snf2H (4.2.2.3) 
Snf2H Lysis  
25 mM Hepes-KOH (pH 8.0), 300 mM KCl, 
7.5 mM imidazole (pH 7.4), 10% (v/v) 
glycerol, 1 mM DTT 
Purification of Snf2H (4.2.2.3) 
Snf2H-SEC 
25 mM Hepes-KOH (pH 7.5), 300 mM KCl, 
1 mM DTT 
Purification of Snf2H (4.2.2.3) 
Snf2H-
storage 
25 mM Hepes-KOH (pH 7.5), 210 mM KCl, 
15% (v/v) glycerol, 1 mM DTT 
Purification of Snf2H (4.2.2.3) 
SPE elution 
50% (v/v) water, 50% (v/v) acetonitrile, 
0.1% (v/v) formic acid 
Solid-phase extraction of tryptic 
peptides (4.2.4.3) 
SPE wash 
95% (v/v) water, 5% (v/v) acetonitrile, 0.1% 
(v/v) formic acid  
Solid-phase extraction of tryptic 
peptides (4.2.4.3) 
TE  
10 mM Tris-KOH (pH 8.0), 0.1 mM EDTA 
(pH 8.0) 
Preparation of DNA fragments 
(4.2.3.1) 
TLC 
developer  
0.3 M NaH2PO4, 1 M LiCl  
TLC-based ATPase assay 
(4.2.7.2.1) 
TLC quench  
2 mM EDTA (pH 8.0), 1 M LiCl, 0.3 M 
NaH2PO4 
TLC-based ATPase assay 
(4.2.7.2.1) 
TLC 
reaction  
25 mM Hepes-KOH (pH 7.6), 1.5 mM 
Mg(OAc)2, 0.1 mM EDTA (pH 8.0), 10% 
(v/v) glycerol, 100 mM KOAc, 0.2 g/L 
BSA, 1 mM DTT 
TLC-based ATPase assay 
(4.2.7.2.1) 
Urea loading  
9 M urea, 25 mM Tris-HCl (pH 6.8), 1% 
(w/v) SDS, 1 mM EDTA (pH 8.0), 0.02% 
(w/v) bromophenol blue, 100 mM DTT 
SDS-PAGE analysis (4.2.1.7) 
UV-XL  
25 mM Hepes-KOH (pH 7.6), 0.1 mM 
EDTA (pH 8.0), 10% (v/v) glycerol, 100 
mM KOAc, 1.5 mM MgCl2, 1 mM DTT 
UV cross-linking (4.2.4.1.1) 
   
  
* continues next page * 
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UZ-10% 
glycerol 
20 mM Hepes-KOH (pH 7.4), 0.005% (v/v) 
Igepal CA-630, 0.1 mM EDTA (pH 8.0), 
10% (v/v) glycerol 
Nucleosome reconstitution 
(4.2.3.3) 
UZ-30% 
glycerol 
20 mM Hepes-KOH (pH 7.4), 0.005% (v/v) 
Igepal CA-630, 0.1 mM EDTA (pH 8.0), 
30% (v/v) glycerol 
Nucleosome reconstitution 
(4.2.3.3) 
XL-
denaturation 
6 M urea, 2 M thiourea, 10 mM Hepes-KOH 
(pH 8.0), 200 mM NH4HCO3 
In-solution tryptic digestion 
(4.2.4.2.2) 
 
 
 
 
 
4.2. Methods 
4.2.1. Molecular biology methods 
4.2.1.1. Cloning of ISWI constructs 
Point mutations were introduced into DmISWIWT (i.e., ISWIK337D, ISWID485K, and ISWIK337D 
D485K) using the Gibson assembly cloning method (281).  
Each polymerase chain reaction (PCR) sample comprised the following components: 50 ng of 
the template plasmid (pFMP210, pFMP383 or pFMP384, cf. Table 10), 5 µL of 5x HF reaction 
buffer, 0.5 µL of 10 mM deoxynucleotide triphosphates (dNTPs) solution mix, 1.3 µL of 10 
µM forward and reverse primers (cf. Table 11), and 0.5 µL of 2 U/µL Phusion High-Fidelity 
DNA polymerase. The components were mixed on ice and the volume of the reaction mixture 
adjusted to 25 µL with H2O. The PCR was performed using a thermocycler and relied on the 
following thermal cycling protocol: Initialization at 98 °C for 3 min followed by 25 cycles of 
DNA denaturation (98 °C for 30 s), primer annealing (63 °C for 30 s), and DNA elongation 
(72 °C for 120 s).  
To digest the parental plasmid, 1 µL of the DpnI restriction enzyme (10 U/µL) was added to 
the PCR product and the sample was incubated at 37 °C for 1 h. The restriction enzyme was 
subsequently inactivated by heat (80 °C for 20 min). 
The assembly of amplified DNA fragments was initiated by mixing 5 µL of the digested PCR 
product with 15 µL of the Gibson master mix [117 mM Tris-HCl (pH 7.5), 6.5% (v/v) 
polyethylene glycol (PEG) 8000, 13 mM MgCl2, 13 mM DTT, 0.26 mM dNTPs, 1.3 mM 
nicotinamide adenine dinucleotide (NAD), 0.005 U/µL T5 exonuclease, 0.033 U/µL Phusion 
polymerase, and 5.3 U/µL Taq ligase]. Following incubation of the reaction mixture at 50 °C 
for 1 h, the assembled DNA was transformed into competent E. coli cells (cf. section 4.2.1.2) 
and the sequence verified by DNA sequencing (cf. section 4.2.1.4). 
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4.2.1.2. Transformation in E. coli 
The competent E. coli strains BL21-Gold(DE3), RosettaTM 2(DE3) or DH5α (cf. Table 9) were 
transformed with plasmid DNA using the heat shock method (282). That is, approximately 100 
µL E. coli cells were thawed on ice and 40−100 ng of purified plasmid DNA was added. After 
10 min of incubation on ice, the E. coli cells were heat shocked at 42 °C for 45 s and the 
suspension was immediately placed back on ice for another 10 min. Following addition of 1 
mL lysogeny broth (LB) medium (cf. Table 12), the cell suspension was incubated at 37 °C for 
10 to 60 min under gentle shaking (600 rpm, Thermomixer comfort). In a last step, the E. coli 
cells were plated on LB agar plates containing the appropriate antibiotics for the plasmid 
vector (cf. section 4.2.1.3). 
 
4.2.1.3. Culture of E. coli 
The different E. coli strains were grown at 37 °C either on LB agar plates [1.5% (w/v) LB 
agar] or in liquid LB medium (cf. Table 12) under constant shaking. The LB agar plates and 
the LB medium were supplemented with 100 µg/mL ampicillin and/or 34 µg/mL 
chloramphenicol depending on the plasmid vector. In the case of the ISWIM578B construct, the 
transformed bacteria culture was grown in LB medium supplemented with 200 µg/mL 
ampicillin, 34 µg/mL chloramphenicol, and 1 mM Bpa (0.2 M Bpa stock solution, dissolved in 
1 M NaOH). 
 
4.2.1.4. Isolation of plasmid DNA and sequencing 
Single colonies of DH5α cells, which had been transformed with plasmid DNA (cf. section 
4.2.1.2), were picked from LB agar plates and used for inoculation in LB medium 
supplemented with the appropriate antibiotics (cf. section 4.2.1.3). The E. coli cells were 
incubated overnight at 37 °C and harvested by centrifugation (4000 rpm, Sorvall SLA3000 
rotor). The amplified plasmid DNA was extracted from cells using a commercially available 
kit (NucleoSpin Plasmid EasyPure, Plasmid Mini, Midi or Giga, cf. Table 8) according to the 
manufacturer’s protocol. To verify the correct DNA sequence, purified plasmids were sent for 
DNA sequencing to Eurofins Genomics in Munich. 
 
4.2.1.5. Agarose gel electrophoresis 
DNA fragments were separated according to size by agarose gel electrophoresis. Agarose gels 
were casted by dissolving 0.8 to 1.2% (w/v) agarose in either TAE buffer or in 0.5x TBE 
buffer (cf. Table 12) supplemented with 5 µg/mL ethidium bromide. DNA samples were 
mixed with an appropriate volume of 6x Gel Loading Dye and then run alongside a DNA 
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ladder (100 bp and/or 1 kb ladder, cf. Table 8) by applying a constant voltage of 140 V. In a 
last step, agarose gels were digitized using the ChemiDoc imaging system. 
 
4.2.1.6. Native polyacrylamide gel electrophoresis 
For native polyacrylamide gel electrophoresis (PAGE), 4.5% polyacrylamide gels were casted 
using a 30% acrylamide/bisacrylamide stock solution, 0.6% (v/v) tetramethylethylenediamine 
(TEMED), and 0.4% (w/v) ammonium persulfate (APS) in 0.2 to 1.0x TBE buffer. Each gel 
was run at 4 °C and 100 V for 60 min prior to sample loading. Samples were mixed with an 
appropriate volume of 6x Orange G-based loading dye supplemented with 5% (v/v) glycerol 
and were separated at 4 °C by applying a constant voltage ranging from 100 to 140 V. DNA 
detection was accomplished by measuring the intrinsic fluorescence of DNA with an UV lamp 
at 254 nm wavelength. Alternatively, polyacrylamide gels were stained with 50 µg/mL 
ethidium bromide in TBE buffer at room temperature for 60 min, rinsed with water, and 
digitized employing the ChemiDoc gel documentation instrument. 
 
4.2.1.7. SDS-PAGE analysis 
Proteins were separated according to size by SDS-PAGE (283). The sample preparation 
procedure for SDS-PAGE analysis of whole cell extracts and purified protein samples slightly 
differed. In the case of whole cell extracts, pelleted samples were resuspended in urea loading 
buffer [100 µl loading buffer per optical density at 600 nm (OD600) value, Table 12]. The 
resuspended cells were heated at 65 °C for 15 min and were well mixed to shear genomic 
DNA. For purified proteins, pelleted samples were resuspended in an appropriate volume of 5x 
Laemmli loading buffer (cf. Table 12) and boiled at 95 °C for 5 min. Individual samples were 
loaded onto precast SDS-PAGE gels and were separated alongside PeqGOLD protein marker 
IV or V by applying a constant current of 25 mA and using SDS-PAGE running buffer (cf. 
Table 12). Subsequent to electrophoresis, gels were fixed with SDS-PAGE fixing solution and 
proteins were stained with Coomassie Blue staining solution (Table 12). Excess of dye was 
removed with water and the gel was digitized using the ChemiDoc gel documentation 
instrument. 
 
4.2.1.8. Protein precipitation 
Proteins were precipitated either to reduce the sample volume required for SDS-PAGE 
analysis or to exchange the sample buffer. The volume of the sample was adjusted to 100 µL 
using a matching sample buffer and trichloroacetic acid (TCA) was added to a final 
concentration of 15% (v/v). Following an incubation period of 20 min on ice, the precipitated 
proteins were separated by centrifugation (13000 rpm, SS34 rotor, Sorvall RC 6 Plus) at 4 °C 
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for 30 min. The supernatant was discarded and the pellet was washed two times with 300 µl of 
cold acetone. The air-dried pellet was resuspended in the corresponding buffer needed for 
downstream application. 
 
4.2.2. Protein expression and purification 
4.2.2.1. Protein expression in E. coli 
For the expression of Drosophila core histones and several ISWI constructs (i.e., ISWIWT, 
ISWI∆HSS, HSSISWI, ISWIK337D, ISWID485K, and ISWIK337D D485K), BL21-Gold(DE3) cells were 
transformed with the corresponding expression plasmid (cf. section 4.2.1.2 and Table 10) and 
were subsequently plated on selective LB agar plates (cf. section 4.2.1.3). A single colony was 
used to inoculate approximately 15–150 mL of LB medium supplemented with 100 µg/mL 
ampicillin and the pre-culture was incubated overnight at 37 °C under constant shaking. The 
main culture encompassed 2 L of LB medium supplemented with 100 µg/mL ampicillin, which 
was inoculated to an OD600 value of approximately 0.005 or 0.01 using an Ultrospec 2000 
spectrophotometer. Following incubation at 37 °C under constant shaking, protein expression 
was induced at an OD600 value of 0.6 to 0.8 using 1 mM isopropyl-β-D-thiogalactopyranosid 
(IPTG) and the cell suspension was incubated overnight at 18 °C. The E. coli cells were 
harvested by centrifugation (4000 rpm, Sorvall SLA3000 rotor) at 4 °C for 10 min. The cell 
pellet was washed with either water or the first purification buffer, flash frozen in liquid 
nitrogen, and stored at -80 °C until further use.  
For the expression of the His6-ISWIM578B variant, the corresponding plasmid DNA was 
transformed into BL21-Gold(DE3) cells that already contained a plasmid (pFMP153, Table 
10) encoding for both a Bpa-comprising mutant tRNA as well as a Bpa-specific aminoacyl-
tRNA synthetase. The anticodon of the mutant tRNA was complementary to the TAG stop 
codon in order to facilitate the site-specific incorporation of the photo-reactive amino acid Bpa 
during translation. A single colony from chloramphenicol/ampicillin-selective LB agar plates 
was used to inoculate approximately 15 mL of LB medium supplemented with 34 µg/mL 
chloramphenicol and 200 µg/mL ampicillin and the pre-culture was incubated overnight at 37 
°C under constant shaking. The main culture encompassed 2 L of LB medium supplemented 
with 34 µg/mL chloramphenicol, 200 µg/mL ampicillin, and 1 mM Bpa. Protein expression 
was induced at an OD600 value of 0.6 to 0.8 using 0.2 mM IPTG and cells were allowed to 
grow overnight at 18 °C under constant shaking. Subsequent preparatory steps were identical 
to the ones described above for Drosophila proteins.  
For the expression of the Snf2H enzyme, I transformed RosettaTM 2 (DE3) cells with the 
corresponding expression plasmid (cf. Table 10). A single colony from 
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chloramphenicol/ampicillin-selective LB agar plates was used to inoculate approximately 15–
150 mL of LB medium supplemented with 34 µg/mL chloramphenicol and 100 µg/mL 
ampicillin and the pre-culture was incubated overnight at 37 °C under constant shaking. The 
main culture encompassed 2 L of “rich” LB medium (cf. Table 12) supplemented with 34 
µg/mL chloramphenicol and 100 µg/mL ampicillin. Protein expression was induced at an 
OD600 value of 0.6 to 0.8 using 0.4 mM IPTG. Subsequent preparatory steps were identical to 
the ones described above. 
The overexpression of proteins was generally monitored by SDS-PAGE analysis. That is, 
during each protein expression, 1 mL of the cell culture prior to IPTG-induced overexpression 
and cell harvesting were removed, pelleted, and processed as described in section 4.2.1.7.  
 
4.2.2.2. Purification of ISWI constructs 
4.2.2.2.1. Purification of DmISWIWT and additional point mutation constructs 
Pellets of E. coli cells expressing either His6-tagged DmISWIWT or point-mutant constructs 
(i.e., ISWIK337D, ISWID485K, and ISWIK337D D485K) were resuspended in 30 mL ISWI His-A 
buffer (cf. Table 12). The ISWI His-A buffer was supplemented with 1 mg/L aprotinin, 1 mg/L 
leupeptin, 0.7 mg/L pepstatin, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 1 Complete 
Protease Inhibitor Cocktail tablet to prevent protein proteolysis. The bacteria cells were lysed 
by passing the suspension three times through a French Press (1500 psi, French Pressure Cell 
Press Model FA-078) followed by sonication (Sonifier S-250 D) for a total time of 1 min at an 
amplitude of 25% on ice. Alternatively, E. coli cells were lysed employing a microfluidizer 
instrument (5 runs at 1000 bar, Microfluidizer LM10). Following addition of benzonase (1000 
U/L cell culture) to degrade DNA and RNA, the cell lysate was centrifuged for 30 min at 
19000 rpm and 4 °C (SS34 rotor, Sorvall RC 6 Plus) and the soluble fraction was filtered using 
0.45 µm Rotilabo-syringe filters. 
The His6-tagged ISWI constructs were subsequently purified by nickel affinity 
chromatography (1 or 5 mL HisTrap HP columns) using an ÄKTA FPLC system. That is, the 
instrument was pre-equilibrated with ISWI-His-A buffer supplemented with 20 mM imidazole 
and the clarified lysate was loaded onto the HisTrap HP column. Unwanted protein species 
were washed off the column using ISWI-His-B buffer (cf. Table 12) and the following step 
imidazole gradient: 10 column volumes (CVs) of 20 mM imidazole, 6 CVs of 40 mM 
imidazole, and 1 CV of 80 mM imidazole. The flow-rate for the 1 and 5 mL HisTrap HP 
columns during the wash procedure was set to 1.5 and 2.5 mL/min, respectively. The full-
length ISWI proteins were subsequently eluted by applying a linear gradient from 80 to 400 
mM imidazole over 10 CVs at a flow rate of 1 mL/min or 2 mL/min. ISWI fractions were 
pooled and the combined sample supplemented with His-tagged TEV protease (prepared in-
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house) to a final concentration of 0.06 mg/mL. The sample was subsequently dialyzed against 
ISWI dialysis buffer (1 L for at least 1 h, 1 L overnight, cf. Table 12) using 6000–8000 Da 
molecular weight cut-off (MWCO) Spectra/Por dialysis tubing. TEV-cleaved ISWI proteins 
were separated from unwanted protein species and reaction products by means of nickel 
affinity chromatography. The collected flow-through was subsequently diluted four-fold with 
buffer [10 mM Tris-HCl (pH 7.6), 10% (v/v) glycerol, and 1 mM DTT] to lower the salt 
concentration prior to cation exchange chromatography and the sample was filtered using 0.2 
µm syringe filters. ISWI proteins were immobilized on a Mono S 5/50 GL ion exchange 
column, which had been pre-equilibrated with ISWI MonoS-A buffer (cf. Table 12) 
supplemented with 40 mM NaCl. Unwanted protein species were washed off the column with 
17 CVs of ISWI MonoS-A buffer supplemented with 40 mM NaCl. ISWI proteins were eluted 
by applying a 6.67 min linear gradient at a constant flow-rate of 1.5 mL/min and increasing 
concentrations (40 to 600 mM) of NaCl. ISWI fractions were pooled and the combined sample 
concentrated using Amicon Ultra-4 centrifugal filter units (30 kDa MWCO). In a final step, 
ISWI samples were subjected to size-exclusion chromatography. The sample was loaded onto 
a Superdex 200 column (i.e., Superdex 200 HiLoad 16/60, Superdex 200 Increase 10/300 GL, 
or Superdex 200 10/300 GL) that had been pre-equilibrated with ISWI SEC buffer (cf. Table 
12). Fractions that contained ISWI proteins were pooled and concentrated to 1–10 mg/mL 
using 30 kDa MWCO Amicon Ultra-4 centrifugal filter units. Small aliquots of the purified 
protein were flash frozen in liquid nitrogen and stored at -80 °C until further use. The yield for 
DmISWIWT was between 0.5 and 3.1 mg per liter cell culture (n = 4). Purification of ISWI 
point-mutant constructs (i.e., ISWIK337D, ISWID485K, and ISWIK337D D485K) typically yielded 
between 0.2 to 0.5 mg of protein per liter cell culture (n = 1). 
 
4.2.2.2.2. Purification of ISWIM578B 
Pellets of E. coli cells expressing the His6-tagged ISWIM578B construct were resuspended in an 
identical manner as described for DmISWIWT in section 4.2.2.2.1. Cell lysis was achieved by 
passing the suspension five times through a microfluidizer instrument (1000 bar, 
Microfluidizer LM10). Following addition of benzonase (1000 U/L cell culture), the cell lysate 
was cleared by centrifugation and filtration and the sample was subjected to nickel affinity 
chromatography in an identical manner as specified for DmISWIWT in section 4.2.2.2.1. 
Notably, the UV light of the FPLC instrument was switched off during the purification 
procedure to prevent unwanted cross-linking reactions of the ISWIM578B variant. Following 
TEV-mediated cleavage of the His6-tag, ISWIM578B samples were further purified by nickel 
affinity and size-exclusion chromatography as described for DmISWIWT in section 4.2.2.2.1. 
The yield was 0.4 mg per liter cell culture (n = 1).  
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4.2.2.2.3. Purification of ISWIΔHSS 
Cells expressing His6-ISWIΔHSS were resuspended in 35 mL of ISWIΔHSS lysis buffer (cf. Table 
12). The lysis buffer was supplemented with 1 mM PMSF, 20 mM imidazole, 1 mM DTT, and 
1 Complete Protease Inhibitor Cocktail tablet. The bacterial cells were lysed by passing the 
suspension five times through a microfluidizer instrument (1000 bar, Microfluidizer LM10). 
Following addition of benzonase (1000 U/L cell culture), the cell lysate was cleared by 
centrifugation and filtration as specified for DmISWIWT in section 4.2.2.2.1. The sample was 
subsequently subjected to nickel affinity chromatography and thus was loaded onto a 1 mL 
HisTrap HP column, which had been pre-equilibrated with ISWI ΔHSS-A buffer (cf. Table 12) 
supplemented with 20 mM imidazole. Most sample impurities were efficiently removed at a 
constant flow-rate of 1 mL/min using ISWI ΔHSS-B buffer (cf. Table 12) and the following 
step imidazole gradient: 7 CVs of 40 mM imidazole, followed by 5 CVs of 80 mM imidazole, 
and 2.5 CVs of 120 mM imidazole. The final wash step encompassed a 1 min linear gradient at 
a constant flow-rate of 1 mL/min and increasing concentrations (120−160 mM) of imidazole. 
Prior to elution of the ISWIΔHSS protein with 400 mM imidazole, a pre-equilibrated 5 mL 
HiTrap Q HP anion exchange column was mounted down-stream to the nickel affinity column 
in order to remove negatively charged contaminants. ISWIΔHSS fractions were pooled and the 
combined sample was subjected to size-exclusion chromatography. That is, ISWIΔHSS samples 
were loaded onto a 120 mL Superdex 200 HiLoad 16/60 column, which had been pre-
equilibrated with ISWI ΔHSS SEC buffer (cf. Table 12). Individual ISWIΔHSS fractions were 
pooled and concentrated to approximately 7 mg/mL using 30 kDa MWCO Amicon Ultra-4 
centrifugal filter units before being flash frozen in liquid nitrogen and stored as small aliquots 
at -80 °C. The yield was 6.3 mg of protein per liter cell culture (n = 1). 
 
4.2.2.2.4. Purification of HSSISWI 
Pellets of E. coli cells expressing the His6-tagged HSSISWI protein were resuspended in 30 mL 
HSS-NiA buffer (cf. Table 12). The HSS-NiA buffer was supplemented with 1 mg/L aprotinin, 
1 mg/L leupeptin, 0.7 mg/L pepstatin, 1 mM PMSF, 0.5 mM DTT, and 1 Complete Protease 
Inhibitor Cocktail tablet. Bacterial cells were lysed as described for DmISWIWT in section 
4.2.2.2.1. Following addition of benzonase (1000 U/L cell culture), the cell lysate was cleared 
by centrifugation and filtration as described in section 4.2.2.2.1. The His6-tagged HSSISWI 
protein was subsequently purified by nickel affinity chromatography. The cleared cell lysate 
was loaded onto a 5 mL HisTrap HP column, which had been pre-equilibrated with HSS-NiA 
buffer (cf. Table 12). Contaminating protein species were washed off the column using HSS-
NiB buffer (cf. Table 12) and the following step imidazole gradient: 8 CVs of HSS-NiA buffer 
followed by 4 CVs of 20 mM imidazole. The HSSISWI protein was eluted by applying a linear 
gradient over 13 CVs at a flow-rate of 1 mL/min and increasing (20–500 mM) imidazole 
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concentrations. HSSISWI fractions were pooled and the sample was supplemented with TEV 
protease to a final concentration of 0.06 mg/mL. The sample was subsequently dialyzed 
overnight against 1 L HSS-Dialysis buffer (cf. Table 12) using 6000–8000 Da MWCO 
Spectra/Por dialysis tubing. The TEV-cleaved HSSISWI protein was further purified by means 
of nickel affinity chromatography and the flow-through was collected and was subsequently 
concentrated to 0.5–1 mL using Amicon Ultra-4 centrifugal filter units (10 kDa MWCO). The 
protein sample was further purified by size-exclusion chromatography. Thereby, the sample 
was loaded onto either a Superdex 200 Increase 10/300 GL or a Superdex 200 10/300 GL 
column, which had been pre-equilibrated with HSS-SEC buffer (cf. Table 12). In a final step, 
the eluted HSSISWI protein was pooled and concentrated to 2–5 mg/mL before being flash 
frozen in liquid nitrogen and stored as small aliquots at -80 °C. The yields were 0.4 and 6.5 mg 
of protein per liter cell culture (n = 2). 
 
4.2.2.3. Purification of Snf2H 
Pellets of E. coli cells overexpressing His6-tagged Snf2H were resuspended in Snf2H lysis 
buffer (20 mL/L cell culture, cf. Table 12). The Snf2H lysis buffer was supplemented with 1 
mg/L aprotinin, 1 mg/L leupeptin, 0.7 mg/L pepstatin, 1 mM PMSF, and 1 Complete Protease 
Inhibitor Cocktail tablet. Cell lysis was accomplished as described in section 4.2.2.2.1 by 
passing the suspension through a French Press followed by sonication or by employing a 
Microfluidizer LM10 instrument. Following addition of benzonase (1000 U/L cell culture), the 
cell lysate was cleared by centrifugation and filtration as specified in section 4.2.2.2.1. The 
His6-tagged Snf2H protein was subsequently purified by nickel affinity chromatography. The 
sample was loaded onto a 5 mL HisTrap HP column, which had been pre-equilibrated with 
Snf2H lysis buffer, at a flow rate of 1.0 mL/min. Unwanted protein species were washed off 
the column using 8 CVs of Snf2H lysis buffer at a flow-rate of 1.5 mL/min. The Snf2H 
enzyme was eluted by applying a linear gradient over 8 CVs from 0 to 100% Snf2H elution 
buffer (cf. Table 12) at a constant flow-rate of 1.5 mL/min. Enzyme fractions were 
subsequently pooled and subjected to anion exchange chromatography in order to separate 
Snf2H molecules from contaminating DNA. The protein sample was loaded onto a Mono Q 
5/50 GL column, which had been pre-equilibrated with Snf2H-SEC buffer (cf. Table 12). The 
flow-through was collected and concentrated to 0.5–1 mL per liter cell culture using Amicon 
Ultra-4 centrifugal filter units (30 kDa MWCO). Following addition of TEV protease to a final 
concentration of 0.075–0.15 mg/mL, the protein sample was dialyzed overnight against 1 L of 
Snf2H-SEC buffer using Spectra/Por dialysis tubing (6000–8000 Da MWCO). The purity of 
the Snf2H sample was further enhanced using size-exclusion chromatography. The filtered 
sample (0.2 µm syringe filter) was loaded onto a 120 mL Superdex 200 HiLoad 16/60 column, 
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which had been pre-equilibrated with Snf2H-SEC buffer. Snf2H fractions were pooled and 
concentrated (Amicon Ultra-4 centrifugal filter unit, 30 kDa MWCO) before being dialyzed 
against 0.5 L of Snf2H-storage buffer (cf. Table 12) for at least 16 hours. Small aliquots of 
purified Snf2H were flash frozen in liquid nitrogen and stored at -80 °C. The purification 
yielded 3.0 and 4.4 mg of protein per liter cell culture (n = 2).  
 
4.2.2.4. Purification of core histones 
4.2.2.4.1. Histone purification according to the IBP protocol 
Pellets of E. coli cells overexpressing a Drosophila core histone protein (i.e., H2A, H2B, H3, 
or H4) were resuspended in 35 mL of histone-wash buffer (cf. Table 12). The histone-wash 
buffer was supplemented with 1 mg/L aprotinin, 1 mg/L leupeptin, and 0.7 mg/L pepstatin. 
The bacterial cells were lysed by sonication (Digital Sonifier S-250 D) for a total time of 2 min 
at an amplitude of 30% followed by passing the suspension three times through a French Press 
(1500 psi, French Pressure Cell Press Model FA-078). The cell lysate was pelleted by 
centrifugation for 30 min at 19000 rpm and 4 °C (SS34 rotor, Sorvall RC 6 Plus). Inclusion 
bodies were purified by a series of washing steps, in which the insoluble fraction of the lysate 
was repeatedly resuspended in buffer and pelleted by centrifugation. During the first washing 
step, the pelleted lysate was resuspended in histone-wash buffer, which was supplemented with 
1% (v/v) of the Triton X-100 surfactant. During the following two cycles, the insoluble 
fraction was washed with histone-wash buffer without any additives. Extraction of histone 
proteins was accomplished by suspension of the inclusion bodies in histone-unfolding buffer 
(cf. Table 12) and incubation of the sample for 1 hour under constant rotation. The sample was 
subsequently dialyzed overnight against 1 L of SAU buffer supplemented with 200 mM NaCl 
(cf. Table 12, the buffer was exchanged three times) using Spectra/Por dialysis tubing (6000–
8000 Da MWCO). Following filtration of the sample using 0.45 µm syringe filters, histone 
proteins were purified by means of cation exchange chromatography. The sample was loaded 
onto a 5 mL HiTrap SP column, which had been pre-equilibrated with SAU buffer 
supplemented with 200 mM NaCl. Unwanted protein species were washed off the column 
using SAU buffer and the following step NaCl gradient: 5 CVs of 200 mM NaCl, followed by 
3 CVs of 250 mM NaCl, and 3 CVs of 300 mM NaCl. Histone proteins were eluted by 
applying a nonlinear gradient from 300 to 800 mM NaCl (increase to 350 mM NaCl over 5 
CVs followed by an increase to 800 mM NaCl over 7 CVs) at a constant flow-rate of 1.7 
mL/min. Histone fractions were pooled and dialyzed overnight against 3 L of deionized water 
(water was exchanged three times) using Spectra/Por dialysis tubing (6000–8000 Da MWCO). 
The concentration of individual histone proteins was determined by UV absorption 
measurements at 280 nm using a NanoDrop spectrophotometer and taking into account the 
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respective extinction coefficient (Table 13). Sample purity was calculated as described by 
Glasel (229). Small aliquots of purified histone proteins were flash frozen in liquid nitrogen 
and stored at -80 °C until further use. 
 
 
Table 13: Histone extinction coefficients. Extinction coefficients of individual Drosophila core histones are 
listed according to Klinker et al. (227).  
Histone MW [Da] ε280 [M
-1 cm-1] 
H2A 13232 4470 
H2B 13565 7450 
H3 15257 4470 
H4 11250 5960 
 
 
4.2.2.4.2. Histone purification according to the RHP protocol 
Pellets of E. coli cells overexpressing a Drosophila core histone protein (i.e., H2A, H2B, H3, 
or H4) were resuspended in 35 mL of SAU buffer (cf. Table 12). The SAU buffer was 
supplemented with 200 mM NaCl, 1 mg/L aprotinin, 1 mg/L leupeptin, 0.7 mg/L pepstatin, 
and 1 mM PMSF. Bacterial cells were lysed by sonication (Digital Sonifier S-250 D) for a total 
time of 2 min at an amplitude of 30% followed by passing the suspension three times through a 
French Press (1500 psi, French Pressure Cell Press Model FA-078). The lysate was pelleted by 
centrifugation for 30 min at 19000 rpm and 4 °C (SS34 rotor, Sorvall RC 6 Plus) and the 
supernatant was filtered using HPF Millex syringe filters. 
In the RHP “Variant 1” protocol (cf. Figure 8B), histone proteins were subsequently purified 
by cation exchange chromatography in an identical manner as described in section 4.2.2.4.1. 
Histone fractions were pooled and dialyzed overnight against 1.5 L of deionized water (the 
dialysate was exchanged three times) using Spectra/Por dialysis tubing (6000–8000 Da 
MWCO). Protein samples were supplemented with 15 mM Tris-HCl (pH 8.0), filtered using 
0.45 µm syringe filters, and subjected to anion exchange chromatography in order to remove 
contaminating DNA. The sample was loaded onto a 5 mL HiTrap Q HP column, which had 
been pre-equilibrated with 15 mM Tris-HCl (pH 8.0). Following collection of the flow-
through, protein concentration and sample purity were determined as specified in section 
4.2.2.4.1. Small aliquots of purified histone proteins were flash frozen in liquid nitrogen and 
stored at -80 °C until further use. 
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In the RHP “Variant 2” protocol (cf. Figure 8B), removal of contaminating DNA was coupled 
to cation exchange chromatography by placing the HiTrap Q HP column upstream of the 
HiTrap SP HP column during histone purification. Once the protein sample bound to the cation 
exchange column, the HiTrap Q HP column was simply detached from the FPLC system and 
the purification procedure proceeded as described above for “Variant 1” of the RHP protocol. 
 
4.2.3. Reconstitution of nucleosomes 
4.2.3.1. DNA digestion and purification 
DNA that was used during nucleosome reconstitution (cf. section 4.2.3.3) was prepared from 
plasmid DNA harboring the 601 positioning sequence (235) using restriction enzyme-mediated 
digestion in combination with size separation by native PAGE.  
The corresponding plasmid (i.e., pFMP109 or pFMP151, cf. Table 10) was transformed into 
DH5α E. coli cells for amplification (cf. section 4.2.1.2). The plasmid DNA was subsequently 
isolated and purified as described in section 4.2.1.4. 
Restriction enzyme-mediated digestion of the plasmid DNA was initiated by diluting the DNA 
to a final concentration of 1 mg/mL in 1x Buffer 4 supplemented with 70 U/mL of SmaI. The 
reaction mixture was subsequently incubated at 37 °C for 18 to 20 h. Notably, digestion of 
plasmid pFMP151 with the SmaI enzyme results in four identical DNA fragments of 187 bp 
length with terminal nucleosome positioning sequence. Following precipitation of DNA with 
1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5-times the initial volume of ethanol, the 
sample was centrifuged for 30 min at 19000 rpm and 4 °C (SS34 rotor, Sorvall RC 6 Plus). 
DNA fragments were subsequently dissolved in approximately 500 µL TE buffer (cf. Table 
12) at room temperature and the sample was separated by native PAGE (cf. section 4.2.1.6). 
UV shadowing using an UV lamp (Ultra Violet Products) at 254 nm allowed the localization 
and isolation of the target DNA fragments. The DNA fragments were subsequently eluted from 
the polyacrylamide slices using the Whatman Elutrap electroelution system according to the 
manufacturer’s guidelines at 100−140 V for at least 3 h. The eluted DNA was precipitated as 
described above and then resuspended in TE buffer. DNA concentration was determined by 
UV measurements at 254 nm employing a NanoDrop ND1000 spectrophotometer. 
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4.2.3.2. Octamer reconstitution 
Each of the purified core histones was lyophilized overnight (Alpha 1–2 and RZ 2.5) and 
solubilized in octamer unfolding buffer (cf. Table 12) to a concentration of approximately 4 
mg/mL. Following incubation for 30 min under constant rotation at room temperature, the 
concentration of each histone was determined as described in section 4.2.2.4.1. The four core 
histones H2A, H2B, H3, and H4 were subsequently mixed in a molar ratio of 1.6:1.4:1:1, 
respectively, and histone stoichiometry was evaluated by SDS-PAGE analysis (cf. section 
4.2.1.7). The sample was dialyzed overnight at 4 °C against octamer refolding buffer (cf. Table 
12) using Spectra/Por dialysis tubing (3500 Da MWCO). Following centrifugation of the 
sample at 19000 rpm (SS34 rotor, Sorvall RC 6 Plus) for 30 min, the supernatant was 
concentrated to 2–4 mL using 30 kDa MWCO Amicon Ultra-4 centrifugal filter units. 
Assembled octamers were separated from different protein species by means of size-exclusion 
chromatography. The sample was therefore loaded onto a 120 mL Superdex 200 HiLoad 16/60 
column, which had been pre-equilibrated with octamer refolding buffer. Histone octamers 
exhibiting correct subunit stoichiometry typically eluted at approximately 60 mL. The 
respective fractions were pooled and octamer concentration was determined using a NanoDrop 
ND1000 spectrophotometer and assuming an extinction coefficient of 44700 M-1cm-1. Small 
aliquots of purified core histone octamers were flash frozen in liquid nitrogen and stored at -80 
°C. 
 
4.2.3.3. Nucleosome reconstitution 
Mononucleosomes were reconstituted by salt gradient dialysis using purified histone octamers 
(cf. 4.2.2.4) and defined DNA fragments of 187 bp length (cf. section 4.2.3.1) in a 300 µL 
reaction volume.  
To find an optimal molar ratio between DNA and histone octamers in preliminary experiments, 
increasing amounts of histone octamers were mixed with 0.3 µg/µL DNA in buffer [20 mM 
Tris-HCl (pH 7.7), 2 M KCl, and 10 mM DTT] and nucleosome formation was evaluated by 
native PAGE analysis (cf. section 4.2.1.6). Nucleosome reconstitution was typically found to 
be most efficient at a molar DNA:octamer ratio of approximately 1 (i.e., 0.93 ± 0.14, n = 25). 
Salt gradient dialysis was performed at 4 °C using either Slide-A-Lyzer MINI dialysis devices 
(7000 Da MWCO) or a custom-built dialysis chamber equipped with 7000 Da MWCO 
Spectra/Por dialysis tubing. Salt gradient dialysis was initiated by dialyzing the sample against 
100 mL of Mononuc-2000 buffer (cf. Table 12). The salt concentration of the buffer was 
lowered over time using Mononuc-0 buffer (cf. Table 12) and a peristaltic pump (MINIPULS 
Evolution). The flow-rate of the peristaltic pump was thereby set to 0.35 rpm for the initial 24 
hours and was then increased to 0.8 rpm for at least another 3 h. The volume of the dialysate 
was kept constant throughout dialysis procedure. 
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Following centrifugation for 15 min at 13000 rpm (Eppendorf 5417C centrifuge) and 4 °C, 
nucleosome concentration was estimated by UV measurements at 254 nm using a NanoDrop 
ND1000 spectrophotometer and the quality of the sample assessed by native PAGE analysis 
(cf. section 4.2.1.6). 
 
Samples subjected to XL-MS analysis, mononucleosomes were further purified by glycerol 
gradient ultracentrifugation. The gradient ranging from 10 to 30% glycerol was prepared in 
polypropylene tubes (14 x 89 mm) by mixing UZ-10% and UZ-30% solutions (cf. Table 12) 
with the help of the Gradient Master instrument and the following settings: 2.25 min, 81.5°, 11 
rpm, and UP rotation. The nucleosome sample (V < 500 µL) was layered on top of the glycerol 
gradient and centrifuged for 19 hours at 34000 rpm (SW 41 Ti rotor) and 4 °C. Drop fractions 
of 200–300 µL were collected from the bottom of the glycerol gradient by the use of a 20-
gauge needle and the quality of the sample was evaluated by native PAGE analysis (cf. section 
4.2.1.6). Qualitatively satisfying nucleosome fractions (i.e., high nucleosome concentrations, 
low concentration of unbound DNA) were pooled and concentrated to 2–5 µM using 30 kDa 
MWCO Amicon Ultra-4 centrifugal filter units. Nucleosome concentration was estimated by 
UV measurements at 254 nm using a NanoDrop spectrophotometer and the quality of the 
sample assessed by native PAGE analysis. Purified mononucleosomes were stored up to six 
weeks in the fridge at approximately 8 °C.  
 
4.2.4. Protein cross-linking coupled to mass spectrometry 
4.2.4.1. Protein cross-linking  
4.2.4.1.1. UV cross-linking 
UV cross-linking was performed essentially as described previously by Forné et al. (157). 
Briefly, 100 µL samples comprising 1.0 µM of purified ISWIM578B protein and UV-XL buffer 
(cf. Table 12) were exposed to long-wave UV light (365 nm) in a Bio-Link 365 UV-
Crosslinker system on ice. Following UV irradiation for various time intervals (i.e., 0, 30, and 
120 min), 30 µL of the sample was removed and subjected to SDS-PAGE analysis (cf. section 
4.2.1.7) and in-gel tryptic digestion (cf. section 4.2.4.2.1). 
 
4.2.4.1.2. Chemical cross-linking  
Enzyme-nucleosome and enzyme-ADP-BeFx complexes were formed by incubating the 
respective molecules for 10 min on ice in the respective c-XL buffer (cf. Table 12) in order to 
allow binding to equilibrate. The ADP-BeFx solution was prepared by mixing equal volumes 
of a 50 mM ADP-Mg2+ stock solution (prepared by dissolving ADP and MgCl2 in an 
equimolar ratio in water at pH 7) with a premixed solution containing 50 mM BeSO4 and 150 
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mM NaF. Following centrifugation of protein samples for 10 min at 13000 rpm and 4 °C 
(Eppendorf 5417C centrifuge), chemical cross-linking was initiated by addition of either the 
BS2G or the BS3 cross-linking agent (dissolved in DMSO). Table 14 summarizes the distinct 
cross-linking conditions for the DmISWI and Snf2H enzymes that resulted in productive XL-
MS data for different functional states of the catalytic cycle (cf. STable 1–STable 5).  
 
 
Table 14: Chemical cross-linking conditions for the DmISWI and Snf2H enzymes. The specific cross-
linking conditions that resulted in productive XL-MS data are summarized for each protein state. The cross-
linking buffers c-XL #1–5 are specified in Table 12. 
Protein state 
Enzyme 
[µM] 
Nucleotide 
[mM] 
Nucleosome 
[µM] 
BS2G 
[mM] 
  
BS3  
[mM] 
Buffer or 
  
DmISWI - Apo 1.0–1.5 0 0 0.5–3.0   1.0 c-XL #1 
Snf2H - Apo 1.0–8.0 0 0 0   0.7–1.4 c-XL #2 / #3  
Snf2H - ADP-BeFx 1.0–1.5 3.0 0 0   1.0 c-XL #2 / #4 
Snf2H - Nucleosome 1.5 3.0 0.8 or 1.5 0   1.0 c-XL #5 
 
 
Following incubation of the sample for 30 min on ice or at 30 °C, the cross-linking reaction 
was quenched by adding NH4HCO3 to a final concentration of 200 mM and the sample was 
incubated for another 20 min on ice. Potential protein aggregates were removed by 
centrifugation for 10 min at 13000 rpm and 4 °C (Eppendorf 5417C centrifuge). Notably, each 
XL-MS experiment also included a DMSO-treated negative control sample, in which target 
protein(s) were processed in an identical manner in the absence of a chemical cross-linker. 
 
Cross-linked proteins were subsequently precipitated by TCA (cf. section 4.2.1.8) and 
subjected to in-solution tryptic digestion (cf. section 4.2.4.2.2). Alternatively, selected samples 
(cf. column “Size selection” in STable 1–STable 5) were subjected to size-exclusion 
chromatography prior to in-solution digestion. Size-exclusion chromatography was performed 
by loading the sample onto either a Superdex 200 Increase 10/300 GL or a Superdex 200 
10/300 GL column, which had been pre-equilibrated with ISWI SEC or c-XL #2 buffer for 
DmISWI and Snf2H samples, respectively. Enzyme fractions were pooled, proteins were 
precipitated by TCA, and the sample was subjected to in-solution tryptic digestion (cf. section 
4.2.4.2.2).   
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4.2.4.2. Protein proteolysis 
4.2.4.2.1. In-gel tryptic digestion 
Cross-linked ISWIM578B samples (cf. section 4.2.4.1.1) were separated by SDS-PAGE analysis 
and stained with Coomassie Blue. Bands corresponding to ISWIM578B were excised from the 
polyacrylamide gel and each gel slice was thoroughly washed with water and 40 mM 
NH4HCO3 at room temperature. The gel slices were subsequently shrunken by submerging 
them in acetonitrile (ACN) for 20 min at room temperature. The gel slices were air-dried for 2 
min and then rehydrated under reducing solution conditions (10 mM DTT in 40 mM 
NH4HCO3). Following incubation of the sample for 1 hour at room temperature, thiol groups 
were alkylated with 55 mM iodoacetamide (IAA) in the absence of light for another 30 min at 
room temperature. Each gel slide was subsequently washed three times with 40 mM NH4HCO3 
and ACN before being air-dried for 5 min. Tryptic digestion was initiated by rehydrating each 
gel slice with 10 µL digestion buffer (200 ng sequencing grade modified trypsin, 5 mM acetic 
acid, and 36 mM NH4HCO3). Following an initial incubation period of 2–3 min on ice, the 
volume of the reaction mixture was adjusted to 50 µL using 40 mM NH4HCO3 and the sample 
incubated for another 5 min. Following addition of another 40 µL of 40 mM NH4HCO3, the 
sample was incubated overnight at 37 °C under constant shaking (600 rpm, Thermomixer 
comfort). The solution was transferred to a new tube and the sample was acidified by addition 
of trifluoroacetic acid (TFA) to a final concentration of 0.1% (v/v). The tryptic peptide mixture 
was subsequently desalted and concentrated by solid-phase extraction (SPE) as described in 
section 4.2.4.3. 
 
4.2.4.2.2. In-solution tryptic digestion 
Chemically cross-linked protein samples, which had been precipitated by TCA (cf. section 
4.2.4.1.2), were solubilized in XL-denaturation buffer (cf. Table 12) to a final protein 
concentration of approximately 1 mg/mL. Disulfide bonds were reduced by addition of DTT to 
a final concentration of 5 mM and incubation of the sample for 1 hour at room temperature. 
Reactive thiol groups were subsequently alkylated in the presence of 10 mM IAA for 30 min in 
the dark at room temperature. Following dilution of the sample with 25 mM NH4HCO3 to a 
final concentration of 1 M urea, protein proteolysis was initiated by addition of trypsin (200 
ng/µL sequencing grade modified trypsin in 50 mM acetic acid) in a 1:50 enzyme to substrate 
ratio. Tryptic digestion was allowed to proceed overnight at 37 °C under constant shaking (600 
rpm, Thermomixer comfort). Trypsin was inactivated by lowering pH to 2–3 using formic acid 
and the sample was subsequently desalted and concentrated by SPE as described in section 
4.2.4.3.   
 135 Materials and Methods 
4.2.4.3. Solid-phase extraction and enrichment of tryptic peptides 
The tryptic peptide mixture was subjected to SPE using either OMIX C18 pipette tips (10–100 
µL) or Sep-Pak tC18 cartridges. 
In the case of the OMIX C18 pipette tips, the chromatography resin was activated and 
equilibrated by flushing the pipette tips three times with 100 µL of 50% (v/v) ACN and 100 µL 
of 0.1% (v/v) TFA, respectively. The acidified tryptic digest was loaded onto the C18 resin and 
was washed five times with 100 µL of 0.1% (v/v) TFA. Tryptic peptides were eluted in 50 µL 
of 60% (v/v) ACN supplemented with 0.25% (v/v) TFA. 
In the case of the Sep-Pak tC18 cartridges, the chromatography resin was activated and 
equilibrated by flushing the cartridges with 700 µL ACN and two times 700 µL of SPE wash 
solution (cf. Table 12), respectively. Following acidification of the tryptic digest to pH 2−3 
with formic acid, the sample was loaded onto the resin and the cartridge was washed twice 
with 700 µL SPE wash solution. Tryptic peptides were eluted in 500 µL of SPE elution 
solution (cf. Table 12). 
Following SPE by either OMIX C18 pipette tips or Sep-Pak tC18 cartridges, samples were 
evaporated to dryness in a vacuum centrifuge at 30 °C. Tryptic peptides were subsequently 
resuspended in either 10−20 µL of 0.1% (v/v) TFA and the sample subjected to LC-MS/MS 
analysis (cf. section 4.2.4.4) or in 25 µL of SEC mobile phase (cf. Table 12) for size-exclusion 
chromatography. 
Selected samples were subjected to size-exclusion chromatography in order to enrich cross-
linked peptides as described previously by Leitner et al. (284). The peptide mixture was loaded 
onto a Superdex Peptide PC 3.2/300 column, which had been pre-equilibrated with 30% (v/v) 
ACN supplemented with 0.1% (v/v) TFA. Fractions were collected every 2 min at a flow-rate 
of 50 µL/min in 96-well MultiScreen HTS plates. Samples were subsequently evaporated to 
dryness as described above and were resuspended in 10−20 µL of 0.1% (v/v) TFA before 
being subjected to LC-MS/MS analysis. 
 
4.2.4.4. LC-MS/MS analysis 
LC-MS/MS analysis was kindly performed by Dr. I. Forné (LMU, Munich). Samples were 
injected into an UltiMate 3000 or RSLCnano HPLC system, which had been equipped with a 
15 cm analytical C18 nano column (75 μm ID, packed with ReproSil-Pur C18-AQ 2.4 μm). 
Peptides were gradually eluted by applying a 40−60 min linear gradient and increasing 
concentrations (i.e., 5−60%) of ACN in 0.1% formic acid. The effluent was directly 
electrosprayed into the ion source of either a LTQ-Orbitrap XL or Q-Exactive HF mass 
spectrometer. Both instruments were operated in positive ionization mode with precursor and 
fragment ions being detected in data-dependent acquisition mode with high resolution and 
accuracy. 
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In the case of the LTQ-Orbitrap XL instrument, ionization was accomplished by applying a 
constant spray voltage of 1.4 kV and a capillary temperature of 200 °C in the absence of any 
sheath or auxiliary gas flow. Precursor ions were detected in survey full-scan MS mode 
ranging from 300−2000 m/z with a resolution of 60000 at m/z 400. The six most abundant 
peptide ions with charge states between 2+ and 5+ were sequentially isolated to a target value 
of 10000 and fragmented in the linear ion trap by collision-induced dissociation (CID, 35% 
normalized collision energy). The collision voltage and activation time was set to q = 0.25 and 
30 ms, respectively. The ion selection threshold was set to 10000 counts for MS/MS. Fragment 
ion spectra were recorded with the Orbitrap detector. Internal calibration was achieved as 
described previously by Forné et al. (157) using a total of three lock mass ions from ambient 
air (m/z = 371.10123, 445.12002, and 519.13882). 
In the case of the Q-Exactive HF mass spectrometer, spray voltage and capillary temperature 
were set to 1.5 kV and 250 °C, respectively. Sheath and auxiliary gas flow were turned off. 
Precursor ions were detected in survey full-scan MS mode ranging from 375−1600 m/z with 
high resolution as specified above. The ten most intense peptide ions with charge states 
between 3+ and 5+ were sequentially isolated to a target value of 100000 and subjected to CID 
fragmentation at 27% normalized collision energy. The ion selection threshold was set to 
33000 counts for MS/MS. 
Thermo binary raw files were converted into mzXML or mgf format using msconvert 
(ProteoWizard Tools, http://proteowizard.sourceforge.net/tools.shtml) and Proteome 
Discoverer 1.4-PostSearch Recalibrator Node (ThermoFisher Scientific), respectively. 
 
4.2.4.5. Data analysis and identification of cross-linked peptides 
Cross-linked peptides were identified using the Crossfinder software (157, 200). In the case of 
chemical cross-linking data, only lysine residues of the target protein(s) were considered as 
potential cross-linking sites. In contrast, all residues of the ISWIM578B variant were considered 
to facilitate the Bpa-mediated formation of cross-links upon UV irradiation. The number of 
missed trypsin cleavage sites was set to 2 or 3. Oxidation of methionine and 
carbamidomethylation of cysteine residues were defined as variable and fixed modifications, 
respectively. Peptide hits for individual steady-state conditions were subsequently filtered 
according to the Crossfinder score, fragmentation quality, and peptide length as specified in 
Table 15. Precursor and fragment ion mass accuracy was set to 9 and 12.5 parts per million 
(ppm), respectively. The FDR did not exceed 7% for any functional state when applying these 
filtering criteria.  
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Table 15: Peptide identification criteria. 
Protein ISWIWT ISWIM578B Snf2H  Snf2H 
Snf2H-
nucleosome 
Cross-linker 
BS2G, 
BS3 
UV BS3 BS3 BS3 
Ligand none none none ADP-BeFx ADP-BeFx 
Score > 800 > 400 > 1000 > 700 > 1200 
Relative filter score  100 100 100 100 100 
Number of fragment ions per 
spectrum 
> 6 > 5 > 5 > 5 > 6 
Number of fragment ions per peptide > 2 > 2 > 2 > 2 > 3 
Fractional intensity of assigned MS2 
peaks 
> 0.05 > 0.05 > 0.05 > 0.05 > 0.05 
Minimal peptide length 1 1 1 1 3 
False-discovery rate (FDR) < 0.05 < 0.05 < 0.07 < 0.05 < 0.03 
 
 
Peptide hits were manually discarded from further analysis if one of the following was true: (i) 
the same candidate was identified in the negative (i.e., DMSO-treated or unirradiated) control 
sample, (ii) the spacing between cross-linked residues of intra-domain linkages was below ten, 
and (iii) the cross-linked lysine residue was at the C-terminal end of the peptide (285). 
Sequence assignments were subsequently manually verified by assessing the correct 
assignment of precursor and fragment ions in MS/MS spectra. A tabular overview of identified 
cross-links for the DmISWI and Snf2H remodeling enzymes across different functional states 
is provided in STable 1–STable 5. Notably, STable 1 furthermore includes previously 
published Bpa-mediated cross-links for ISWIM578B (157) and ISWIH483B (115) that were used 
during computational modeling and data interpretation of the DmISWI enzyme as well as an 
unpublished data set, which was kindly provided by Dr. Felix Müller-Planitz (LMU, Munich). 
 
4.2.4.6. Relative quantification of cross-linked peptides 
The relative quantification of cross-linked peptides relied on the use of isotopically labeled 
BS3-H4 and BS
3-D4 cross-linking agents. The Snf2H enzyme was chemically cross-linked in 
the apo, ADP-BeFx-, and nucleosome-bound state with either BS
3-H4 or BS
3-D4 as described in 
section 4.2.4.1.2. Following quenching of the cross-linking reaction, heavy and light cross-
linked samples were mixed in an equimolar ratio and then subjected to in-solution tryptic 
digestion (cf. section 4.2.4.2.2), size-exclusion chromatography (cf. section 4.2.4.3), and LC-
MS/MS analysis (cf. section 4.2.4.4). Identification of cross-linked peptides was accomplished 
using the Crossfinder software as detailed in section 4.2.4.5. Individual pairs of heavy and light 
cross-linked peptides were further analyzed with the Skyline software package (version 
3.5.0.9319; https://skyline.ms/) (286). In the Skyline software, the sequence of identified cross-
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links was linearized and included customized modifications to account for the BS3-H4 cross-
linker (156.078644 Da) and the mass difference between the isotopically labeled cross-linking 
agents (4.025107 Da). The elution peaks of these linearized cross-links were subsequently 
found in Thermo binary raw files and integrated in a semi-automated manner in the Skyline 
software. Each peak assignment was manually verified on the basis of the following criteria: (i) 
correct retention time (tolerance: 2 min), (ii) correct and appropriate elution peak boundaries, 
(iii) correct charge state of the precursor ion, (iv) transition items for the precursor ion > 0.75, 
and (v) precursor mass accuracy < 7.5 ppm. Peak assignments that did not meet the 
aforementioned criteria were discarded from further analysis. The average BS3-H4/BS
3-D4 ratio 
for individual cross-links was obtained as described in section 2.5.3.  
 
4.2.5. SAXS 
4.2.5.1. Sample preparation 
Freshly purified protein samples (V = 0.3−1.1 mL) were dialyzed against 500 mL SAXS buffer 
(cf. Table 12, the dialysate was exchanged three times) for approximately 24 hours at 4 °C 
using 3000–6000 Da MWCO Spectra/Por dialysis tubing. Following centrifugation for 10 min 
at 13000 rpm and 4 °C (Eppendorf 5417C centrifuge), samples were concentrated to 1−7 
mg/mL (cf. Table 16) using Amicon Ultra-4 centrifugal filter units (10 or 30 kDa MWCO). 
Protein concentrations were determined by measuring the UV absorption at 280 nm employing 
a NanoDrop ND1000 spectrophotometer. Extinction coefficients for DmISWI and Snf2H 
proteins were obtained using the ProtParam tool from the ExPASy Proteomics server 
(http://web.expasy.org/protparam/). Sample purity was evaluated by SDS-PAGE analysis (cf. 
section 4.2.1.7). Finally, small aliquots of the purified proteins as well as respective buffer 
samples were flash frozen in liquid nitrogen and stored at -80 °C until further use.  
 
 
Table 16: Prepared protein samples for SAXS measurements.  
# Enzyme 
Enzyme con-
centration [g/l]  
ADP-BeFx 
[mM]  # Enzyme 
Enzyme con- 
centration [g/l]  
ADP-BeFx 
[mM] 
1 ISWIWT 1.00 0  11 His6-ISWIΔHSS 3.34 3 
2 ISWIWT 2.00 0  12 His6-ISWIΔHSS 6.67 3 
3 ISWIWT 4.00 0  13 HSSISWI 1.83 0 
4 ISWIWT 1.00 3  14 HSSISWI 4.58 0 
5 ISWIWT 2.00 3  15 Snf2H  1.00 0 
6 ISWIWT 4.00 3  16 Snf2H 2.00 0 
7 His6-ISWIΔHSS 1.50 0  17 Snf2H 4.00 0 
8 His6-ISWIΔHSS 3.34 0  18 Snf2H 1.00 3 
9 His6-ISWIΔHSS 7.00 0  19 Snf2H 2.00 3 
10 His6-ISWIΔHSS 1.50 3  20 Snf2H 4.00 3 
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4.2.5.2. Data acquisition and analysis 
SAXS measurements of different ISWI and Snf2H samples (cf. Table 16) as well as data 
analysis were kindly performed by Dr. L. Brützel (LMU, Munich) as described in (1). Briefly, 
data were collected at beamline BM29, ESRF, Grenoble (287) at an X-ray wavelength (λ) of 
0.99 Å using a sample-to-detector distance of 2.87 m and a Pilatus 1M detector. This 
experimental setup resulted in an acceptable q-range of approximately 0.1−3.5 nm−1 [q = 
4π⋅sin(θ)/λ, where θ is defined as the total scattering angle]. Following syringe filtration (0.22 
µm) and centrifugation for 10 min at 13500 rpm (tabletop centrifuge from Eppendorf), each 
protein sample listed in Table 16 was measured 10 times using an exposure time of 4 s in 
‘flow’ mode at room temperature. Matching buffer samples were measured in an identical 
manner before and after each protein sample. Neither protein nor buffer samples exhibited 
signs of radiation damage.  
The collected SAXS data were processed by means of a custom-written MATLAB script (The 
MathWorks Inc.). That is, matching protein sample profiles were averaged and then 
background corrected by subtracting the averaged profiles of the respective buffer. In a final 
step, SAXS data of the lowest and highest concentrated protein sample were scaled and 
merged for the low- and high q-region, respectively. 
Radii of gyration were calculated for each protein construct and condition by Guinier analyses 
using a custom-written MATLAB script. That is, the logarithm of the scattering intensity was 
fitted as a function of q2 to a straight line for small values of q (288). The respective mean and 
standard deviation for each protein construct were obtained by repeating Guinier analysis ten 
times for varying fitting ranges between 1.0 < qmax⋅Rg < 1.3. 
Low-resolution density maps for individual protein constructs and conditions were generated 
by applying a simulated annealing protocol in the DAMMIF software (289). For each 
scattering profile, 20 independent runs in the “slow” mode were performed with default 
parameters and assuming no symmetry. The low-resolution structures of each molecule were 
subsequently aligned using a normalized spatial discrepancy (NSD) criterion (290) and 
averaged in the DAMAVER software (291). Notably, models for each protein and condition 
were structurally similar as indicated by pairwise NSD values between zero and one. The 
aligned bead models were averaged and loosely connected beads were removed by filtering. 
These models were subsequently converted into electron density maps using the pdb2vol 
program from the SITUS package (version 2.7.2) (292) and aligned to the respective atomic 
structures. The nominal resolution of the scattering data may be expressed on the basis of the 
highest measured q-values (i.e., 3.5 nm−1) as 2π/qmax (293). According to this equation, we 
obtained a nominal resolution of approximately 2 nm. However, the resolution assessment for 
ab-initio shape reconstructions is not clearly defined; the resolution of individual models 
determined from the SAXS scattering data is estimated to be in the range of 2–3 nm (Prof. Dr. 
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Jan Lipfert, LMU, personal communication). Finally, molecular envelope shapes with aligned 
structures were prepared using visual molecular dynamics (294).  
 
4.2.6. Computational modeling 
XL-MS-driven modeling of all DmISWI and Snf2H structures was kindly performed by Dr. C. 
Schindler (TUM, Munich).  
 
4.2.6.1. Structure preparation 
The input structures for rigid body docking were prepared by homology modeling of individual 
DmISWI and Snf2H domains based on available X-ray structures of related remodeling 
enzymes using the MODELLER software (295). The ATPase modules of DmISWI and Snf2H 
were homology modeled from the X-ray structure of ScChd1 (pdb 3MWY) (141). Residues N- 
and C-terminal to residue 116 and 637, respectively, were excluded from the final models due 
to poor sequence conservation and structure dissimilarities in these regions between different 
experimental structures. The ATPase domain was subsequently cleaved at a predicted hinge 
region (i.e., residues 351–352 in DmISWI) (Emekli et al., 2008) that connects both ATPase 
lobes. Consequently, the two rigid bodies of the ATPase domain used for docking of the 
DmISWI enzyme comprised residues 116–351 and 352–637. Likewise, the two lobes used for 
docking of the Snf2H enzyme comprised residues 120–403 and 404–689. There was no need to 
homology model the HSS domain of the DmISWI enzyme because the structure of the DNA-
binding domain has been successfully determined by X-ray crystallography (116). The HSS 
domain of Snf2H in turn was homology modeled from the HSS structure of the DmISWI 
enzyme (pdb 1OFC). In a final step, protein structures were transformed into the ATTRACT 
coarse-grained (296, 297) and all-atom representation (298, 299) using the ATTRACT tools 
‘reduce’ and ‘aareduce’. Missing atoms were reconstructed with PDB2PQR (300, 301). 
Protonation states were assigned with PropKa (302). 
 
4.2.6.2. Rigid body docking 
Rigid body docking was performed using a custom-modified ATTRACT protein-protein 
docking protocol (303) that enabled the implementation of XL-MS-derived distance restraints 
between pairs of Cα atoms. The distance between Cα atoms of selected cross-linked residue 
pairs was restrained by an upper harmonic potential with a maximum distance of 25 and 29 Å 
for chemical BS2G and BS3 cross-links, respectively. Likewise, the maximum distance for 
Bpa-mediated cross-links was set to 20 Å. Cross-links that were implemented in the docking 
protocol yielded excellent fragmentation data during MS/MS analysis (cf. Figure 19, Figure 
44A, and SFigure 5–SFigure 7) and are marked in STable 1–STable 5. In addition, the distance 
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between residues of the predicted hinge region of the ATPase domain (i.e., residues 351–352 
and 403–404 in DmISWI and Snf2H, respectively) was restrained in order to keep these 
adjacent residues within a maximum distance of 10 Å during computational docking. 
In the case of the DmISWI enzyme, integrative modeling of the ATPase domain was initiated 
by generating 100000 starting configurations with both rigid bodies being placed at random 
positions and orientations. For each starting configuration, the center-of-mass translation and 
orientation of rigid bodies was optimized in a potential energy minimization using the 
ATTRACT coarse-grained force field (296, 297) and XL-MS-derived distance restraints for 
the ATPase domain (cf. STable 1). Notably, ab-initio docking of the ATPase domain was 
performed in an identical manner in the absence of XL-MS-derived distance restraints. The 
different structures were ranked on the basis of their ATTRACT score evaluated within a 
squared cutoff of 50 Å2 and the restraint potentials. The top-ranked 200 ATPase structures 
were considered for further refinement with the flexible interface refinement method 
iATTRACT (304). The XL-MS-derived distance restraints were also implemented during 
flexible refinement. The convergence of individual structures was assessed by calculating the 
model precision as the minimal average pair-wise Cα RMSD (305) between the respective 200 
final models. 
To model the full-length DmISWI enzyme, the ten best models of the ATPase domain were 
docked against the crystal structure of the HSS domain (pdb 1OFC) (116) in an ensemble 
docking approach. The above described modeling procedure was repeated with 100000 starting 
configurations for each of the ten ATPase structures. The computational docking was guided 
by selected, XL-MS-derived distance restraints between the ATPase domain and the HSS 
domain as further specified in STable 2.  
In the case of the Snf2H enzyme, the modeling strategy had to be slightly adapted compared to 
the one described for the DmISWI enzyme in order to overcome the limited number of 
identified cross-links between both rigid bodies of the ATPase domain. That is, integrative 
modeling of the full-length Snf2H protein was initiated by placing individual Snf2H domains 
(i.e., both rigid bodies of the ATPase domain and the HSS homology model) at random 
positions and orientations (1x105 starting configurations). Using a three-body docking 
protocol, the arrangement of both ATPase lobes in the modeled Snf2H structures would 
primarily depend on their relative orientation towards the HSS domain. Optimization of each 
starting configuration in terms of potential energy minimization and flexible refinement was 
identical as described above and was guided by selected XL-MS-derived distance restraints (cf. 
STable 3and STable 4) between individual structural bodies. 
 
Individual enzyme models were compared against SAXS data using FoXS with defaults 
settings. The calculated values are reported as reduced χ-values (306). The model with the best 
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χ-fit to the SAXS data was typically selected as representative structural model. Finally, 
DmISWI and Snf2H models were visualized with the PyMOL software (versions 1.1eval and 
1.30) and identified cross-links mapped onto the structures for the evaluation of Cα-Cα 
distances (cf. STable 1–STable 5).  
 
4.2.7. Functional assays 
4.2.7.1. Electrophoretic mobility shift assay 
The formation of enzyme-nucleosome complexes was investigated by an electrophoretic 
mobility shift assay (EMSA). That is, increasing amounts of either DmISWI or Snf2H were 
titrated to a constant amount of 0N40 mononucleosomes in EMSA buffer #1–5 (cf. Table 12). 
Protein concentrations and buffer conditions that were used during EMSA analysis are 
specified in Figure 40 and SFigure 3. In addition, selected samples contained 3 mM of a 
particular nucleotide (i.e., ADP, ADP-BeFx, and AMP-PNP) and/or 0N0 instead of 0N40 
mononucleosomes. Following incubation for 10 min on ice, the sample was separated by 
native PAGE/0.2x TBE as described in section 4.2.1.6. To evaluate the impact of chemical 
cross-linking on complex formation, the sample was supplemented with either the BS2G or BS3 
cross-linking agent. Following incubation for 20 min on ice, the cross-linking reaction was 
quenched with 200 mM NH4HCO3 and the sample was separated by native PAGE/0.2x TBE.  
 
4.2.7.2. ATPase assays 
4.2.7.2.1. Thin-layer chromatography ATPase assay 
ATP hydrolysis of DmISWI and Snf2H was assessed by means of a thin-layer chromatography 
(TLC)-based ATPase assay as described previously (140). Briefly, individual samples were 
prepared by mixing the remodeling enzyme, salmon sperm DNA, and increasing 
concentrations of ADP-BeFx according to Table 17 in TLC reaction buffer (cf. Table 12).  
 
 
Table 17: Prepared protein samples for TLC ATPase assay.  
# Enzyme 
Enzyme concen- 
tration [nM] 
Salmon sperm 
DNA [g/L] 
ADP-BeFx 
[mM] 
1 Snf2H 300 0.2 0, 0.5 or 5.0 
2 Snf2H 1000 0 0, 0.5 or 5.0 
3 Snf2H 6000 0 0, 0.5 or 5.0 
4 ISWIWT 80 0.2 0, 0.5 or 5.0 
5 ISWIWT 6000 0 0, 0.5 or 5.0 
6 ISWIWT 1000 0 0, 0.5 or 5.0 
7 ISWI∆HSS 6000 0 0, 0.5 or 5.0 
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ATP hydrolysis was initiated by addition of 1 µM Mg2+-ATP and 0.2 µCi [γ-32P]ATP (3000 
Ci/mmol) and the sample was incubated for various time intervals at 28 °C. Data for the 0 min 
time point were collected in the absence of the respective remodeling enzyme. The enzymatic 
reaction was quenched by diluting the sample into 3 volumes of TLC quench solution (cf. 
Table 12). A total of 0.5 µL of the quenched sample was subsequently spotted onto TLC PEI 
cellulose F plates, which were developed in TLC developer solution (cf. Table 12) for 
approximately 20 min. Air-dried plates were exposed for approximately four hours to an 
imaging plate, which was read out by a Fluorescent Image Analyzer FLA-3000 instrument. 
The signals corresponding to unhydrolyzed ATP and free phosphate were quantified using the 
AIDA Image Analyzer software (Elysia-Raytest GmbH). The percentage of hydrolyzed ATP 
was calculated for each time point and condition. These values were plotted as a function of 
time and were fitted to a linear function to deduce the slope that corresponds to the percentage 
of hydrolyzed ATP per minute. Finally, results from the TLC-based ATPase assay were 
normalized for enzyme concentration and the number of ATP molecules hydrolyzed per 
enzyme per minute was plotted as a function of ADP-BeFx concentration. 
 
4.2.7.2.2. NADH-coupled ATPase assay 
ATP hydrolysis of DmISWI and individual point-mutant constructs (i.e., ISWIK337D, 
ISWID485K, and ISWIK337D D485K) was measured using a NADH-coupled ATPase assay as 
described previously (140). Individual samples were prepared by mixing the enzyme (300 
nM), pyruvate kinase (15.5 U/mL), phosphoenolpyruvate (6 mM), lactate dehydrogenase (15.5 
U/mL), reduced nicotinamide adenine dinucleotide (NADH, 1.2 mM), and varying amounts of 
salmon sperm DNA (0–1.3 g/L) in ATPase assay buffer (cf. Table 12). ATP hydrolysis was 
subsequently initiated by addition of 3 mM ATP-Mg2+. The ATPase assay was performed in 
flat bottom 384 well plates at 26 °C using a final reaction volume of 30 µL. The concentration 
of NADH was monitored by absorption measurements for 30 min employing a PowerWave 
HT 384 well plate reader. ATPase activities were calculated from linear fits to the data. To 
determine the maximal turnover rate of individual remodeling enzymes at saturating DNA 
concentrations, the ATPase activities were subsequently fitted to the Michaelis-Menten 
equation using the KaleidaGraph software (version 4.03). To ensure equal enzyme amounts 
during the NADH-coupled ATPase assay, a fraction of each reaction mixture was analyzed by 
SDS-PAGE and Coomassie Blue staining. Bands corresponding to DmISWI were quantified 
with the Bio-Rad Image Lab 5.2.1 software (cf. Figure 17D). 
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6. Appendix 
6.1. Enrichment of cross-linked peptides by size-exclusion chromatography 
I optimized the chemical cross-linking workflow by implementing an additional enrichment 
step for cross-linked peptides, in a similar manner as described previously (284). Briefly, 
following chemical cross-linking of the remodeling enzyme using either the BS2G or the BS3 
agent (SFigure 1A), the sample was subjected to size-exclusion chromatography (SFigure 1B) 
and in-solution tryptic digestion. The tryptic digest was subsequently separated by size-
exclusion chromatography (SFigure 1C), which resulted in an enrichment of cross-linked 
peptides relative to the input sample (SFigure 1D). The enrichment of cross-linked peptides 
was beneficial in terms of number of identified cross-links that could be used as distance 
restraints during computational modeling. 
 
SFigure 1: Enrichment of cross-linked peptides by size-exclusion chromatography. (A) Chemical cross-
linking of the Snf2H enzyme using increasing concentrations of the BS
3
 cross-linker viewed by SDS-PAGE 
analysis. (B) The results from size-exclusion chromatography of cross-linked and DMSO-treated Snf2H 
samples are shown. Notably, the elution profiles for the Snf2H enzyme (1 µM) in the presence of either 
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DMSO (green) or 1 mM BS
3
 (blue) did not provide evidence for protein di- or multimerization under the 
tested conditions. Fractions corresponding to the colored peak areas were pooled and subjected to in-solution 
tryptic digestion. (C) The results from the separation of the tryptic peptide mixture by size-exclusion 
chromatography are shown. Fractions #1–6 were subsequently analyzed by LC-MS/MS measurements. (D) 
The total number of identified cross-linked (blue) and linear peptides (grey) for BS
3
- (left) and DMSO-
treated (right) samples are presented. The enrichment of cross-linked peptides prior to LC-MS/MS analysis 
resulted in more cross-link identifications for fractions #4–6 relative to the input sample, which was not 
subjected to size-exclusion chromatography. Peptides were identified using the Crossfinder software using 
comparable identification criteria as specified in Table 15. 
Dr. I. Forné (LMU, Munich) performed the LC-MS/MS analysis. 
 
6.2. Studying the impact of ADP-BeFx-binding on ATP hydrolysis of ISWI-
type remodeling enzymes 
I determined the impact of the non-hydrolysable ADP-BeFx analog on ATP turnover rate of 
Snf2H, DmISWI, and DmISWI∆HSS using a TLC-based ATPase assay as described in section 
4.2.7.2.1. Increasing concentrations of ADP-BeFx readily inhibited ATP hydrolysis of the 
studied ISWI-type remodeling enzymes in a dose-dependent manner (SFigure 2). Results 
should be considered as preliminary as the assay was only performed once. 
 
SFigure 2: Preliminary results from the TLC-based ATPase assay for individual ISWI-type enzymes. 
The number of ATP molecules that were hydrolyzed per enzyme per minute is plotted against increasing 
concentrations of ADP-BeFx for (A) Snf2H, (B) DmISWI, and (C) DmISWI∆HSS. Unfilled and filled symbols 
refer to data collected in the absence and presence of 0.2 g/L salmon sperm DNA (n = 1). Individual sample 
conditions #1–7 are specified in Table 17. The results from the TLC-based ATPase assay collectively 
suggested that ATP hydrolysis of the studied Snf2H and DmISWI constructs is inhibited at > 0.5 mM ADP-
BeFx.   
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6.3. Studying the formation of enzyme-nucleosome complexes by EMSA 
SFigure 3 summarizes my efforts on finding optimal solution conditions to chemically cross-
link the Snf2H and DmISWI remodeling enzymes in complex with the nucleosomal substrate. 
The formation of enzyme-nucleosome complexes was monitored by EMSA as further specified 
in section 4.2.7.1. Notably, SFigure 3 is related to Figure 40 of the main text and thus includes 
replicate measurements as well as data for additionally tested conditions for the DmISWI and 
Snf2H remodeling enzymes.  
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SFigure 3: Monitoring the formation of enzyme-nucleosome complexes by EMSA. The interaction of 
either Snf2H or DmISWI with mononucleosomes was studied for different solution conditions by EMSA. 
Protein species were separated by a 4.5% native PAGE/0.2x TBE approach and were stained with ethidium 
bromide (cf. section 4.2.1.6). The composition of individual EMSA buffers #1–6 is specified in Table 12. 
DNA ladders are denoted as ‘M1’ and ‘M2’. Asterisks (*) indicate overassembled nucleosomes. (A, B) 
Increasing concentrations of the Snf2H enzyme were incubated with a constant amount of 0N40 
mononucleosomes and ADP-BeFx in EMSA buffer #4. (C) Increasing concentrations of the DmISWI enzyme 
were incubated with a constant amount of 0N40 nucleosomes in EMSA buffer #1. (D) The DmISWI enzyme 
was incubated in the presence or absence of the indicated nucleotide (ADP or ADP-BeFx) with a constant 
amount of 0N40 nucleosomes in EMSA buffer #1. (E) The DmISWI enzyme was incubated in the presence 
or absence of ADP with a constant amount of 0N40 nucleosomes in EMSA buffer #1 containing different 
concentrations of Mg
2+
. (F, G) The DmISWI protein was incubated in the presence of the indicated 
nucleotide (ADP, ADP-BeFx or AMP-PNP) with a constant amount of either 0N40 or 0N0 nucleosomes in 
EMSA buffer #5. The enzyme-nucleosome complex was chemically cross-linked using 1 mM of the BS
2
G 
cross-linking agent. (H–L) In order to evaluate the impact of the different EMSA buffers on complex 
formation, DmISWI was incubated with a constant amount 0N40 nucleosomes in distinct buffers. Notably, 
the samples were supplemented with the indicated nucleotide and/or chemical cross-linking agent. 
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6.4. Sequence alignments of remodeling enzymes 
 
SFigure 4: Sequence alignments of remodeling enzymes. The protein sequences of DmISWI, Snf2H, MtISWI, and ScChd1were aligned using the Clustal Omega 
webserver (https://www.ebi.ac.uk/Tools/msa/clustalo/). Numbers and colored bars below the sequence alignments specify the range of enzyme domains, i.e. NTR (cyan), 
ATPase lobe 1 (yellow), ATPase lobe 2 (red), and HSS (green), for the Snf2H enzyme. Grey and black arrows indicate the positions of Bpa-substituted amino acids and 
positions of point mutations, respectively, which were introduced into full-length DmISWI. Rectangles indicate structural motifs I, II, and VI.  
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6.5. Tabular overview of identified cross-links for DmISWI and Snf2H 
 
STable 1: Cross-links within the ATPase module of the DmISWI enzyme under apo state conditions. Cross-linked peptides are listed in an ordered manner according 
to their cross-link identification number (XLISWI 1–30) together with information about the cross-linked residues and MS-related identification parameters (e.g., precursor 
mass and charge state). Cross-linked sites are color-coded according to the domain architecture in Figure 12 with respective residues being underlined in the peptide 
sequences (B signifies Bpa). Data derive from four independent XL-MS experiments using either BS
2
G or BS
3
 as well as from additional data sources as specified in table 
footnotes. Accordingly, each cross-link was categorized into one of the following ‘reproducibility groups’: (I) the cross-linked peptide was independently reproduced, (II) 
the cross-linked residue pair was independently reproduced, (III) the cross-linked residue pair was repoduced in technical replicates, and (IV) not reproduced. The Cα-Cα 
distances of individual cross-links were measured in the indicated structures using PyMOL. Orange and red values signify Cα-Cα distances that violated the defined 
distance threshold by < 5 Å and > 5 Å, respectively. The table was adapted from (1) in accordance with Elsevier’s policies. 
XL 
ISWI 
Vari-
ant 
Site 
1 
Site 
2 Peptide 1 sequence  Peptide 2 sequence  
Mass 
(Da) 
Charg
e 
Error 
(ppm) 
DmISWI 
protein 
Cross-
linker 
Repro-
ducibility 
group 
Size 
selec-
tion 
Cα-Cα distances (Å) 
cf. model 
in Figure 
14A 
cf. model 
in Figure 
14E 
cf. model 
in Figure 
16 
cf. model 
in Figure 
23B 
cf. model 
in Figure 
26D 
[Cross-linking sites 1, 
2 in pdb 5JXR] 
cf. structure in  
Figure 26C 
1
ǂ
 a 578 172 BVIQGGR HFK 1309.693 3 0.1 M578B Bpa I In-gel 13.8
x
 13.8
x
 45.9 13.3
x
 16.8 16.9 [637, 230] 
1
ǂ
 b 578 172 BVIQGGR TLQTISLLGYLKHFK  2640.479 4 9.0 M578B Bpa I In-gel 13.8
x
 13.8
x
 45.9 13.3
x
 16.8 16.9 [637, 230] 
2
ǂ
  578 120 LDKBVIQGGR  FDASPAYIK  2246.174 3 8.3 M578B Bpa I In-gel 11.2
x
 10.0
x
 39.4 10.6
x
 12.4 12.3 [637, 179] 
3
ǂ
  338 483 LHAVLKPFLLR  LDGQTPBEDR  2586.396 4 8.0 H483B Bpa I In-gel 12.8
x
 10.2
x
 23.9 20.7
x
 18.1 18.1 [395, 542] 
4 a 547 350 IGQKKQVR  LKAEVEKR  2065.237 4 0.1 WT BS
3
 II SEC 10.2 11.4
x
 21.4 17.0 9.8 9.7 [606, 407] 
4 b 547 350 IGQKK LKAEVEKR 1682.009 3 0.3 WT BS
3
 I SEC 10.2 11.4
x
 21.4 17.0 9.8 9.7 [606, 407] 
4 c 547 350 IGQKKQVR  LKAEVEKR  2065.237 4 0.1 WT BS
3
 II SEC 10.2 11.4
x
 21.4 17.0 9.8 9.7 [606, 407] 
5  337 547 LHAVLKPFLLRR  IGQKK  2172.363 4 -0.1 WT BS
3
 IV none 28.9 23.9
x
 29.8 17.7 20.7 21.0 [395, 606] 
6 a 350 353 LKAEVEKR LKPKKEMK 2110.255 5 -0.8 WT BS
3
 II SEC 10.9 9.0
x
 16.7 12.5 9.7 9.6 [407, 410] 
6
†
 b 350 353 AEVEKR  LKPK  1310.756 4 1.4 WT BS
2
G II SEC 10.9 9.0
x
 16.7 12.5 9.7 9.6 [407, 410] 
6
†
 c 350 353 LKAEVEKR  LKPK  1551.935 3 4.1 WT BS
2
G I SEC 10.9 9.0
x
 16.7 12.5 9.7 9.6 [407, 410] 
7  169 578 TLQTISLLGYLKHFK  LDKBVIQGGR  2996.685 4 5.1 M578B Bpa I In-gel 11.9 12.0
x
 41.0 13.3 18.4 18.4 [227, 637] 
8  637 345 TAEQKAALDSLGESSLR  LKAEVEKR  2884.551 4 1.9 WT BS
3
 IV none 34.1 30.9
x
 20.8 27.1 51.7 51.2 (34.2
$
) [705, 402] 
9 a 637 577 TAEQKAALDSLGESSLR  LDKMVIQGGR  3028.587 3 2.2 WT BS
3
 I SEC 13.7 13.9 13.9 13.9 26.8 26.5 (12.4
$
) [705, 636] 
9 b 637 577 GEAKTAEQKAALDSLGESSLR  LDKMVIQGGR  3413.783 4 1.1 WT BS
3
 II SEC 13.7 13.9 13.9 13.9 26.8 26.5 (12.4
$
) [705, 636] 
9 c 637 577 GEAKTAEQKAALDSLGESSLR  LRLDKMVIQGGR  3682.968 5 1.2 WT BS
3
 II SEC 13.7 13.9 13.9 13.9 26.8 26.5 (12.4
$
) [705, 636] 
9
†
 d 637 577 TAEQKAALDSLGESSLR  LDKMVIQGGR  2986.540 3 3.9 WT BS2G II SEC 13.7 13.9 13.9 13.9 26.8 26.5 (12.4
$
) [705, 636] 
9
†
 e 637 577 TAEQKAALDSLGESSLR  LRLDKMVIQGGR  3271.720 4 6.0 WT BS2G II SEC 13.7 13.9 13.9 13.9 26.8 26.5 (12.4
$
) [705, 636] 
10
†
 a 637 356 TAEQKAALDSLGESSLR  KEMK  2405.211 3 6.6 WT BS2G II SEC 16.8 16.8 16.8 16.8 44.7 43.9 (13.2
$
) [705, 413] 
10 b 637 356 TAEQKAALDSLGESSLR  KEMKIFVGLSK  3191.711 4 2.8 WT BS
3
 II SEC 16.8 16.8 16.8 16.8 44.7 43.9 (13.2
$
) [705, 413] 
11 a 391 595 DIDVVNGAGKVEKMR  SNQLNKDEMLNIIR  3454.792 4 1.4 WT BS
3
 I SEC 4.8 4.8 4.8 4.8 53.0 54.8 (6.1
$
) [450, 654] 
11
†
 b 391 595 VEKMR SNQLNKDEMLNIIR 2444.252 4 6.0 WT BS
2
G II SEC 4.8 4.8 4.8 4.8 53.0 54.8 (6.1
$
) [450, 654] 
11
†
 c 391 595 DIDVVNGAGKVEKMR  SNQLNKDEMLNIIR  3412.745 3 7.2 WT BS
2
G I SEC 4.8 4.8 4.8 4.8 53.0 54.8 (6.1
$
) [450, 654] 
11
†
 d 391 595 DIDVVNGAGKVEKMR  SNQLNKDEMLNIIR  3870.101 4 9.6 WT BS
2
G I SEC 4.8 4.8 4.8 4.8 53.0 54.8 (6.1
$
) [450, 654] 
12 a 388 595 VLLKDIDVVNGAGKVEK SNQLNKDEMLNIIR  3620.981 4 -0.7 WT BS
3
 I SEC 9.4 9.4 9.5 9.4 55.9 60.3 (11.8
$
) [445, 654] 
12 b 388 595 DIDVVNGAGKVEK  SNQLNKDEMLNIIR  3167.650 3 0.8 WT BS
3
 II SEC 9.4 9.4 9.5 9.4 55.9 60.3 (11.8
$
) [445, 654] 
12 c 388 595 VLLKDIDVVNGAGKVEK  LVDNRSNQLNKDEMLNIIR  4218.305 5 1.5 WT BS
3
 II SEC 9.4 9.4 9.5 9.4 55.9 60.3 (11.8
$
) [445, 654] 
12
†
 d 388 595 VLLKDIDVVNGAGKVEKMR  SNQLNKDEMLNIIR  3870.101 4 7.8 WT BS
2
G I SEC 9.4 9.4 9.5 9.4 55.9 60.3 (11.8
$
) [445, 654] 
13
†
  337 70 LHAVLKPFLLR  SPTKPK  2058.236 4 6.0 WT BS
2
G IV SEC N/A N/A N/A N/A 25.4 25.3 [394, 119] 
14  52 70 RFDFLLKQTEIFTHFMTNSAK  SPTKPK  3329.742 4 4.5 WT BS
2
G I SEC N/A N/A N/A N/A 17.2 17.6 [101, 119] 
15  276 247 EFKTANR  KFNWR  1751.911 3 0.7 WT BS
3
 III none 8.1 8.1 8.1 8.1 8.6 8.5 [334, 305] 
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16
†
  276 246 EFKTANR  SVFKK  1567.836 3 1.8 WT BS
2
G I SEC 7.4 7.4 7.4 7.4 7.1 7.1 [334, 304] 
17
†
  186 267 NQAGPHIVIVPKSTLQNWVNEFK SKLSEILR  3658.984 3 7.9 WT BS
2
G III SEC 17.7 17.7 17.7 17.7 15.9 16.2 [244, 325] 
18
†
  267 242 SKLSEILR  EKSVFK 1776.999 3 4.5 WT BS
2
G I SEC 10.4 10.4 10.4 10.4 12.5 12.5 [325, 300] 
19 a 564 577 LITESTVEEKIVER  LDKMVIQGGR  2898.574 4 -0.3 WT BS
3
 III none 22.6 22.6 22.6 22.9 20.4 20.2 [623, 636] 
19 b 564 577 LITESTVEEKIVERAEVK  LRLDKMVIQGGR  3595.002 4 0.6 WT BS
3
 III none 22.6 22.6 22.6 22.9 20.4 20.2 [623, 636] 
20  356 548 KEMKIFVGLSK  IGQKKQVR 2372.398 5 0.9 WT BS
3
 III none 11.8 11.8 11.8 11.8 11.3 11.3 [413, 607] 
21  353 547 LKPKKEMK  IGQKK  1711.043 3 -0.7 WT BS
3
 I SEC 6.9 6.9 6.9 6.9 7.9 7.8 [410, 606] 
22
†
  353 548 LKPKKEMK  KQVR  1629.990 4 1.4 WT BS
2
G I SEC 6.7 6.7 6.7 6.7 7.9 7.1 [410, 607] 
23
†
  391 675 VEKMR  EKQK 1288.681 3 4.1 WT BS
2
G IV SEC N/A N/A N/A N/A N/A N/A [450, 735] 
24
 ǂ
 a 578 664 BVIQGGR AALDSLGESSLR 2097.086 3 6.3 M578B Bpa II SEC N/A N/A N/A N/A N/A 10.3 [637, 712] 
24
 ǂ
 b 578 664 LDKBVIQGGR AALDSLGESSLR 2453.292 3 9.0 M578B Bpa II SEC N/A N/A N/A N/A N/A 10.3 [637, 712] 
24
 ǂ
 c 578 664 LRLDKBVIQGGR AALDSLGESSLR 2722.477 4 5.0 M578B Bpa II SEC N/A N/A N/A N/A N/A 10.3 [637, 712] 
25
 ǂ
  578 665 BVIQGGR AALDSLGESSLR 2097.086 3 6.3 M578B Bpa II SEC N/A N/A N/A N/A N/A 8.6 [637, 713] 
26 a 693 577 KANYAVDAYFREALR  LRLDKMVIQGGR  3308.782 5 -0.8 WT BS
3
 IV none N/A N/A N/A N/A N/A N/A [752, 638] 
26 b 693 577 KANYAVDAYFR  LDKMVIQGGR  2570.332 4 0.9 WT BS
3
 IV none N/A N/A N/A N/A N/A N/A [752, 638] 
27 a 693 564 KANYAVDAYFR LITESTVEEKIVER 3099.613 4 1.4 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [623, 752] 
27 b 693 564 KANYAVDAYFREALR  LITESTVEEKIVER  3568.878 5 2.7 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [752, 623] 
28 a 613 693 
FGANQVFSSKETDITDEDIDVILER
GEAK 
KANYAVDAYFR  4680.288 5 4.0 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [672, 752] 
28 b 613 693 FGANQVFSSKETDITDEDIDVILER  KANYAVDAYFR  4295.091 4 3.6 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [672, 752] 
29  637 693 TAEQKAALDSLGESSLR  KANYAVDAYFR  3229.626 4 1.1 WT BS
3
 IV none N/A N/A N/A N/A N/A N/A [705, 752] 
30 a 595 693 LVDNRSNQLNKDEMLNIIR  KANYAVDAYFREALR  4208.180 5 -3.7 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [654, 752] 
30 b 595 693 SNQLNKDEMLNIIR  KANYAVDAYFR  3141.592 3 1.1 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [654, 752] 
30 c 595 693 LVDNRSNQLNKDEMLNIIR  KANYAVDAYFR  3754.910 5 1.8 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [654, 752] 
30 d 595 693 SNQLNKDEMLNIIR KANYAVDAYFREALR 3626.852 5 -0.3 WT BS
3
 III none N/A N/A N/A N/A N/A N/A [752, 654] 
 
ǂ
 Cross-link was described in either Forné et al. (157) or Ludwigsen et al. (115). 
†
 Cross-link was identified in an unpublished data set provided by Dr. F. Müller-Planitz (LMU, Munich). 
x
 Cross-link was used as distance restraint during rigid body docking.  
$
 Cα-Cα distance between two protomers in the crystal structure. 
N/A = Not available, at least one amino acid is missing in the structure. 
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STable 2: Cross-links originating from the HSS domain of the DmISWI enzyme under apo state conditions. Cross-linked peptides are listed in an ordered manner 
according to their cross-link identification number (XLISWI 31–61). The table is structured in an identical manner as described for STable 1. Data derive from five 
independent UV-induced or chemical cross-linking experiments as well as from an additional data source as specified in table footnotes. The table was adapted from (1) in 
accordance with Elsevier’s policies. 
XL 
ISWI 
Vari-
ant 
Site 
1 
Site 
2 Peptide 1 sequence Peptide 2 sequence 
Mass 
(Da) Charge 
Error 
(ppm) 
DmISWI 
protein 
Cross-
linker 
Repro-
ducibility 
group 
Size 
selec-
tion 
Cα-Cα distances (Å) 
cf. model in 
Figure 21 
cf. model in 
Figure 23A 
cf. model in 
Figure 23B 
cf. model in 
Figure 25 
cf. model in 
Figure 26D 
31
†□
 a 391 900 VEKMR GKNYTEIEDR 1980.958 3 5.2 WT BS
2
G I SEC 25.7
x
 39.8
x
 23.9
x
 25.6
x
 33.3
x
 
31
†
 b 391 900 DIDVVNGAGKVEKMR  GKNYTEIEDR  2949.450 3 8.4 WT BS
2
G I SEC 25.7
x
 39.8
x
 23.9
x
 25.6
x
 33.3
x
 
32
□
 a 595 810 LVDNRSNQLNKDEMLNIIR  DFNQFIKANEK  3774.937 4 -2.0 WT BS
3
 II SEC 31.7
x
 32.6
x
 29.0
x
 N/A 37.2
x
 
32
†
 b 595 810 SNQLNKDEMLNIIR  DFNQFIKANEK  3135.566 3 6.4 WT BS
2
G II SEC 31.7 32.6
x
 29.0 N/A 37.2 
32 c 595 810 SNQLNKDEMLNIIR  DFNQFIKANEK  3177.613 3 1.8 WT BS
3
 I SEC 31.7
x
 32.6
x
 29.0
x
 N/A 37.2
x
 
33
†□
  388 810 DIDVVNGAGKVEK  DFNQFIKANEK  2791.403 3 6.6 WT BS
2
G II SEC 23.7
x
 26.0
x
 22.6
x
 34.5
x
 33.8
x
 
34
†◊
  124 900 FDASPAYIKSGEMR  GKNYTEIEDR  2890.345 3 5.4 WT BS
2
G IV SEC 19.4
x
 33.0
x
 21.4
x
 18.6
x
 27.0
x
 
35
†□
  124 945 FDASPAYIKSGEMR  FDWFIKSR  2764.332 3 7.5 WT BS
2
G I SEC 29.1
x
 31.8
x
 25.8
x
 33.3
x
 33.9
x
 
36  865 391 GEGKIQR  VEKMR  1585.861 3 1.1 WT BS
3
 II SEC 26.2 30.1
x
 23.3 32.4 34.5 
37  945 247 ASPQFRFDWFIKSR  KFNWR  2671.381 4 0.2 WT BS
3
 IV none 49.6 32.7
x
 52.2 31.7 54.2 
38  973 353 RCNTLITLIERENIELEEKER  LKPKK  3369.859 3 -3.2 WT BS
2
G II SEC 59.6 46.2
x
 63.9 31.4 52.7 
39 a 564 945 LITESTVEEKIVERAEVK  FDWFIKSR  3307.771 4 2.3 WT BS
3
 II SEC 25.7 34.7
x
 17.8 28.4 7.9 
39
†
 b 564 945 LITESTVEEKIVER  FDWFIKSR  2838.481 3 5.8 WT BS
2
G I SEC 25.7 34.7
x
 17.8 28.4 7.9 
40  359 874 EMKIFVGLSK  KALDQK  2006.112 3 3.3 WT BS
3
 IV none 53.7 32.4
x
 49.9 35.1 44.0 
41  578 942 BVIQGGR  FDWFIK  1733.893 3 -2.2 M578B Bpa IV In-gel 18.6 27.1 15.2 31.0 20.8 
42 a 595 865 SNQLNKDEMLNIIR  GEGKIQR  2611.375 4 0.5 WT BS
3
 I SEC 24.9 27.7
x
 22.2 N/A 31.5 
42 b 595 865 LVDNRSNQLNKDEMLNIIR  GEGKIQR  3208.699 5 -0.1 WT BS
3
 II SEC 24.9 27.7
x
 22.2 N/A 31.5 
43  595 874 SNQLNKDEMLNIIR  KALDQK  2526.348 4 0.0 WT BS
3
 III none 33.3 21.8
x
 30.2 N/A 40.1 
44  595 879 SNQLNKDEMLNIIR  ALDQKMSR  2772.426 4 0.3 WT BS
3
 III none 34.5 22.1
x
 31.3 N/A 43.2 
45  595 900 SNQLNKDEMLNIIR  GKNYTEIEDR  3048.519 4 3.6 WT BS
3
 IV none 22.0 36.1
x
 20.2 N/A 37.7 
46
†
  900 70 GKNYTEIEDR  SPTKPK  1975.985 3 5.2 WT BS
2
G IV SEC N/A N/A N/A 33.2
x
 57.6 
47
†
  900 72 GKNYTEIEDR  SPTKPKGRPK  2414.256 4 4.4 WT BS
2
G IV SEC N/A N/A N/A 29.2
x
 53.1 
48  898 70 LQYGNNKGK  SPTKPK  1772.942 4 2.0 WT BS
2
G I SEC N/A N/A N/A 39.2
x
 62.1 
49  810 865 DFNQFIKANEK  GEGKIQR  2277.176 3 -0.5 WT BS
3
 I SEC 13.6 13.6 13.6 13.6 13.6 
50  810 825 DFNQFIKANEKYGR  DDIDNIAKDVEGK  3297.616 5 0.0 WT BS
3
 IV none 12.2 12.2 12.2 12.2 12.2 
51 a 879 945 ALDQKMSR  FDWFIKSR  2183.120 3 0.2 WT BS
3
 III none 25.2 25.2 25.2 25.2 25.2 
51 b 879 945 ALDQKMSR ASPQFRFDWFIKSR 2869.470 4 1.1 WT BS
3
 III none 25.2 25.2 25.2 25.2 25.2 
52
†
  756 712 VPKNTELGSDATK  VSEPKAPK  2309.212 3 5.8 WT BS
2
G I SEC N/A N/A N/A N/A N/A 
53
†
  814 865 ANEKYGRDDIDNIAK  GEGKIQR  2603.294 3 4.8 WT BS
2
G IV SEC 9.0 9.0 9.0 9.0 9.0 
54  830 810 DDIDNIAKDVEGKTPEEVIEYNAVFWER  DFNQFIKANEKYGR  5118.453 5 7.2 WT BS
2
G I SEC 14.3 14.3 14.3 14.3 14.3 
55  898 945 LQYGNNKGK  FDWFIKSR  2256.169 3 7.5 WT BS
3
 IV none 19.0 19.0 19.0 19.0 19.0 
56 a 945 874 FDWFIKSR  KALDQK  1937.041 4 0.5 WT BS
3
 III none 28.5 28.5 28.5 28.5 28.5 
56 b 945 874 ASPQFRFDWFIKSR  KALDQK  2623.391 5 0.6 WT BS
3
 III none 28.5 28.5 28.5 28.5 28.5 
57 a 756 693 TVGYKVPKNTELGSDATK  KANYAVDAYFR  3361.720 4 -0.1 WT BS
3
 III none N/A N/A N/A N/A N/A 
57 b 756 693 TVGYKVPKNTELGSDATK  KANYAVDAYFREALR  3830.985 5 0.4 WT BS
3
 III none N/A N/A N/A N/A N/A 
58  693 874 KANYAVDAYFR  KALDQK  2156.127 3 1.0 WT BS
3
 III none N/A N/A N/A N/A N/A 
59
†
  677 865 QKLNALGNWIEPPKR  GEGKIQR  2645.440 5 5.3 WT BS
2
G IV SEC N/A N/A N/A N/A N/A 
60
†
  865 675 GEGKIQR  EKQK  1413.758 3 5.6 WT BS
2
G IV SEC N/A N/A N/A N/A N/A 
61
†
  1023 1010 KSEVVATSSNSKK  ASQKR  2048.086 4 6.1 WT BS
2
G I SEC N/A N/A N/A N/A N/A 
 
†
 Cross-link was identified in an unpublished data set provided by Dr. F. Müller-Planitz (LMU, Munich). 
◊
, 
□ 
MS/MS spectra are provided in Figure 19 and SFigure 5, respectively. 
x
 Cross-link was used as distance restraint during rigid body docking. 
N/A = Not available, at least one amino acid is missing from the structure.   
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STable 3: Cross-links for the Snf2H enzyme under apo state conditions. Cross-linked peptides are listed in an ordered manner according to their cross-link 
identification number (XLSnf2H 1–84). The table is structured in an indentical manner as described for STable 1 with cross-linked sites being color-coded according to the 
domain architecture in Figure 27. Data derive from two independent XL-MS experiments. 
XL 
Snf2H 
Vari- 
ant 
Site 
1
#
 
Site 
2 Peptide 1 sequence Peptide 2 sequence 
Mass 
(Da) Charge 
Error 
(ppm) 
Cross-
linker 
Repro-
ducibility 
group 
Size 
selec-
tion 
Peptide 
enrich- 
ment 
Cα-Cα distances (Å) 
cf. model #1 in  
Figure 31A 
1 
 
899 176 CNELQDIEKIMAQIER  FEDSPSYVKWGK  3568.7221 3 4.8 BS
3
 IV SEC + 42.5 
2 
 
929 314 YKAPFHQLR  IKNEK  1927.0681 5 -0.8 BS
3
 IV SEC + 24.3 
3 
 
929 328 YKAPFHQLR  EFKTTNR  2191.1540 3 0 BS
3
 III SEC + 30.5 
4 
 
397 758 RIKADVEK  VSEPKAPK  1950.1152 3 0.5 BS
3
 IV SEC + 56.4 
5 a 397 799 RIKADVEK  TIGYKVPR  2028.1734 3 0.5 BS
3
 III SEC + 64.4 
5 b 799 397 TIGYKVPR  IKADVEK  1872.0722 3 -0.1 BS
3
 III SEC + 64.4 
6 a 990 397 FDWFLKSR  IKADVEK  2037.0937 3 0.9 BS
3
 II none + 43.2 
6 b 990 397 FDWFLKSR  RIKADVEK  2193.1948 3 2.3 BS
3
 II SEC + 43.2 
7 a 929 397 YKAPFHQLR  IKADVEK  2098.1577 3 1.1 BS
3
 III SEC + 28.8
x
 
7
□
 b 929 397 YKAPFHQLR  RIKADVEK  2254.2588 3 3.0 BS
3
 III SEC + 28.8
x
 
8
□
 
 
264 929 SVCLIGDKEQR  YKAPFHQLR  2600.3536 4 0.7 BS
3
 III SEC + 19.1
x
 
9
□
 
 
176 855 FEDSPSYVKWGK  DFNQFIKANEK  2932.4285 3 2.0 BS
3
 IV SEC + 31.3
x
 
10
□
 
 
223 929 TLQTISLLGYMKHYR  YKAPFHQLR  3119.6745 4 2.1 BS
3
 III SEC + 31.8
x
 
11
□
 a 264 990 SVCLIGDKEQR  FDWFLKSR  2539.2896 3 -1.1 BS
3
 I SEC + 33.7
x
 
11 b 264 990 SVCLIGDKEQR  FDWFLKSR  2543.3147 3 -0.8 BS
3
 I none + 33.7
x
 
12
□
 
 
176 929 FEDSPSYVKWGK  YKAPFHQLR  2738.3859 3 0.4 BS
3
 IV SEC + 29.2
x
 
13 
 
160 929 RTEQEEDEELLTESSKATNVCTR  YKAPFHQLR  4020.9490 5 3.1 BS
3
 III SEC + 39.9 
14
□
 a 176 990 FEDSPSYVKWGK  FDWFLKSR  2677.3219 3 2.0 BS
3
 I SEC + 31.3
x
 
14 b 176 990 FEDSPSYVKWGK  FDWFLKSR  2681.3470 4 0.4 BS
3
 I none + 31.3
x
 
15 
 
160 990 TEQEEDEELLTESSKATNVCTR  FDWFLKSR  3803.7839 3 2.9 BS
3
 III SEC + 51.1 
16 
 
847 264 LLTQGFTNWNKR  SVCLIGDKEQR  2918.5075 3 3.1 BS
3
 III SEC + 69.7 
17 
 
990 408 FDWFLKSR  KEVK  1737.9456 3 0.3 BS
3
 IV none + 45.3 
18 a 929 408 YKAPFHQLR  KEVK  1803.0347 4 -1.0 BS
3
 IV none + 41.8 
18 b 408 929 SLPPKKEVK  YKAPFHQLR  2321.3262 5 1.7 BS
3
 II SEC + 41.8 
19 
 
855 418 DFNQFIKANEK  IYVGLSKMQR  2684.3998 3 2.0 BS
3
 III SEC + 33.0 
20 
 
929 494 YKAPFHQLR  LLPKLK  2007.2035 3 0.3 BS
3
 IV SEC + 43.3 
21 
 
990 600 FDWFLKSR  IGQTKTVR  2137.1686 3 -1.6 BS
3
 IV SEC + 49.6 
22 
 
929 600 YKAPFHQLR  IGQTKTVR  2198.2326 3 1.1 BS
3
 II SEC + 51.1 
23 
 
418 758 IYVGLSKMQR  VSEPKAPK  2202.2084 3 1.1 BS
3
 II SEC + 51.1 
24 
 
430 855 ILMKDIDILNSAGK  DFNQFIKANEK  3020.5895 3 -1.6 BS
3
 III SEC + 48.5 
25
∆
 
 
430 929 ILMKDIDILNSAGK  YKAPFHQLR  2826.5468 4 -2.8 BS
3
 IV SEC + 48.4 
26
□
 
 
418 929 IYVGLSKMQR  YKAPFHQLR  2490.3571 3 1.8 BS
3
 III SEC + 38.4
x
 
27 
 
407 929 SLPPKKEVK  YKAPFHQLR  2321.3262 5 1.7 BS
3
 IV SEC + 45.2 
28
□
 
 
430 990 ILMKDIDILNSAGK  FDWFLKSR  2765.4828 3 1.3 BS
3
 III SEC + 31.5
x
 
29
□
 
 
418 990 IYVGLSKMQR  FDWFLKSR  2429.2932 3 -0.3 BS
3
 I SEC + 19.1
x
 
30
◊
 a 647 929 IGKDEMLQMIR  YKAPFHQLR  2629.3875 4 -3.3 BS
3
 IV SEC + 51.7 
30 b 647 929 YKAPFHQLR  IKKDEK  2056.1471 5 -0.4 BS
3
 III SEC + 51.7 
31
◊
 
 
665 990 HGATHVFASKESEITDEDIDGILER FDWFLKSR  4003.9595 5 3.0 BS
3
 I none + 13.5 
32 
 
694 990 LSKMGESSLR  FDWFLKSR  2358.2044 4 -1.8 BS
3
 IV SEC + N/A 
33
◊
 
 
990 128 FDWFLKSR  IKKDEK  1995.0831 3 0.6 BS
3
 IV SEC + 23.7 
34
◊
 
 
990 121 FDWFLKSR  MKPGRPR  2076.1093 5 -0.3 BS
3
 III SEC + 25.0 
35
◊
 a 132 990 DEKQNLLSVGDYR  FDWFLKSR  2771.3921 4 0.9 BS
3
 III SEC + 20.5 
35 b 132 990 KDEKQNLLSVGDYR  FDWFLKSR  2899.4871 4 -0.3 BS
3
 III SEC + 20.5 
36 
 
97 990 ANRFEYLLKQTELFAHFIQPAAQK  FDWFLKSR  4098.1522 5 0.6 BS
3
 III SEC + N/A 
37 
 
71 990 QKEIQEPDPTYEEK  FDWFLKSR  2968.4497 3 0 BS
3
 IV SEC + N/A 
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38 
 
71 299 QKEIQEPDPTYEEK  KFNWR  2620.2811 4 -1.6 BS
3
 III SEC + N/A 
39 
 
71 328 QKEIQEPDPTYEEK  EFKTTNR  2765.3398 4 -0.3 BS
3
 III SEC + N/A 
40 a 160 121 RTEQEEDEELLTESSKATNVCTR  MKPGRPR  3702.7944 5 -0.7 BS
3
 III SEC + 32.5 
40 b 160 121 TEQEEDEELLTESSKATNVCTR  MKPGRPR  3546.6933 4 1.6 BS
3
 III SEC + 32.5 
41 a 160 128 RTEQEEDEELLTESSKATNVCTR  IKKDEK  3621.7683 5 -0.5 BS
3
 III SEC + 35.4 
41 b 160 128 TEQEEDEELLTESSKATNVCTR  IKKDEK  3465.6671 5 0.5 BS
3
 III SEC + 35.4 
42 a 160 129 RTEQEEDEELLTESSKATNVCTR  IKKDEK  3621.7683 4 2.5 BS
3
 III SEC + 33.6 
42 b 160 129 TEQEEDEELLTESSKATNVCTR  IKKDEK  3465.6671 5 1.4 BS
3
 III SEC + 33.6 
43 
 
397 624 IKADVEK  AEMKLR  1701.9337 3 0.6 BS
3
 II SEC + 35.3 
44
□
 
 
160 644 TEQEEDEELLTESSKATNVCTR  LVDQNLNKIGKDEMLQMIR 4963.4104 5 2.8 BS
3
 IV SEC + 37.2
x
 
45
◊
 
 
440 647 DIDILNSAGKMDK  IGKDEMLQMIR  2889.4652 3 -1.8 BS
3
 II SEC + 8.8 
46 a 644 443 LVDQNLNKIGKDEMLQMIR  MDKMR  3078.6002 4 -0.9 BS
3
 I none + 16.8 
46
◊
 b 644 443 LVDQNLNKIGK  MDKMR  2058.0967 3 3.1 BS
3
 II SEC + 16.8 
47
◊
 
 
647 443 IGKDEMLQMIR  MDKMR  2150.0722 3 0.7 BS
3
 II SEC + 8.0 
48
◊
 a 665 418 HGATHVFASKESEITDEDIDGILER  IYVGLSKMQR  4100.0527 4 3.5 BS
3
 I SEC + 21.5 
48 b 665 418 HGATHVFASK  IYVGLSKMQR  2385.2629 3 -0.2 BS
3
 IV SEC + 21.5 
49
◊
 
 
665 430 HGATHVFASKESEITDEDIDGILER  ILMKDIDILNSAGK  4436.2424 4 2.2 BS
3
 III SEC + 21.5 
50
∆
 
 
684 408 KTAEMNEK  KEVK  1593.8587 3 0.1 BS
3
 I none + 9.1 
51 a 665 683 HGATHVFASKESEITDEDIDGILER  GAKK  3308.6527 3 3.3 BS
3
 II SEC + 28.3 
51 b 665 683 HGATHVFASK  GAKK  1593.8629 4 -1.1 BS
3
 II SEC + 28.3 
52 a 665 684 HGATHVFASKESEITDEDIDGILER  KTAEMNEK  3855.8475 4 -0.2 BS
3
 III SEC + 29.4 
52 b 665 684 HGATHVFASK  KTAEMNEK  2141.0577 3 1.2 BS
3
 III SEC + 29.4 
53 
 
407 494 SLPPKKEVK  LLPKLK  1873.2018 3 0.8 BS
3
 I SEC + 19.5 
54  407 600 SLPPKKEVK  IGQTKTVR  2068.2560 4 0.6 BS
3
 I none + 9.2 
55 
 
408 494 SLPPKKEVK  LLPKLK  1873.2018 3 -0.5 BS
3
 I SEC + 17.9 
56 a 408 600 SLPPKKEVK  IGQTKTVR  2064.2309 3 -1.0 BS
3
 I SEC + 11.8 
56 b 600 408 IGQTKTVR  KEVK  1545.9394 3 0.7 BS
3
 I none + 11.8 
57 
 
430 418 ILMKDIDILNSAGK  IYVGLSKMQR  2861.5761 4 3.2 BS
3
 III SEC + 18.8 
58 
 
494 407 MVVLDKLLPKLK  SLPPKKEVK  2558.5851 3 1.4 BS
3
 II SEC + 19.5 
59 a 494 408 MVVLDKLLPKLK  KEVK  2036.2685 3 1.3 BS
3
 II SEC + 17.9 
59 b 494 408 LLPKLK  KEVK  1350.8852 3 -0.6 BS
3
 I SEC + 17.9 
59 c 494 408 MVVLDKLLPKLK  SLPPKKEVK  2574.5800 4 0.5 BS
3
 II SEC + 17.9 
59 d 494 408 LLPKLKEQGSR  KEVK  1908.1410 4 -0.2 BS
3
 II SEC + 17.9 
59 e 494 408 MVVLDKLLPKLK  SLPPKKEVK  2558.5851 3 1.4 BS
3
 II SEC + 17.9 
60 a 494 411 MVVLDKLLPKLK  KEVK  2036.2685 4 0.8 BS
3
 III SEC + 17.7 
60 b 494 411 LLPKLK  KEVK  1350.8852 3 -0.7 BS
3
 III SEC + 17.7 
60 c 494 411 LLPKLKEQGSR  KEVK  1908.1410 3 0.6 BS
3
 III SEC + 17.7 
61 a 494 600 MVVLDKLLPKLK  IGQTKTVR  2435.4915 4 -0.1 BS
3
 III SEC + 17.9 
61 b 600 494 IGQTKTVR  LLPKLK  1750.1082 3 0.7 BS
3
 III SEC + 17.9 
62 a 600 496 IGQTKTVR  LKEQGSR  1860.0732 4 0.8 BS
3
 I SEC + 15.5 
63 
 
600 624 IGQTKTVR  AEMKLR  1790.0388 3 -0.4 BS
3
 I none + 29.3 
64 
 
264 294 SVCLIGDKEQR  EKSVFK  2178.1357 3 0.1 BS
3
 III SEC + 13.9 
65 
 
264 298 SVCLIGDKEQR  EKSVFKK  2306.2307 3 0.1 BS
3
 IV SEC + 17.7 
66 
 
264 299 SVCLIGDKEQR  KFNWR  2195.1461 4 -0.3 BS
3
 I none + 19.1 
67 
 
264 314 SVCLIGDKEQR  IKNEK  2072.0938 4 0.1 BS
3
 III SEC + 29.4 
68 
 
264 317 SVCLIGDKEQR  IKNEKSK  2287.2208 4 0 BS
3
 IV SEC + 26.7 
69 a 264 319 SVCLIGDKEQR  SKLSEIVR  2372.2736 3 -0.1 BS
3
 III SEC + 20.5 
69 b 264 319 WVPTLRSVCLIGDKEQR  SKLSEIVR  3124.7070 3 4.7 BS
3
 III SEC + 20.5 
70 
 
767 847 APRPPKQPNVQDFQFFPPR  LLTQGFTNWNKR  3880.0328 5 2.1 BS
3
 III SEC + 20.6 
71  929 990 YKAPFHQLR  FDWFLKSR  2394.2639 3 5.5 BS
3
 III SEC + 26.8 
72 
 
847 761 LLTQGFTNWNKR  APKAPRPPK  2575.4389 3 -1.1 BS
3
 III SEC + 22.3 
73 
 
899 847 CNELQDIEKIMAQIER  LLTQGFTNWNKR  3603.8180 3 -0.8 BS
3
 III SEC + 15.2 
74 a 814 799 NPELPNAAQAQKEEQLK  KTIGYKVPR  3105.6825 4 -0.8 BS
3
 II SEC + 10.0 
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74 b 814 799 NPELPNAAQAQKEEQLK  TIGYKVPR  2977.5875 3 2.2 BS
3
 II SEC + 10.0 
75 a 799 758 TIGYKVPR  VSEPKAPK  1925.0988 3 0.2 BS
3
 I SEC + 20.2 
75 b 799 758 KTIGYKVPR  VSEPKAPK  2053.1937 3 0.5 BS
3
 II SEC + 20.2 
76 a 71 121 QKEIQEPDPTYEEK  MKPGRPR  2711.3591 5 -0.6 BS
3
 III SEC + N/A 
76 b 71 121 QKEIQEPDPTYEEK  TPTSPLKMKPGRPR  3435.7710 5 -2.9 BS
3
 IV SEC + N/A 
77 
 
71 128 QKEIQEPDPTYEEK  IKKDEK  2630.3329 4 -2.8 BS
3
 III SEC + N/A 
78 
 
71 129 QKEIQEPDPTYEEK  IKKDEK  2630.3329 4 0.6 BS
3
 IV SEC + N/A 
79 a 83 121 EIQEPDPTYEEKMQTDR  MKPGRPR  3086.4804 4 -2.8 BS
3
 III SEC + N/A 
79 b 83 121 EIQEPDPTYEEKMQTDRANR  MKPGRPRIKK  3812.9304 4 -7.9 BS
3
 IV SEC + N/A 
80 
 
97 121 ANRFEYLLKQTELFAHFIQPAAQK  MKPGRPR  3841.0616 5 3.8 BS
3
 II SEC + N/A 
81 a 97 128 ANRFEYLLKQTELFAHFIQPAAQK  IKKDEK  3760.0355 4 2.2 BS
3
 III SEC + N/A 
81 b 97 128 FEYLLKQTELFAHFIQPAAQK  IKKDEK  3418.8543 5 -0.7 BS
3
 III SEC + N/A 
82 a 97 129 ANRFEYLLKQTELFAHFIQPAAQK  KDEK  3518.8564 4 -3.8 BS
3
 III SEC + N/A 
82 b 97 129 FEYLLKQTELFAHFIQPAAQK  IKKDEK  3418.8543 5 3.4 BS
3
 III SEC + N/A 
83 a 855 739 DFNQFIKANEK  KANYAVDAYFR 2807.3921 3 2.1 BS
3
 I none + N/A 
83 b 855 739 RDFNQFIKANEK  KANYAVDAYFR  2963.4932 4 0.9 BS
3
 II SEC + N/A 
84 
 
919 1020 KALDTK  EKAEK  1415.7873 4 0.8 BS
3
 I none + N/A 
 
□
, 
◊
, 
∆
 MS/MS spectra are provided in SFigure 6, SFigure 9A, and SFigure 10A, respectively. 
x
 Cross-link was used as distance restraint during rigid body docking. 
N/A = Not available, at least one amino acid is missing in the structure. N/D = Not determined.  
 
 
 
 
 
 
 
 
 
 
 
STable 4: Cross-links for the Snf2H enzyme in the presence of ADP-BeFx. Cross-linked peptides are listed in an ordered manner according to their cross-link 
identification number (XLSnf2H,nt 1–154). The table is structured in an indentical manner as described for STable 1 with cross-linked sites being color-coded according to 
the domain architecture in Figure 27. Data derive from three independent XL-MS experiments. 
XL 
Snf2H,nt 
Vari- 
ant Site 1 Site 2 Peptide 1 sequence Peptide 2 sequence 
Mass 
(Da) Charge 
Error 
(ppm) 
Cross-
linker 
Repro-
ducibility 
group 
Size 
selec-
tion 
Peptide 
enrich- 
ment 
Cα-Cα distances (Å) 
cf. model #1 in  
Figure 37A 
1
∆
  176 847 FEDSPSYVKWGK  LLTQGFTNWNKR  3056.5398 3 2.3 BS
3
 III none + 54.5 
2
□
  176 855 FEDSPSYVKWGK  DFNQFIKANEK  2932.4285 3 0.2 BS
3 I SEC + 43.8x 
3
□
  176 929 FEDSPSYVKWGK  YKAPFHQLR  2738.3859 3 1.9 BS
3 I SEC + 18.3x 
4
□
  176 990 FEDSPSYVKWGK  FDWFLKSR  2677.3219 3 3.5 BS
3 I SEC + 40.8x 
5  223 855 TLQTISLLGYMKHYR  DFNQFIKANEK  3313.7171 3 3.4 BS
3 IV none + 45.5 
6
□
  223 929 TLQTISLLGYMKHYR  YKAPFHQLR  3119.6745 4 -1.1 BS
3 I SEC + 26.5x 
7  264 758 SVCLIGDKEQR  VSEPKAPK  2296.2099 3 -6.0 BS
3 IV SEC + 47.8 
8
□
  264 929 SVCLIGDKEQR  YKAPFHQLR  2600.3536 4 -1.6 BS
3 III SEC + 32.3x 
9
□
  264 990 SVCLIGDKEQR  FDWFLKSR  2539.2896 3 3.8 BS
3 III SEC + 25.2x 
10  758 397 VSEPKAPK  IKADVEK  1794.0140 3 0.9 BS
3 IV SEC + 86.4 
11
□
  847 264 LLTQGFTNWNKR  SVCLIGDKEQR  2918.5075 3 2.9 BS
3 IV SEC + 32.8x 
12
□
  855 299 DFNQFIKANEK  KFNWR  2240.1380 3 1.1 BS
3 I SEC + 40.1x 
13
□
  929 299 YKAPFHQLR  KFNWR  2046.0954 3 -3.0 BS
3 I SEC + 35.9x 
14  929 328 YKAPFHQLR  EFKTTNR  2191.1540 3 -1.0 BS
3 I SEC + 32.8 
15
□
 a 929 397 YKAPFHQLR  IKADVEK  2098.1577 3 1.2 BS
3 I SEC + 15.6x 
15 b 929 397 YKAPFHQLR  RIKADVEK  2254.2588 5 -0.3 BS
3 I SEC + 15.6 
16
□
  990 299 FDWFLKSR  KFNWR  1985.0314 4 -2.2 BS
3 I SEC + 33.7x 
17
□
  990 328 FDWFLKSR  EFKTTNR  2130.0900 3 1.1 BS
3 I none + 33.4x 
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18
□
 a 990 397 FDWFLKSR  IKADVEK  2037.0937 3 0.2 BS
3 I none + 33.4x 
18 b 990 397 FDWFLKSR  RIKADVEK  2193.1948 3 0.3 BS
3 II none + 33.4 
18 c 990 397 NSPQFRFDWFLKSR  IKADVEK  2766.4496 4 3.1 BS
3 II none + 33.4 
18 d 990 397 NSPQFRFDWFLKSR  RIKADVEK  2922.5507 4 2.3 BS
3 II none + 33.4 
19  176 1036 FEDSPSYVKWGK  KMDGAPDGR  2525.1899 4 4.1 BS
3 I none + N/A 
20  264 1036 SVCLIGDKEQR  KMDGAPDGR  2403.1525 4 2.8 BS
3 III SEC + N/A 
21  223 739 TLQTISLLGYMKHYR  KANYAVDAYFR  3277.6960 3 1.1 BS
3 I none + N/A 
22  176 739 FEDSPSYVKWGK  KANYAVDAYFR  2896.4074 3 2.2 BS
3 I none + N/A 
23  418 929 IYVGLSKMQR  YKAPFHQLR  2490.3571 3 2.4 BS
3 I none + 38.1 
24
□
  418 990 IYVGLSKMQR  FDWFLKSR  2429.2932 3 2.1 BS
3 I none + 24.8x 
25  430 855 ILMKDIDILNSAGK  DFNQFIKANEK  3020.5895 3 3.1 BS
3 I none + 73.4 
26
□
 a 430 990 ILMKDIDILNSAGK  FDWFLKSR  2765.4828 3 4.7 BS
3 I SEC + 36.2x 
26 b 430 990 ILMKDIDILNSAGKMDK  FDWFLKSR  3139.6452 4 0.1 BS
3 II none + 36.2 
26 c 430 990 ILMKDIDILNSAGK  NSPQFRFDWFLKSR  3494.8387 4 3.6 BS
3 III none + 36.2 
27  440 990 ILMKDIDILNSAGKMDK  FDWFLKSR  3139.6452 4 1.7 BS
3 IV none + 43.9 
28  990 624 FDWFLKSR  AEMKLR  1982.0450 3 -1.0 BS
3 I SEC + 40.4 
29  990 496 FDWFLKSR  LKEQGSR  2052.0794 3 0.3 BS
3 IV SEC + 39.8 
30  418 1036 IYVGLSKMQR  KMDGAPDGR  2277.1612 3 3.4 BS
3 I none + N/A 
31  430 739 ILMKDIDILNSAGK  KANYAVDAYFR  2984.5684 4 -0.3 BS
3 I SEC + N/A 
32  71 684 QKEIQEPDPTYEEK  KTAEMNEK  2820.3377 3 1.8 BS
3 I SEC + N/A 
33  160 644 TEQEEDEELLTESSKATNVCTR  LVDQNLNKIGKDEMLQMIR 4963.4104 5 -1.1 BS
3 III SEC + 72.3 
34  496 129 LKEQGSR  IKKDEK  1713.9627 3 -1.4 BS
3 IV SEC + 54.3 
35  83 328 EIQEPDPTYEEKMQTDR  EFKTTNR  3140.4610 3 -0.2 BS
3 IV SEC + N/A 
36  97 328 ANRFEYLLKQTELFAHFIQPAAQK  EFKTTNR  3895.0423 5 4.1 BS
3 IV SEC + N/A 
37  71 929 QKEIQEPDPTYEEK  YKAPFHQLR  3029.5137 4 1.6 BS
3 I SEC + N/A 
38  71 990 QKEIQEPDPTYEEK  FDWFLKSR  2968.4497 3 0.1 BS
3 I SEC + N/A 
39  83 929 EIQEPDPTYEEKMQTDR  YKAPFHQLR  3404.6349 4 1.0 BS
3 IV SEC + N/A 
40  97 990 ANRFEYLLKQTELFAHFIQPAAQK  FDWFLKSR  4098.1522 5 -4.3 BS
3 IV SEC + N/A 
41
∆
  132 990 DEKQNLLSVGDYR  FDWFLKSR  2771.3921 3 -0.7 BS
3 IV SEC + 36.9 
42 a 160 929 RTEQEEDEELLTESSKATNVCTR  YKAPFHQLR  4020.9490 5 -1.4 BS
3 III SEC + 36.4 
42 b 160 929 TEQEEDEELLTESSKATNVCTR  YKAPFHQLR  3864.8479 4 4.0 BS
3 III SEC + 36.4 
43
∆
  929 128 YKAPFHQLR  IKKDEK  2056.1471 3 0.6 BS
3 IV SEC + 24.9 
44
∆
  990 129 FDWFLKSR  IKKDEK  1995.0831 3 -0.9 BS
3 I SEC + 27.9 
45
∆
 a 990 128 FDWFLKSR  IKKDEK  1995.0831 3 1.2 BS
3 II SEC + 25.2 
45 b 990 128 NSPQFRFDWFLKSR  IKKDEK  2724.4390 4 4.8 BS
3 II none + 25.2 
46
∆
 a 990 121 FDWFLKSR  MKPGRPR  2076.1093 4 -0.5 BS
3 I SEC + 36.6 
46 b 990 121 NSPQFRFDWFLKSR  MKPGRPR  2805.4652 5 1.3 BS
3 II none + 36.6 
47  97 128 ANRFEYLLKQTELFAHFIQPAAQK  IKKDEK  3760.0355 5 0.8 BS
3 I none + N/A 
48 a 160 128 RTEQEEDEELLTESSKATNVCTR  IKKDEK  3621.7683 5 1.6 BS
3 II SEC + 35.7 
48 b 160 128 TEQEEDEELLTESSKATNVCTR  IKKDEK  3465.6671 3 1.0 BS
3 II SEC + 35.7 
49  83 121 EIQEPDPTYEEKMQTDR  MKPGRPR  3086.4804 5 2.9 BS
3 II none + N/A 
50
∆
 a 647 443 LVDQNLNKIGKDEMLQMIR  MDKMR  3074.5751 3 2.4 BS
3 II none + 8.0 
50 b 647 443 IGKDEMLQMIR  MDKMR  2150.0722 3 1.1 BS
3 I none + 8.0 
51
∆
 a 440 647 DIDILNSAGKMDK  IGKDEMLQMIR  2889.4652 3 2.5 BS
3 I SEC + 8.8 
51 b 440 647 ILMKDIDILNSAGKMDK  IGKDEMLQMIR  3374.7688 5 2.6 BS
3 II SEC + 8.8 
51 c 440 647 DIDILNSAGKMDKMR  IGKDEMLQMIR  3176.6068 4 3.6 BS
3 II none + 8.8 
52
∆
  665 430 HGATHVFASKESEITDEDIDGILER ILMKDIDILNSAGK  4436.2424 4 2.0 BS
3 I SEC + 21.5 
53
∆
  665 418 HGATHVFASKESEITDEDIDGILER  IYVGLSKMQR  4100.0527 4 1.2 BS
3 I none + 5.6 
54
∆
  647 929 LVDQNLNKIGKDEMLQMIR  YKAPFHQLR  3553.8904 4 1.0 BS
3 I none + 45.5 
55
∆
 a 647 990 LVDQNLNKIGKDEMLQMIR  FDWFLKSR  3492.8264 4 1.8 BS
3
  none + 43.1 
55 b 647 990 IGKDEMLQMIR  FDWFLKSR  2568.3235 3 0.4 BS
3 I none + 43.1 
56
□
  665 929 HGATHVFASKESEITDEDIDGILER  YKAPFHQLR  4065.0235 5 1.4 BS
3 I none + 36.8x 
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57
∆
  665 990 HGATHVFASKESEITDEDIDGILER  FDWFLKSR  4003.9595 4 -1.3 BS
3 I none + 20.1 
58  990 684 FDWFLKSR  KTAEMNEK  2185.0880 3 5.5 BS
3 IV SEC + 32.5 
59  665 684 HGATHVFASKESEITDEDIDGILER KTAEMNEK  3855.8475 4 1.4 BS
3 I SEC + 29.4 
60  665 724 HGATHVFASKESEITDEDIDGILER QKIAFTEWIEPPKR  4648.3452 5 5.7 BS
3 IV SEC + N/A 
61  665 735 HGATHVFASKESEITDEDIDGILER  IAFTEWIEPPKR  4392.1917 5 3.3 BS
3 IV none + N/A 
62 a 665 739 HGATHVFASKESEITDEDIDGILER KANYAVDAYFR  4223.0450 4 -1.8 BS
3 I SEC + N/A 
62 b 665 739 HGATHVFASKESEITDEDIDGILER ERKANYAVDAYFR  4508.1887 5 1.2 BS
3 IV SEC + N/A 
63  647 739 IGKDEMLQMIR  KANYAVDAYFR  2787.4090 3 -0.8 BS
3 I none + N/A 
64  665 1036 HGATHVFASKESEITDEDIDGILER KMDGAPDGR  3851.8275 4 0.2 BS
3 I SEC + N/A 
65  694 683 TAEMNEKLSKMGESSLR  GAKK  2450.2511 3 1.5 BS
3 III none + N/A 
66  694 758 LSKMGESSLR  VSEPKAPK  2115.1247 3 1.3 BS
3 IV SEC + N/A 
67  223 176 TLQTISLLGYMKHYR  FEDSPSYVKWGK  3402.7325 3 0.2 BS
3 IV none + 14.4 
68  249 298 STLHNWMSEFK  SVFKK  2140.0665 3 -6.6 BS
3 IV none + 26.8 
69  264 294 SVCLIGDKEQR  EKSVFK  2178.1357 4 1.1 BS
3 III SEC + 13.9 
70 a 264 299 SVCLIGDKEQR  KFNWR  2191.1210 3 0.5 BS
3 III none + 19.1 
70 b 264 299 SVCLIGDKEQR  SVFKKFNWR  2652.3849 3 3.9 BS
3 IV SEC + 19.1 
71  264 317 SVCLIGDKEQR  IKNEKSK  2287.2208 4 1.2 BS
3 IV SEC + 26.7 
72  264 319 SVCLIGDKEQR  SKLSEIVR  2372.2736 3 1.4 BS
3 IV SEC + 20.5 
73  292 319 DVLLPGEWDVCVTSYEMLIKEK  SKLSEIVR  3691.9096 3 5.8 BS
3 IV SEC + 11.1 
74  319 298 SKLSEIVR  SVFKK  1675.9874 3 0.3 BS
3 IV SEC + 13.0 
75  319 294 SKLSEIVR  EKSVFK  1805.0300 3 0.3 BS
3 IV SEC + 10.3 
76 a 328 299 EFKTTNR  KFNWR  1781.9215 4 2.7 BS
3 I none + 8.2 
76 b 328 299 LSEIVREFKTTNR  KFNWR  2479.3338 4 0.6 BS
3 II none + 8.2 
77 a 328 298 EFKTTNR  SVFKK  1639.8935 3 -1.0 BS
3 I SEC + 7.6 
77 b 328 298 LSEIVREFKTTNR  SVFKK  2337.3058 4 -4.0 BS
3 III none + 7.6 
78 a 397 314 IKADVEK  IKNEK  1573.9230 3 -0.8 BS
3 I none + 26.1 
78 b 397 314 RIKADVEK  IKNEK  1725.9991 3 -0.7 BS
3 I SEC + 26.1 
79  694 397 LSKMGESSLR  IKADVEK  2046.1033 3 -0.1 BS
3 I SEC + N/A 
80  724 176 QKIAFTEWIEPPKR  FEDSPSYVKWGK  3321.7076 5 3.7 BS
3 IV SEC + N/A 
81 a 739 397 KANYAVDAYFR  IKADVEK  2256.1792 3 0.4 BS
3 I none + N/A 
81 b 739 397 KANYAVDAYFR  RIKADVEK  2412.2804 3 -1.8 BS
3 III none + N/A 
82  739 328 KANYAVDAYFR  EFKTTNR  2349.1755 3 0.9 BS
3 IV SEC + N/A 
83  739 299 KANYAVDAYFR  KFNWR  2204.1169 3 3.9 BS
3 I none + N/A 
84 a 402 600 ADVEKSLPPK  IGQTKTVR  2122.2000 3 -0.1 BS
3 II SEC + 15.8 
84 b 402 600 IKADVEKSLPPK  IGQTKTVR  2363.3790 3 -3.1 BS
3 II SEC + 15.8 
85  407 600 SLPPKKEVK  IGQTKTVR  2064.2309 3 1.1 BS
3 I none + 9.2 
86 a 494 408 MVVLDKLLPKLK  KEVK  2036.2685 3 2.0 BS
3 III none + 17.9 
86 b 494 408 LLPKLKEQGSR  KEVK  1908.1410 3 -0.3 BS
3 III none + 17.9 
86 c 494 408 LLPKLK  KEVK  1350.8852 3 -2.2 BS
3 III none + 17.9 
86 d 494 408 LLPKLKEQGSR  SLPPKKEVK  2430.4576 3 3.4 BS
3 III none + 17.9 
86 e 494 408 MVVLDKLLPKLK  SLPPKKEVK  2558.5851 4 1.8 BS
3 III none + 17.9 
87  494 600 MVVLDKLLPKLK  IGQTKTVR  2435.4915 4 2.0 BS
3 III none + 17.9 
88 a 600 496 IGQTKTVR  LKEQGSR  1856.0481 3 -1.3 BS
3 IV SEC + 15.5 
88 b 600 494 IGQTKTVR  LLPKLK  1750.1082 3 0.8 BS
3 I SEC + 15.5 
89 a 408 600 SLPPKKEVK  IGQTKTVR  2064.2309 3 0.2 BS
3 I none + 11.7 
89 b 600 408 IGQTKTVR  KEVK  1545.9394 3 -0.5 BS
3 I none + 11.7 
89 c 600 408 AHRIGQTKTVR  KEVK  1906.1114 4 -1.1 BS
3 II none + 11.7 
90  624 443 AEMKLR  MDKMR  1563.7937 3 3.3 BS
3 IV none + 24.7 
91  739 600 KANYAVDAYFR  IGQTKTVR  2356.2541 3 3.4 BS
3 I SEC + N/A 
92  739 496 KANYAVDAYFR  LKEQGSR  2271.1650 3 -0.3 BS
3 II SEC + N/A 
93  739 418 KANYAVDAYFR  IYVGLSKMQR  2648.3787 3 1.4 BS
3 I none + N/A 
94 a 761 799 APKAPRPPK  TIGYKVPR  2031.1995 3 0.6 BS
3 I SEC + 12.0 
94 b 761 799 APKAPRPPK  KTIGYKVPR  2159.2945 4 -1.6 BS
3 I none + 12.0 
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94 c 761 799 APKAPRPPKQPNVQDFQFFPPR  TIGYKVPR  3631.9782 5 0.3 BS
3 II SEC + 12.0 
95  767 847 APRPPKQPNVQDFQFFPPR  LLTQGFTNWNKR  3880.0328 5 3.3 BS
3 IV SEC + 20.6 
96  794 758 KTIGYKVPR  VSEPKAPK  2053.1937 4 1.3 BS
3 IV SEC + 23.6 
97 a 799 758 KTIGYKVPR  VSEPKAPK  2053.1937 3 -0.8 BS
3 I SEC + 20.2 
97 b 799 758 TIGYKVPR  VSEPKAPK  1925.0988 3 0.3 BS
3 I none + 20.2 
98 a 814 799 NPELPNAAQAQKEEQLK  KTIGYKVPR  3105.6825 5 2.5 BS
3 I SEC + 10.0 
98 b 814 799 NPELPNAAQAQKEEQLK  TIGYKVPR  2977.5875 3 2.6 BS
3 III none + 10.0 
99  847 761 LLTQGFTNWNKR  APKAPRPPK  2575.4389 3 -0.8 BS
3 I SEC + 22.3 
100  847 758 LLTQGFTNWNKR  VSEPKAPK  2469.3382 3 1.3 BS
3 I none + 21.6 
101 a 859 918 ANEKWGRDDIENIAR  ISIKK  2511.3448 4 1.9 BS
3 III none + 18.0 
101 b 859 918 ANEKWGRDDIENIAR  RISIKK  2667.4459 4 0.1 BS
3 III none + 18.0 
102 a 899 855 CNELQDIEKIMAQIER  DFNQFIKANEK  3479.7068 3 -1.8 BS
3 III SEC + 12.4 
102 b 899 855 CNELQDIEKIMAQIER  RDFNQFIKANEK  3635.8079 5 -0.5 BS
3 III SEC + 12.4 
103  899 847 CNELQDIEKIMAQIER  LLTQGFTNWNKR  3603.8180 3 0.4 BS
3 I SEC + 15.2 
104 a 929 918 YKAPFHQLR  ISIKK  1884.0987 4 -4.9 BS
3 I SEC + 18.6 
104 b 929 918 YKAPFHQLR  RISIKK  2040.1998 5 -1.6 BS
3 II SEC + 18.6 
105  929 990 YKAPFHQLR  FDWFLKSR  2394.2639 3 -3.8 BS
3 IV SEC + 26.8 
106  990 919 FDWFLKSR  KALDTK  1910.0304 3 4.3 BS
3 IV SEC + 28.2 
107  990 918 FDWFLKSR  ISIKK  1823.0347 3 1.0 BS
3 IV none + 25.9 
108  1020 919 ENMELEEKEKAEK  KALDTK  2418.2202 3 2.2 BS
3 I none + N/A 
109 a 691 943 TAEMNEKLSK  ISYGTNKGK  2254.1517 3 0.8 BS
3 III none + N/A 
109 b 691 943 KTAEMNEKLSK  ISYGTNKGK  2382.2467 3 -1.7 BS
3 III none + N/A 
110 a 691 990 TAEMNEKLSK  FDWFLKSR  2385.2041 3 -1.8 BS
3 I SEC + N/A 
110 b 691 990 KTAEMNEKLSK  FDWFLKSR  2513.2990 3 -3.2 BS
3 II none + N/A 
111  694 758 LSKMGESSLR  VSEPKAPK  2099.1298 3 -1.7 BS
3 III none + N/A 
112  694 929 LSKMGESSLR  YKAPFHQLR  2403.2735 3 3.5 BS
3 IV SEC + N/A 
113  694 943 LSKMGESSLR  ISYGTNKGK  2211.1571 3 -0.1 BS
3 I SEC + N/A 
114  694 990 LSKMGESSLR  FDWFLKSR  2342.2095 3 1.1 BS
3 I none + N/A 
115  724 919 QKIAFTEWIEPPKR  KALDTK  2554.4161 5 -1.0 BS
3 IV SEC + N/A 
116  724 929 QKIAFTEWIEPPKR  YKAPFHQLR  3038.6497 5 -3.5 BS
3 IV SEC + N/A 
117  724 990 QKIAFTEWIEPPKR  FDWFLKSR  2977.5857 4 2.7 BS
3 IV SEC + N/A 
118  735 761 IAFTEWIEPPKR  APKAPRPPK  2584.4532 4 1.2 BS
3 IV SEC + N/A 
119  735 855 IAFTEWIEPPKR  DFNQFIKANEK  2976.5388 3 3.5 BS
3 IV SEC + N/A 
120  735 919 IAFTEWIEPPKR  KALDTK  2298.2626 4 1.8 BS
3 IV SEC + N/A 
121 a 739 758 KANYAVDAYFR  VSEPKAPK  2309.2058 3 0.3 BS
3 I none + N/A 
121 b 739 758 KANYAVDAYFREALR  VSEPKAPK  2778.4707 4 2.2 BS
3 II none + N/A 
122  739 761 KANYAVDAYFR  APKAPRPPK  2415.3065 3 -2.1 BS
3 I SEC + N/A 
123 a 739 799 KANYAVDAYFR  TIGYKVPR  2387.2640 3 -2.6 BS
3 
 
SEC + N/A 
123 b 739 799 KANYAVDAYFR  KTIGYKVPR  2515.3589 4 1.6 BS
3 IV SEC + N/A 
124  739 918 KANYAVDAYFR  ISIKK  2042.1202 3 -0.9 BS
3 I none + N/A 
125  739 919 KANYAVDAYFR  KALDTK  2129.1159 3 2.3 BS
3 I none + N/A 
126  739 929 KANYAVDAYFR  YKAPFHQLR  2613.3494 3 -2.3 BS
3 III none + N/A 
127  739 943 KANYAVDAYFR  ISYGTNKGK  2421.2330 3 0.9 BS
3 IV SEC + N/A 
128  739 990 KANYAVDAYFR  FDWFLKSR  2552.2854 3 3.8 BS
3 I SEC + N/A 
129  767 739 APRPPKQPNVQDFQFFPPR  KANYAVDAYFR  3719.9004 4 0.5 BS
3 IV SEC + N/A 
130  847 739 LLTQGFTNWNKR  KANYAVDAYFR  2931.5034 3 -0.2 BS
3 I SEC + N/A 
131  855 739 DFNQFIKANEK  KANYAVDAYFR  2807.3921 3 2.5 BS
3 I SEC + N/A 
132  855 694 DFNQFIKANEK  LSKMGESSLR  2597.3161 3 1.3 BS
3 I SEC + N/A 
133  859 739 ANEKWGRDDIENIAR  KANYAVDAYFR  3240.5955 5 0.3 BS
3 IV SEC + N/A 
134  875 724 EVEGKTPEEVIEYSAVFWER  QKIAFTEWIEPPK  4120.0724 5 4.1 BS
3 IV none + N/A 
135 a 899 739 CNELQDIEKIMAQIER  KANYAVDAYFR  3443.6856 4 1.3 BS
3 III SEC + N/A 
135 b 899 739 CNELQDIEKIMAQIERGEAR  KANYAVDAYFR  3856.8879 5 0.9 BS
3 III SEC + N/A 
136 a 1029 919 RGPKPSTQKR  KALDTK  1966.1325 4 0.3 BS
3 II none + N/A 
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136 b 1029 919 GPKPSTQKR  KALDTK  1810.0314 4 -0.6 BS
3 I SEC + N/A 
136 c 1029 919 GPKPSTQK  KALDTK  1653.9303 4 -2.0 BS
3 II SEC + N/A 
137 a 1034 919 GPKPSTQKR  KALDTK  1810.0314 3 -3.6 BS
3 I SEC + N/A 
137 b 1034 919 RGPKPSTQKR  KALDTK  1966.1325 4 -0.8 BS
3 I SEC + N/A 
138 a 1036 929 KMDGAPDGR  YKAPFHQLR  2242.1319 3 -0.8 BS
3 I none + N/A 
138 b 1036 929 KMDGAPDGRGR  YKAPFHQLR  2455.2545 4 1.2 BS
3 II none + N/A 
139 a 1036 919 KMDGAPDGR  KALDTK  1757.8984 3 -0.4 BS
3 II none + N/A 
139 b 1036 919 RKMDGAPDGR  KALDTK  1929.9944 4 1.1 BS
3 II SEC + N/A 
139 c 1036 919 KMDGAPDGRGR  KALDTK  1971.0210 3 2.4 BS
3 II none + N/A 
140 a 1036 918 KMDGAPDGR  RISIKK  1827.0038 4 0 BS
3 II none + N/A 
140 b 1036 918 KMDGAPDGR  ISIKK  1670.9027 3 2.4 BS
3 II none + N/A 
140 c 1036 918 KMDGAPDGRGR  ISIKK  1884.0253 4 1.3 BS
3 II none + N/A 
141 a 694 1036 LSKMGESSLR  KMDGAPDGR  2190.0775 3 -0.7 BS
3 I none + N/A 
141 b 694 1036 TAEMNEKLSKMGESSLR  KMDGAPDGR  2993.4259 3 1.7 BS
3 II none + N/A 
142  722 694 NFTMDTESSVYNFEGEDYREKQK  LSKMGESSLR  4060.8673 5 4.7 BS
3 I SEC + N/A 
143  722 691 NFTMDTESSVYNFEGEDYREKQK  TAEMNEKLSK  4103.8619 4 0.2 BS
3 III none + N/A 
144  722 1036 NFTMDTESSVYNFEGEDYREKQK  KMDGAPDGR  3899.7257 4 1.7 BS
3 III none + N/A 
145  724 739 QKIAFTEWIEPPKR  KANYAVDAYFR  3196.6712 5 0.4 BS
3 I SEC + N/A 
146  724 694 QKIAFTEWIEPPKR  LSKMGESSLR  2986.5952 4 1.0 BS
3 IV SEC + N/A 
147  735 694 IAFTEWIEPPKR  LSKMGESSLR  2730.4417 3 -2.5 BS
3 IV SEC + N/A 
148  735 1036 IAFTEWIEPPKR  KMDGAPDGR  2569.3001 4 -1.1 BS
3 IV SEC + N/A 
149  739 694 KANYAVDAYFR  LSKMGESSLR  2577.2899 3 2.6 BS
3 I SEC + N/A 
150  739 691 KANYAVDAYFR  KTAEMNEKLSK  2732.3846 3 2.5 BS
3 I SEC + N/A 
151  739 691 KANYAVDAYFR  TAEMNEKLSK  2604.2896 3 1.4 BS
3 I none + N/A 
152 a 739 1036 KANYAVDAYFR  KMDGAPDGR  2400.1534 4 -4.7 BS
3 III none + N/A 
152 b 739 1036 KANYAVDAYFR  KMDGAPDGRGR  2613.2760 4 -3.3 BS
3 III none + N/A 
152 c 739 1036 ERKANYAVDAYFR  KMDGAPDGR  2685.2972 3 -5.6 BS
3 III none + N/A 
153  739 1051 KANYAVDAYFR  LKL  1826.9932 3 3.0 BS
3 III none + N/A 
154  1020 1036 ENMELEEKEKAEK  KMDGAPDGR  2689.2577 3 0 BS
3 I SEC + N/A 
 
□
, 
∆
 MS/MS spectra are provided in SFigure 7 and SFigure 9B, respectively. 
x
  Cross-link was used as distance restraint during rigid body docking.  
N/A = Not available, at least one amino acid is missing in the structure. 
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STable 5: Cross-links for the Snf2H enzyme in the presence of nucleosomes. Cross-linked peptides are listed in an ordered manner according to their cross-link 
identification number (XLSnf2H,c 1–181). The table is structured in an indentical manner as described for STable 1 with cross-linked sites being color-coded according to 
the domain architecture in Figure 41. Data derive from two independent XL-MS experiments. 
XL 
Snf2H,c 
Vari- 
ant 
Site 
1 
Site 
2 
Pro- 
tein 1 
Pro- 
tein 2 Peptide 1 sequence Peptide 2 sequence 
Mass 
(Da) Charge 
Error 
(ppm) 
Cross-
linker 
Repro-
ducibility 
group 
Size 
selec-
tion 
Peptide 
enrich- 
ment 
Cα-Cα distances (Å) 
cf. structure (pdb 2PYO)  
in Figure 42A 
1  17 7 H2B H2B AQKNITK TSGKAAK 1604.9401 3 0 BS
3
 III none + N/A 
2  31 82 H2B H2B KESYAIYIYK LAHYNKR 2319.2567 4 -0.5 BS
3
 IV none + 13.3; 13.7 
3  14 4 H3 H3 KSTGGKAPR TKQTAR 1746.0052 4 -2.8 BS
3
 III none + N/A 
4  14 37 H3 H3 KSTGGKAPR KPHR 1578.9258 4 -1.6 BS
3
 II none + N/A 
5  18 4 H3 H3 KQLATK TKQTAR 1532.9189 3 -0.2 BS
3
 I none + N/A 
6 a 23 4 H3 H3 KQLATKAAR TKQTAR 1831.0943 4 -0.2 BS
3
 I none + N/A 
6 b 23 4 H3 H3 KQLATKAAR TKQTARK 1959.1893 5 -2.0 BS
3
 II none + N/A 
7 a 23 9 H3 H3 KQLATKAAR KSTGGKAPR 2028.2108 4 -0.6 BS
3
 I none + N/A 
7 b 23 9 H3 H3 KQLATKAAR KSTGGK 1704.0197 4 -2.7 BS
3
 I none + N/A 
8  23 37 H3 H3 KQLATKAAR KPHR 1664.0149 4 -0.4 BS
3
 I none + N/A 
9 a 27 4 H3 H3 KSAPATGGVKKPHR TKQTAR 2278.3173 5 -1.4 BS
3
 I none + N/A 
9 b 27 4 H3 H3 KSAPATGGVK TKQTAR 1760.0096 3 0.9 BS
3
 I none + N/A 
10 a 27 9 H3 H3 KSAPATGGVK KSTGGKAPR 1957.1260 4 -1.3 BS
3
 I none + N/A 
10 b 27 9 H3 H3 KSAPATGGVK KSTGGK 1632.9350 3 -4.9 BS
3
 II none + N/A 
11 a 27 14 H3 H3 KSAPATGGVKKPHR KSTGGKAPR 2475.4338 5 1.1 BS
3
 II none + N/A 
11 b 27 14 H3 H3 KSAPATGGVKKPHR STGGKAPR 2347.3388 5 -0.5 BS
3
 I none + N/A 
11 c 27 14 H3 H3 KSAPATGGVK KSTGGKAPR 1957.1260 4 2.5 BS
3
 I none + N/A 
11 d 27 14 H3 H3 KSAPATGGVK STGGKAPR 1829.0311 3 3.7 BS
3
 I none + N/A 
12  36 18 H3 H3 KSAPATGGVKKPHR KQLATK 2262.3476 4 -1.0 BS
3
 I none + N/A 
13 a 36 23 H3 H3 SAPATGGVKKPHR KQLATKAAR 2432.4280 5 -2.2 BS
3
 II none + N/A 
13 b 36 23 H3 H3 KSAPATGGVKKPHR KQLATKAAR 2560.5229 5 -0.9 BS
3
 I none + N/A 
14  37 14 H3 H3 SAPATGGVKKPHR KSTGGKAPR 2347.3388 4 -0.6 BS
3
 IV none + N/A 
15 a 56 18 H3 H3 YQKSTELLIR KQLATK 2079.2243 3 -1.2 BS
3
 I none + N/A 
15 b 56 18 H3 H3 RYQKSTELLIR KQLATK 2235.3254 4 3.7 BS
3
 II none + N/A 
16  8 20 H4 H4 GKGGKGLGK KVLR 1456.9393 3 -1.4 BS
3
 IV none + N/A 
17  20 8 H4 H4 KVLRDNIQGITKPAIR GKGGKGLGK 2763.6751 5 0.2 BS
3
 IV none + N/A 
18  31 35 H2B H2A RKESYAIYIYK KGNYAER 2411.2789 4 -1.7 BS
3
 III none + 15.5; 15.9 
19  12 23 H4 H3 GLGKGGAKR KQLATKAAR 1970.2053 4 1.8 BS
3
 III none + N/A 
20  8 23 H4 H3 GKGGKGLGK KQLATKAAR 1928.1835 4 0.2 BS
3
 IV none + N/A 
21  56 73 H3 H2A RYQKSTELLIR DNKK 2051.1679 3 0.8 BS
3
 IV none + 15.3; 15.7 
22 a 56 74 H3 H2A YQKSTELLIR DNKKTR 2152.2155 3 0 BS
3
 II none + 15.5;15.9 
22 b 56 74 H3 H2A RYQKSTELLIR DNKKTR 2308.3167 4 -0.9 BS
3
 II none + 15.5;15.9 
23  27 8 H3 H4 KSAPATGGVK GKGGKGLGK 1857.0987 3 0.4 BS
3
 III none + N/A 
24  105 79 H2B H3 LLLPGELAKHAVSEGTK EIAQDFKTDLR 3238.7753 3 1.5 BS
3
 I none + 16.3; 16.6 
25  35 7 H2A H2B KGNYAER TSGKAAK 1639.8833 3 0.4 BS
3
 IV none + N/A 
26  35 82 H2A H2B KGNYAER LAHYNKR 1879.0004 4 1.8 BS
3
 I none + 19.9; 20.3 
27  91 35 H4 H2A TVTAMDVVYALKR KGNYAER 2444.3037 4 2.1 BS
3
 IV none + 25.6; 25.7 
28  23 118 H3 H2A KQLATKAAR KTEK 1631.9874 3 -1.5 BS
3
 IV none + N/A 
29 a 117 14 H2B H2A AVTKYTSSK GKAKSR 1771.0143 3 0.2 BS
3
 I none + 13.4; 14.0 
29 b 117 14 H2B H2A HAVSEGTKAVTKYTSSK AKSR 2395.3011 5 -0.2 BS
3
 I none + 13.4; 14.0 
29 c 117 14 H2B H2A HAVSEGTKAVTKYTSSK GKAKSR 2580.4175 5 0.1 BS
3
 I none + 13.4; 14.0 
29 d 117 14 H2B H2A AVTKYTSSK AKSR 1585.8979 3 0.2 BS
3
 IV none + 13.4; 14.0 
30 a 117 10 H2B H2A HAVSEGTKAVTKYTSSK VKGK 2365.3157 4 0.2 BS
3
 IV none + N/A 
30 b 117 10 H2B H2A AVTKYTSSK GGKVKGK 1798.0504 3 0.6 BS
3
 IV none + N/A 
30 c 117 10 H2B H2A HAVSEGTKAVTKYTSSK GGKVKGK 2607.4536 5 -1.2 BS
3
 IV none + N/A 
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31  117 8 H2B H2A AVTKYTSSK GKGGKVK 1798.0504 3 -0.7 BS
3
 I none + N/A 
32
◊
 
 
176 847 Snf2H Snf2H FEDSPSYVKWGK LLTQGFTNWNKR 3060.5649 3 1.7 BS
3
 IV none + N/D 
33
◊
 176 929 Snf2H Snf2H FEDSPSYVKWGK YKAPFHQLR 2742.4110 3 -2 BS
3
 III none + N/D 
34
◊
  176 990 Snf2H Snf2H FEDSPSYVKWGK FDWFLKSR 2681.3470 3 0.4 BS
3
 III none + N/D 
35
◊
  929 264 Snf2H Snf2H YKAPFHQLR SVCLIGDK 2191.1764 4 -6.5 BS
3
 IV none + N/D 
36
◊
  929 299 Snf2H Snf2H YKAPFHQLR KFNWR 2050.1204 4 1.4 BS
3
 IV none + N/D 
37
◊
  990 299 Snf2H Snf2H FDWFLKSR KFNWR 1989.0565 4 1.2 BS
3
 III none + N/D 
38  176 739 Snf2H Snf2H FEDSPSYVKWGK KANYAVDAYFR 2900.4325 3 0.8 BS
3
 I none + N/A 
39
□
  176 758 Snf2H Snf2H FEDSPSYVKWGK VSEPKAPK 2438.2673 3 1.9 BS
3
 III none + N/D 
40
□
  176 799 Snf2H Snf2H FEDSPSYVKWGK TIGYKVPR 2516.3255 3 -0.8 BS
3
 III none + N/D 
41  176 1036 Snf2H Snf2H FEDSPSYVKWGK KMDGAPDGR 2529.2150 3 -1.8 BS
3
 IV none + N/A 
42  724 176 Snf2H Snf2H QKIAFTEWIEPPKR FEDSPSYVKWGK 3325.7327 5 -1.7 BS
3
 IV none + N/A 
43
◊
  418 990 Snf2H Snf2H IYVGLSKMQR FDWFLKSR 2433.3182 3 0.3 BS
3
 IV none + N/D 
44
□
  430 929 Snf2H Snf2H ILMKDIDILNSAGK YKAPFHQLR 2830.5719 4 0.9 BS
3
 IV none + N/D 
45
◊
  430 990 Snf2H Snf2H ILMKDIDILNSAGK FDWFLKSR 2769.5079 3 -0.8 BS
3
 III none + N/D 
46  418 1036 Snf2H Snf2H IYVGLSKMQR KMDGAPDGR 2281.1863 3 -3.2 BS
3
 IV none + N/A 
47  430 739 Snf2H Snf2H ILMKDIDILNSAGK KANYAVDAYFR 2988.5935 3 -1.4 BS
3
 III none + N/A 
48  739 418 Snf2H Snf2H KANYAVDAYFR IYVGLSKMQR 2652.4038 3 2.1 BS
3
 III none + N/A 
49  440 739 Snf2H Snf2H ILMKDIDILNSAGKMDK KANYAVDAYFR 3362.7559 4 -0.5 BS
3
 III none + N/A 
50
□
  119 328 Snf2H Snf2H TPTSPLKMKPGRPR EFKTTNR 2601.4365 4 -1.2 BS
3
 IV none + N/A 
51
□
  319 121 Snf2H Snf2H SKLSEIVREFK MKPGRPR 2333.3193 3 -2.9 BS
3
 IV none + N/D 
52
□
  176 121 Snf2H Snf2H FEDSPSYVKWGK MKPGRPR 2424.2564 3 0.4 BS
3
 III none + N/D 
53
□
 a 83 990 Snf2H Snf2H EIQEPDPTYEEKMQTDR FDWFLKSR 3347.5960 4 -4.2 BS
3
 III none + N/A 
53 b 83 990 Snf2H Snf2H EIQEPDPTYEEKMQTDR NSPQFRFDWFLKSR 4076.9519 4 1.8 BS
3
 III none + N/A 
54
□
 
 
112 814 Snf2H Snf2H QTELFAHFIQPAAQKTPTSPLK 
VPRNPELPNAAQAQKE
EQLK 
4853.6021 5 0.5 BS
3
 IV none + 
N/A 
55
◊
 
 
119 990 Snf2H Snf2H TPTSPLKMKPGRPR FDWFLKSR 2804.5464 4 -1.6 BS
3
 III none + N/A 
56
◊
 
 
121 990 Snf2H Snf2H TPTSPLKMKPGRPR FDWFLKSR 2804.5464 4 -1.6 BS
3
 III none + N/A 
57
◊
 
 
929 121 Snf2H Snf2H YKAPFHQLR MKPGRPR 2141.1984 5 -3.4 BS
3
 IV none + N/A 
58
◊
 
 
990 129 Snf2H Snf2H FDWFLKSR IKKDEK 1999.1082 4 -1.9 BS
3
 III none + N/D 
59
□
 a 647 490 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR MVVLDKLLPK 3553.9954 4 3.5 BS
3
 III none + N/D 
59 b 647 490 Snf2H Snf2H IGKDEMLQMIR MVVLDKLLPK 2629.4925 3 2.8 BS
3
 III none + N/D 
60
□
 
 
665 490 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER MVVLDKLLPK 4065.1285 4 -3.9 BS
3
 III none + N/D 
61
□
 
 
490 684 Snf2H Snf2H MVVLDKLLPK KTAEMNEK 2246.2570 3 2.5 BS
3
 IV none + N/D 
62
◊
 a 644 443 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR MDKMR 3078.6002 3 -1.5 BS
3
 III none + N/D 
62 b 644 443 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR DIDILNSAGKMDKMR 4105.1348 4 2.2 BS
3
 III none + N/D 
63
◊
 a 443 647 Snf2H Snf2H DIDILNSAGKMDKMR IGKDEMLQMIR 3180.6319 3 1.8 BS
3
 III none + N/D 
63 b 647 443 Snf2H Snf2H IGKDEMLQMIR MDKMR 2154.0973 3 1.1 BS
3
 III none + N/D 
63 c 647 443 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR DIDILNSAGKMDKMR 4105.1348 5 0.1 BS
3
 III none + N/D 
64
◊
 a 440 647 Snf2H Snf2H DIDILNSAGKMDK IGKDEMLQMIR 2893.4903 3 6.4 BS
3
 III none + N/D 
64 b 440 647 Snf2H Snf2H DIDILNSAGKMDKMR IGKDEMLQMIR 3180.6319 4 1.3 BS
3
 III none + N/D 
64 c 440 647 Snf2H Snf2H ILMKDIDILNSAGKMDK IGKDEMLQMIR 3378.7939 4 0.9 BS
3
 III none + N/D 
64 d 647 440 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR DIDILNSAGKMDK 3817.9932 4 6.6 BS
3
 III none + N/D 
64 e 647 440 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR DIDILNSAGKMDKMR 4105.1348 5 -4.8 BS
3
 III none + N/D 
65
□
 a 430 647 Snf2H Snf2H ILMKDIDILNSAGK IGKDEMLQMIR 3004.6315 3 -1.2 BS
3
 III none + N/D 
65 b 647 430 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR ILMKDIDILNSAGK 3929.1344 4 0.9 BS
3
 III none + N/D 
66
◊
 
 
665 430 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER ILMKDIDILNSAGKMDK 4814.4299 5 -2.9 BS
3
 IV none + N/D 
67
◊
 
 
665 418 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER IYVGLSKMQR 4104.0778 4 -2.9 BS
3
 III none + N/D 
68
□
 
 
418 684 Snf2H Snf2H IYVGLSKMQR KTAEMNEK 2285.2063 3 -1.9 BS
3
 III none + N/D 
69
□
 
 
408 684 Snf2H Snf2H SLPPKKEVK KTAEMNEK 2116.1753 4 0.3 BS
3
 IV none + N/D 
70
□
 
 
407 684 Snf2H Snf2H SLPPKKEVK KTAEMNEK 2116.1753 4 0.3 BS
3
 III none + N/D 
71
◊
 
 
665 929 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER YKAPFHQLR 4069.0486 5 -0.1 BS
3
 I none + N/D 
72
◊
 
 
647 929 Snf2H Snf2H IGKDEMLQMIR YKAPFHQLR 2633.4126 4 0.1 BS
3
 IV none + N/D 
73
◊
 
 
665 990 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER FDWFLKSR 4007.9846 4 -0.4 BS
3
 III none + N/D 
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74 a 990 647 Snf2H Snf2H NSPQFRFDWFLKSR IGKDEMLQMIR 3301.7044 4 4.4 BS
3
 III none + N/D 
74
◊
 b 647 990 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR FDWFLKSR 3496.8515 4 0.5 BS
3
 III none + N/D 
74 c 647 990 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR NSPQFRFDWFLKSR 4226.2073 5 -0.4 BS
3
 III none + N/D 
74 d 647 990 Snf2H Snf2H IGKDEMLQMIR FDWFLKSR 2572.3486 4 0.7 BS
3
 III none + N/D 
75 
 
694 684 Snf2H Snf2H LSKMGESSLR KTAEMNEK 2198.1226 4 0.7 BS
3
 III none + N/A 
76 
 
694 683 Snf2H Snf2H LSKMGESSLR GAKK 1650.9278 3 1.2 BS
3
 IV none + N/A 
77 
 
665 694 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER LSKMGESSLR 4016.9942 4 -3.0 BS
3
 IV none + N/A 
78 a 647 691 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR TAEMNEKLSK 3548.8557 4 -1.6 BS
3
 III none + N/A 
78 b 647 691 Snf2H Snf2H IGKDEMLQMIR TAEMNEKLSK 2624.3527 3 2.6 BS
3
 III none + N/A 
79 a 647 694 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR LSKMGESSLR 3505.8611 5 2.5 BS
3
 III none + N/A 
79 b 647 694 Snf2H Snf2H IGKDEMLQMIR LSKMGESSLR 2581.3582 3 1.4 BS
3
 III none + N/A 
79 c 644 694 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR LSKMGESSLR 3505.8611 4 2.6 BS
3
 III none + N/A 
80 a 665 735 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER IAFTEWIEPPKRER 4681.3605 4 -1.3 BS
3
 III none + N/A 
80 b 665 735 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER IAFTEWIEPPKR 4396.2168 4 4.8 BS
3
 III none + N/A 
81 a 647 739 Snf2H Snf2H IGKDEMLQMIR KANYAVDAYFR 2791.4341 3 -0.7 BS
3
 II none + N/A 
81 b 647 739 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR KANYAVDAYFR 3715.9370 3 1.4 BS
3
 II none + N/A 
81 c 739 647 Snf2H Snf2H ERKANYAVDAYFR IGKDEMLQMIR 3076.5778 5 0.8 BS
3
 II none + N/A 
82 
 
644 739 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR KANYAVDAYFR 3715.937 4 0.4 BS
3
 I none + N/A 
83 
 
665 1036 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER KMDGAPDGR 3855.8526 4 5.5 BS
3
 IV none + N/A 
84 a 647 684 Snf2H Snf2H IGKDEMLQMIR KTAEMNEK 2424.2366 3 -0.3 BS
3
 III none + N/A 
84 b 647 684 Snf2H Snf2H LVDQNLNKIGKDEMLQMIR KTAEMNEK 3348.7396 4 1.0 BS
3
 III none + N/A 
85 
 
665 683 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER GAKK 3312.6778 3 0.8 BS
3
 IV none + N/A 
86 a 665 684 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER KTAEMNEKLSK 4188.0837 5 3.4 BS
3
 II none + N/A 
86 b 665 684 Snf2H Snf2H HGATHVFASKESEITDEDIDGILER KTAEMNEK 3859.8726 5 -2.4 BS
3
 I none + N/A 
87 
 
97 121 Snf2H Snf2H ANRFEYLLKQTELFAHFIQPAAQK MKPGRPR 3845.0867 5 -3.5 BS
3
 IV none + N/A 
88 
 
97 128 Snf2H Snf2H ANRFEYLLKQTELFAHFIQPAAQK IKKDEK 3764.0606 4 0.3 BS
3
 III none + N/A 
89 
 
112 128 Snf2H Snf2H QTELFAHFIQPAAQKTPTSPLK IKKDEK 3353.8539 4 1.1 BS
3
 IV none + N/A 
90 a 160 176 Snf2H Snf2H RTEQEEDEELLTESSK FEDSPSYVKWGK 3505.6565 4 1.0 BS
3
 III none + N/D 
90
□
 b 160 176 Snf2H Snf2H TEQEEDEELLTESSK FEDSPSYVKWGK 3349.5553 3 3.4 BS
3
 III none + N/D 
91
□
 
 
176 128 Snf2H Snf2H FEDSPSYVKWGK IKKDEK 2343.2302 3 2.1 BS
3
 IV none + N/D 
92 a 176 249 Snf2H Snf2H FEDSPSYVKWGK STLHNWMSEFKR 3118.5162 3 2.1 BS
3
 I none + N/D 
92 b 176 249 Snf2H Snf2H FEDSPSYVKWGKLR STLHNWMSEFKR 3387.7014 4 2.1 BS
3
 II none + N/D 
93 
 
176 397 Snf2H Snf2H FEDSPSYVKWGK IKADVEK 2385.2408 3 -2.0 BS
3
 IV none + N/D 
94 
 
223 176 Snf2H Snf2H TLQTISLLGYMKHYR FEDSPSYVKWGK 3406.7576 4 -0.4 BS
3
 IV none + N/D 
95 
 
319 298 Snf2H Snf2H SKLSEIVREFK SVFKK 2084.2185 4 1.4 BS
3
 III none + N/D 
96 
 
328 298 Snf2H Snf2H EFKTTNR SVFKK 1643.9186 3 -0.2 BS
3
 IV none + N/D 
97  328 299 Snf2H Snf2H EFKTTNR KFNWR 1785.9466 4 0.9 BS
3
 IV none + N/D 
98  397 314 Snf2H Snf2H IKADVEK IKNEK 1573.9230 3 -0.2 BS
3
 IV none + N/D 
99  407 600 Snf2H Snf2H SLPPKKEVK IGQTKTVR 2068.2560 4 -1.6 BS
3
 III none + N/D 
100 a 600 408 Snf2H Snf2H IGQTKTVR KEVK 1545.9394 3 2.3 BS
3
 III none + N/D 
100 b 408 600 Snf2H Snf2H SLPPKKEVK IGQTKTVR 2068.2560 4 -1.6 BS
3
 III none + N/D 
101  411 490 Snf2H Snf2H KEVKIYVGLSK MVVLDK 2108.2470 3 -0.7 BS
3
 IV none + N/D 
102  494 407 Snf2H Snf2H MVVLDKLLPKLK SLPPKKEVK 2562.6102 3 -1.1 BS
3
 IV none + N/D 
103 a 494 408 Snf2H Snf2H LLPKLKEQGSR SLPPKKEVK 2434.4827 3 -0.5 BS
3
 III none + N/D 
103 b 494 408 Snf2H Snf2H LLPKLKEQGSR KEVK 1912.1661 4 -1.4 BS
3
 III none + N/D 
103 c 494 408 Snf2H Snf2H MVVLDKLLPKLK KEVK 2040.2936 3 -1.4 BS
3
 III none + N/D 
103 d 494 408 Snf2H Snf2H MVVLDKLLPKLK SLPPKKEVK 2562.6102 3 -1.1 BS
3
 III none + N/D 
104  929 919 Snf2H Snf2H YKAPFHQLR KALDTK 1975.1195 3 4.2 BS
3
 I none + N/D 
105 a 929 918 Snf2H Snf2H IGRYKAPFHQLR ISIKK 2214.3305 4 0.5 BS
3
 I none + N/D 
105 b 929 918 Snf2H Snf2H YKAPFHQLR ISIKK 1888.1238 3 3.7 BS
3
 I none + N/D 
105 c 929 918 Snf2H Snf2H YKAPFHQLR RISIKK 2044.2249 5 -2.3 BS
3
 I none + N/D 
106  847 859 Snf2H Snf2H LLTQGFTNWNKRDFNQFIK ANEKWGRDDIENIAR 4297.1973 5 0.5 BS
3
 IV none + N/D 
107  943 929 Snf2H Snf2H ISYGTNKGK YKAPFHQLR 2267.2366 5 -3.0 BS
3
 IV none + N/D 
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108  814 799 Snf2H Snf2H NPELPNAAQAQKEEQLK TIGYKVPR 2981.6126 4 -2.4 BS
3
 I none + N/D 
109 a 761 799 Snf2H Snf2H APKAPRPPK KTIGYKVPR 2163.3196 4 -1.7 BS
3
 III none + N/D 
109 b 761 799 Snf2H Snf2H APKAPRPPK TIGYKVPR 2035.2246 3 1.1 BS
3
 III none + N/D 
110 
 
758 799 Snf2H Snf2H EALRVSEPKAPK TIGYKVPR 2398.3888 3 -0.1 BS
3
 III none + N/D 
111 a 799 758 Snf2H Snf2H TIGYKVPR VSEPKAPK 1929.1239 3 1.1 BS
3
 III none + N/D 
111 b 799 758 Snf2H Snf2H KTIGYKVPR VSEPKAPK 2057.2188 3 0 BS
3
 III none + N/D 
112  943 990 Snf2H Snf2H ISYGTNKGK FDWFLKSR 2206.1726 3 3.2 BS
3
 IV none + N/D 
113 a 929 990 Snf2H Snf2H IGRYKAPFHQLR FDWFLKSR 2724.4956 5 -0.3 BS
3
 II none + N/D 
113 b 990 929 Snf2H Snf2H NSPQFRFDWFLKSR YKAPFHQLR 3127.6448 4 1.2 BS
3
 II none + N/D 
113 c 929 990 Snf2H Snf2H YKAPFHQLR FDWFLKSR 2398.289 3 2.7 BS
3
 I none + N/D 
114 a 990 919 Snf2H Snf2H FDWFLKSR KALDTK 1914.0555 4 -1.4 BS
3
 II none + N/D 
114 b 990 919 Snf2H Snf2H NSPQFRFDWFLKSR KALDTK 2643.4113 4 2.4 BS
3
 I none + N/D 
115  847 761 Snf2H Snf2H LLTQGFTNWNKR APKAPRPPK 2579.4640 3 -2.7 BS
3
 III none + N/D 
116 a 758 847 Snf2H Snf2H EALRVSEPKAPK LLTQGFTNWNKR 2942.6282 4 2.5 BS
3
 III none + N/D 
116 b 847 758 Snf2H Snf2H LLTQGFTNWNKR VSEPKAPK 2473.3633 3 0.2 BS
3
 III none + N/D 
116 c 847 758 Snf2H Snf2H LLTQGFTNWNKRDFNQFIK VSEPKAPK 3365.8076 3 1.3 BS
3
 III none + N/D 
117
►
  929 799 Snf2H Snf2H YKAPFHQLR TIGYKVPR 2233.2675 3 0.7 BS
3
 IV none + N/D 
118
►
  990 799 Snf2H Snf2H FDWFLKSR TIGYKVPR 2172.2035 3 1.5 BS
3
 IV none + N/D 
119
►
  990 758 Snf2H Snf2H NSPQFRFDWFLKSR VSEPKAPK 2823.5012 4 0.5 BS
3
 IV none + N/D 
120  847 739 Snf2H Snf2H LLTQGFTNWNKR KANYAVDAYFR 2935.5285 3 -0.2 BS
3
 IV none + N/A 
121  739 758 Snf2H Snf2H KANYAVDAYFR VSEPKAPK 2313.2309 3 1.3 BS
3
 I none + N/A 
122  1036 990 Snf2H Snf2H KMDGAPDGR FDWFLKSR 2185.0930 3 1.5 BS
3
 I none + N/A 
123  990 1049 Snf2H Snf2H FDWFLKSR KLKL 1740.0278 3 0.3 BS
3
 IV none + N/A 
124  739 799 Snf2H Snf2H KANYAVDAYFR TIGYKVPR 2391.2891 3 -0.5 BS
3
 I none + N/A 
125  990 1051 Snf2H Snf2H FDWFLKSR KLKL 1740.0278 3 -0.4 BS
3
 III none + N/A 
126  694 758 Snf2H Snf2H LSKMGESSLR VSEPKAPK 2103.1549 4 -0.3 BS
3
 IV none + N/A 
127  1034 943 Snf2H Snf2H GPKPSTQKR ISYGTNKGK 2106.1737 3 0.7 BS
3
 III none + N/A 
128  943 1036 Snf2H Snf2H ISYGTNKGK KMDGAPDGR 2054.0406 3 0.4 BS
3
 III none + N/A 
129  1018 919 Snf2H Snf2H ENMELEEKEKAEK KALDTK 2422.2453 3 0.1 BS
3
 III none + N/A 
130 a 919 1020 Snf2H Snf2H KALDTK EKAEK 1419.8124 3 1.2 BS
3
 IV none + N/A 
130 b 1020 919 Snf2H Snf2H ENMELEEKEKAEK KALDTK 2422.2453 3 1.1 BS
3
 IV none + N/A 
131 a 929 1034 Snf2H Snf2H IGRYKAPFHQLR GPKPSTQKR 2624.4967 5 -4.0 BS
3
 II none + N/A 
131 b 1034 929 Snf2H Snf2H GPKPSTQKR YKAPFHQLR 2298.2901 5 -0.9 BS
3
 I none + N/A 
131 c 1034 929 Snf2H Snf2H RGPKPSTQKR YKAPFHQLR 2454.3912 5 1.8 BS
3
 I none + N/A 
132 a 929 1036 Snf2H Snf2H IGRYKAPFHQLR KMDGAPDGR 2572.3637 5 2.5 BS
3
 I none + N/A 
132 b 929 1036 Snf2H Snf2H IGRYKAPFHQLR KMDGAPDGRGR 2801.4811 5 2.0 BS
3
 II none + N/A 
132 c 1036 929 Snf2H Snf2H KMDGAPDGRGR YKAPFHQLR 2475.2745 5 1.1 BS
3
 II none + N/A 
132 d 1036 929 Snf2H Snf2H KMDGAPDGR YKAPFHQLR 2246.1570 4 -0.5 BS
3
 I none + N/A 
133  1029 919 Snf2H Snf2H GPKPSTQKR KALDTK 1814.0565 4 -0.3 BS
3
 I none + N/A 
134 a 1034 919 Snf2H Snf2H GPKPSTQKR KALDTK 1814.0565 4 0.4 BS
3
 II none + N/A 
134 b 1034 919 Snf2H Snf2H RGPKPSTQKR KALDTK 1970.1576 4 -1.9 BS
3
 I none + N/A 
135  855 739 Snf2H Snf2H DFNQFIKANEK KANYAVDAYFR 2811.4172 3 -1.9 BS
3
 IV none + N/A 
136 a 919 1036 Snf2H Snf2H ISIKKALDTK KMDGAPDGR 2219.2135 4 -1.0 BS
3
 II none + N/A 
136 b 919 1036 Snf2H Snf2H KALDTKIGR KMDGAPDGR 2104.1250 4 -0.3 BS
3
 II none + N/A 
136 c 1036 919 Snf2H Snf2H KMDGAPDGRGR KALDTK 1975.0461 4 -0.5 BS
3
 II none + N/A 
136 d 1036 919 Snf2H Snf2H KMDGAPDGR KALDTK 1761.9235 3 -0.5 BS
3
 II none + N/A 
137  1036 918 Snf2H Snf2H KMDGAPDGR ISIKK 1674.9278 3 0.8 BS
3
 IV none + N/A 
138 a 929 1051 Snf2H Snf2H YKAPFHQLR LKL 1672.9968 3 0 BS
3
 III none + N/A 
138 b 929 1051 Snf2H Snf2H YKAPFHQLR KLKL 1801.0918 4 0.5 BS
3
 III none + N/A 
139  739 929 Snf2H Snf2H KANYAVDAYFR YKAPFHQLR 2617.3745 4 -0.2 BS
3
 I none + N/A 
140  694 943 Snf2H Snf2H LSKMGESSLR ISYGTNKGK 2215.1822 3 -1.5 BS
3
 III none + N/A 
141  739 990 Snf2H Snf2H KANYAVDAYFR FDWFLKSR 2556.3105 3 1.5 BS
3
 IV none + N/A 
142  691 990 Snf2H Snf2H TAEMNEKLSK FDWFLKSR 2389.2292 3 2.7 BS
3
 III none + N/A 
143  1036 1049 Snf2H Snf2H KMDGAPDGR KLKL 1587.8958 3 -4.3 BS
3
 I none + N/A 
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144  1036 1051 Snf2H Snf2H KMDGAPDGR KLKL 1587.8958 4 -3.7 BS
3
 I none + N/A 
145  722 694 Snf2H Snf2H NFTMDTESSVYNFEGEDYREKQK LSKMGESSLR 4064.8924 4 -4.6 BS
3
 II none + N/A 
146  694 739 Snf2H Snf2H TAEMNEKLSKMGESSLR KANYAVDAYFR 3368.6685 4 -2.1 BS
3
 III none + N/A 
147  739 691 Snf2H Snf2H KANYAVDAYFR TAEMNEKLSK 2608.3147 3 -2.0 BS
3
 III none + N/A 
148  1036 758 Snf2H Snf2H KMDGAPDGR VSEPKAPK 1942.0134 4 0.1 BS
3
 III none + N/A 
149 a 739 1036 Snf2H Snf2H KANYAVDAYFR KMDGAPDGR 2404.1785 3 -5.1 BS
3
 I none + N/A 
149 b 739 1036 Snf2H Snf2H KANYAVDAYFR KMDGAPDGRGR 2633.2960 4 2.5 BS
3
 II none + N/A 
149 c 694 1036 Snf2H Snf2H LSKMGESSLR KMDGAPDGR 2194.1026 4 -1.2 BS
3
 I none + N/A 
           
 
 
  
 
Cα-Cα distances (Å) 
               cf. model in Figure 44B 
150°  990 118 Snf2H H2A FDWFLKSR KTEK 1743.9499 3 4.8 BS
3
 III none + 42.4 
151°  105 739 H2B Snf2H LLLPGELAKHAVSEGTK KANYAVDAYFR 3220.7436 3 2.5 BS
3
 I none + N/A 
152°  105 758 H2B Snf2H LLLPGELAKHAVSEGTK VSEPKAPK 2758.5785 3 3.9 BS
3
 IV none + N/A 
153°  990 117 Snf2H H2B NSPQFRFDWFLKSR AVTKYTSSK 2952.5438 4 1.9 BS
3
 IV none + 27.0 
154
▼
  105 929 H2B Snf2H LLLPGELAKHAVSEGTK YKAPFHQLR 3062.7221 5 0.8 BS
3
 III none + 14.7
x
 
155°  105 990 H2B Snf2H LLLPGELAKHAVSEGTK FDWFLKSR 3001.6581 3 4.8 BS
3
 III none + 19.8 
156°  105 1036 H2B Snf2H LLLPGELAKHAVSEGTK KMDGAPDGR 2849.5261 3 -5.3 BS
3
 I none + N/A 
157°  105 1049 H2B Snf2H LLLPGELAKHAVSEGTK KLKL 2404.4609 3 1.8 BS
3
 III none + N/A 
158°  117 1036 H2B Snf2H AVTKYTSSK KMDGAPDGR 2071.0559 3 4.9 BS
3
 III none + N/A 
159°  739 11 Snf2H H2B KANYAVDAYFR KAGK 1861.0038 3 2.5 BS
3
 IV none + N/A 
160°  739 117 Snf2H H2B KANYAVDAYFR AVTKYTSSK 2442.2735 3 1.7 BS
3
 III none + N/A 
161°  739 122 Snf2H H2B KANYAVDAYFR AVTKYTSSK 2442.2735 3 1.2 BS
3
 IV none + N/A 
162°  249 4 Snf2H H3 STLHNWMSEFKR TKQTAR 2380.2261 4 1.3 BS
3
 IV none + N/A 
163°  739 4 Snf2H H3 KANYAVDAYFR TKQTAR 2162.1424 3 0.2 BS
3
 IV none + N/A 
164°  929 4 Snf2H H3 YKAPFHQLR TKQTAR 2004.1208 3 0.5 BS
3
 I none + N/A 
165° a 990 4 Snf2H H3 NSPQFRFDWFLKSR TKQTAR 2672.4127 4 1.5 BS
3
 III none + N/A 
165 b 990 4 Snf2H H3 FDWFLKSR TKQTAR 1943.0569 3 2.5 BS
3
 III none + N/A 
166°  9 929 H3 Snf2H KSTGGKAPR YKAPFHQLR 2201.2373 5 -0.1 BS
3
 III none + N/A 
167° a 929 14 Snf2H H3 YKAPFHQLR STGGKAPR 2073.1423 3 -1.1 BS
3
 II none + N/A 
167 b 14 929 H3 Snf2H KSTGGKAPR YKAPFHQLR 2201.2373 5 -0.6 BS
3
 I none + N/A 
168°  919 18 Snf2H H3 KALDTK KQLATK 1503.9175 3 -0.2 BS
3
 III none + N/A 
169°  929 18 Snf2H H3 YKAPFHQLR KQLATK 1988.1511 3 0.6 BS
3
 I none + N/A 
170° a 990 18 Snf2H H3 FDWFLKSR KQLATK 1927.0871 4 -0.9 BS
3
 I none + N/A 
170 b 990 18 Snf2H H3 NSPQFRFDWFLKSR KQLATK 2656.4429 5 1.3 BS
3
 I none + N/A 
171°  1036 18 Snf2H H3 KMDGAPDGRGR KQLATK 2004.0726 5 -1.4 BS
3
 IV none + N/A 
172°  23 919 H3 Snf2H KQLATKAAR KALDTK 1802.0929 3 -0.4 BS
3
 IV none + N/A 
173°  23 929 H3 Snf2H KQLATKAAR YKAPFHQLR 2286.3264 4 -0.5 BS
3
 I none + N/A 
174°  27 929 H3 Snf2H KSAPATGGVK YKAPFHQLR 2215.2417 4 -0.5 BS
3
 I none + N/A 
175°  27 943 H3 Snf2H KSAPATGGVK ISYGTNKGK 2023.1253 3 2.8 BS
3
 IV none + N/A 
176° a 990 27 Snf2H H3 NSPQFRFDWFLKSR KSAPATGGVK 2883.5336 4 2.2 BS
3
 I none + N/A 
176 b 27 990 H3 Snf2H KSAPATGGVK FDWFLKSR 2154.1777 3 -3.5 BS
3
 II none + N/A 
177°  27 1036 H3 Snf2H KSAPATGGVKKPHR KMDGAPDGR 2536.3484 5 -3.6 BS
3
 II none + N/A 
178°  56 758 H3 Snf2H YQKSTELLIR VSEPKAPK 2246.2826 3 7.8 BS
3
 IV none + N/A 
179° a 929 8 Snf2H H4 YKAPFHQLR GGKGLGK 1916.0936 4 0.1 BS
3
 III none + N/A 
179 b 8 929 H4 Snf2H GKGGKGLGK YKAPFHQLR 2101.2100 5 -1.2 BS
3
 III none + N/A 
180° a 12 929 H4 Snf2H GLGKGGAKR YKAPFHQLR 2143.2318 4 1.5 BS
3
 III none + N/A 
180 b 929 12 Snf2H H4 YKAPFHQLR GLGKGGAK 1987.1307 3 -0.2 BS
3
 III none + N/A 
181 a 16 929 H4 Snf2H GLGKGGAKR YKAPFHQLR 2143.2318 5 -0.9 BS
3
 I none + N/A 
181° b 929 16 Snf2H H4 YKAPFHQLR GGAKR 1788.0098 4 -1.0 BS
3
 II none + N/A 
181 c 929 16 Snf2H H4 IGRYKAPFHQLR GGAKR 2114.2165 5 -0.4 BS
3
 II none + N/A 
 
▼
, 
►
, 
◊
, 
□
, °  MS/MS spectra are provided in Figure 44A, SFigure 8, SFigure 9C, SFigure 10B, and SFigure 11, respectively.  
x
 Cross-link was used as distance restraint during rigid body docking. 
N/A = Not available, at least one amino acid is missing in the structure. N/D = Not determined.  
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6.6. MS/MS spectra of cross-linked peptides 
6.6.1. Additional MS/MS spectra of cross-links used for modeling 
 
  
SFigure 5: Additional MS/MS spectra of cross-links used to model the full-length DmISWI enzyme. 
Related to Figure 21. Cross-links (A)–(D) are denoted according to their XLISWI identification number 
provided in STable 2. Adapted and reprinted from (1) in accordance with Elsevier’s policies. 
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SFigure 6: MS/MS spectra of cross-links used to model the structure of Snf2H under apo state 
conditions. Related to Figure 31A. Cross-links (A)–(K) are denoted according to their XLSnf2H identification 
number provided in STable 3. 
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SFigure 7: MS/MS spectra of cross-links used to model the structure of Snf2H in the presence of ADP-
BeFx. Related to Figure 37A. Cross-links (A)–(P) are denoted according to their XLSnf2H,nt identification 
number provided in STable 4. 
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6.6.2. Additional MS/MS spectra of cross-links for the Snf2H enzyme 
 
SFigure 8: MS/MS spectra of identified cross-links XLSnf2H,c 117–119. Related to Figure 42C. These 
cross-links connect residues within the HSS domain of the Snf2H enzyme in the presence of nucleosomes 
and exceed the BS
3
 distance threshold in the respective homology model. Cross-links are denoted according 
to their XLSnf2H,c identification number provided in STable 5. 
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SFigure 9: MS/MS spectra of Snf2H cross-links that are listed in Table 4. Identical and similar inter-
domain cross-links for the Snf2H enzyme in the (A) apo, (B) ADP-BeFx, and (C) nucleosome state. Cross-
links are denoted according to their XL identification number provided in STable 3–STable 5. Individual 
cross-links listed in Table 4 were implemented during computation modeling and thus the MS/MS spectra for 
these cross-linked peptides (i.e., XLSnf2H 8, 12, 14, 28, 29 and XLSnf2H,nt 3, 4, 8, 13, 16, 24, 26, 56) can be 
found in either SFigure 6 or SFigure 7. 
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SFigure 10: MS/MS spectra of nucleosome-dependent inter-domain cross-links for the Snf2H enzyme 
listed in Table 5. Cross-links for the Snf2H enzyme in the (A) apo and (B) nucleosome state are denoted 
according to their XL identification number provided in STable 3 and STable 5, respectively. 
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SFigure 11: Additional MS/MS spectra of inter-molecular cross-links between the Snf2H enzyme and 
the histone octamer. Cross-links are denoted according to their XLSnf2H,c identification number provided in 
STable 5. 
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